[
    {
        "realidx": 0,
        "question": "A junior orthopaedic surgery resident is completing a carpal tunnel repair with the department chairman as the attending physician. During the case, the resident inadvertently cuts a flexor tendon. The tendon is repaired without complication. The attending tells the resident that the patient will do fine, and there is no need to report this minor complication that will not harm the patient, as he does not want to make the patient worry unnecessarily. He tells the resident to leave this complication out of the operative report. Which of the following is the correct next action for the resident to take?",
        "answer": "Tell the attending that he cannot fail to disclose this mistake",
        "options": {
            "A": "Disclose the error to the patient and put it in the operative report",
            "B": "Tell the attending that he cannot fail to disclose this mistake",
            "C": "Report the physician to the ethics committee",
            "D": "Refuse to dictate the operative report"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "junior orthopaedic surgery resident",
            "completing",
            "carpal tunnel repair",
            "department chairman",
            "attending physician",
            "case",
            "resident",
            "cuts",
            "flexor tendon",
            "tendon",
            "repaired",
            "complication",
            "attending",
            "resident",
            "patient",
            "fine",
            "need to report",
            "minor complication",
            "not",
            "patient",
            "not",
            "to make",
            "patient worry",
            "resident to leave",
            "complication out",
            "operative report",
            "following",
            "correct next action",
            "resident to take"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4308,
            "completion_tokens": 3258
        },
        "time_elapsed": 55.28541564941406,
        "raw_responses": [
            "Step 1: The key issue here is the ethical obligation to be honest and fully disclose all complications that occur during surgery, regardless of whether the complication might have been minor or ultimately unharmful, particularly to maintain transparency, trust, and accountability to the patient.\n\nStep 2: Analyze the options:\n\u2022 Option A: Disclose the error to the patient and include it in the operative report. This is the most ethically sound option because it ensures transparency and respects patient autonomy.\n\u2022 Option B: Telling the attending that the error cannot be concealed may address the ethical concern but does not resolve the obligation to document and communicate to the patient.\n\u2022 Option C: Reporting the attending to the ethics committee is an extreme measure that may be considered if the attending repeatedly commits unethical acts; however, in this case, the appropriate response is proper disclosure to the patient.\n\u2022 Option D: Refusing to dictate the operative report is not the correct approach as it may compromise proper documentation and does not fulfill the duty to transparency.\n\nStep 3: Final Answer\nThe best action for the resident is to follow Option A\u2014to disclose the error to the patient and include it in the operative report.",
            "Step 1: From the discussed examples, we learn that ethical and safe practices in medicine require transparent communication, honest documentation of complications, and proper disclosure to patients. Just as in Example 2 where preventive measures and honest recommendations are emphasized, it is critical in this scenario to accurately document and share all intraoperative events with the patient.\n\nStep 2: Looking at the answer choices:\n\u2022 Option A, \"Disclose the error to the patient and put it in the operative report,\" adheres to the ethical responsibility to fully document surgical events and to inform the patient, fostering trust and accountability.\n\u2022 Option B, \"Tell the attending that he cannot fail to disclose this mistake,\" while addressing the issue, does not resolve the immediate ethical breach of not including the complication in the operative report.\n\u2022 Option C, \"Report the physician to the ethics committee,\" is an extreme action that is not warranted as the first step for a minor but documented technical error that has been repaired.\n\u2022 Option D, \"Refuse to dictate the operative report,\" fails to address the ethical obligation both for complete documentation and informed consent by the patient.\n\nStep 3: The best course of action is to ensure that the error is documented and disclosed to the patient. This promotes informed consent and respects the patient\u2019s right to know about their care, even when complications are minor.\n\nFinal answer: A. Disclose the error to the patient and put it in the operative report.",
            "Step-by-step reasoning:\n\n1. The scenario involves a resident whose mistake\u2014cutting a flexor tendon\u2014was immediately repaired. Despite the child's care, the attending instructs to exclude the incident from the operative report. However, transparency and honesty in reporting complications are key ethical and legal obligations.\n2. Drawing on ethical principles of full disclosure and standard practice in healthcare, the incident should be reported even if the patient is not immediately harmed.\n3. Option A (\u201cDisclose the error to the patient and put it in the operative report\u201d) is the appropriate response to uphold honesty, ensure accurate medical records, and maintain trust.\n4. Options B, C, and D do not represent professional or ethical behavior in this situation.\n\nFinal answer: A. Disclose the error to the patient and put it in the operative report."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step-by-step reasoning:\n\n1. The scenario involves a resident whose mistake\u2014cutting a flexor tendon\u2014was immediately repaired. Despite the child's care, the attending instructs to exclude the incident from the operative report. However, transparency and honesty in reporting complications are key ethical and legal obligations.\n2. Drawing on ethical principles of full disclosure and standard practice in healthcare, the incident should be reported even if the patient is not immediately harmed.\n3. Option A (\u201cDisclose the error to the patient and put it in the operative report\u201d) is the appropriate response to uphold honesty, ensure accurate medical records, and maintain trust.\n4. Options B, C, and D do not represent professional or ethical behavior in this situation.\n\nFinal answer: A. Disclose the error to the patient and put it in the operative report."
    },
    {
        "realidx": 5,
        "question": "A 39-year-old man presents to the emergency department because of progressively worsening chest pain and nausea that started at a local bar 30 minutes prior. The pain radiates to the epigastric area. He has a 5-year history of untreated hypertension. He has smoked 1 pack of cigarettes daily for the past 5 years and started abusing cocaine 2 weeks before his emergency room visit. The patient is diaphoretic and in marked distress. What should be the first step in management?",
        "answer": "Reassurance and continuous monitoring",
        "options": {
            "A": "Diltiazem",
            "B": "Labetalol",
            "C": "Propranolol",
            "D": "Reassurance and continuous monitoring"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man presents",
            "emergency department",
            "worsening chest pain",
            "nausea",
            "started",
            "local",
            "30 minutes prior",
            "pain radiates",
            "epigastric area",
            "5 year history of untreated hypertension",
            "smoked 1 pack",
            "cigarettes daily",
            "past",
            "years",
            "started abusing cocaine 2 weeks",
            "emergency room visit",
            "patient",
            "diaphoretic",
            "marked distress",
            "first step",
            "management"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4704,
            "completion_tokens": 5357
        },
        "time_elapsed": 129.96219539642334,
        "raw_responses": [
            "Step 1: Analyze the case. The patient is a 39\u2010year\u2010old man with chest pain and nausea that began acutely, with a history of untreated hypertension, smoking, and recent cocaine abuse. Cocaine can cause coronary vasospasm and myocardial ischemia.\n\nStep 2: Recognize that in the setting of cocaine-induced chest pain, the sympathetic surge is significant. The first management steps typically include benzodiazepines to reduce sympathetic drive, nitroglycerin to manage chest pain and coronary vasospasm, and aspirin. However, among the available options, we must choose the one that safely addresses his condition.\n\nStep 3: Evaluate the answer choices:\n\u2022 Diltiazem \u2013 This is a calcium channel blocker that can relieve coronary vasospasm and lower blood pressure without the risk of unopposed alpha stimulation.\n\u2022 Labetalol \u2013 Although it has both alpha and beta blocking properties, it still has beta-blocking effects that can worsen vasospasm in the context of cocaine use.\n\u2022 Propranolol \u2013 This is a nonselective beta-blocker and is contraindicated in cocaine-induced chest pain because it increases the risk of unopposed alpha-adrenergic stimulation, worsening vasospasm.\n\u2022 Reassurance and continuous monitoring \u2013 This is not appropriate given the severity and nature of his symptoms.\n\nStep 4: Conclude that the best immediate agent for addressing the patient's symptoms, given the risks associated with beta-blockade, is Diltiazem.\n\nFinal answer: A. Diltiazem",
            "Step 1: Recognize that the patient\u2019s presentation is concerning for cocaine-induced chest pain, which is managed differently from typical acute coronary syndromes. Cocaine causes increased sympathetic activity with vasoconstriction, and treatment must avoid exacerbating this effect.\n\nStep 2: Identify that beta blockers (like labetalol and propranolol) are contraindicated in cocaine-induced chest pain because they can lead to unopposed alpha-adrenergic stimulation, worsening hypertension and coronary vasospasm.\n\nStep 3: Understand that while benzodiazepines are usually considered first-line for symptomatic relief in cocaine toxicity, they are not one of the options provided. Among the available choices, diltiazem\u2014a calcium channel blocker\u2014is safe and reduces coronary vasospasm by decreasing smooth muscle contraction without the risks associated with beta blockade.\n\nStep 4: Compare the options:\n\u2022 Diltiazem: A calcium channel blocker that can help relieve coronary vasospasm.\n\u2022 Labetalol: Contains beta-blocking effects and is contraindicated.\n\u2022 Propranolol: A nonselective beta blocker and is contraindicated.\n\u2022 Reassurance and continuous monitoring: Inadequate for a patient with cocaine-induced chest pain and active symptoms.\n\nFinal answer: A. Diltiazem",
            "Step 1: Recognize the clinical scenario.\n\u2022 The patient presents with chest pain in the setting of recent cocaine use. Cocaine causes sympathetic stimulation leading to coronary vasospasm and myocardial ischemia. \n\nStep 2: Identify treatment considerations.\n\u2022 In cocaine-induced chest pain, initial management should aim to reduce sympathetic overactivity. Benzodiazepines, nitrates, and calcium channel blockers are considered first-line therapies.\n\u2022 Beta blockers are generally avoided because inhibiting beta receptors (especially with non-selective agents like propranolol) can lead to unopposed alpha\u2010adrenergic stimulation, worsening coronary vasoconstriction.\n\nStep 3: Analyze the answer choices.\nA. Diltiazem \u2013 A calcium channel blocker that can help relieve coronary vasospasm without the risk of unopposed alpha stimulation.\nB. Labetalol \u2013 Although it blocks both alpha and beta receptors, its use in cocaine-induced chest pain is controversial, and it is generally less preferred.\nC. Propranolol \u2013 A non-selective beta blocker that is contraindicated in cocaine-induced chest pain due to the risk of unopposed alpha stimulation.\nD. Reassurance and continuous monitoring \u2013 Inadequate because the patient is showing signs of cardiac ischemia and requires active management.\n\nStep 4: Final answer.\nThe best first step in management for this patient is to use diltiazem.\n\nFinal Answer: A. Diltiazem."
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "1"
        ],
        "final_solution": "Step 1: Recognize the clinical scenario.\n\u2022 The patient presents with chest pain in the setting of recent cocaine use. Cocaine causes sympathetic stimulation leading to coronary vasospasm and myocardial ischemia. \n\nStep 2: Identify treatment considerations.\n\u2022 In cocaine-induced chest pain, initial management should aim to reduce sympathetic overactivity. Benzodiazepines, nitrates, and calcium channel blockers are considered first-line therapies.\n\u2022 Beta blockers are generally avoided because inhibiting beta receptors (especially with non-selective agents like propranolol) can lead to unopposed alpha\u2010adrenergic stimulation, worsening coronary vasoconstriction.\n\nStep 3: Analyze the answer choices.\nA. Diltiazem \u2013 A calcium channel blocker that can help relieve coronary vasospasm without the risk of unopposed alpha stimulation.\nB. Labetalol \u2013 Although it blocks both alpha and beta receptors, its use in cocaine-induced chest pain is controversial, and it is generally less preferred.\nC. Propranolol \u2013 A non-selective beta blocker that is contraindicated in cocaine-induced chest pain due to the risk of unopposed alpha stimulation.\nD. Reassurance and continuous monitoring \u2013 Inadequate because the patient is showing signs of cardiac ischemia and requires active management.\n\nStep 4: Final answer.\nThe best first step in management for this patient is to use diltiazem.\n\nFinal Answer: A. Diltiazem."
    },
    {
        "realidx": 6,
        "question": "A 68-year-old male comes to the physician for evaluation of right flank pain. He has a history of diabetes and peripheral artery disease. His blood pressure is 160/90 mm Hg. Physical examination shows abdominal tenderness and right flank tenderness. An ultrasound shows dilation of the right ureter and renal pelvis. Which of the following is the most likely underlying cause of this patient's condition?",
        "answer": "Common iliac artery aneurysm",
        "options": {
            "A": "Renal artery stenosis",
            "B": "Benign prostatic hyperplasia",
            "C": "Common iliac artery aneurysm",
            "D": "Urethral stricture"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "68 year old male",
            "physician",
            "evaluation",
            "right flank pain",
            "history",
            "diabetes",
            "peripheral artery disease",
            "blood pressure",
            "90 mm Hg",
            "Physical examination shows abdominal tenderness",
            "right",
            "ultrasound shows dilation of",
            "right ureter",
            "renal pelvis",
            "following",
            "most likely underlying cause",
            "patient's condition"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4545,
            "completion_tokens": 3938
        },
        "time_elapsed": 32.05343747138977,
        "raw_responses": [
            "Step 1: Examine the patient\u2019s information and imaging findings  \n\u2022 The patient is a 68\u2010year\u2011old male with atherosclerotic risk factors (diabetes, peripheral artery disease, and hypertension).  \n\u2022 He presents with right flank pain, and the ultrasound shows dilation of the right ureter and renal pelvis, indicating hydronephrosis that is likely due to a localized obstruction.\n\nStep 2: Consider each option  \nA. Renal artery stenosis \u2013 This condition mainly affects blood flow to the kidney and can cause hypertension but does not directly result in ureteral or pelvic dilation.  \nB. Benign prostatic hyperplasia \u2013 BPH causes bladder outlet obstruction typically leading to bilateral hydronephrosis due to increased bladder pressure, not unilateral dilation of the right ureter and renal pelvis.  \nC. Common iliac artery aneurysm \u2013 An aneurysm in this area could compress the right ureter externally, leading to localized dilation (unilateral hydronephrosis), which fits this patient\u2019s presentation.  \nD. Urethral stricture \u2013 Similar to BPH, a stricture would more likely cause obstructive symptoms affecting the bladder and potentially lead to bilateral hydronephrosis rather than a unilateral presentation.\n\nStep 3: Final determination  \nGiven the patient\u2019s risk factors for atherosclerosis, the localized nature of the obstruction (affecting the right ureter and renal pelvis), and the exclusion of other causes based on typical clinical presentations, the most likely underlying cause is a common iliac artery aneurysm.\n\nFinal answer: C. Common iliac artery aneurysm",
            "Step 1: Identify the key clinical features.\n\u2022 The patient is a 68\u2010year\u2011old man with right flank pain.\n\u2022 His ultrasound shows dilation of the right ureter and renal pelvis, suggesting an obstruction causing hydronephrosis.\n\u2022 He has a history of diabetes and peripheral artery disease, which are risk factors for vascular disease.\n\nStep 2: Analyze the options.\nA. Renal artery stenosis \u2013 This condition affects the kidney's blood supply but does not cause ureteral dilation or hydronephrosis.\nB. Benign prostatic hyperplasia \u2013 While common in older men, BPH usually leads to bladder outlet obstruction, which typically causes bilateral hydronephrosis and lower urinary tract symptoms; it would be unlikely to cause isolated right-sided hydronephrosis.\nC. Common iliac artery aneurysm \u2013 An aneurysm in the iliac artery can cause extrinsic compression of the adjacent ureter. In a patient with known vascular disease (peripheral artery disease) and hypertension, this is a plausible cause of a unilateral ureteral obstruction.\nD. Urethral stricture \u2013 This would typically cause obstruction at the urethra level resulting in bilateral hydronephrosis, not an isolated right-sided problem.\n\nStep 3: Final Answer.\nThe best explanation for this patient\u2019s presentation is an external compression of the ureter by a common iliac artery aneurysm.\n\nFinal Answer: C. Common iliac artery aneurysm",
            "Step 1: Analyze the Question\n\u2022 A 68-year-old man with diabetes and peripheral artery disease has right flank pain, abdominal and flank tenderness, and his ultrasound shows dilation of the right ureter and renal pelvis (signs of hydronephrosis).\n\nStep 2: Rule Out Incorrect Choices\n\u2022 Renal artery stenosis (Option A) typically leads to hypertension and renal ischemia but not to ureteral dilation or hydronephrosis.\n\u2022 Benign prostatic hyperplasia (Option B) causes bladder outlet obstruction, generally leading to bilateral hydronephrosis rather than isolated right ureter dilation.\n\u2022 Urethral stricture (Option D) would usually affect the urethra and also cause more diffuse urinary symptoms rather than localized hydronephrosis of one ureter.\n\nStep 3: Determine the Correct Answer\n\u2022 A common iliac artery aneurysm (Option C) can compress adjacent structures such as the ureter. In this elderly patient with significant vascular disease, an aneurysm in the common iliac artery could externally compress the right ureter, leading to the observed hydronephrosis on ultrasound.\n\nFinal answer: C. Common iliac artery aneurysm"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Examine the patient\u2019s information and imaging findings  \n\u2022 The patient is a 68\u2010year\u2011old male with atherosclerotic risk factors (diabetes, peripheral artery disease, and hypertension).  \n\u2022 He presents with right flank pain, and the ultrasound shows dilation of the right ureter and renal pelvis, indicating hydronephrosis that is likely due to a localized obstruction.\n\nStep 2: Consider each option  \nA. Renal artery stenosis \u2013 This condition mainly affects blood flow to the kidney and can cause hypertension but does not directly result in ureteral or pelvic dilation.  \nB. Benign prostatic hyperplasia \u2013 BPH causes bladder outlet obstruction typically leading to bilateral hydronephrosis due to increased bladder pressure, not unilateral dilation of the right ureter and renal pelvis.  \nC. Common iliac artery aneurysm \u2013 An aneurysm in this area could compress the right ureter externally, leading to localized dilation (unilateral hydronephrosis), which fits this patient\u2019s presentation.  \nD. Urethral stricture \u2013 Similar to BPH, a stricture would more likely cause obstructive symptoms affecting the bladder and potentially lead to bilateral hydronephrosis rather than a unilateral presentation.\n\nStep 3: Final determination  \nGiven the patient\u2019s risk factors for atherosclerosis, the localized nature of the obstruction (affecting the right ureter and renal pelvis), and the exclusion of other causes based on typical clinical presentations, the most likely underlying cause is a common iliac artery aneurysm.\n\nFinal answer: C. Common iliac artery aneurysm"
    },
    {
        "realidx": 33,
        "question": "An otherwise healthy 50-year-old man comes to the physician because of a 6-month history of increasingly frequent episodes of upper abdominal pain, nausea, vomiting, and diarrhea. He has had a 3.2-kg (7-lb) weight loss during this time. Physical examination shows bilateral pitting pedal edema. An endoscopy shows prominent rugae in the gastric fundus. Biopsy shows parietal cell atrophy. Which of the following is the most likely underlying cause?",
        "answer": "Proliferation of gastric mucus-producing cells",
        "options": {
            "A": "Serotonin-secreting gastric tumor",
            "B": "Proliferation of gastric mucus-producing cells",
            "C": "Excessive somatostatin secretion",
            "D": "Ectopic secretion of gastrin"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "healthy 50 year old man",
            "physician",
            "of",
            "month history",
            "frequent episodes",
            "upper abdominal pain",
            "nausea",
            "vomiting",
            "diarrhea",
            "3.2 kg",
            "weight loss",
            "time",
            "Physical examination shows bilateral pitting pedal edema",
            "endoscopy shows prominent rugae",
            "gastric",
            "Biopsy shows parietal cell atrophy",
            "following",
            "most likely underlying cause"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5292,
            "completion_tokens": 4525
        },
        "time_elapsed": 77.76048994064331,
        "raw_responses": [
            "Step 1: Examine the Clinical Picture\n\u2022 The patient is a 50-year-old man with a 6-month history of upper abdominal discomfort, nausea, vomiting, diarrhea, weight loss, and bilateral pitting pedal edema.\n\u2022 The edema suggests a protein-losing process, as seen in conditions where protein is lost from the gastrointestinal tract.\n\nStep 2: Review the Endoscopic and Histologic Findings\n\u2022 The endoscopy shows prominent (hypertrophic) rugae in the gastric fundus.\n\u2022 The biopsy reveals parietal cell atrophy. In the context of hypertrophic rugae, this finding is consistent with a disease where the normal acid-producing cells are reduced and are replaced by proliferating cells that secrete mucus.\n\nStep 3: Correlate With Known Diseases\n\u2022 M\u00e9n\u00e9trier disease is characterized by the proliferation of gastric mucus-producing (foveolar) cells, resulting in hypertrophic rugae on endoscopy. This disease also causes a protein-losing gastropathy due to the excessive mucus secretion, leading to hypoalbuminemia and edema.\n\u2022 The parietal cell atrophy seen in the biopsy is also a classic finding in M\u00e9n\u00e9trier disease due to the overgrowth of mucus-producing cells taking over the normal architecture.\n\nStep 4: Evaluate the Options\nA. Serotonin-secreting gastric tumor \u2013 Such tumors (carcinoids) do not typically cause these gross changes in the gastric mucosa or the protein-losing gastropathy seen here.\nB. Proliferation of gastric mucus-producing cells \u2013 This is the mechanism in M\u00e9n\u00e9trier disease, which fits the clinical and histologic picture.\nC. Excessive somatostatin secretion \u2013 Excess somatostatin is not known to cause the described hypertrophic changes with parietal cell atrophy.\nD. Ectopic secretion of gastrin \u2013 This would be associated with Zollinger-Ellison syndrome, which usually presents with refractory peptic ulcers, not the protein-losing gastropathy and giant rugae seen in this case.\n\nFinal Answer: B. Proliferation of gastric mucus-producing cells",
            "Step 1: Recognize the Presentation\n\u2022 The patient has upper abdominal pain with nausea, vomiting, and diarrhea, weight loss, and peripheral edema. The pedal edema suggests a protein-losing state.\n\u2022 Endoscopic findings of prominent rugae in the gastric fundus, along with a biopsy showing parietal cell atrophy, point toward a disease involving abnormal gastric mucosal proliferation.\n\nStep 2: Identify the Likely Diagnosis\n\u2022 Menetrier disease is characterized by hypertrophic gastric folds (prominent rugae) in the fundus, foveolar (mucus cell) hyperplasia, and parietal cell atrophy.\n\u2022 It leads to a protein-losing gastropathy, resulting in edema.\n\u2022 Menetrier disease is due to an abnormal proliferation of gastric mucus-producing (foveolar) cells.\n\nStep 3: Evaluate Each Answer Option\nA. Serotonin-secreting gastric tumor \u2013 Typically associated with carcinoid syndrome, not the described presentation.\nB. Proliferation of gastric mucus-producing cells \u2013 This is the pathologic process in Menetrier disease, which fits the clinical and biopsy findings.\nC. Excessive somatostatin secretion \u2013 Not implicated in the described pathology.\nD. Ectopic secretion of gastrin \u2013 Would lead to Zollinger-Ellison syndrome, which is marked by parietal cell hyperplasia, increased acid secretion, and peptic ulcer disease, not atrophy.\n\nStep 4: Provide the Final Answer\nThe most likely underlying cause is the proliferation of gastric mucus-producing cells.\n\nFinal answer: B. Proliferation of gastric mucus-producing cells.",
            "Step 1: Recognize that the patient\u2019s clinical presentation (epigastric pain, nausea, vomiting, diarrhea, weight loss, and peripheral edema) along with the endoscopic finding of prominent rugae in the gastric fundus suggests a protein-losing gastropathy.\n\nStep 2: Understand that the biopsy shows parietal cell atrophy. In this context, these findings are most consistent with Menetrier disease, a condition characterized by foveolar (gastric mucus-producing cell) hyperplasia with concomitant parietal cell loss, leading to diminished acid production and protein loss from the gastric mucosa.\n\nStep 3: Evaluate the options:\n\u2022 Option A (Serotonin-secreting gastric tumor) would more typically produce carcinoid syndrome features, which are not seen here.\n\u2022 Option C (Excessive somatostatin secretion) is not associated with the described gastric findings.\n\u2022 Option D (Ectopic secretion of gastrin) would increase parietal cell activity and acid production, contrary to the atrophy seen.\n\u2022 Option B (Proliferation of gastric mucus-producing cells) accurately describes the foveolar hyperplasia seen in Menetrier disease which results in the prominent rugae and parietal cell atrophy observed in this patient.\n\nFinal Answer: B. Proliferation of gastric mucus-producing cells"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Examine the Clinical Picture\n\u2022 The patient is a 50-year-old man with a 6-month history of upper abdominal discomfort, nausea, vomiting, diarrhea, weight loss, and bilateral pitting pedal edema.\n\u2022 The edema suggests a protein-losing process, as seen in conditions where protein is lost from the gastrointestinal tract.\n\nStep 2: Review the Endoscopic and Histologic Findings\n\u2022 The endoscopy shows prominent (hypertrophic) rugae in the gastric fundus.\n\u2022 The biopsy reveals parietal cell atrophy. In the context of hypertrophic rugae, this finding is consistent with a disease where the normal acid-producing cells are reduced and are replaced by proliferating cells that secrete mucus.\n\nStep 3: Correlate With Known Diseases\n\u2022 M\u00e9n\u00e9trier disease is characterized by the proliferation of gastric mucus-producing (foveolar) cells, resulting in hypertrophic rugae on endoscopy. This disease also causes a protein-losing gastropathy due to the excessive mucus secretion, leading to hypoalbuminemia and edema.\n\u2022 The parietal cell atrophy seen in the biopsy is also a classic finding in M\u00e9n\u00e9trier disease due to the overgrowth of mucus-producing cells taking over the normal architecture.\n\nStep 4: Evaluate the Options\nA. Serotonin-secreting gastric tumor \u2013 Such tumors (carcinoids) do not typically cause these gross changes in the gastric mucosa or the protein-losing gastropathy seen here.\nB. Proliferation of gastric mucus-producing cells \u2013 This is the mechanism in M\u00e9n\u00e9trier disease, which fits the clinical and histologic picture.\nC. Excessive somatostatin secretion \u2013 Excess somatostatin is not known to cause the described hypertrophic changes with parietal cell atrophy.\nD. Ectopic secretion of gastrin \u2013 This would be associated with Zollinger-Ellison syndrome, which usually presents with refractory peptic ulcers, not the protein-losing gastropathy and giant rugae seen in this case.\n\nFinal Answer: B. Proliferation of gastric mucus-producing cells"
    },
    {
        "realidx": 34,
        "question": "A 27-year-old man presents to the emergency department. He was brought in by staff from the homeless shelter when they found him unresponsive. The patient is a known IV drug abuser but otherwise has an unknown past medical history. He currently attends a methadone clinic. His temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 97/48 mmHg, pulse is 140/min, respirations are 29/min, and oxygen saturation is 98% on room air. Initial laboratory values are shown below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 6.3 mEq/L\nHCO3-: 17 mEq/L\nGlucose: 589 mg/dL\n\nThe patient is given treatment. After treatment, his temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 117/78 mmHg, pulse is 100/min, respirations are 23/min, and oxygen saturation is 98% on room air. His laboratory values are seen below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 19 mEq/L\nGlucose: 90 mg/dL\n\nWhich of the following is the best next step in management?",
        "answer": "Insulin, potassium, IV fluids, and glucose",
        "options": {
            "A": "Insulin, potassium, IV fluids, and glucose",
            "B": "IV fluids only",
            "C": "Oral rehydration",
            "D": "Supportive therapy and close monitoring"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "27 year old man presents",
            "emergency department",
            "brought",
            "staff",
            "homeless shelter",
            "found",
            "unresponsive",
            "patient",
            "known IV drug abuser",
            "unknown past medical history",
            "currently attends",
            "methadone clinic",
            "temperature",
            "99",
            "blood pressure",
            "97 48 mmHg",
            "pulse",
            "min",
            "respirations",
            "29 min",
            "oxygen saturation",
            "98",
            "room air",
            "Initial laboratory values",
            "shown",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "6.3 mEq/L HCO3",
            "mEq/L Glucose",
            "mg/dL",
            "patient",
            "given treatment",
            "treatment",
            "temperature",
            "99",
            "blood pressure",
            "mmHg",
            "pulse",
            "100 min",
            "respirations",
            "23 min",
            "oxygen saturation",
            "98",
            "room air",
            "laboratory values",
            "seen",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L Glucose",
            "90 mg/dL",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6141,
            "completion_tokens": 4579
        },
        "time_elapsed": 32.97991919517517,
        "raw_responses": [
            "Step 1: Recognize that the patient initially presented with diabetic ketoacidosis (DKA). His initial labs showed hyperglycemia (glucose 589 mg/dL), low bicarbonate (17 mEq/L), and a high potassium (6.3 mEq/L) that is typically elevated in DKA due to acidemia, even though total body potassium is usually low.\n\nStep 2: After treatment, his labs now show a normal potassium (4.3 mEq/L) and his serum glucose has dropped to 90 mg/dL. Despite the improvement in vital signs, his bicarbonate remains low (19 mEq/L), suggesting that the metabolic acidosis has not completely resolved yet.\n\nStep 3: In the management of DKA, once the blood glucose falls below a threshold (commonly <200 mg/dL), dextrose must be added to the IV fluids while continuing insulin therapy to avoid hypoglycemia and to promote clearance of ketoacids.\n\nStep 4: Given the current labs and clinical scenario, the most appropriate next step is to continue treating his DKA with IV fluids supplemented with dextrose, along with ongoing insulin infusion and potassium monitoring/repletion if necessary.\n\nFinal Answer: A. Insulin, potassium, IV fluids, and glucose",
            "Step 1: This patient initially presented with severe hyperglycemia (blood glucose 589 mg/dL), a metabolic acidosis (HCO3\u207b of 17 mEq/L), and an elevated serum potassium of 6.3 mEq/L\u2014a typical picture in a diabetic emergency (likely diabetic ketoacidosis, where acidosis causes a shift of potassium out of cells). The standard immediate treatment involves aggressive hydration with IV fluids, insulin to lower blood glucose (and to help correct acidosis), and careful monitoring and management of potassium.\n\nStep 2: After treatment, his glucose dropped to 90 mg/dL and potassium normalized to 4.3 mEq/L, but the bicarbonate remains slightly low at 19 mEq/L reflecting ongoing correction of the metabolic acidosis. In diabetic emergencies, even after normalization of blood sugar, it is important to continue an insulin infusion to allow for continued metabolism of ketones and resolution of acidosis. However, given the now normal (and low) blood sugar, adding dextrose to the IV fluids is crucial to prevent hypoglycemia while still permitting the continuation of insulin. His potassium is now normal, so it should be added back in if further insulin is continued to avoid a drop in serum potassium levels as insulin drives it intracellularly.\n\nStep 3: Given these considerations, the best next step is to continue treating him with a combination of insulin, potassium supplementation, IV fluids, and now IV dextrose\u2014to maintain normoglycemia while ensuring the resolution of the acidosis.\n\nFinal Answer: A. Insulin, potassium, IV fluids, and glucose",
            "Step 1: Identify the initial diagnosis. The patient came in with hyperglycemia (glucose of 589 mg/dL), metabolic acidosis (HCO\u2083\u207b of 17 mEq/L), and an elevated potassium level (6.3 mEq/L) due to the extracellular shift seen in diabetic ketoacidosis (DKA). His initial treatment likely included IV fluids, insulin, and potassium management.\n\nStep 2: Evaluate the post-treatment labs. After treatment, his glucose has normalized to 90 mg/dL and his potassium has decreased to 4.3 mEq/L. Although his bicarbonate improves slightly, it remains low, indicating that while hyperglycemia is resolved, the underlying metabolic derangements (ketoacidosis) may still need continued management.\n\nStep 3: Know the standard DKA treatment protocol. In DKA, even after glucose levels drop to <250 mg/dL, it is critical to continue insulin infusion to resolve the acidosis. To prevent hypoglycemia while maintaining insulin, dextrose is added to the IV fluids. Ongoing potassium monitoring is also needed to avoid reinduction of hypokalemia once insulin shifts potassium intracellularly.\n\nStep 4: Compare the management options.  \n\u2022 Option A (Insulin, potassium, IV fluids, and glucose) aligns perfectly with the next steps in DKA management \u2013 continuing insulin while adding dextrose to the fluids and monitoring potassium.  \n\u2022 Option B (IV fluids only) would not address the need for ongoing insulin to clear ketoacid accumulation.  \n\u2022 Option C (Oral rehydration) is inappropriate due to the severity of his presentation and the need for controlled IV therapy.  \n\u2022 Option D (Supportive therapy and close monitoring) neglects the benefit of continuing targeted metabolic therapy.\n\nFinal Answer:\nA. Insulin, potassium, IV fluids, and glucose"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Identify the initial diagnosis. The patient came in with hyperglycemia (glucose of 589 mg/dL), metabolic acidosis (HCO\u2083\u207b of 17 mEq/L), and an elevated potassium level (6.3 mEq/L) due to the extracellular shift seen in diabetic ketoacidosis (DKA). His initial treatment likely included IV fluids, insulin, and potassium management.\n\nStep 2: Evaluate the post-treatment labs. After treatment, his glucose has normalized to 90 mg/dL and his potassium has decreased to 4.3 mEq/L. Although his bicarbonate improves slightly, it remains low, indicating that while hyperglycemia is resolved, the underlying metabolic derangements (ketoacidosis) may still need continued management.\n\nStep 3: Know the standard DKA treatment protocol. In DKA, even after glucose levels drop to <250 mg/dL, it is critical to continue insulin infusion to resolve the acidosis. To prevent hypoglycemia while maintaining insulin, dextrose is added to the IV fluids. Ongoing potassium monitoring is also needed to avoid reinduction of hypokalemia once insulin shifts potassium intracellularly.\n\nStep 4: Compare the management options.  \n\u2022 Option A (Insulin, potassium, IV fluids, and glucose) aligns perfectly with the next steps in DKA management \u2013 continuing insulin while adding dextrose to the fluids and monitoring potassium.  \n\u2022 Option B (IV fluids only) would not address the need for ongoing insulin to clear ketoacid accumulation.  \n\u2022 Option C (Oral rehydration) is inappropriate due to the severity of his presentation and the need for controlled IV therapy.  \n\u2022 Option D (Supportive therapy and close monitoring) neglects the benefit of continuing targeted metabolic therapy.\n\nFinal Answer:\nA. Insulin, potassium, IV fluids, and glucose"
    },
    {
        "realidx": 44,
        "question": "A 45-year-old G5P4105 presents to her gynecologist\u2019s office with six months of increasingly heavy periods. She now soaks one super absorbent tampon every two hours for five days each cycle. Her cycles have also become irregular, with intermenstrual bleeding for the last two months. She now experiences significant dysmenorrhea, requiring 400 mg ibuprofen every four hours for the majority of each menses. In addition, she reports new onset mild dyspareunia with intercourse and a \u201cheavy feeling\u201d in her pelvis. She has also noticed increased urinary frequency but denies bowel changes. The patient has a past medical history of obesity and type II diabetes on metformin. Her last child was born four years ago, and she has had five spontaneous vaginal deliveries. At this office visit, temperature is 98.5\u00b0F (36.9\u00b0C), blood pressure is 137/84 mmHg, pulse is 87/min, and respirations are 14/min. Which of the following physical exam findings is most likely to be present in this patient?",
        "answer": "Globular 10-week sized uterus",
        "options": {
            "A": "Globular 10-week sized uterus",
            "B": "Adnexal mass",
            "C": "Irregular 14-week sized uterus",
            "D": "No remarkable physical exam finding"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old",
            "presents",
            "gynecologists office",
            "six months",
            "heavy periods",
            "now soaks one",
            "absorbent tampon",
            "two hours",
            "five",
            "cycle",
            "cycles",
            "irregular",
            "intermenstrual bleeding",
            "two months",
            "now experiences significant dysmenorrhea",
            "400 mg ibuprofen",
            "four hours",
            "majority",
            "menses",
            "addition",
            "reports new onset mild dyspareunia",
            "intercourse",
            "heavy feeling",
            "pelvis",
            "increased urinary frequency",
            "denies bowel changes",
            "patient",
            "past medical",
            "type II diabetes",
            "metformin",
            "last child",
            "born four years",
            "five spontaneous vaginal deliveries",
            "office visit",
            "temperature",
            "98",
            "36",
            "blood pressure",
            "84 mmHg",
            "pulse",
            "87 min",
            "respirations",
            "min",
            "following physical exam findings",
            "most likely to",
            "present",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4596,
            "completion_tokens": 3028
        },
        "time_elapsed": 168.2107973098755,
        "raw_responses": [
            "Step 1: Analyze the patient's presentation. The 45-year-old multiparous patient reports heavy, prolonged menstrual bleeding with intermenstrual spotting, significant dysmenorrhea, dyspareunia, pelvic fullness, and urinary frequency. These symptoms are classic for adenomyosis, which commonly presents in women in their 40s who've had children.\n\nStep 2: Recognize typical physical exam findings. Adenomyosis typically leads to a uniformly enlarged, \"globular\" uterus (often around 10-weeks size). This is in contrast to fibroids, which usually cause an irregularly enlarged uterus.\n\nStep 3: Compare the options.\n\u2022 Option A (Globular 10-week sized uterus) is typical for adenomyosis.\n\u2022 Option B (Adnexal mass) is more suggestive of an ovarian etiology.\n\u2022 Option C (Irregular 14-week sized uterus) is more indicative of fibroids rather than adenomyosis.\n\u2022 Option D (No remarkable physical exam finding) does not fit the described clinical scenario.\n\nFinal Answer: A. Globular 10-week sized uterus",
            "The patient is a 45-year-old multiparous woman presenting with heavy menstrual bleeding, intermenstrual spotting, progressive dysmenorrhea, a sensation of pelvic heaviness, and urinary frequency. These findings are highly suggestive of adenomyosis, which is characterized by the presence of endometrial tissue within the myometrium. On physical examination, adenomyosis typically presents with a uniformly enlarged, boggy, and tender uterus that is often described as globular. A uterus of about 10 weeks\u2019 gestational size fits this description.\n\nOption A (\"Globular 10-week sized uterus\") is the most likely finding.\n\nFinal Answer: A. Globular 10-week sized uterus",
            "Step 1: Analyze the patient\u2019s presentation. This 45\u2010year-old multiparous woman reports progressively heavy menstrual bleeding, dysmenorrhea, dyspareunia, pelvic heaviness, and urinary frequency. These symptoms are classic for adenomyosis\u2014a condition more common in multiparous women where endometrial tissue invades the myometrium.\n\nStep 2: Consider the exam findings associated with adenomyosis. Adenomyosis typically leads to a uniformly enlarged (globular), tender uterus that is often described as being approximately 8\u201312 weeks in size.\n\nStep 3: Compare answer choices.  \n\u2022 Option A (Globular 10-week sized uterus) matches the classic exam finding for adenomyosis.  \n\u2022 Option B (Adnexal mass) would suggest an ovarian process.  \n\u2022 Option C (Irregular 14-week sized uterus) is more consistent with uterine fibroids, where the uterus is irregular and firm.  \n\u2022 Option D (No remarkable physical exam finding) is unlikely given her significant symptoms.\n\nFinal Answer: A. Globular 10-week sized uterus"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the patient's presentation. The 45-year-old multiparous patient reports heavy, prolonged menstrual bleeding with intermenstrual spotting, significant dysmenorrhea, dyspareunia, pelvic fullness, and urinary frequency. These symptoms are classic for adenomyosis, which commonly presents in women in their 40s who've had children.\n\nStep 2: Recognize typical physical exam findings. Adenomyosis typically leads to a uniformly enlarged, \"globular\" uterus (often around 10-weeks size). This is in contrast to fibroids, which usually cause an irregularly enlarged uterus.\n\nStep 3: Compare the options.\n\u2022 Option A (Globular 10-week sized uterus) is typical for adenomyosis.\n\u2022 Option B (Adnexal mass) is more suggestive of an ovarian etiology.\n\u2022 Option C (Irregular 14-week sized uterus) is more indicative of fibroids rather than adenomyosis.\n\u2022 Option D (No remarkable physical exam finding) does not fit the described clinical scenario.\n\nFinal Answer: A. Globular 10-week sized uterus"
    },
    {
        "realidx": 59,
        "question": "A 17-year-old girl is referred by her dentist for a suspected eating disorder. She has been visiting the same dentist since childhood and for the past 2 years has had at least 2 visits for dental caries. She eventually admitted to him that she regularly induces vomiting by putting her fingers down her throat. She says she has been doing this for the last few years and purging at least once a week. More recently, she has been inducing emesis more often and even looked into diuretics as she feels that she is gaining more and more weight compared to her \u2018skinny friends\u2019. Her BMI is at the 50th percentile for her age and sex. Which of the following features is most consistent with this patient\u2019s condition?",
        "answer": "Patients with this disorder are not further sub-typed",
        "options": {
            "A": "Patients with this disorder are not further sub-typed",
            "B": "Patients do not usually initiate treatment",
            "C": "Patients can have a history of both anorexia and bulimia",
            "D": "Patients will typically have a BMI between 17\u201318.5 kg/m2"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old girl",
            "referred by",
            "dentist",
            "suspected eating disorder",
            "visiting",
            "same dentist",
            "childhood",
            "past",
            "years",
            "visits",
            "dental caries",
            "admitted",
            "induces vomiting",
            "putting",
            "fingers",
            "throat",
            "last",
            "years",
            "purging",
            "week",
            "recently",
            "inducing emesis",
            "often",
            "looked",
            "diuretics",
            "feels",
            "gaining more",
            "more weight compared",
            "friends",
            "BMI",
            "50th percentile",
            "age",
            "sex",
            "following features",
            "most consistent with",
            "patients condition"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4866,
            "completion_tokens": 3627
        },
        "time_elapsed": 49.432992696762085,
        "raw_responses": [
            "Step 1: Determine the diagnosis.\nThis 17-year-old girl presents with regular self-induced vomiting and an otherwise normal BMI (50th percentile), which is consistent with bulimia nervosa.\n\nStep 2: Analyze the answer choices.\nA. \"Patients with this disorder are not further sub-typed.\" \u2013 This is incorrect because bulimia nervosa has been sub-classified into purging and nonpurging types in previous DSM editions, even though the most current criteria may not emphasize the subtypes. Regardless, this statement is misleading in the context of historical classification.\n\nB. \"Patients do not usually initiate treatment.\" \u2013 This is not a recognized or distinguishing feature of bulimia nervosa.\n\nC. \"Patients can have a history of both anorexia and bulimia.\" \u2013 This is correct. Many individuals with bulimia nervosa have a past history of anorexia nervosa, particularly of the binge-purge subtype.\n\nD. \"Patients will typically have a BMI between 17\u201318.5 kg/m2.\" \u2013 This is incorrect. Unlike anorexia nervosa, patients with bulimia nervosa usually maintain a normal or near-normal BMI.\n\nStep 3: Final Answer\nC\n\nThus, the feature most consistent with this patient\u2019s condition is that patients can have a history of both anorexia and bulimia.",
            "Step 1: Note that the patient is a 17-year-old girl with normal BMI (50th percentile), recurrent purging behaviors, and dental caries\u2014all findings that are consistent with bulimia nervosa rather than anorexia nervosa.\n\nStep 2: Evaluate the options:\n\u2022 Option A: This is incorrect because bulimia nervosa is further subtyped (into purging vs. non-purging types).\n\u2022 Option B: There is no specific characteristic of bulimia nervosa that indicates patients \u201cdo not usually initiate treatment.\u201d\n\u2022 Option C: This is correct. It is not uncommon for patients with bulimia nervosa to have a history of anorexia nervosa. Bulimia can develop after an initial presentation of anorexia, particularly if the patient transitions from restrictive behaviors to episodes of bingeing and purging.\n\u2022 Option D: This is incorrect because bulimia nervosa patients typically have a normal BMI, not a BMI between 17\u201318.5 kg/m2 (which is more characteristic of anorexia nervosa).\n\nFinal Answer: C. Patients can have a history of both anorexia and bulimia.",
            "Step 1: Review the key features in the question. The patient is a 17-year-old girl who regularly induces vomiting but has a normal BMI (50th percentile), making a diagnosis of bulimia nervosa more likely than anorexia nervosa.\n\nStep 2: Evaluate the options:\n\u2022 Option A: \"Patients with this disorder are not further sub-typed.\" This is incorrect because bulimia nervosa is indeed subtyped into categories such as the purging type and the non-purging type.\n\u2022 Option B: \"Patients do not usually initiate treatment.\" Although patients with bulimia nervosa may be reluctant to seek help due to stigma, this statement isn\u2019t a recognized defining feature of the disorder.\n\u2022 Option C: \"Patients can have a history of both anorexia and bulimia.\" This is correct. Many patients transition between anorexia and bulimia over time; especially those with a history of anorexia nervosa (binge-purge type) may later present with bulimia nervosa.\n\u2022 Option D: \"Patients will typically have a BMI between 17\u201318.5 kg/m\u00b2.\" This description is more characteristic of anorexia nervosa. Patients with bulimia nervosa typically have a normal BMI.\n\nStep 3: Conclusion\nThe feature most consistent with this patient\u2019s condition (bulimia nervosa) is that patients can have a history of both anorexia and bulimia.\n\nFinal Answer: C. Patients can have a history of both anorexia and bulimia."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Review the key features in the question. The patient is a 17-year-old girl who regularly induces vomiting but has a normal BMI (50th percentile), making a diagnosis of bulimia nervosa more likely than anorexia nervosa.\n\nStep 2: Evaluate the options:\n\u2022 Option A: \"Patients with this disorder are not further sub-typed.\" This is incorrect because bulimia nervosa is indeed subtyped into categories such as the purging type and the non-purging type.\n\u2022 Option B: \"Patients do not usually initiate treatment.\" Although patients with bulimia nervosa may be reluctant to seek help due to stigma, this statement isn\u2019t a recognized defining feature of the disorder.\n\u2022 Option C: \"Patients can have a history of both anorexia and bulimia.\" This is correct. Many patients transition between anorexia and bulimia over time; especially those with a history of anorexia nervosa (binge-purge type) may later present with bulimia nervosa.\n\u2022 Option D: \"Patients will typically have a BMI between 17\u201318.5 kg/m\u00b2.\" This description is more characteristic of anorexia nervosa. Patients with bulimia nervosa typically have a normal BMI.\n\nStep 3: Conclusion\nThe feature most consistent with this patient\u2019s condition (bulimia nervosa) is that patients can have a history of both anorexia and bulimia.\n\nFinal Answer: C. Patients can have a history of both anorexia and bulimia."
    },
    {
        "realidx": 64,
        "question": "A healthy 19-year-old man presents to his primary care provider complaining of painless \u201cblisters\u201d in his mouth. He reports that he noticed a white film on his tongue and the sides of his mouth 2 days ago while brushing his teeth. The film was easily brushed off. He also complains of a bitter metallic taste in his mouth but otherwise denies pain, burning, dysphagia, or hoarseness. He is otherwise healthy and takes no medications. He is a competitive swimmer and has had 8 sexual partners in the past year. He intermittently uses barrier protection. On exam, he is well-appearing and in no acute distress. His oral examination demonstrates patches of white pseudomembranes that can be wiped away to reveal erythematous mucosa. A medication with which of the following mechanisms of action is most appropriate in this patient?",
        "answer": "Disruption of cell membrane permeability",
        "options": {
            "A": "Disruption of cell membrane permeability",
            "B": "Disruption of microtubule formation",
            "C": "Inhibition of 14-alpha-demethylase",
            "D": "Inhibition of beta-glucan synthase"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "healthy",
            "year old man presents",
            "primary care provider",
            "painless blisters",
            "mouth",
            "reports",
            "white film",
            "tongue",
            "sides",
            "mouth 2 days",
            "brushing",
            "teeth",
            "film",
            "easily brushed",
            "bitter metallic",
            "mouth",
            "denies pain",
            "burning",
            "dysphagia",
            "hoarseness",
            "healthy",
            "takes",
            "medications",
            "competitive swimmer",
            "sexual partners",
            "past year",
            "uses barrier protection",
            "exam",
            "well appearing",
            "acute distress",
            "oral examination demonstrates patches",
            "white pseudomembranes",
            "wiped",
            "to reveal erythematous mucosa",
            "medication",
            "of",
            "following mechanisms",
            "action",
            "most appropriate",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5178,
            "completion_tokens": 3011
        },
        "time_elapsed": 23.639899253845215,
        "raw_responses": [
            "Step 1: The patient's presentation of white plaques in the mouth that can be brushed off to reveal erythematous mucosa is most consistent with oral candidiasis (thrush).\n\nStep 2: The first-line treatment for oral candidiasis is typically a topical antifungal, such as nystatin, which is administered as a mouth rinse.\n\nStep 3: The mechanism of action of nystatin (a polyene antifungal) is the disruption of fungal cell membrane permeability by binding to ergosterol.\n\nStep 4: Comparing the options:\nA. Disruption of cell membrane permeability \u2013 This is the mechanism of polyene antifungals like nystatin.\nB. Disruption of microtubule formation \u2013 This mechanism is seen with agents like griseofulvin, used for dermatophyte infections.\nC. Inhibition of 14-alpha-demethylase \u2013 This is the mechanism of azole antifungals; while effective, they are not first-line for uncomplicated oral candidiasis.\nD. Inhibition of beta-glucan synthase \u2013 This is the mechanism of echinocandins, used in systemic candidiasis, not for oral thrush.\n\nFinal Answer: A. Disruption of cell membrane permeability",
            "Step 1: Recognize that the patient's presentation\u2014white, removable pseudomembranous patches on his tongue and oral mucosa with underlying erythema\u2014is consistent with oral candidiasis.\n\nStep 2: For management of oral candidiasis in an otherwise healthy individual, a topical antifungal agent is typically used. Nystatin is a common first-line treatment.\n\nStep 3: Nystatin works by binding to ergosterol in the fungal cell membrane, leading to pores and disruptions of the membrane's permeability.\n\nStep 4: Review the options:\n\u2022 Option A (Disruption of cell membrane permeability) matches the mechanism of polyene antifungals like nystatin.\n\u2022 Option B (Disruption of microtubule formation) describes drugs like griseofulvin, which is used for dermatophyte infections.\n\u2022 Option C (Inhibition of 14-alpha-demethylase) describes azoles (e.g., fluconazole), an alternative treatment but not first-line in this case.\n\u2022 Option D (Inhibition of beta-glucan synthase) describes drugs like echinocandins, which are typically used for systemic candidiasis.\n\nFinal Answer: A. Disruption of cell membrane permeability",
            "Step 1: Identify the Diagnosis\nThe patient\u2019s presentation of white pseudomembranes in the mouth that can be easily wiped away with a revealing of erythematous mucosa is characteristic of oral candidiasis.\n\nStep 2: Determine the Appropriate Treatment\nOral candidiasis is typically treated with a topical antifungal agent. In mild cases, nystatin mouthwash is usually the first-line treatment.\n\nStep 3: Recognize the Mechanism of Action\nNystatin works by binding to ergosterol, which is a key component of the fungal cell membrane. This binding disrupts the cell membrane\u2019s permeability, leading to leakage of cellular contents and eventual cell death.\n\nStep 4: Compare the Mechanisms of the Answer Choices\n\u2022 Option A \u2013 Disruption of cell membrane permeability: This describes the mechanism of nystatin, which is the appropriate treatment for oral candidiasis.\n\u2022 Option B \u2013 Disruption of microtubule formation: This is the mechanism of griseofulvin, which is used for dermatophyte infections, not Candida.\n\u2022 Option C \u2013 Inhibition of 14-alpha-demethylase: This is the mechanism of azoles (e.g., fluconazole), which are also used for candidiasis but are typically reserved for more extensive or refractory cases.\n\u2022 Option D \u2013 Inhibition of beta-glucan synthase: This is the mechanism of echinocandins (e.g., caspofungin), used primarily in systemic candidiasis or other invasive fungal infections.\n\nStep 5: Conclude with the Best Answer\nGiven that the patient has uncomplicated oral candidiasis and would be best treated with nystatin, the correct mechanism to focus on is the disruption of cell membrane permeability.\n\nFinal answer: A. Disruption of cell membrane permeability"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: The patient's presentation of white plaques in the mouth that can be brushed off to reveal erythematous mucosa is most consistent with oral candidiasis (thrush).\n\nStep 2: The first-line treatment for oral candidiasis is typically a topical antifungal, such as nystatin, which is administered as a mouth rinse.\n\nStep 3: The mechanism of action of nystatin (a polyene antifungal) is the disruption of fungal cell membrane permeability by binding to ergosterol.\n\nStep 4: Comparing the options:\nA. Disruption of cell membrane permeability \u2013 This is the mechanism of polyene antifungals like nystatin.\nB. Disruption of microtubule formation \u2013 This mechanism is seen with agents like griseofulvin, used for dermatophyte infections.\nC. Inhibition of 14-alpha-demethylase \u2013 This is the mechanism of azole antifungals; while effective, they are not first-line for uncomplicated oral candidiasis.\nD. Inhibition of beta-glucan synthase \u2013 This is the mechanism of echinocandins, used in systemic candidiasis, not for oral thrush.\n\nFinal Answer: A. Disruption of cell membrane permeability"
    },
    {
        "realidx": 81,
        "question": "A 54-year-old male makes an appointment with his primary care physician due to chronic fatigue that has left him unable to hike or do other physically demanding activities with his friends. He has well-controlled hypertension and diabetes but has otherwise been healthy. He does not smoke but drinks socially with his friends. Physical exam reveals enlarged nodules that are not tender to palpation. A biopsy is obtained showing a characteristic change in chromosome 18. The regulation of which of the following proteins will be most abnormal in this patient?",
        "answer": "Caspase-9",
        "options": {
            "A": "Caspase-9",
            "B": "CD15",
            "C": "Cyclin-dependent kinase 4",
            "D": "Ras pathway transcription factors"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "54 year old male makes",
            "appointment",
            "primary care physician",
            "chronic fatigue",
            "left",
            "unable to",
            "physically demanding activities",
            "friends",
            "well-controlled hypertension",
            "diabetes",
            "healthy",
            "not smoke",
            "drinks",
            "friends",
            "Physical exam reveals enlarged nodules",
            "not tender",
            "palpation",
            "biopsy",
            "obtained showing",
            "characteristic change",
            "chromosome 18",
            "regulation",
            "following proteins",
            "most abnormal",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5196,
            "completion_tokens": 7690
        },
        "time_elapsed": 54.074934005737305,
        "raw_responses": [
            "Step 1 \u2013 Identify the clinical picture:\n\u2022 The patient is a 54\u2010year\u2010old male with chronic fatigue.\n\u2022 Physical exam reveals enlarged, nontender nodules (i.e., lymphadenopathy).\n\u2022 The biopsy shows a characteristic change in chromosome 18.\n\nStep 2 \u2013 Recognize the key genetic abnormality:\n\u2022 The description of a chromosome 18 abnormality in a nodal lymphoma (often associated with the t(14;18) translocation) is classic for follicular lymphoma.\n\u2022 The t(14;18) translocation results in overexpression of the Bcl\u20102 protein, which normally functions to inhibit apoptosis in cells.\n\nStep 3 \u2013 Link the abnormal protein to an option:\n\u2022 Bcl\u20102\u2019s overexpression prevents programmed cell death (apoptosis) by interfering with the apoptotic cascade.\n\u2022 One of the key proteins in the apoptotic cascade is caspase\u20109, which gets activated once cytochrome c is released from mitochondria. When Bcl\u20102 is overexpressed, it prevents the release of cytochrome c, thus indirectly affecting the regulation and activation of caspase\u20109.\n\nStep 4 \u2013 Eliminate other answer choices:\n\u2022 CD15 is a marker frequently positive in Hodgkin lymphoma, not follicular lymphoma.\n\u2022 Cyclin-dependent kinase 4 is involved in cell cycle regulation and is not the protein affected by the t(14;18) translocation.\n\u2022 Ras pathway transcription factors are part of cell-signaling cascades and are not directly tied to the apoptotic inhibition seen in this scenario.\n\nFinal Answer:\nA. Caspase-9",
            "Step 1: Recognize the clinical scenario. The 54\u2010year-old male presents with chronic fatigue and enlarged, non-tender nodules. In an adult with painless lymphadenopathy, a common consideration is lymphoma.\n\nStep 2: Note the cytogenetic clue. The biopsy indicates a characteristic change in chromosome 18. In follicular lymphoma\u2014a type of non-Hodgkin lymphoma\u2014a t(14;18) translocation is classically seen. This translocation moves the BCL-2 gene from chromosome 18 to the immunoglobulin heavy chain locus on chromosome 14, leading to overexpression of the antiapoptotic BCL\u20112 protein.\n\nStep 3: Understand the impact of abnormal BCL\u20112. Overexpression of BCL\u20112 inhibits apoptosis, thereby allowing the malignant lymphocytes to survive longer. In the intrinsic pathway of apoptosis, BCL\u20112 normally functions to block the release of cytochrome c from mitochondria. Without cytochrome c, formation of the apoptosome (which normally includes Apaf-1 and procaspase-9) is impaired, leading to decreased activation of caspase-9 and subsequent failure to initiate the caspase cascade.\n\nStep 4: Relate the options to the mechanism. The options given are:\n\u2022 A. Caspase-9 \n\u2022 B. CD15 \n\u2022 C. Cyclin-dependent kinase 4 \n\u2022 D. Ras pathway transcription factors\n\nBCL\u20112 overexpression in follicular lymphoma results in decreased activation of the apoptotic pathway, particularly affecting caspase-9. Thus, it is the regulation (or activation) of caspase-9 that is most abnormal in this context.\n\nStep 5: Final answer.\nAnswer: A. Caspase-9",
            "Step 1: Recognize the clinical scenario.\n\u2022 The patient is a 54\u2010year\u2010old male with chronic fatigue and non-tender enlarged nodules. In an adult patient, painless lymphadenopathy (enlarged lymph nodes) along with systemic \"B symptoms\" like fatigue raises suspicion for a lymphoproliferative disorder.\n\nStep 2: Identify the characteristic chromosomal abnormality.\n\u2022 The biopsy shows a characteristic change in chromosome 18. In the context of lymphadenopathy, the translocation t(14;18) is classic for follicular lymphoma.\n\u2022 In t(14;18), the BCL2 gene on chromosome 18 is translocated to the immunoglobulin heavy chain region on chromosome 14, resulting in BCL-2 overexpression.\n\nStep 3: Understand the role of BCL-2.\n\u2022 BCL-2 is an anti-apoptotic protein whose overexpression prevents programmed cell death.\n\u2022 One of its key effects is to inhibit mitochondrial cytochrome c release, which is necessary for the formation of the apoptosome and subsequent activation of initiator caspases, notably caspase-9.\n\nStep 4: Link to the answer options.\n\u2022 Option A (Caspase-9) is directly connected because BCL-2\u2019s overexpression prevents the activation of the apoptotic cascade, including caspase-9.\n\u2022 The other options (CD15, Cyclin-dependent kinase 4, and Ras pathway transcription factors) are not the key players in the apoptotic pathway affected in follicular lymphoma.\n\nFinal Answer: A. Caspase-9"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Recognize the clinical scenario. The 54\u2010year-old male presents with chronic fatigue and enlarged, non-tender nodules. In an adult with painless lymphadenopathy, a common consideration is lymphoma.\n\nStep 2: Note the cytogenetic clue. The biopsy indicates a characteristic change in chromosome 18. In follicular lymphoma\u2014a type of non-Hodgkin lymphoma\u2014a t(14;18) translocation is classically seen. This translocation moves the BCL-2 gene from chromosome 18 to the immunoglobulin heavy chain locus on chromosome 14, leading to overexpression of the antiapoptotic BCL\u20112 protein.\n\nStep 3: Understand the impact of abnormal BCL\u20112. Overexpression of BCL\u20112 inhibits apoptosis, thereby allowing the malignant lymphocytes to survive longer. In the intrinsic pathway of apoptosis, BCL\u20112 normally functions to block the release of cytochrome c from mitochondria. Without cytochrome c, formation of the apoptosome (which normally includes Apaf-1 and procaspase-9) is impaired, leading to decreased activation of caspase-9 and subsequent failure to initiate the caspase cascade.\n\nStep 4: Relate the options to the mechanism. The options given are:\n\u2022 A. Caspase-9 \n\u2022 B. CD15 \n\u2022 C. Cyclin-dependent kinase 4 \n\u2022 D. Ras pathway transcription factors\n\nBCL\u20112 overexpression in follicular lymphoma results in decreased activation of the apoptotic pathway, particularly affecting caspase-9. Thus, it is the regulation (or activation) of caspase-9 that is most abnormal in this context.\n\nStep 5: Final answer.\nAnswer: A. Caspase-9"
    },
    {
        "realidx": 112,
        "question": "A 43-year-old woman presents with complaints of retrosternal burning associated with eating. It has persisted for the past several years but has been getting worse. Her past medical history is unknown and this is her first time seeing a doctor. She states she is otherwise healthy and review of systems is notable for episodic hand pain that is worse in the winter as well as a chronic and severe cough with dyspnea which she attributes to her smoking. Her temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 174/104 mmHg, pulse is 80/min, respirations are 22/min, and oxygen saturation is 92% on room air. Physical exam is notable for a young appearing woman with coarse breath sounds. Laboratory studies and urinalysis are ordered and currently pending. Which of the following is the pathophysiology of this patient's chief complaint?",
        "answer": "Esophageal fibrosis",
        "options": {
            "A": "Decreased lower esophageal tone",
            "B": "Esophageal fibrosis",
            "C": "Increased lower esophageal tone",
            "D": "Spastic cricopharyngeal muscle"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman presents",
            "complaints",
            "retrosternal burning associated with eating",
            "past",
            "years",
            "getting worse",
            "past medical history",
            "unknown",
            "first time seeing",
            "doctor",
            "states",
            "healthy",
            "review of systems",
            "notable",
            "episodic hand",
            "worse",
            "winter",
            "chronic",
            "severe cough",
            "dyspnea",
            "attributes",
            "smoking",
            "temperature",
            "97",
            "36",
            "blood pressure",
            "mmHg",
            "pulse",
            "80 min",
            "respirations",
            "min",
            "oxygen saturation",
            "room air",
            "Physical exam",
            "notable",
            "young appearing woman",
            "coarse breath sounds",
            "Laboratory studies",
            "urinalysis",
            "ordered",
            "currently",
            "following",
            "pathophysiology",
            "patient's chief complaint"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4767,
            "completion_tokens": 3165
        },
        "time_elapsed": 32.63907313346863,
        "raw_responses": [
            "Step 1: Analyze the patient's presentation. She is a relatively young 43-year-old woman with chronic retrosternal burning (likely reflux symptoms), episodic hand pain that worsens in the winter (suggestive of Raynaud phenomenon), and pulmonary findings (coarse breath sounds and dyspnea). These findings are consistent with systemic sclerosis (scleroderma), a connective tissue disorder.\n\nStep 2: Understand the pathophysiology relevant to her chief complaint. In scleroderma, there is fibrosis and atrophy of the smooth muscle in the lower esophagus, leading to decreased lower esophageal sphincter (LES) tone. A decreased LES tone predisposes to gastroesophageal reflux, which explains her retrosternal burning.\n\nStep 3: Evaluate the answer choices:\n\u2022 A. Decreased lower esophageal tone \u2013 Correct, as this is the mechanism in scleroderma causing reflux.\n\u2022 B. Esophageal fibrosis \u2013 While scleroderma does cause fibrosis, the reflux is due specifically to a decrease in LES tone rather than primary esophageal fibrosis.\n\u2022 C. Increased lower esophageal tone \u2013 Incorrect; increased tone would be more likely to cause dysphagia rather than reflux.\n\u2022 D. Spastic cricopharyngeal muscle \u2013 Incorrect; this would cause issues at the upper esophageal sphincter, not the LES.\n\nFinal Answer: A: Decreased lower esophageal tone.",
            "Step 1: Look at the clinical presentation. The patient presents with chronic retrosternal burning associated with eating, which is a classic description of gastroesophageal reflux disease (GERD). Notably, her history includes episodic hand pain worse in the winter, which is suggestive of Raynaud phenomenon, and a chronic cough with dyspnea. These findings raise suspicion for an underlying connective tissue disorder, such as systemic sclerosis (scleroderma).\n\nStep 2: In systemic sclerosis, fibrosis and collagen deposition involve various organs including the esophagus. This leads to damage of the smooth muscle in the lower esophagus, resulting in decreased lower esophageal sphincter (LES) tone. The diminished LES tone predisposes to reflux of gastric contents into the esophagus, which explains her chronic burning symptoms.\n\nStep 3: Evaluate the answer options:\n\u2003A. Decreased lower esophageal tone \u2013 This is consistent with the pathophysiology in systemic sclerosis leading to GERD.\n\u2003B. Esophageal fibrosis \u2013 While fibrosis occurs in systemic sclerosis, it is the decreased LES tone, rather than fibrosis itself, that most directly causes reflux.\n\u2003C. Increased lower esophageal tone \u2013 This would actually prevent reflux, not cause it.\n\u2003D. Spastic cricopharyngeal muscle \u2013 This is unrelated to the patient's symptoms of GERD.\n\nFinal Answer: A. Decreased lower esophageal tone",
            "The correct answer is A. Decreased lower esophageal tone.\n\nThis finding is consistent with esophageal involvement in systemic sclerosis (scleroderma). In scleroderma, immune-mediated damage leads to smooth muscle atrophy in the esophagus, most notably causing a decrease in lower esophageal sphincter tone. This predisposes patients to gastroesophageal reflux disease (GERD), which explains the patient\u2019s persistent retrosternal burning associated with eating. The additional clues\u2014episodic hand pain (likely due to Raynaud phenomenon) and pulmonary findings (coarse breath sounds and chronic cough with dyspnea)\u2014further support the diagnosis of scleroderma, which commonly affects the skin, vascular system, esophagus, and lungs."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Look at the clinical presentation. The patient presents with chronic retrosternal burning associated with eating, which is a classic description of gastroesophageal reflux disease (GERD). Notably, her history includes episodic hand pain worse in the winter, which is suggestive of Raynaud phenomenon, and a chronic cough with dyspnea. These findings raise suspicion for an underlying connective tissue disorder, such as systemic sclerosis (scleroderma).\n\nStep 2: In systemic sclerosis, fibrosis and collagen deposition involve various organs including the esophagus. This leads to damage of the smooth muscle in the lower esophagus, resulting in decreased lower esophageal sphincter (LES) tone. The diminished LES tone predisposes to reflux of gastric contents into the esophagus, which explains her chronic burning symptoms.\n\nStep 3: Evaluate the answer options:\n\u2003A. Decreased lower esophageal tone \u2013 This is consistent with the pathophysiology in systemic sclerosis leading to GERD.\n\u2003B. Esophageal fibrosis \u2013 While fibrosis occurs in systemic sclerosis, it is the decreased LES tone, rather than fibrosis itself, that most directly causes reflux.\n\u2003C. Increased lower esophageal tone \u2013 This would actually prevent reflux, not cause it.\n\u2003D. Spastic cricopharyngeal muscle \u2013 This is unrelated to the patient's symptoms of GERD.\n\nFinal Answer: A. Decreased lower esophageal tone"
    },
    {
        "realidx": 114,
        "question": "A 41-year-old man presents to the emergency department with a 6-hour history of muscle cramping, decreased appetite, and diarrhea. He says that these symptoms came on rapidly but does not recall anything that may have triggered the episode. He has never experienced these symptoms before. His past medical history is significant for obesity, sleep apnea, and type 2 diabetes that is well controlled on metformin. He also has gastroesophageal reflux disease for which he occasionally takes antacids. On presentation he is found to have fast, shallow breathing and abdominal pain that is poorly localized. Basic labs as well as an arterial blood gas are obtained and the results are shown below:\n\nNa+: 139 mEq/L\nCl-: 106 mEq/L\nHCO3-: 11 mEq/L\npH: 7.25\npCO2: 22 mmHg\n\nWhich of the following is the most likely cause of the changes seen in this patient's labs?",
        "answer": "Metformin",
        "options": {
            "A": "Anxiety",
            "B": "Diarrhea",
            "C": "Metformin",
            "D": "Sleep apnea"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old man presents",
            "emergency department",
            "6-hour history",
            "muscle cramping",
            "decreased appetite",
            "diarrhea",
            "symptoms",
            "rapidly",
            "not recall",
            "triggered",
            "episode",
            "never experienced",
            "symptoms",
            "past medical history",
            "significant",
            "obesity",
            "sleep apnea",
            "type 2 diabetes",
            "well controlled",
            "metformin",
            "gastroesophageal reflux disease",
            "occasionally takes antacids",
            "presentation",
            "found to",
            "fast",
            "shallow breathing",
            "abdominal pain",
            "poorly localized",
            "Basic labs",
            "arterial blood gas",
            "obtained",
            "results",
            "shown",
            "Na",
            "mEq/L Cl",
            "mEq/L HCO3",
            "mEq/L pH",
            "pCO2",
            "mmHg",
            "following",
            "most likely cause",
            "changes seen",
            "patient's labs"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5079,
            "completion_tokens": 5782
        },
        "time_elapsed": 127.71770358085632,
        "raw_responses": [
            "The patient presents with muscle cramping, decreased appetite, and diarrhea. His labs show a low bicarbonate (11 mEq/L) and a low pH (7.25), indicating metabolic acidosis, with a compensatory decrease in pCO\u2082 (22 mmHg). Diarrhea is a common cause of metabolic acidosis due to the loss of bicarbonate in the stool. \n\nStep-by-step reasoning:\n1. The clinical symptoms including diarrhea support a gastrointestinal cause for the acidosis.\n2. The lab findings (low HCO\u2083\u207b and low pH with appropriate respiratory compensation) are most consistent with a metabolic acidosis rather than other causes.\n3. The other options (anxiety, metformin, sleep apnea) are less likely to produce these particular lab abnormalities in the setting described.\n \nFinal answer: B. Diarrhea",
            "Step 1: This 41-year-old man presents with muscle cramping, decreased appetite, and diarrhea. His labs show a low bicarbonate (HCO3- of 11 mEq/L) and a low pH of 7.25, indicating metabolic acidosis. Additionally, his low pCO2 of 22 mmHg suggests respiratory compensation via hyperventilation.\n\nStep 2: Anxiety (A) primarily causes respiratory alkalosis (via hyperventilation) rather than a low bicarbonate metabolic acidosis. Metformin (C) can cause lactic acidosis, but it is relatively rare and typically seen in patients with renal impairment. His presentation and lab findings are more consistent with bicarbonate loss rather than lactic acidosis. Sleep apnea (D) doesn\u2019t account for metabolic acidosis or the described symptoms.\n\nStep 3: The most likely cause is diarrhea (B). Diarrhea results in loss of bicarbonate in the intestinal contents, leading to metabolic acidosis. The rapid onset of symptoms and the lab findings are in keeping with this diagnosis.\n\nFinal answer: B. Diarrhea",
            "Step 1: Examine the lab data. The arterial blood gas shows a pH of 7.25 (acidemia) with a low bicarbonate (HCO\u2083\u207b of 11 mEq/L) and a low pCO\u2082 (22 mmHg), indicating a metabolic acidosis with respiratory compensation.\n\nStep 2: Calculate the anion gap:\n\u2003Anion gap = Na\u207a \u2013 (Cl\u207b + HCO\u2083\u207b) = 139 \u2013 (106 + 11) = 139 \u2013 117 = 22.\nA normal anion gap is roughly 8\u201312, so an anion gap of 22 is elevated.\n\nStep 3: Consider the likely causes. In a patient with an elevated anion gap metabolic acidosis, causes include lactic acidosis, ketoacidosis, ingestion of toxins, and certain medications. Although diarrhea can cause metabolic acidosis, it typically leads to a normal anion gap (hyperchloremic metabolic acidosis), not an elevated one.\n\nStep 4: Evaluate the answer options:\n\u2022 Anxiety (Option A) would more likely cause respiratory alkalosis rather than metabolic acidosis.\n\u2022 Diarrhea (Option B) usually causes a normal anion gap acidosis because of bicarbonate loss, not the elevated gap seen here.\n\u2022 Metformin (Option C) is known to possibly cause lactic acidosis, especially if there is any precipitating factor (such as dehydration) that might lead to accumulation of the drug and subsequent lactic acid buildup.\n\u2022 Sleep apnea (Option D) might contribute to other respiratory complications but is not directly associated with the metabolic and anion gap findings seen in this case.\n\nStep 5: Synthesize the information. The patient\u2019s elevated anion gap metabolic acidosis, coupled with his history of type 2 diabetes and metformin use, strongly points to a metformin-induced lactic acidosis as the most likely explanation for the lab abnormalities.\n\nFinal Answer: C. Metformin"
        ],
        "ensemble_raw_responses": [
            "1\n\nSolution Explanation:\nWhen analyzing the lab data, the pH is 7.25 (acidemia) and the bicarbonate is low at 11 mEq/L, indicating a metabolic acidosis. The low pCO\u2082 of 22 mmHg shows respiratory compensation. Calculating the anion gap using the formula (Na\u207a - [Cl\u207b + HCO\u2083\u207b]) gives 139 - (106 + 11) = 22, which is elevated (normal is roughly 8\u201312). Diarrhea typically causes a normal anion gap, hyperchloremic metabolic acidosis, so the elevated anion gap points to another cause. In a type 2 diabetic on metformin, metformin-induced lactic acidosis is a recognized complication and best explains the high anion gap metabolic acidosis seen in this patient.",
            "0",
            "The correct answer is option 1.\n\nHere's why:\n\nThe arterial blood gas shows a pH of 7.25 (acidemia) with a bicarbonate of 11 mEq/L and a pCO\u2082 of 22 mmHg, indicating a metabolic acidosis with respiratory compensation. When you calculate the anion gap using the formula \u204d AG = Na\u207a \u2013 (Cl\u207b + HCO\u2083\u207b) \u204d, you get:\n\n\u2003\u2003139 \u2013 (106 + 11) = 139 \u2013 117 = 22\n\nAn anion gap of 22 is elevated (normal is roughly 8\u201312). Diarrhea usually causes a normal anion gap (hyperchloremic) metabolic acidosis because the bicarbonate loss is balanced by an increase in chloride. The elevated anion gap points to the presence of unmeasured anions, such as lactate. In a patient with type 2 diabetes who is on metformin, the most likely explanation is metformin-induced lactic acidosis\u2014especially if there is any renal impairment or dehydration that could precipitate this condition.\n\nThus, option 1 is the best answer."
        ],
        "final_solution": "Step 1: Examine the lab data. The arterial blood gas shows a pH of 7.25 (acidemia) with a low bicarbonate (HCO\u2083\u207b of 11 mEq/L) and a low pCO\u2082 (22 mmHg), indicating a metabolic acidosis with respiratory compensation.\n\nStep 2: Calculate the anion gap:\n\u2003Anion gap = Na\u207a \u2013 (Cl\u207b + HCO\u2083\u207b) = 139 \u2013 (106 + 11) = 139 \u2013 117 = 22.\nA normal anion gap is roughly 8\u201312, so an anion gap of 22 is elevated.\n\nStep 3: Consider the likely causes. In a patient with an elevated anion gap metabolic acidosis, causes include lactic acidosis, ketoacidosis, ingestion of toxins, and certain medications. Although diarrhea can cause metabolic acidosis, it typically leads to a normal anion gap (hyperchloremic metabolic acidosis), not an elevated one.\n\nStep 4: Evaluate the answer options:\n\u2022 Anxiety (Option A) would more likely cause respiratory alkalosis rather than metabolic acidosis.\n\u2022 Diarrhea (Option B) usually causes a normal anion gap acidosis because of bicarbonate loss, not the elevated gap seen here.\n\u2022 Metformin (Option C) is known to possibly cause lactic acidosis, especially if there is any precipitating factor (such as dehydration) that might lead to accumulation of the drug and subsequent lactic acid buildup.\n\u2022 Sleep apnea (Option D) might contribute to other respiratory complications but is not directly associated with the metabolic and anion gap findings seen in this case.\n\nStep 5: Synthesize the information. The patient\u2019s elevated anion gap metabolic acidosis, coupled with his history of type 2 diabetes and metformin use, strongly points to a metformin-induced lactic acidosis as the most likely explanation for the lab abnormalities.\n\nFinal Answer: C. Metformin"
    },
    {
        "realidx": 128,
        "question": "A 47-year-old woman comes to the physician because of progressive muscle weakness for five months. She feels that the muscles in her shoulders and hips have been getting weaker and sometimes feel sore. She now has difficulty getting up from chairs, climbing stairs, and combing her hair. She has also noticed new difficulty with swallowing solid foods, but has no trouble with liquids. She has a 5-year history of hyperlipidemia controlled with fluvastatin. Her maternal uncle died at age 26 from Duchenne's muscular dystrophy and her mother has Hashimoto's thyroiditis. Vital signs are within normal limits. Neurologic examination shows moderate weakness in the arm abductors and hip flexors bilaterally. Deep tendon reflexes are 2+ bilaterally. Laboratory studies show:\nHemoglobin 13.7 g/dL\nLeukocytes 11,200/mm3\nErythrocyte sedimentation rate 33 mm/h\nSerum\nCreatine kinase 212 U/L\nLactate dehydrogenase 164 U/L\nAST 34 U/L\nALT 35 U/L\nWhich of the following is most likely to confirm the diagnosis?\"",
        "answer": "Intrafascicular infiltration on muscle biopsy",
        "options": {
            "A": "Intrafascicular infiltration on muscle biopsy",
            "B": "Perifascicular and perivascular infiltration on muscle biopsy",
            "C": "Positive anti-acetylcholine receptor antibodies",
            "D": "Dystrophin gene mutation on genetic analysis"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old woman",
            "physician",
            "of progressive muscle weakness",
            "five months",
            "feels",
            "muscles",
            "shoulders",
            "hips",
            "getting weaker",
            "sometimes feel sore",
            "now",
            "difficulty getting",
            "chairs",
            "climbing stairs",
            "combing",
            "hair",
            "new difficulty",
            "swallowing solid foods",
            "liquids",
            "5 year history of hyperlipidemia controlled",
            "fluvastatin",
            "maternal uncle died",
            "age",
            "Duchenne",
            "uscular dystrophy ",
            "other ",
            "ashimoto'",
            "yroiditis. ",
            "tal signs a",
            "rmal limits. ",
            "urologic examination s ows m derate w akness i",
            "m a",
            "p f exors b",
            "ep tendon reflexes a",
            " ",
            "boratory studies s ow: ",
            "moglobin 1",
            "dL L ukocytes 1 0/m 3 E ythrocyte sedimentation rate 3",
            "S rum C",
            "Lactate dehydrogenase 1",
            " U",
            "llowing i",
            "st likely t  c nfirm t",
            "agnosis?\""
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6870,
            "completion_tokens": 5207
        },
        "time_elapsed": 87.83184289932251,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s presentation.  \n\u2022 The patient is a 47\u2010year-old woman experiencing slowly progressive proximal muscle weakness (difficulty getting up, climbing stairs, combing hair) over five months.  \n\u2022 She reports dysphagia that affects solid foods more than liquids, suggesting involvement of striated muscles of the esophagus.  \n\u2022 Her laboratory studies show only a slight elevation in creatine kinase (CK), which can be seen in certain inflammatory myopathies.  \n\u2022 Family history of autoimmune disease (Hashimoto's thyroiditis) also raises suspicion for an autoimmune process.\n\nStep 2: Narrow down the differential diagnosis.  \n\u2022 Polymyositis is an autoimmune inflammatory myopathy characterized by symmetrical proximal muscle weakness and occasionally dysphagia.  \n\u2022 Dermatomyositis is another inflammatory myopathy but usually presents with skin findings (e.g., heliotrope rash, Gottron papules), which are not mentioned here.  \n\u2022 Myasthenia gravis (which would show positive anti-acetylcholine receptor antibodies) tends to cause fluctuating weakness with ocular and bulbar involvement, not the slowly progressive symmetric proximal weakness seen here.  \n\u2022 Muscular dystrophies stemming from dystrophin gene mutations present in childhood and are less consistent with this patient\u2019s age and presentation.\n\nStep 3: Determine the confirmatory diagnostic test based on muscle biopsy findings.  \n\u2022 In polymyositis, the muscle biopsy typically shows endomysial (or intrafascicular) inflammatory infiltrates predominantly composed of CD8+ T cells invading muscle fibers.  \n\u2022 Option A (\u201cIntrafascicular infiltration on muscle biopsy\u201d) is the finding consistent with polymyositis.  \n\u2022 Option B (\u201cPerifascicular and perivascular infiltration on muscle biopsy\u201d) is characteristic of dermatomyositis.  \n\u2022 Option C and Option D relate to myasthenia gravis and muscular dystrophy, respectively, which do not match this clinical scenario.\n\nFinal Answer: A. Intrafascicular infiltration on muscle biopsy",
            "Step 1: Analyze the clinical presentation.\n\u2022 The patient is a 47-year-old woman with a five-month history of progressive, symmetric, proximal muscle weakness, causing difficulty with tasks such as getting up from chairs, climbing stairs, and combing her hair.\n\u2022 She also has dysphagia, particularly with solid foods, which is a common feature when pharyngeal muscles are involved.\n\u2022 Her laboratory results show a mildly elevated inflammatory marker (ESR), but a creatine kinase that is only slightly elevated, which can be seen in inflammatory myopathies.\n\u2022 There is no rash, which helps steer away from dermatomyositis.\n\nStep 2: Consider the likely diagnosis.\n\u2022 Inflammatory myopathies are high on the differential. Polymyositis is characterized by symmetric proximal muscle weakness (including swallowing difficulties) without skin findings.\n\u2022 Her family history (maternal uncle with Duchenne's and a mother with Hashimoto's) is less relevant here, as Duchenne\u2019s is an X-linked disorder mainly affecting males and Hashimoto\u2019s reflects a propensity for autoimmunity.\n\u2022 Statin-induced myopathy is another consideration, but it generally presents with more pronounced creatine kinase elevations, and the clinical progression over five months suggests an inflammatory process rather than a toxic myopathy.\n\nStep 3: Review the options.\nA. Intrafascicular infiltration on muscle biopsy  \n\u2003\u2003\u2013 Polymyositis is characterized by an endomysial (within fascicles) inflammatory infiltrate predominantly composed of CD8+ T cells invading non-necrotic muscle fibers.\nB. Perifascicular and perivascular infiltration on muscle biopsy  \n\u2003\u2003\u2013 This finding is characteristic of dermatomyositis, which is typically accompanied by a rash.\nC. Positive anti-acetylcholine receptor antibodies  \n\u2003\u2003\u2013 This finding is diagnostic of myasthenia gravis, which commonly presents with ocular symptoms and fluctuating weakness, unlike the persistent proximal weakness here.\nD. Dystrophin gene mutation on genetic analysis  \n\u2003\u2003\u2013 This is associated with Duchenne muscular dystrophy, an X-linked condition that typically presents in childhood.\n\nStep 4: Arrive at the final answer.\nGiven the clinical findings and the corresponding muscle biopsy results that would confirm polymyositis (intramuscular or intrafascicular inflammatory infiltrates), the best confirmatory test is a muscle biopsy showing intrafascicular (endomysial) infiltration.\n\nFinal answer: A. Intrafascicular infiltration on muscle biopsy",
            "The patient is a 47\u2010year\u2010old woman with a five\u2010month history of progressive, symmetric proximal muscle weakness (difficulty getting up from chairs, climbing stairs, and combing her hair), plus dysphagia for solids. Although her statin use could raise concern for a statin-associated myopathy, her symptoms of dysphagia and significant proximal weakness strongly favor an inflammatory myopathy, such as polymyositis. In polymyositis, one expects to see endomysial (i.e. within the fascicle) inflammatory infiltrates composed primarily of CD8+ T cells invading non-necrotic muscle fibers. \n\nReviewing the options:\n\u2022 Option A, \u201cIntrafascicular infiltration on muscle biopsy,\u201d is describing the presence of inflammation within the muscle fascicle (essentially the same as an endomysial inflammatory infiltrate), which is characteristic of polymyositis.\n\u2022 Option B, \u201cPerifascicular and perivascular infiltration on muscle biopsy,\u201d is typical for dermatomyositis, which would usually also include a rash \u2013 not described here.\n\u2022 Option C, \u201cPositive anti-acetylcholine receptor antibodies,\u201d is associated with myasthenia gravis, which typically presents with fluctuating weakness (often with ocular symptoms) rather than the steadily progressive proximal weakness seen in this patient.\n\u2022 Option D, \u201cDystrophin gene mutation on genetic analysis,\u201d would be indicative of a dystrophinopathy (e.g., Duchenne\u2019s or Becker\u2019s muscular dystrophy), which is not consistent with her presentation or age.\n\nThus, the best confirmatory test for her likely diagnosis (polymyositis) is a muscle biopsy demonstrating an intrafascicular (endomysial) inflammatory infiltrate.\n\nFinal answer: A. Intrafascicular infiltration on muscle biopsy"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "The patient is a 47\u2010year\u2010old woman with a five\u2010month history of progressive, symmetric proximal muscle weakness (difficulty getting up from chairs, climbing stairs, and combing her hair), plus dysphagia for solids. Although her statin use could raise concern for a statin-associated myopathy, her symptoms of dysphagia and significant proximal weakness strongly favor an inflammatory myopathy, such as polymyositis. In polymyositis, one expects to see endomysial (i.e. within the fascicle) inflammatory infiltrates composed primarily of CD8+ T cells invading non-necrotic muscle fibers. \n\nReviewing the options:\n\u2022 Option A, \u201cIntrafascicular infiltration on muscle biopsy,\u201d is describing the presence of inflammation within the muscle fascicle (essentially the same as an endomysial inflammatory infiltrate), which is characteristic of polymyositis.\n\u2022 Option B, \u201cPerifascicular and perivascular infiltration on muscle biopsy,\u201d is typical for dermatomyositis, which would usually also include a rash \u2013 not described here.\n\u2022 Option C, \u201cPositive anti-acetylcholine receptor antibodies,\u201d is associated with myasthenia gravis, which typically presents with fluctuating weakness (often with ocular symptoms) rather than the steadily progressive proximal weakness seen in this patient.\n\u2022 Option D, \u201cDystrophin gene mutation on genetic analysis,\u201d would be indicative of a dystrophinopathy (e.g., Duchenne\u2019s or Becker\u2019s muscular dystrophy), which is not consistent with her presentation or age.\n\nThus, the best confirmatory test for her likely diagnosis (polymyositis) is a muscle biopsy demonstrating an intrafascicular (endomysial) inflammatory infiltrate.\n\nFinal answer: A. Intrafascicular infiltration on muscle biopsy"
    },
    {
        "realidx": 145,
        "question": "A 5-year-old boy is brought to the physician because of facial swelling that started 5 days ago. Two weeks ago, he had a sore throat that resolved spontaneously. His temperature is 37\u00b0C (98.6\u00b0F), pulse is 107/min, and blood pressure is 94/67 mm Hg. Examination shows pitting edema of the upper and lower extremities as well as periorbital edema. The abdomen is mildly distended. Laboratory studies show:\nHemoglobin 13.1 g/dL\nSerum\nAlbumin 2.1 g/dL\nTotal cholesterol 270 mg/dL\nTriglycerides 175 mg/dL\nUrine\nBlood negative\nGlucose negative\nProtein 4+\nLeukocyte esterase negative\nA renal biopsy of this patient is most likely to show which of the following findings?\"",
        "answer": "Normal light microscopy findings",
        "options": {
            "A": "Mesangial proliferation on light microscopy",
            "B": "Subepithelial dense deposits on electron microscopy",
            "C": "Deposits of IgG and C3 at the glomerular basement membrane on immunofluoresence",
            "D": "Normal light microscopy findings"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "5 year old boy",
            "brought",
            "physician",
            "facial swelling",
            "started 5 days",
            "Two weeks",
            "sore throat",
            "resolved",
            "temperature",
            "98",
            "pulse",
            "min",
            "blood pressure",
            "67 mm Hg",
            "Examination shows pitting edema",
            "upper",
            "lower extremities",
            "periorbital edema",
            "abdomen",
            "mildly distended",
            "Laboratory studies show",
            "Hemoglobin",
            "Serum",
            "Triglycerides",
            "Urine",
            "negative",
            "Leukocyte",
            "renal biopsy",
            "patient",
            "most likely to show",
            "following findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4815,
            "completion_tokens": 2795
        },
        "time_elapsed": 86.52456521987915,
        "raw_responses": [
            "Step 1: The clinical picture\u2014facial and peripheral edema, ascites, hypoalbuminemia, hypercholesterolemia, and significant proteinuria\u2014in a 5-year-old boy is most indicative of nephrotic syndrome. Although his history of a sore throat might initially raise concern for post-streptococcal glomerulonephritis, the absence of hematuria and red cell casts, along with the laboratory findings, point toward minimal change disease (MCD), which is the most common cause of nephrotic syndrome in children.\n\nStep 2: Let's review the choices:\n\nA. Mesangial proliferation on light microscopy \u2013 This is seen in conditions like IgA nephropathy, not MCD.  \nB. Subepithelial dense deposits on electron microscopy \u2013 These findings are characteristic of membranous nephropathy, which is uncommon in this age group.  \nC. Deposits of IgG and C3 at the glomerular basement membrane on immunofluorescence \u2013 These findings are typical of post-streptococcal glomerulonephritis (a nephritic syndrome), not MCD.  \nD. Normal light microscopy findings \u2013 This is the hallmark finding in minimal change disease on light microscopy, with the diagnosis confirmed by electron microscopy, which would show effacement of the podocyte foot processes.\n\nStep 3: Based on this reasoning, the best answer is:\n\nD. Normal light microscopy findings",
            "Step 1: Analyze the clinical presentation. The 5-year-old boy presents with edema (facial, periorbital, and generalized), hypoalbuminemia (albumin 2.1 g/dL), hypercholesterolemia (total cholesterol 270 mg/dL), and significant proteinuria (4+ protein). These findings are consistent with nephrotic syndrome. \n\nStep 2: Consider the common causes of nephrotic syndrome in children. Minimal change disease is the most common cause in this age group. Although the patient had a sore throat two weeks ago, the absence of hematuria and the laboratory findings (significant proteinuria without blood, hypoalbuminemia, and hypercholesterolemia) make post-streptococcal glomerulonephritis less likely.\n\nStep 3: Recall the pathology findings for minimal change disease. The disease is characterized by its normal appearance under light microscopy, with the key diagnostic feature being diffuse effacement of the podocyte foot processes seen on electron microscopy. Immunofluorescence typically does not show immune complex deposits.\n\nStep 4: Evaluate the answer options:\nA. Mesangial proliferation on light microscopy \u2013 This is more consistent with IgA nephropathy or other proliferative glomerulonephritides.\nB. Subepithelial dense deposits on electron microscopy \u2013 This finding is typical of membranous nephropathy.\nC. Deposits of IgG and C3 at the glomerular basement membrane on immunofluorescence \u2013 This pattern is seen in post-streptococcal glomerulonephritis.\nD. Normal light microscopy findings \u2013 This is the hallmark of minimal change disease on light microscopy.\n\nFinal Answer: D. Normal light microscopy findings",
            "The patient's presentation is most consistent with minimal change disease, which is the most common cause of nephrotic syndrome in children. Despite the significant proteinuria and edema seen on laboratory studies, a renal biopsy in minimal change disease typically shows normal findings on light microscopy, with the only abnormality being the effacement of foot processes seen on electron microscopy.\n\nAnswer: D. Normal light microscopy findings"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation. The 5-year-old boy presents with edema (facial, periorbital, and generalized), hypoalbuminemia (albumin 2.1 g/dL), hypercholesterolemia (total cholesterol 270 mg/dL), and significant proteinuria (4+ protein). These findings are consistent with nephrotic syndrome. \n\nStep 2: Consider the common causes of nephrotic syndrome in children. Minimal change disease is the most common cause in this age group. Although the patient had a sore throat two weeks ago, the absence of hematuria and the laboratory findings (significant proteinuria without blood, hypoalbuminemia, and hypercholesterolemia) make post-streptococcal glomerulonephritis less likely.\n\nStep 3: Recall the pathology findings for minimal change disease. The disease is characterized by its normal appearance under light microscopy, with the key diagnostic feature being diffuse effacement of the podocyte foot processes seen on electron microscopy. Immunofluorescence typically does not show immune complex deposits.\n\nStep 4: Evaluate the answer options:\nA. Mesangial proliferation on light microscopy \u2013 This is more consistent with IgA nephropathy or other proliferative glomerulonephritides.\nB. Subepithelial dense deposits on electron microscopy \u2013 This finding is typical of membranous nephropathy.\nC. Deposits of IgG and C3 at the glomerular basement membrane on immunofluorescence \u2013 This pattern is seen in post-streptococcal glomerulonephritis.\nD. Normal light microscopy findings \u2013 This is the hallmark of minimal change disease on light microscopy.\n\nFinal Answer: D. Normal light microscopy findings"
    },
    {
        "realidx": 149,
        "question": "An 11-month-old boy is brought to the clinic by his mother for a rash on his trunk, which he has had for the past 2 days. She notes that he is eating less and is more cranky than usual. His birth history is insignificant, and his immunizations are up to date. Vital signs include: temperature is 37.8\u00b0C (100.0\u00b0F), pulse is 98/min, and respiratory rate is 16/min. The rash features thin-walled, fluid-filled blisters that rupture easily. Fluid samples from the lesions are sent for analysis to a microbiology lab. The results reveal an infection by the gram-positive bacterium Staphylococcus aureus. The patient is diagnosed with staphylococcal scalded skin syndrome. Which of the following is involved with the primary defense in response to the bacteria and toxins produced by this organism?",
        "answer": "Immunoglobulin- IgM",
        "options": {
            "A": "Immunoglobulin- IgG",
            "B": "Immunoglobulin- IgD",
            "C": "Immunoglobulin- IgA",
            "D": "Immunoglobulin- IgM"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "month old boy",
            "brought",
            "clinic",
            "mother",
            "rash",
            "trunk",
            "past 2 days",
            "notes",
            "eating less",
            "more",
            "usual",
            "birth history",
            "immunizations",
            "date",
            "Vital signs include",
            "temperature",
            "100",
            "pulse",
            "98 min",
            "respiratory rate",
            "min",
            "rash features thin walled",
            "fluid filled blisters",
            "rupture easily",
            "Fluid samples",
            "lesions",
            "sent",
            "analysis",
            "microbiology lab",
            "results reveal",
            "infection",
            "gram-positive bacterium Staphylococcus aureus",
            "patient",
            "diagnosed",
            "staphylococcal scalded skin syndrome",
            "following",
            "involved",
            "primary defense",
            "response to",
            "bacteria",
            "toxins",
            "organism"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4965,
            "completion_tokens": 4010
        },
        "time_elapsed": 30.237607955932617,
        "raw_responses": [
            "Step 1: Recognize that staphylococcal scalded skin syndrome (SSSS) is caused by exfoliative toxins (exotoxins) released by Staphylococcus aureus.\n\nStep 2: Recall that the body's primary humoral defense against extracellular toxins and bacteria is mediated by antibodies, especially IgG, which neutralize toxins and promote opsonization.\n\nStep 3: Eliminate the other immunoglobulins:\n\u2022 IgD is largely present on the surface of B cells and is not the main player in the defense against toxins.\n\u2022 IgA is important in mucosal immunity but is less effective in neutralizing circulating toxins.\n\u2022 IgM is the first immunoglobulin produced in an acute response, but IgG provides a more specific and long-lasting defense along with opsonization and complement activation.\n\nStep 4: The correct answer is that the primary defense involves Immunoglobulin IgG.\n\nFinal answer: A. Immunoglobulin- IgG",
            "Step 1: Staphylococcal scalded skin syndrome (SSSS) is caused by an exotoxin produced by Staphylococcus aureus. The toxin leads to the separation of the superficial epidermal layers. One of the main mechanisms the body uses to defend itself against such toxins (and the bacteria producing them) is the production of neutralizing antibodies.\n\nStep 2: Among immunoglobulins, IgG is the predominant class in serum and is most effective at binding toxins and facilitating opsonization of bacteria for clearance by phagocytic cells. IgM is usually the first antibody produced during an initial immune response, but for toxin neutralization and long-term protective immunity, IgG plays the key role. IgA primarily protects mucosal surfaces, and IgD is mainly a receptor on B cells rather than a secreted antibody involved in toxin neutralization.\n\nStep 3: Therefore, the best answer for the primary defense against the bacteria and its toxins in a case like SSSS is Immunoglobulin IgG.\n\nFinal answer: A. Immunoglobulin- IgG",
            "Step 1: Review the Clinical Scenario and Diagnosis\n\u2022 The patient is an 11-month-old boy with a rash characterized by thin-walled, fluid-filled blisters that rupture easily.\n\u2022 Fluid analysis indicates Gram-positive Staphylococcus aureus.\n\u2022 He is diagnosed with staphylococcal scalded skin syndrome (SSSS), which is mediated by exotoxins produced by S. aureus.\n\nStep 2: Identify the Required Defense Mechanism\n\u2022 The question asks which immunoglobulin is involved in the primary defense response to the bacteria and the toxins it produces.\n\u2022 In SSSS, the toxins released by S. aureus are neutralized by the host\u2019s antibody response. The most significant antibodies that neutralize circulating toxins and also opsonize bacteria to aid in phagocytosis are IgG.\n\nStep 3: Evaluate the Answer Choices\nA. Immunoglobulin IgG \u2013 The most abundant immunoglobulin in the serum. IgG neutralizes toxins and enhances opsonization, which is critical for defense against S. aureus exotoxins.\nB. Immunoglobulin IgD \u2013 Primarily functions as a receptor on B cells and has a minimal role in circulating toxin neutralization.\nC. Immunoglobulin IgA \u2013 Involved in mucosal immunity and protection of mucosal surfaces, not the major immunoglobulin for systemic toxin neutralization.\nD. Immunoglobulin IgM \u2013 Although it is produced early in an immune response and activates complement, it is not the primary immunoglobulin for neutralizing bacterial toxins.\n\nStep 4: Conclude with the Final Answer\nThe immunoglobulin primarily involved in neutralizing the toxins produced by S. aureus, as well as in opsonizing the bacteria, is Immunoglobulin IgG.\n\nFinal Answer: A. Immunoglobulin IgG"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Review the Clinical Scenario and Diagnosis\n\u2022 The patient is an 11-month-old boy with a rash characterized by thin-walled, fluid-filled blisters that rupture easily.\n\u2022 Fluid analysis indicates Gram-positive Staphylococcus aureus.\n\u2022 He is diagnosed with staphylococcal scalded skin syndrome (SSSS), which is mediated by exotoxins produced by S. aureus.\n\nStep 2: Identify the Required Defense Mechanism\n\u2022 The question asks which immunoglobulin is involved in the primary defense response to the bacteria and the toxins it produces.\n\u2022 In SSSS, the toxins released by S. aureus are neutralized by the host\u2019s antibody response. The most significant antibodies that neutralize circulating toxins and also opsonize bacteria to aid in phagocytosis are IgG.\n\nStep 3: Evaluate the Answer Choices\nA. Immunoglobulin IgG \u2013 The most abundant immunoglobulin in the serum. IgG neutralizes toxins and enhances opsonization, which is critical for defense against S. aureus exotoxins.\nB. Immunoglobulin IgD \u2013 Primarily functions as a receptor on B cells and has a minimal role in circulating toxin neutralization.\nC. Immunoglobulin IgA \u2013 Involved in mucosal immunity and protection of mucosal surfaces, not the major immunoglobulin for systemic toxin neutralization.\nD. Immunoglobulin IgM \u2013 Although it is produced early in an immune response and activates complement, it is not the primary immunoglobulin for neutralizing bacterial toxins.\n\nStep 4: Conclude with the Final Answer\nThe immunoglobulin primarily involved in neutralizing the toxins produced by S. aureus, as well as in opsonizing the bacteria, is Immunoglobulin IgG.\n\nFinal Answer: A. Immunoglobulin IgG"
    },
    {
        "realidx": 155,
        "question": "A 19-year-old man is brought to the emergency department by ambulance because of unusual behavior that started 3 hours ago while he was at a party. He has a history of major depressive disorder and seasonal allergies. His mother has a history of anxiety. He drinks 5 beers on the weekends. Current medications include amitriptyline and diphenhydramine. The patient does not respond to questions and repeatedly says, \"\"The government is following me everywhere.\"\" His temperature is 37.9\u00b0C (100.2\u00b0F), pulse is 115/min, respirations are 24/min, and blood pressure is 160/89 mm Hg. He is diaphoretic. He is not oriented to place or time. Neurologic examination shows dilated pupils bilaterally and diffuse hyperreflexia. His feet are cold, and capillary refill time is 3 seconds. After the examination, the patient starts screaming and tries to bite the physician. Urine toxicology screening is positive for ethyl glucuronide. Which of the following is the most likely explanation for this patient's symptoms?\"",
        "answer": "Synthetic cathinone intoxication",
        "options": {
            "A": "Brief psychotic disorder",
            "B": "Neuroleptic malignant syndrome",
            "C": "Anticholinergic toxicity",
            "D": "Synthetic cathinone intoxication"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man",
            "brought",
            "emergency department",
            "ambulance",
            "unusual behavior",
            "started 3 hours",
            "party",
            "history of major depressive disorder",
            "seasonal allergies",
            "mother",
            "history",
            "anxiety",
            "drinks 5 beers",
            "weekends",
            "Current medications include amitriptyline",
            "diphenhydramine",
            "patient",
            "not",
            "questions",
            "repeatedly",
            "government",
            "following",
            "temperature",
            "100",
            "pulse",
            "min",
            "respirations",
            "min",
            "blood pressure",
            "mm Hg",
            "diaphoretic",
            "not oriented to place",
            "time",
            "Neurologic examination shows dilated pupils",
            "diffuse hyperreflexia",
            "feet",
            "cold",
            "capillary refill time",
            "3 seconds",
            "examination",
            "patient starts screaming",
            "to bite",
            "physician",
            "Urine toxicology",
            "positive",
            "ethyl glucuronide",
            "following",
            "most likely explanation",
            "patient",
            "ymptoms?"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6909,
            "completion_tokens": 5470
        },
        "time_elapsed": 39.97090435028076,
        "raw_responses": [
            "Step 1: Analyze the clinical presentation. The patient is a 19\u2010year\u2010old man who, following a party, exhibits agitation, delusional paranoid ideation (\"The government is following me everywhere\"), disorientation, combativeness, tachycardia, hypertension, and hyperreflexia. Notably, his physical exam is marked by diaphoretic skin and dilated pupils.\n\nStep 2: Consider the possible toxicologic or psychiatric etiologies.\n\n\u2022 Brief psychotic disorder (Option A) might explain acute psychosis, but it would not account for the significant autonomic instability (tachycardia, hypertension, diaphoresis) or hyperreflexia seen here.\n\n\u2022 Neuroleptic malignant syndrome (Option B) is associated with the use of antipsychotics and is characterized by severe rigidity, muscle pain, fever, and altered mental status. The patient\u2019s medication history (amitriptyline and diphenhydramine) is not consistent with this disorder, and the exam does not reveal the \"lead-pipe\" rigidity typical of NMS.\n\n\u2022 Anticholinergic toxicity (Option C) could produce symptoms such as mydriasis and confusion, but it usually causes dry, flushed skin rather than diaphoresis. In this case, the patient is diaphoretic, which argues against an anticholinergic syndrome.\n\n\u2022 Synthetic cathinone intoxication (Option D), often associated with \u201cbath salts,\u201d fits the clinical picture. These substances can cause severe agitation, delirium, paranoia, autonomic hyperactivity, and combativeness. They are not detected on standard urine toxicology screens, which is consistent with the fact that although his screening is positive for ethyl glucuronide (indicating recent alcohol ingestion), the exam findings suggest another agent is responsible for his symptoms. Synthetic cathinones are known to cause sympathomimetic effects (elevated heart rate and blood pressure), as well as neurological manifestations like hyperreflexia and combativeness.\n\nStep 3: Compare and eliminate the options. Based on the signs of autonomic hyperactivity, neurologic excitation, combativeness, and the context of party drug use, synthetic cathinone intoxication (Option D) is the most consistent with these findings.\n\nFinal Answer: D. Synthetic cathinone intoxication.",
            "Step 1: Review the patient\u2019s presentation.  \n\u2022 The patient is a 19\u2010year\u2010old male with acute onset of bizarre, paranoid behavior and agitation that started 3 hours ago at a party.  \n\u2022 Vital signs reveal tachycardia (115/min), hypertension (160/89 mm Hg), mildly elevated temperature (37.9\u00b0C), and increased respirations (24/min).  \n\u2022 On exam, he demonstrates dilated pupils and diffuse hyperreflexia and is diaphoretic. His altered mental status, agitation, and even aggressive behavior (screaming, trying to bite) are noted.  \n\u2022 Urine toxicology is positive for ethyl glucuronide, indicating recent alcohol use, but the clinical picture suggests an additional substance.\n\nStep 2: Compare the answer choices based on the presentation.  \nA. Brief Psychotic Disorder  \n\u2003\u2013 Typically does not present with significant autonomic instability (tachycardia, hypertension) or hyperreflexia.  \nB. Neuroleptic Malignant Syndrome  \n\u2003\u2013 Usually occurs in patients on antipsychotics and is characterized by severe rigidity and high fever. Our patient\u2019s history and exam features (e.g., diaphoresis without \u201clead-pipe\u201d rigidity) do not match this syndrome.  \nC. Anticholinergic Toxicity  \n\u2003\u2013 Although amitriptyline and diphenhydramine have anticholinergic properties and could cause mydriasis, anticholinergic toxicity usually presents with dry skin (anhidrosis), urinary retention, and decreased bowel sounds. This patient is diaphoretic, which is not consistent with an anticholinergic syndrome.  \nD. Synthetic Cathinone Intoxication  \n\u2003\u2013 Synthetic cathinones (\u201cbath salts\u201d) are stimulants that can cause severe agitation, paranoia, hallucinations, tachycardia, hypertension, hyperthermia, and hyperreflexia. Diaphoresis is common as well. The patient's symptoms, timeline (after a party), and autonomic signs strongly point toward intoxication with a synthetic cathinone.\n\nStep 3: Final Answer  \nThe constellation of symptoms\u2014acute onset of agitation, paranoia, autonomic hyperactivity (tachycardia, hypertension, mild hyperthermia), hyperreflexia, diaphoresis, and the behavioral aggression\u2014is most consistent with synthetic cathinone intoxication.\n\nFinal answer: D. Synthetic cathinone intoxication",
            "Step 1: Analyze the Presentation\n\u2022 The patient is a 19-year-old man brought in after unusual behavior at a party.\n\u2022 He exhibits delusions (\"The government is following me everywhere\"), disorientation (not oriented to place or time), agitation (screaming and attempting to bite), and significant autonomic instability, including tachycardia, hypertension, and hyperreflexia.\n\u2022 Physical exam also reveals dilated pupils and diaphoresis, along with cold extremities (trimodal cap refill time).\n\nStep 2: Evaluate the Options\nA. Brief Psychotic Disorder \u2013 While the patient has some psychotic features (delusions), his marked autonomic instability (tachycardia, hypertension, hyperreflexia) and combativeness are less typical for a primary psychotic disorder and more indicative of a substance intoxication.\nB. Neuroleptic Malignant Syndrome \u2013 This syndrome is typically related to the use of antipsychotic medications and is characterized by rigidity, high fever, and altered mental status. This patient is not on antipsychotics, and his temperature is not markedly high.\nC. Anticholinergic Toxicity \u2013 Although his medications (amitriptyline and diphenhydramine) have anticholinergic properties which can cause confusion and mydriasis, anticholinergic toxicity is usually associated with dry skin and mucous membranes, whereas this patient is diaphoretic.\nD. Synthetic Cathinone Intoxication \u2013 Known as \"bath salts,\" synthetic cathinones are stimulants that can cause severe agitation, delusions, combativeness, autonomic instability (tachycardia and hypertension), hyperreflexia, and mydriasis. The setting (a party) and the aggressive, disorganized behavior strongly support this diagnosis.\n\nStep 3: Final Answer\nThe most likely explanation for this patient\u2019s symptoms is D. Synthetic cathinone intoxication."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation. The patient is a 19\u2010year\u2010old man who, following a party, exhibits agitation, delusional paranoid ideation (\"The government is following me everywhere\"), disorientation, combativeness, tachycardia, hypertension, and hyperreflexia. Notably, his physical exam is marked by diaphoretic skin and dilated pupils.\n\nStep 2: Consider the possible toxicologic or psychiatric etiologies.\n\n\u2022 Brief psychotic disorder (Option A) might explain acute psychosis, but it would not account for the significant autonomic instability (tachycardia, hypertension, diaphoresis) or hyperreflexia seen here.\n\n\u2022 Neuroleptic malignant syndrome (Option B) is associated with the use of antipsychotics and is characterized by severe rigidity, muscle pain, fever, and altered mental status. The patient\u2019s medication history (amitriptyline and diphenhydramine) is not consistent with this disorder, and the exam does not reveal the \"lead-pipe\" rigidity typical of NMS.\n\n\u2022 Anticholinergic toxicity (Option C) could produce symptoms such as mydriasis and confusion, but it usually causes dry, flushed skin rather than diaphoresis. In this case, the patient is diaphoretic, which argues against an anticholinergic syndrome.\n\n\u2022 Synthetic cathinone intoxication (Option D), often associated with \u201cbath salts,\u201d fits the clinical picture. These substances can cause severe agitation, delirium, paranoia, autonomic hyperactivity, and combativeness. They are not detected on standard urine toxicology screens, which is consistent with the fact that although his screening is positive for ethyl glucuronide (indicating recent alcohol ingestion), the exam findings suggest another agent is responsible for his symptoms. Synthetic cathinones are known to cause sympathomimetic effects (elevated heart rate and blood pressure), as well as neurological manifestations like hyperreflexia and combativeness.\n\nStep 3: Compare and eliminate the options. Based on the signs of autonomic hyperactivity, neurologic excitation, combativeness, and the context of party drug use, synthetic cathinone intoxication (Option D) is the most consistent with these findings.\n\nFinal Answer: D. Synthetic cathinone intoxication."
    },
    {
        "realidx": 160,
        "question": "A 5-year-old boy of African descent is presented to the emergency department by his parents. The child is clutching his abdomen and crying about pain in his belly. His mother reports intermittent episodes of jaundice with joint and bone pain since he was 5 months old. At presentation, the patient\u2019s vital signs are within normal limits. Physical examination reveals slight jaundice and pale conjunctiva. The spleen is tender and easily palpable. After a complete blood count with differential and an abdominal ultrasound, the patient is found to have sickle-cell disease with splenic infarct. A partial splenectomy is performed. After the operation, the physician provides vaccines against Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae. The picture shows a slide obtained from the resected portion of the patient\u2019s spleen. Dysfunction of the zone marked with which number predisposes the patient to the aforementioned infections?",
        "answer": "1 and 2",
        "options": {
            "A": "2 only",
            "B": "1 only",
            "C": "1 and 2",
            "D": "1, 2, and 3"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "5 year old boy",
            "African descent",
            "presented",
            "emergency department",
            "parents",
            "child",
            "abdomen",
            "crying",
            "pain",
            "belly",
            "mother reports intermittent episodes of jaundice",
            "joint",
            "bone pain",
            "5 months old",
            "presentation",
            "patients vital signs",
            "normal",
            "Physical examination reveals slight jaundice",
            "pale conjunctiva",
            "spleen",
            "tender",
            "easily palpable",
            "complete blood count",
            "differential",
            "abdominal ultrasound",
            "patient",
            "found to",
            "sickle-cell disease",
            "splenic infarct",
            "partial splenectomy",
            "performed",
            "operation",
            "physician provides vaccines",
            "Neisseria meningitidis",
            "Haemophilus influenzae",
            "Streptococcus pneumoniae",
            "picture shows",
            "slide obtained",
            "resected portion of",
            "patients spleen",
            "Dysfunction",
            "zone marked",
            "number",
            "patient",
            "infections"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4938,
            "completion_tokens": 3781
        },
        "time_elapsed": 33.82057785987854,
        "raw_responses": [
            "Step 1: Recognize the patient\u2019s risk factors and reason for immunizations.\n\u2022 This 5\u2010year\u2010old with sickle-cell disease underwent partial splenectomy due to a splenic infarct.\n\u2022 The spleen normally filters blood and, importantly, clears encapsulated bacteria (e.g., Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae).\n\u2022 Splenic dysfunction increases the risk of severe infections by these bacteria, which is why the patient received appropriate vaccines.\n\nStep 2: Identify the relevant splenic zone.\n\u2022 The spleen\u2019s histologic architecture includes three main zones: the white pulp (lymphoid tissue), the marginal zone, and the red pulp.\n\u2022 The marginal zone is located at the interface between the white and red pulp.\n\u2022 It is rich in specialized B cells that are critical for producing IgM antibodies to quickly respond to bloodborne, encapsulated organisms.\n\u2022 Dysfunction or loss of the marginal zone, as seen in asplenic (or functionally hyposplenic) patients, predisposes to infections by these encapsulated organisms.\n\nStep 3: Identify the correct option.\n\u2022 Based on the description and numbering in the provided slide (with \u201czone 2\u201d corresponding to the marginal zone), dysfunction of zone 2 is responsible for the increased infection risk.\n\u2022 Therefore, the correct answer is \u201c2 only.\u201d\n\nFinal Answer: A. 2 only",
            "Step 1: In patients with sickle cell disease, repeated splenic infarcts eventually lead to functional asplenia. The spleen is vital in filtering bacteria, particularly encapsulated organisms (Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae) due to its specialized histologic regions.\n\nStep 2: The spleen is composed of white pulp (which contains lymphoid tissue), the red pulp (responsible for filtering blood and removing defective red cells), and the marginal zone. The marginal zone (often marked as number 2 in histologic diagrams) is especially important because it houses macrophages and B cells that capture antigens from the blood. Dysfunction in this zone impairs the clearance of encapsulated bacteria.\n\nStep 3: Based on the options provided, the correct answer is the dysfunction of the marginal zone only, which is denoted as number 2.\n\nFinal Answer: A. 2 only",
            "We can begin by recalling that the spleen is divided into three main regions: the white pulp (which contains periarteriolar lymphoid sheaths [PALS] and lymphoid nodules), the marginal zone, and the red pulp. The marginal zone, which is the transitional area between the white pulp and red pulp (often marked as \u201c2\u201d in schematic diagrams), is especially important because it contains specialized B cells that rapidly produce IgM. This rapid IgM response is vital for opsonizing encapsulated organisms such as Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae.\n\nIn patients with sickle-cell disease, repeated splenic infarcts (or even partial splenectomy) result in loss of splenic function, particularly affecting the marginal zone. Dysfunction in this area severely impairs the body\u2019s response against encapsulated bacteria.\n\nStep by step:\n1. The patient\u2019s history of sickle-cell disease with splenic infarct is the key point.\n2. Loss of the immunologic function against encapsulated organisms is most closely linked to impairment in the marginal zone.\n3. The diagram of the spleen would typically label the marginal zone as \u201c2.\u201d\n\nThus, the dysfunction that predisposes the patient to these infections is that of the marginal zone, corresponding to number 2.\n\nFinal Answer: Option A: 2 only."
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "2"
        ],
        "final_solution": "We can begin by recalling that the spleen is divided into three main regions: the white pulp (which contains periarteriolar lymphoid sheaths [PALS] and lymphoid nodules), the marginal zone, and the red pulp. The marginal zone, which is the transitional area between the white pulp and red pulp (often marked as \u201c2\u201d in schematic diagrams), is especially important because it contains specialized B cells that rapidly produce IgM. This rapid IgM response is vital for opsonizing encapsulated organisms such as Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae.\n\nIn patients with sickle-cell disease, repeated splenic infarcts (or even partial splenectomy) result in loss of splenic function, particularly affecting the marginal zone. Dysfunction in this area severely impairs the body\u2019s response against encapsulated bacteria.\n\nStep by step:\n1. The patient\u2019s history of sickle-cell disease with splenic infarct is the key point.\n2. Loss of the immunologic function against encapsulated organisms is most closely linked to impairment in the marginal zone.\n3. The diagram of the spleen would typically label the marginal zone as \u201c2.\u201d\n\nThus, the dysfunction that predisposes the patient to these infections is that of the marginal zone, corresponding to number 2.\n\nFinal Answer: Option A: 2 only."
    },
    {
        "realidx": 171,
        "question": "A 38-year-old G4P3 presents to her obstetrician\u2019s office for her 20-week anatomy ultrasound. She reports that she feels well and has not experienced any contractions or vaginal bleeding. She also reports good fetal movement. The patient declined prenatal screening earlier in the pregnancy for religious reasons but would now like an anatomy ultrasound to ensure the fetus is growing appropriately. The patient\u2019s previous pregnancies were uncomplicated, and she delivered three healthy babies at full term. On the ultrasound, the technician observes a male fetus with likely intrauterine growth restriction (IUGR). She also notes microcephaly, convex-rounded feet, and clenched fists with overlapping fingers. The technician further notes a medium-sized ventricular septal defect (VSD). The amniotic fluid index (AFI) is 26 cm.\n\nWhich of the following additional findings is most likely to be observed in this fetus?",
        "answer": "Prominent occiput",
        "options": {
            "A": "Cleft palate",
            "B": "Epicanthal folds",
            "C": "Micropthlamia",
            "D": "Prominent occiput"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old",
            "presents",
            "obstetricians office",
            "20 week anatomy ultrasound",
            "reports",
            "feels well",
            "not experienced",
            "contractions",
            "vaginal bleeding",
            "reports good fetal movement",
            "patient",
            "prenatal screening earlier",
            "pregnancy",
            "religious reasons",
            "now",
            "anatomy ultrasound to ensure",
            "fetus",
            "patients previous pregnancies",
            "uncomplicated",
            "delivered three healthy babies",
            "full term",
            "ultrasound",
            "technician observes",
            "male fetus",
            "likely intrauterine growth restriction",
            "notes microcephaly",
            "convex rounded feet",
            "clenched fists",
            "overlapping fingers",
            "technician further notes",
            "medium sized ventricular septal defect",
            "amniotic fluid index",
            "following additional findings",
            "most likely to",
            "observed",
            "fetus"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4290,
            "completion_tokens": 3664
        },
        "time_elapsed": 111.25297951698303,
        "raw_responses": [
            "Step 1: Recognize that the ultrasound findings (IUGR, microcephaly, convex\u2010rounded/rocker-bottom feet, clenched fists with overlapping fingers, and a VSD) are classic features of Edwards syndrome (Trisomy 18).\n\nStep 2: Review the options:\n\u2022 Cleft palate: Not a characteristic finding of trisomy 18.\n\u2022 Epicanthal folds: More typically associated with trisomy 21 (Down syndrome).\n\u2022 Micropthlamia: Likely intended to mean microphthalmia, which is not a classic feature of trisomy 18.\n\u2022 Prominent occiput: This is a well-recognized finding in fetuses with trisomy 18.\n\nStep 3: Based on the findings and the elimination of other options, the additional finding most likely in this fetus is a prominent occiput.\n\nFinal answer: D. Prominent occiput",
            "Step 1: Recognize the overall syndrome.  \nThe fetus shows signs of intrauterine growth restriction, microcephaly, rocker-bottom feet (convex-rounded feet), clenched fists with overlapping fingers, and a ventricular septal defect. These findings are classic for Edwards syndrome (trisomy 18).\n\nStep 2: Compare the options relative to trisomy 18.  \n\u2022 Option A (Cleft palate) \u2013 More commonly seen in trisomy 13 (Patau syndrome) than in trisomy 18.  \n\u2022 Option B (Epicanthal folds) \u2013 Typically associated with trisomy 21 (Down syndrome) rather than trisomy 18.  \n\u2022 Option C (Microphthalmia) \u2013 Occurs with trisomy 13 as well, not a common feature of trisomy 18.  \n\u2022 Option D (Prominent occiput) \u2013 A well-recognized feature in fetuses with trisomy 18.\n\nStep 3: Final Answer  \nThe additional finding most likely to be observed in this fetus is a prominent occiput.",
            "Step 1: The ultrasound findings along with IUGR, microcephaly, rocker-bottom (convex-rounded) feet, clenched fists with overlapping fingers, VSD, and polyhydramnios suggest the fetus is affected by trisomy 18 (Edwards syndrome).\n\nStep 2: In trisomy 18, additional common features include a prominent occiput, low-set ears, and micrognathia. Other listed findings like cleft palate (more common in trisomy 13), epicanthal folds (more often seen in trisomy 21), and micropthalmia (associated with trisomy 13) are less likely in Edwards syndrome.\n\nStep 3: The most likely additional finding is a prominent occiput.\n\nFinal answer: D. Prominent occiput"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: The ultrasound findings along with IUGR, microcephaly, rocker-bottom (convex-rounded) feet, clenched fists with overlapping fingers, VSD, and polyhydramnios suggest the fetus is affected by trisomy 18 (Edwards syndrome).\n\nStep 2: In trisomy 18, additional common features include a prominent occiput, low-set ears, and micrognathia. Other listed findings like cleft palate (more common in trisomy 13), epicanthal folds (more often seen in trisomy 21), and micropthalmia (associated with trisomy 13) are less likely in Edwards syndrome.\n\nStep 3: The most likely additional finding is a prominent occiput.\n\nFinal answer: D. Prominent occiput"
    },
    {
        "realidx": 178,
        "question": "A 40-year-old businessman who was previously well is brought into the emergency department by his assistant with a complaint of left-sided weakness after a chiropractic neck manipulation. He has never felt like this before. Past medical history is insignificant. His blood pressure is 125/75 mm Hg, pulse 86/min, respiratory rate 13/min, temperature 36.8\u00b0C (98.2\u00b0F). A T2-weighted MRI shows a left C5 hemicord lesion. The patient is treated with cervical immobilization, a course of steroids, and physical therapy. What other finding will most likely be seen in this patient?",
        "answer": "Right-sided analgesia",
        "options": {
            "A": "Spastic paralysis at the level of lesion",
            "B": "Right-sided Horner's syndrome",
            "C": "Contralateral corticospinal tract involvement",
            "D": "Right-sided analgesia"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "40 year old",
            "well",
            "brought",
            "emergency department",
            "assistant",
            "complaint",
            "left-sided weakness",
            "chiropractic neck",
            "never felt",
            "before",
            "Past medical history",
            "blood pressure",
            "75 mm Hg",
            "pulse",
            "min",
            "respiratory rate",
            "min",
            "temperature 36",
            "98",
            "T2 weighted MRI shows",
            "left",
            "lesion",
            "patient",
            "treated with cervical immobilization",
            "course",
            "steroids",
            "physical therapy",
            "finding",
            "most likely",
            "seen",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5103,
            "completion_tokens": 3842
        },
        "time_elapsed": 66.91549515724182,
        "raw_responses": [
            "Step 1: Recognize that the description is consistent with Brown-Sequard syndrome\u2014a hemisection of the spinal cord.\n\nStep 2: Recall that Brown-Sequard syndrome causes:\n\u2003\u2022 Ipsilateral loss of motor function (UMN signs below the lesion) and loss of proprioception/dorsal column function.\n\u2003\u2022 Contralateral loss of pain and temperature sensation starting a few segments below the lesion (due to the crossing of the spinothalamic tract).\n\nStep 3: Evaluate the options:\n\u2003A. Spastic paralysis at the level of the lesion \u2013 Although spastic paralysis (UMN signs) may be present, it affects regions below the level of the lesion rather than at the precise level.\n\u2003B. Right-sided Horner's syndrome \u2013 Horner\u2019s syndrome can occur with lesions affecting the sympathetic pathway, but in cervical lesions, it would be ipsilateral. \u201cRight-sided\u201d is incorrect.\n\u2003C. Contralateral corticospinal tract involvement \u2013 The corticospinal tract decussates in the medulla, so within the cord, its involvement produces ipsilateral deficits, not contralateral.\n\u2003D. Right-sided analgesia \u2013 This finding is consistent with the contralateral loss of pain and temperature sensation seen in Brown-Sequard syndrome.\n\nStep 4: The best answer is:\nD. Right-sided analgesia.",
            "Step 1: Recognize that the patient\u2019s T2-weighted MRI shows a left C5 hemicord lesion, which is characteristic of Brown-S\u00e9quard syndrome. In this syndrome, damage to one half of the spinal cord leads to a pattern of deficits: \n\n\u2022 Ipsilateral (same side as the lesion) loss of proprioception and motor function (upper motor neuron findings, such as spastic paralysis below the level of the lesion).  \n\u2022 Contralateral (opposite side) loss of pain and temperature sensation below the level of the lesion due to damage to the decussating spinothalamic fibers.\n\nStep 2: Review the options:\n\nA. Spastic paralysis at the level of lesion \u2013 Brown-S\u00e9quard syndrome causes ipsilateral spastic paralysis, but this is already reflected in the patient\u2019s left-sided weakness and would not be an \u201cadditional\u201d finding.  \nB. Right-sided Horner's syndrome \u2013 Horner's syndrome would involve ptosis, miosis, and anhidrosis and is not a typical feature of a Brown-S\u00e9quard lesion at C5.  \nC. Contralateral corticospinal tract involvement \u2013 The corticospinal tract decussates in the medulla and runs ipsilaterally in the spinal cord. Thus, damage to one side of the spinal cord affects ipsilateral motor function, not contralateral, making this choice less applicable.  \nD. Right-sided analgesia \u2013 In Brown-S\u00e9quard syndrome, the contralateral spinothalamic tract is affected, producing loss of pain and temperature sensation on the side opposite the lesion (right-sided in this case).\n\nStep 3: The most likely additional finding, given his left-sided hemicord lesion, is right-sided loss of pain and temperature sensation (right-sided analgesia).\n\nFinal Answer: D. Right-sided analgesia",
            "Step 1: Recognize the presentation as Brown-Sequard syndrome. This syndrome results from a hemisection of the spinal cord\u2014in this case at the left C5 level. It produces ipsilateral deficits (weakness and loss of proprioception/vibration sense) below the level of the lesion, and contralateral loss of pain and temperature sensation due to the crossing of the spinothalamic tract.\n\nStep 2: Examine the options:\n\n\u2022 Option A (Spastic paralysis at the level of lesion) is imprecise. While the patient may develop spastic paralysis below the level on the same side (left), saying \u201cat the level of lesion\u201d might not fully capture the classic pattern.\n\n\u2022 Option B (Right-sided Horner's syndrome) is not a classic feature of Brown-Sequard syndrome, especially with a lesion at C5, where sympathetic chain involvement is less common.\n\n\u2022 Option C (Contralateral corticospinal tract involvement) is misleading because the corticospinal tract decussates in the lower medulla. A left-sided cord lesion would cause ipsilateral (left-sided) motor deficits below the lesion rather than contralateral involvement.\n\n\u2022 Option D (Right-sided analgesia) correctly describes the expected loss of pain and temperature sensation on the right side below the level of the lesion, which is characteristic of Brown-Sequard syndrome.\n\nStep 3: Final Answer:\nD: Right-sided analgesia"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Recognize the presentation as Brown-Sequard syndrome. This syndrome results from a hemisection of the spinal cord\u2014in this case at the left C5 level. It produces ipsilateral deficits (weakness and loss of proprioception/vibration sense) below the level of the lesion, and contralateral loss of pain and temperature sensation due to the crossing of the spinothalamic tract.\n\nStep 2: Examine the options:\n\n\u2022 Option A (Spastic paralysis at the level of lesion) is imprecise. While the patient may develop spastic paralysis below the level on the same side (left), saying \u201cat the level of lesion\u201d might not fully capture the classic pattern.\n\n\u2022 Option B (Right-sided Horner's syndrome) is not a classic feature of Brown-Sequard syndrome, especially with a lesion at C5, where sympathetic chain involvement is less common.\n\n\u2022 Option C (Contralateral corticospinal tract involvement) is misleading because the corticospinal tract decussates in the lower medulla. A left-sided cord lesion would cause ipsilateral (left-sided) motor deficits below the lesion rather than contralateral involvement.\n\n\u2022 Option D (Right-sided analgesia) correctly describes the expected loss of pain and temperature sensation on the right side below the level of the lesion, which is characteristic of Brown-Sequard syndrome.\n\nStep 3: Final Answer:\nD: Right-sided analgesia"
    },
    {
        "realidx": 196,
        "question": "A student studying pharmacology is a member of a team that is conducting research related to the elimination of multiple anticoagulant medications. His duty as a member of the team is to collect serum samples of the subjects every 4 hours and send them for analysis of serum drug levels. He is also supposed to collect, document and analyze the data. For one of the subjects, he notices that the subject is eliminating 0.5 mg of the drug every 4 hours. Which of the following anticoagulants did this patient most likely consume?",
        "answer": "Warfarin",
        "options": {
            "A": "Warfarin",
            "B": "Enoxaparin",
            "C": "Fondaparinux",
            "D": "Apixaban"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "student studying pharmacology",
            "member",
            "team",
            "conducting research related",
            "elimination",
            "multiple anticoagulant medications",
            "member",
            "team",
            "to",
            "serum samples",
            "subjects",
            "4 hours",
            "send",
            "analysis",
            "serum drug levels",
            "to",
            "document",
            "data",
            "one",
            "subjects",
            "subject",
            "0.5 mg",
            "drug",
            "4 hours",
            "following anticoagulants",
            "patient most likely"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5805,
            "completion_tokens": 13975
        },
        "time_elapsed": 94.95312881469727,
        "raw_responses": [
            "Step 1: Notice that the subject is eliminating a fixed amount of the drug (0.5 mg) every 4 hours. This measurement \u201cmg lost per unit time\u201d implies that at steady state the elimination is occurring in a roughly linear (first\u2010order) process that predicts a roughly constant fraction of the administered dose being cleared over time. For drugs given in doses measured in milligrams, the amount eliminated per day should roughly equal the maintenance dose.\n\nStep 2: Evaluate the options relative to their usual dosing and elimination patterns:\n\u2022 Warfarin is administered in mg (typically 2\u201310 mg daily) and is metabolized by hepatic enzymes. At therapeutic doses, its clearance is essentially linear so that, at steady state, a fixed amount can be eliminated over a set time. An elimination of 0.5 mg every 4 hours (i.e. 3 mg/day) is consistent with a typical warfarin dosing regimen.\n\u2022 Enoxaparin is a low molecular weight heparin, usually dosed in mg (or weight\u2010based units) subcutaneously and monitored by anti\u2013Xa levels rather than direct serum mg measurements.\n\u2022 Fondaparinux is dosed in small mg amounts (i.e., 2.5\u20137.5 mg daily), but its elimination is measured indirectly, and its pharmacokinetic profile is distinct from the pattern noted here.\n\u2022 Apixaban is a Factor Xa inhibitor dosed at 2.5\u20135 mg usually twice daily; this and its half\u2010life would not manifest as the consistent elimination of 0.5 mg every 4 hours.\n\nStep 3: Given that only warfarin is both dosed in mg and would be cleared at a rate that could correspond to the measurement of approximately 3 mg eliminated per day, the correct answer is:\n\nFinal answer: Warfarin",
            "Step 1: Recognize that the research team is measuring the amount of drug \u201celiminated\u201d (in mg) every 4 hours. This approach implies that the investigators are following the elimination kinetics of drugs dosed in mg with a relatively long half\u2010life where only a small portion is removed over a short interval.\n\nStep 2: Review the options and consider each drug\u2019s pharmacokinetics:\n\u2003\u2022 Warfarin is administered in mg and has a long half\u2010life (typically 36\u201342 hours), so only a small fraction of the total dose is eliminated in any 4\u2010hour period.\n\u2003\u2022 Enoxaparin (a low molecular weight heparin), Fondaparinux, and Apixaban are also dosed in mg, but they have shorter half\u2010lives (or, in the case of fondaparinux, a once\u2010daily dosing interval) such that a larger fraction would be cleared in 4 hours.\n\u2003\u2003\u2013 For example, a drug with a very short half\u2010life would show a more rapid decline in amount (a larger mg elimination over a fixed short time).\n\u2003\u2003\u2013 Apixaban\u2019s half\u2010life is around 12 hours, so elimination over 4 hours would be proportionally greater, and enoxaparin (given parenterally) is eliminated even faster.\n\nStep 3: Do a brief conceptual calculation for Warfarin. With a half\u2010life of roughly 36 hours, the elimination rate constant k \u2248 ln2/36 \u2248 0.0193 hr\u207b\u00b9. Over 4 hours the fraction eliminated would be:\n\u2003Fraction = 1 \u2013 e^(\u20130.0193\u00d74) \u2248 1 \u2013 e^(\u20130.0772) \u2248 1 \u2013 0.9257 \u2248 0.0743 (or about 7.4% of the dose).\nThus, if the patient\u2019s dose was around 7 mg, approximately 0.52 mg (\u22480.5 mg) would be eliminated over 4 hours. This aligns well with the observation.\n\nStep 4: By contrast, the other anticoagulants would have a significantly larger amount eliminated in a 4\u2010hour window due to their shorter half\u2010lives or dosing schedules.\n\nFinal Answer: Warfarin",
            "Step 1: Remember that when a drug\u2019s serum concentration declines by a fixed amount per unit time\u2014that is, a constant number of milligrams are \u201clost\u201d per time interval\u2014this is characteristic of zero\u2010order (constant rate) elimination. In contrast, first\u2010order kinetics means the rate of elimination is proportional to the current concentration of the drug.\n\nStep 2: When comparing anticoagulants:\n\u2022 Warfarin is a vitamin K antagonist that is metabolized hepatically by cytochrome P450 enzymes. In many drugs, including warfarin, the metabolism normally follows first\u2010order kinetics; however, once the enzymes become saturated (even at therapeutic levels in some drugs with narrow therapeutic windows) the drug may be eliminated at a fixed (zero\u2010order) rate.\n\u2022 Enoxaparin (a low molecular weight heparin), fondaparinux (a selective factor Xa inhibitor), and apixaban (an orally administered direct factor Xa inhibitor) are all eliminated in ways that are generally proportional to their concentrations (ie, first\u2010order kinetics).\n\nStep 3: In the scenario described the subject is \u201celiminating 0.5 mg of the drug every 4 hours\u201d \u2013 a constant amount over each time period. This pattern is best explained by a drug that is eliminated via a saturable mechanism such that its metabolism (or clearance) proceeds at a constant rate (zero\u2010order kinetics) rather than one that depends on the current concentration.\n\nStep 4: Of the options provided, Warfarin is the drug most likely to exhibit this fixed-rate elimination under saturating conditions (even though normally it is usually first order, its kinetics can become \u201ccapacity\u2010limited\u201d). The other agents are eliminated in a predictable first\u2010order manner.\n\nFinal Answer: A. Warfarin"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Recognize that the research team is measuring the amount of drug \u201celiminated\u201d (in mg) every 4 hours. This approach implies that the investigators are following the elimination kinetics of drugs dosed in mg with a relatively long half\u2010life where only a small portion is removed over a short interval.\n\nStep 2: Review the options and consider each drug\u2019s pharmacokinetics:\n\u2003\u2022 Warfarin is administered in mg and has a long half\u2010life (typically 36\u201342 hours), so only a small fraction of the total dose is eliminated in any 4\u2010hour period.\n\u2003\u2022 Enoxaparin (a low molecular weight heparin), Fondaparinux, and Apixaban are also dosed in mg, but they have shorter half\u2010lives (or, in the case of fondaparinux, a once\u2010daily dosing interval) such that a larger fraction would be cleared in 4 hours.\n\u2003\u2003\u2013 For example, a drug with a very short half\u2010life would show a more rapid decline in amount (a larger mg elimination over a fixed short time).\n\u2003\u2003\u2013 Apixaban\u2019s half\u2010life is around 12 hours, so elimination over 4 hours would be proportionally greater, and enoxaparin (given parenterally) is eliminated even faster.\n\nStep 3: Do a brief conceptual calculation for Warfarin. With a half\u2010life of roughly 36 hours, the elimination rate constant k \u2248 ln2/36 \u2248 0.0193 hr\u207b\u00b9. Over 4 hours the fraction eliminated would be:\n\u2003Fraction = 1 \u2013 e^(\u20130.0193\u00d74) \u2248 1 \u2013 e^(\u20130.0772) \u2248 1 \u2013 0.9257 \u2248 0.0743 (or about 7.4% of the dose).\nThus, if the patient\u2019s dose was around 7 mg, approximately 0.52 mg (\u22480.5 mg) would be eliminated over 4 hours. This aligns well with the observation.\n\nStep 4: By contrast, the other anticoagulants would have a significantly larger amount eliminated in a 4\u2010hour window due to their shorter half\u2010lives or dosing schedules.\n\nFinal Answer: Warfarin"
    },
    {
        "realidx": 198,
        "question": "A 28-year-old woman comes to the obstetrics and gynecology clinic because she has been unsuccessfully trying to conceive with her husband for the last 2 years. He has had 2 children from a previous marriage and has been tested for causes of male infertility. She has had prior abdominal surgery as well as a family history of endocrine abnormalities. Based on this history, a panel of tests are obtained and treatment is started. This treatment will be administered intermittently one week before her normal menstrual cycle. If the most likely drug prescribed in this case was administered in a different manner, which of the following conditions may also be treated by this drug?",
        "answer": "Prostate cancer",
        "options": {
            "A": "Diabetes",
            "B": "Parkinson disease",
            "C": "Polycystic ovarian syndrome",
            "D": "Prostate cancer"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old woman",
            "obstetrics",
            "gynecology clinic",
            "to",
            "husband",
            "last",
            "years",
            "2 children",
            "previous marriage",
            "tested",
            "causes",
            "male infertility",
            "prior abdominal surgery",
            "family history",
            "endocrine abnormalities",
            "Based",
            "history",
            "panel",
            "tests",
            "obtained",
            "treatment",
            "started",
            "treatment",
            "administered",
            "one week",
            "normal menstrual cycle",
            "most likely drug prescribed",
            "case",
            "administered",
            "different",
            "following conditions",
            "treated",
            "drug"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5808,
            "completion_tokens": 11424
        },
        "time_elapsed": 92.15491342544556,
        "raw_responses": [
            "Step 1: Recognize that the patient\u2019s presentation is that of a woman with infertility who is likely being treated with a medication to induce ovulation. The regimen described\u2014administering the drug intermittently approximately 1 week before the expected menstrual cycle\u2014is the classic protocol for clomiphene citrate, a selective estrogen receptor modulator (SERM).\n\nStep 2: Remember that clomiphene works by antagonizing estrogen receptors in the hypothalamus. This decreases negative feedback by estrogen, increases GnRH secretion, and ultimately raises follicle\u2010stimulating hormone (FSH) and luteinizing hormone (LH) levels to stimulate ovulation. It is classically used in women with infertility, including those with anovulatory cycles from causes such as polycystic ovarian syndrome (PCOS).\n\nStep 3: The question asks: \u201cIf the most likely drug prescribed in this case was administered in a different manner, which of the following conditions may also be treated by this drug?\u201d Although in this case it is used intermittently to induce ovulation, clomiphene (or analogous SERMs) is also used in other reproductive/endocrine conditions. In fact, one of its common uses is in patients with PCOS, a condition characterized by anovulatory cycles that can be treated with clomiphene to help induce ovulation.\n\nStep 4: Compare the options:\n\u2022 Diabetes \u2013 Not a target for SERMs.\n\u2022 Parkinson disease \u2013 Not managed by estrogen receptor modulation.\n\u2022 Polycystic ovarian syndrome \u2013 A condition in which clomiphene is frequently used to treat infertility by inducing ovulation.\n\u2022 Prostate cancer \u2013 Though hormone-altering therapies are used in prostate cancer, clomiphene citrate itself is not typically used for that indication.\n\nFinal Answer: C. Polycystic ovarian syndrome",
            "The key to this question is recognizing the significance of how a hormone-modulating drug\u2019s effect changes based on its administration schedule.\n\nStep 1. Identify the drug used for infertility:\n\u2022 A woman having difficulty conceiving is often treated with an agent that can induce ovulation.\n\u2022 One classic treatment is the use of a gonadotropin\u2010releasing hormone (GnRH) analog given intermittently (in a pulsatile pattern). Pulsatile GnRH stimulates the pituitary gland to secrete luteinizing hormone (LH) and follicle\u2010stimulating hormone (FSH), which in turn promotes ovulation.\n\u2022 (An alternative commonly used for ovulation induction is clomiphene citrate, a selective estrogen receptor modulator. However, clomiphene is specifically given intermittently early in the cycle, and the question\u2019s phrasing \u201cadministered in a different manner\u201d fits better with how GnRH analogs behave with altered dosing.)\n\nStep 2. Understand the effect of the administration method:\n\u2022 When GnRH analogs (such as leuprolide) are given in a pulsatile (intermittent) fashion, they stimulate the pituitary to release gonadotropins.\n\u2022 However, if the same GnRH analog is administered continuously (i.e., with constant exposure), it leads to receptor downregulation in the pituitary. This results in decreased secretion of LH and FSH, thereby reducing the production of ovarian and testicular sex hormones.\n\nStep 3. Connect to other conditions that could be managed by continuous administration:\n\u2022 Continuous GnRH analog administration is a strategy used to decrease sex hormone levels in hormone-dependent conditions.\n\u2022 One of the classic indications for continuous GnRH analog therapy is advanced prostate cancer, where lowering testosterone levels is beneficial.\n\nStep 4. Evaluate the answer choices:\nA. Diabetes \u2013 not treated by altering GnRH signaling.\nB. Parkinson disease \u2013 involves dopamine pathways; GnRH analogs aren\u2019t used here.\nC. Polycystic ovarian syndrome \u2013 although it involves infertility, this condition is actually managed with the intermittent protocols (e.g., with clomiphene or even pulsatile GnRH in select cases), not with the continuous regimen that would cause downregulation.\nD. Prostate cancer \u2013 continuous GnRH analog administration leads to decreased LH and, consequently, reduced testosterone production, which is useful in managing prostate cancer.\n\nFinal Answer: D. Prostate cancer",
            "Step 1: Recognize the infertility treatment strategy. The patient\u2019s history of infertility and the described regimen (\u201cadministered intermittently one week before her normal menstrual cycle\u201d) is consistent with a therapy aimed at inducing ovulation. Although clomiphene citrate is often used for ovulation induction, another important class of drugs used for this purpose is gonadotropin\u2010releasing hormone (GnRH) agonists. When GnRH agonists are given in a pulsatile (intermittent) fashion, they stimulate the secretion of LH and FSH to induce ovulation.\n\nStep 2: Understand the dual action of GnRH agonists. A classic teaching point is that the mode of administration of GnRH agonists determines their effect: pulsatile administration stimulates gonadotropin release (useful for treating infertility), whereas continuous administration leads to receptor downregulation and decreased gonadotropin secretion. This latter effect causes a hypoestrogenic state that is therapeutically useful in conditions like prostate cancer (by reducing testosterone production).\n\nStep 3: Compare the answer choices.  \n\u2022 Diabetes \u2013 Not treated by GnRH agonists.  \n\u2022 Parkinson disease \u2013 Not treated by GnRH agonists.  \n\u2022 Polycystic ovarian syndrome \u2013 Although clomiphene is used in this condition to induce ovulation, this option does not reflect the effect of different administration of a GnRH agonist.  \n\u2022 Prostate cancer \u2013 Continuous GnRH agonist administration is a standard treatment for prostate cancer by achieving chemical castration.\n\nFinal Answer: D. Prostate cancer"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "0"
        ],
        "final_solution": "The key to this question is recognizing the significance of how a hormone-modulating drug\u2019s effect changes based on its administration schedule.\n\nStep 1. Identify the drug used for infertility:\n\u2022 A woman having difficulty conceiving is often treated with an agent that can induce ovulation.\n\u2022 One classic treatment is the use of a gonadotropin\u2010releasing hormone (GnRH) analog given intermittently (in a pulsatile pattern). Pulsatile GnRH stimulates the pituitary gland to secrete luteinizing hormone (LH) and follicle\u2010stimulating hormone (FSH), which in turn promotes ovulation.\n\u2022 (An alternative commonly used for ovulation induction is clomiphene citrate, a selective estrogen receptor modulator. However, clomiphene is specifically given intermittently early in the cycle, and the question\u2019s phrasing \u201cadministered in a different manner\u201d fits better with how GnRH analogs behave with altered dosing.)\n\nStep 2. Understand the effect of the administration method:\n\u2022 When GnRH analogs (such as leuprolide) are given in a pulsatile (intermittent) fashion, they stimulate the pituitary to release gonadotropins.\n\u2022 However, if the same GnRH analog is administered continuously (i.e., with constant exposure), it leads to receptor downregulation in the pituitary. This results in decreased secretion of LH and FSH, thereby reducing the production of ovarian and testicular sex hormones.\n\nStep 3. Connect to other conditions that could be managed by continuous administration:\n\u2022 Continuous GnRH analog administration is a strategy used to decrease sex hormone levels in hormone-dependent conditions.\n\u2022 One of the classic indications for continuous GnRH analog therapy is advanced prostate cancer, where lowering testosterone levels is beneficial.\n\nStep 4. Evaluate the answer choices:\nA. Diabetes \u2013 not treated by altering GnRH signaling.\nB. Parkinson disease \u2013 involves dopamine pathways; GnRH analogs aren\u2019t used here.\nC. Polycystic ovarian syndrome \u2013 although it involves infertility, this condition is actually managed with the intermittent protocols (e.g., with clomiphene or even pulsatile GnRH in select cases), not with the continuous regimen that would cause downregulation.\nD. Prostate cancer \u2013 continuous GnRH analog administration leads to decreased LH and, consequently, reduced testosterone production, which is useful in managing prostate cancer.\n\nFinal Answer: D. Prostate cancer"
    },
    {
        "realidx": 202,
        "question": "A 48-year-old female presents for a follow-up appointment to discuss her ultrasound results. She presented with a lump in her neck 2 weeks ago. On examination, a thyroid nodule was present; the nodule was fixed, immobile, and non-tender. Ultrasound showed a hypoechoic nodule with a size of 2 cm. Histological examination of a fine needle biopsy was performed and cytological examination reported a likely suspicion of neoplasia. CT scan is performed to check for any lesions in the bones and/or lungs, common metastatic sites in this condition. Treatment with radioiodine therapy is planned after near-total thyroidectomy. Considering this tumor, which of the following is the most likely initial metastatic site in this patient?",
        "answer": "Inferior thyroid arteries",
        "options": {
            "A": "Trachea",
            "B": "Cervical lymph nodes",
            "C": "Inferior thyroid arteries",
            "D": "Thyrohyoid muscle"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "48 year old female presents",
            "follow-up appointment to discuss",
            "ultrasound results",
            "presented",
            "lump",
            "neck",
            "weeks",
            "examination",
            "thyroid nodule",
            "present",
            "nodule",
            "fixed",
            "immobile",
            "non-tender",
            "Ultrasound showed",
            "nodule",
            "size of",
            "Histological examination",
            "fine needle biopsy",
            "performed",
            "cytological examination reported",
            "likely suspicion",
            "neoplasia",
            "CT scan",
            "performed to check",
            "lesions",
            "bones",
            "lungs",
            "common metastatic sites",
            "condition",
            "Treatment",
            "radioiodine therapy",
            "planned",
            "total thyroidectomy",
            "Considering",
            "tumor",
            "following",
            "most likely initial metastatic site",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4218,
            "completion_tokens": 2336
        },
        "time_elapsed": 30.880439519882202,
        "raw_responses": [
            "Step 1: Recognize that the patient's presentation is most consistent with papillary carcinoma of the thyroid. This type of thyroid cancer is known to include features such as a fixed, non-tender, hypoechoic nodule on ultrasound and is typically evaluated by fine needle aspiration.\n\nStep 2: Recall that papillary thyroid carcinoma commonly metastasizes initially to the cervical lymph nodes.\n\nStep 3: Evaluate the options:\n\u2022 Trachea (Option A) \u2013 Not typically involved in the initial spread.\n\u2022 Cervical lymph nodes (Option B) \u2013 Common initial metastatic site for papillary carcinoma.\n\u2022 Inferior thyroid arteries (Option C) \u2013 Vascular structures are not the usual site of metastasis.\n\u2022 Thyrohyoid muscle (Option D) \u2013 Not typically a metastasis site.\n\nFinal Answer: B. Cervical lymph nodes",
            "Step 1: Recognize that the description of the thyroid nodule (hypoechoic, fixed, non-tender, and 2 cm in size) along with the cytological findings is highly suggestive of papillary thyroid carcinoma. This type of carcinoma is known for its lymphatic spread.\n\nStep 2: Papillary thyroid carcinoma typically metastasizes initially to regional cervical lymph nodes via the lymphatic system.\n\nStep 3: Reviewing the provided options:\n\u2003\u2013 Trachea (Option A) is less likely since direct invasion or metastasis to the trachea is rare in early staging.\n\u2003\u2013 Cervical lymph nodes (Option B) are the most common initial site of metastasis in papillary thyroid carcinoma.\n\u2003\u2013 Inferior thyroid arteries (Option C) do not represent a typical metastatic pathway.\n\u2003\u2013 Thyrohyoid muscle (Option D) is also not a common metastatic site.\n\nFinal answer: B. Cervical lymph nodes",
            "Step 1: Analyze the patient\u2019s presentation.\n\u2022 A 48-year-old female presents with a thyroid nodule that is fixed, immobile, and non-tender.\n\u2022 Ultrasound shows a 2 cm hypoechoic nodule.\n\u2022 Fine needle aspiration (FNA) suggests a neoplastic process.\n\u2022 The patient is scheduled for near-total thyroidectomy with planned radioactive iodine therapy.\n\u2022 These findings are most consistent with papillary thyroid carcinoma, the most common type of thyroid cancer.\n\nStep 2: Review metastatic patterns.\n\u2022 Papillary thyroid carcinoma typically spreads first to the cervical lymph nodes.\n\u2022 Other listed options (trachea, inferior thyroid arteries, thyrohyoid muscle) are not common initial sites for metastasis in this type of cancer.\n\nStep 3: Eliminate incorrect choices.\n\u2022 Option A (Trachea): Not a common site.\n\u2022 Option C (Inferior thyroid arteries): Not a typical site.\n\u2022 Option D (Thyrohyoid muscle): Not a common metastatic site.\n\nStep 4: Final Answer:\nThe most likely initial metastatic site in this patient is the cervical lymph nodes.\n\nAnswer: B. Cervical lymph nodes"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Analyze the patient\u2019s presentation.\n\u2022 A 48-year-old female presents with a thyroid nodule that is fixed, immobile, and non-tender.\n\u2022 Ultrasound shows a 2 cm hypoechoic nodule.\n\u2022 Fine needle aspiration (FNA) suggests a neoplastic process.\n\u2022 The patient is scheduled for near-total thyroidectomy with planned radioactive iodine therapy.\n\u2022 These findings are most consistent with papillary thyroid carcinoma, the most common type of thyroid cancer.\n\nStep 2: Review metastatic patterns.\n\u2022 Papillary thyroid carcinoma typically spreads first to the cervical lymph nodes.\n\u2022 Other listed options (trachea, inferior thyroid arteries, thyrohyoid muscle) are not common initial sites for metastasis in this type of cancer.\n\nStep 3: Eliminate incorrect choices.\n\u2022 Option A (Trachea): Not a common site.\n\u2022 Option C (Inferior thyroid arteries): Not a typical site.\n\u2022 Option D (Thyrohyoid muscle): Not a common metastatic site.\n\nStep 4: Final Answer:\nThe most likely initial metastatic site in this patient is the cervical lymph nodes.\n\nAnswer: B. Cervical lymph nodes"
    },
    {
        "realidx": 203,
        "question": "A 39-year-old man presents to his primary care physician because he has been having severe headaches and fever for the last 2 days. He also says his right eyelid has been painlessly swelling and is starting to block his vision from that eye. He recently returned from a tour of the world where he visited Thailand, Ethiopia, and Brazil. Otherwise his past medical history is unremarkable. On presentation, his temperature is 102\u00b0F (38.8\u00b0C), blood pressure is 126/81 mmHg, pulse is 125/min, and respirations are 13/min. Physical exam reveals a nontender swelling of the right eyelid, lymphadenopathy, and an indurated red patch with surrounding erythema and local swelling on his left leg. Which of the following drugs should be used to treat this patient's condition?",
        "answer": "Benznidazole",
        "options": {
            "A": "Benznidazole",
            "B": "Ivermectin",
            "C": "Mebendazol",
            "D": "Sodium stibogluconate"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man presents",
            "primary care physician",
            "severe headaches",
            "fever",
            "2 days",
            "right eyelid",
            "swelling",
            "starting to block",
            "vision",
            "eye",
            "recently returned",
            "tour",
            "world",
            "visited Thailand",
            "Ethiopia",
            "Brazil",
            "past medical history",
            "unremarkable",
            "presentation",
            "temperature",
            "blood pressure",
            "81 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "Physical exam reveals",
            "nontender swelling of",
            "right eyelid",
            "lymphadenopathy",
            "indurated red patch",
            "surrounding erythema",
            "local",
            "left",
            "following drugs",
            "used to treat",
            "patient's condition"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5175,
            "completion_tokens": 6020
        },
        "time_elapsed": 43.2603485584259,
        "raw_responses": [
            "Step 1: Recognize the clinical picture and travel history.\n\u2022 The patient presents with fever, severe headaches, and focal findings including a painless swelling on the right eyelid and an indurated, erythematous lesion on the left leg.\n\u2022 His recent travel to Thailand, Ethiopia, and Brazil raises concern for infections endemic to those regions.\n\nStep 2: Consider the differential diagnoses based on his symptoms and travel history.\n\u2022 The skin lesion and ocular involvement suggest a possible cutaneous (or mucocutaneous) process.\n\u2022 Leishmaniasis, which can present with localized skin lesions that sometimes involve the mucous membranes or periorbital area, is endemic in Brazil, Ethiopia, and parts of Asia (including Thailand).\n\nStep 3: Evaluate the treatment options provided.\n\u2022 Benznidazole is used for Chagas disease.\n\u2022 Ivermectin is indicated for conditions like onchocerciasis and strongyloidiasis.\n\u2022 Mebendazole is used as an anthelminthic for intestinal worm infections.\n\u2022 Sodium stibogluconate is a first-line treatment for cutaneous and mucocutaneous leishmaniasis.\n\nStep 4: Eliminate the incorrect choices.\n\u2022 Benznidazole, Ivermectin, and Mebendazole are not appropriate for treating leishmaniasis.\n\nFinal Answer: D. Sodium stibogluconate",
            "Step 1: Recognize key clinical features. This 39-year-old man presents with fever, severe headache, and a painless eyelid swelling. The right eyelid swelling (especially when unilateral and painless) strongly suggests Romana\u2019s sign. Additionally, the indurated red patch on his left leg is an important local lesion known as a chagoma\u2014the site of Trypanosoma cruzi inoculation.\n\nStep 2: Consider important epidemiological clues. His travel history, including a recent visit to Brazil, is significant because Chagas disease (American trypanosomiasis) is endemic in this region.\n\nStep 3: Correlate the diagnosis with the treatment options. Acute Chagas disease presents with signs such as fever, malaise, Romana\u2019s sign (periorbital edema), and a chagoma. Among the drug choices provided:\n\u2022 Benznidazole is used to treat Chagas disease.\n\u2022 Ivermectin and Mebendazole are used to treat parasitic infections unrelated to Chagas disease.\n\u2022 Sodium stibogluconate is used for leishmaniasis, not for Trypanosoma cruzi infections.\n\nStep 4: Final answer selection. Given the clinical scenario and aligning it with the appropriate treatment for acute Chagas disease, the correct treatment is Benznidazole.\n\nFinal Answer: Benznidazole.",
            "Step 1: Analyze the Patient\u2019s Presentation\n\u2022 The patient is a 39-year-old man with fever (102\u00b0F), headache, and a recent travel history to Thailand, Ethiopia, and Brazil.\n\u2022 He has a unilateral, nontender swelling of his right eyelid that is blocking his vision.\n\u2022 There is also lymphadenopathy and an indurated red patch with surrounding erythema on his left leg.\n\u2022 The nontender eyelid swelling is suggestive of Roma\u00f1a\u2019s sign, which is characteristic of acute Chagas disease (American trypanosomiasis). A similar lesion (a \u201cchagoma\u201d) is often present at the inoculation site, which in this case corresponds with the left leg findings.\n\nStep 2: Consider the Differential Diagnosis and Relevant Medications\n\u2022 Benznidazole is used to treat acute Chagas disease.\n\u2022 Ivermectin is used for certain parasitic infections (e.g., onchocerciasis), but the presentation (with a chagoma and Roma\u00f1a\u2019s sign) doesn\u2019t match that condition.\n\u2022 Mebendazole is an anthelminthic for worm infections and does not treat protozoal infections such as Chagas disease.\n\u2022 Sodium stibogluconate is the treatment for leishmaniasis, another tropical infection; however, the painless eyelid swelling (Roma\u00f1a\u2019s sign) and fever are more characteristic of acute T. cruzi infection.\n\nStep 3: Final Answer\nGiven the patient\u2019s clinical findings and travel history, the best treatment is Benznidazole.\n\nFinal answer: A. Benznidazole."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Recognize key clinical features. This 39-year-old man presents with fever, severe headache, and a painless eyelid swelling. The right eyelid swelling (especially when unilateral and painless) strongly suggests Romana\u2019s sign. Additionally, the indurated red patch on his left leg is an important local lesion known as a chagoma\u2014the site of Trypanosoma cruzi inoculation.\n\nStep 2: Consider important epidemiological clues. His travel history, including a recent visit to Brazil, is significant because Chagas disease (American trypanosomiasis) is endemic in this region.\n\nStep 3: Correlate the diagnosis with the treatment options. Acute Chagas disease presents with signs such as fever, malaise, Romana\u2019s sign (periorbital edema), and a chagoma. Among the drug choices provided:\n\u2022 Benznidazole is used to treat Chagas disease.\n\u2022 Ivermectin and Mebendazole are used to treat parasitic infections unrelated to Chagas disease.\n\u2022 Sodium stibogluconate is used for leishmaniasis, not for Trypanosoma cruzi infections.\n\nStep 4: Final answer selection. Given the clinical scenario and aligning it with the appropriate treatment for acute Chagas disease, the correct treatment is Benznidazole.\n\nFinal Answer: Benznidazole."
    },
    {
        "realidx": 211,
        "question": "A 65-year-old man presents with painless swelling of the neck over the past week. He also says he has been having intermittent fevers and severe night sweats which require a change of bed sheets the next day. His past medical history is significant for human immunodeficiency virus (HIV) diagnosed 10 years ago with which he admits to not always being compliant with his antiretroviral medication. The patient reports a 20-pack-year smoking history but no alcohol or recreational drug use. A review of systems is significant for a 6 kg (13.2 lb) unintentional weight loss over the past 2 months. The vital signs include: temperature 37.8\u2103 (100.0\u2109) and blood pressure 120/75 mm Hg. On physical examination, there are multiple non-tender swollen lymph nodes averaging 2 cm in diameter that is palpable in the anterior and posterior triangles of the neck bilaterally. Axillary and inguinal lymphadenopathy is present on the right side. A cardiopulmonary exam is unremarkable. The spleen size is 16 cm on percussion. Laboratory studies show the following:\nHemoglobin 9 g/dL\nMean corpuscular volume 88 \u03bcm3\nLeukocyte count 18,000/mm3\nPlatelet count 130,000/mm3\n    Serum creatinine 1.1 mg/dL\nSerum lactate dehydrogenase 1,000 U/L\nAn excisional biopsy of a superficial axillary lymph node on the right is performed and a histopathologic analysis confirms the most likely diagnosis. Which of the following is the next best diagnostic step in the workup of this patient?",
        "answer": "Hepatitis C virus antibodies",
        "options": {
            "A": "Antinuclear antibody",
            "B": "Hepatitis C virus antibodies",
            "C": "JAK-2 mutation",
            "D": "Tartrate-resistant acid phosphatase (TRAP) test"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "65 year old man presents",
            "painless swelling of the neck",
            "past week",
            "intermittent fevers",
            "severe night sweats",
            "change",
            "bed sheets",
            "next day",
            "past medical history",
            "significant",
            "human immunodeficiency virus",
            "diagnosed 10 years",
            "admits to not always",
            "compliant",
            "antiretroviral medication",
            "patient reports",
            "20 smoking history",
            "alcohol",
            "recreational drug use",
            "review of systems",
            "significant",
            "kg",
            "unintentional weight loss",
            "past",
            "months",
            "vital signs include",
            "temperature",
            "100 0",
            "blood pressure",
            "75 mm Hg",
            "physical examination",
            "multiple non-tender swollen lymph nodes averaging 2",
            "diameter",
            "palpable",
            "anterior",
            "posterior triangles of",
            "neck",
            "Axillary",
            "inguinal lymphadenopathy",
            "present",
            "right side",
            "cardiopulmonary exam",
            "unremarkable",
            "spleen size",
            "percussion",
            "Laboratory studies show",
            "following",
            "Hemoglobin",
            "g",
            "Mean corpuscular volume",
            "Leukocyte 18",
            "mm3 Platelet count",
            "Serum",
            "lactate dehydrogenase",
            "U/L",
            "excisional",
            "superficial axillary",
            "right",
            "performed",
            "histopathologic analysis confirms",
            "most likely diagnosis",
            "following",
            "next best diagnostic step",
            "workup",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 7737,
            "completion_tokens": 8775
        },
        "time_elapsed": 62.5906720161438,
        "raw_responses": [
            "Step 1. Recognize that the patient\u2019s presentation is consistent with a lymphoma. He is an older man with an HIV history (and suboptimal antiretroviral compliance), B symptoms (fevers, night sweats, weight loss), generalized, non\u2010tender lymphadenopathy, splenomegaly, and lab abnormalities (anemia, thrombocytopenia, and an elevated lactate dehydrogenase level). An excisional lymph node biopsy has already confirmed the diagnosis, making further staging and evaluation necessary.\n\nStep 2. When evaluating a lymphoma\u2014especially in a patient with HIV\u2014the workup should also include assessing for underlying infections that might be associated with or even drive the lymphoproliferative process. In particular, hepatitis C virus (HCV) infection has been linked with certain non\u2010Hodgkin lymphomas. Although imaging (for example, CT scans) and a bone marrow biopsy are typically parts of lymphoma staging, of the answer choices provided only one option targets an underlying infection known to be associated with lymphoma.\n\nStep 3. Evaluate the options:\n\u2022 Option A: Antinuclear antibody \u2013 used for diagnosing autoimmune conditions (eg, SLE); not indicated here.\n\u2022 Option C: JAK-2 mutation \u2013 helpful in diagnosing myeloproliferative neoplasms (eg, polycythemia vera, essential thrombocythemia, myelofibrosis); not consistent with this patient\u2019s picture.\n\u2022 Option D: Tartrate-resistant acid phosphatase (TRAP) test \u2013 classically utilized in diagnosing hairy cell leukemia, which typically presents with marked pancytopenia and splenomegaly but rarely with generalized lymphadenopathy.\n\u2022 Option B: Hepatitis C virus antibodies \u2013 HCV is associated with certain B-cell non-Hodgkin lymphomas. Given the confirmed diagnosis of lymphoma in this patient, and knowing that co-infection with HCV can influence both management and prognosis, screening for hepatitis C is warranted.\n\nStep 4. Final Answer:\nThe next best diagnostic step is to obtain Hepatitis C virus antibodies.\n\nFinal answer: Hepatitis C virus antibodies.",
            "Step 1: Analyze the patient\u2019s presentation.  \n\u2022 The 65\u2010year\u2010old HIV\u2010positive man (with inconsistent antiretroviral therapy) presents with painless, generalized lymphadenopathy, B-symptoms (fever, night sweats, weight loss) and splenomegaly. His laboratory studies show anemia, thrombocytopenia, leukocytosis, and an elevated lactate dehydrogenase level\u2014all findings that raise concern for a hematologic malignancy such as a lymphoma (a known complication in patients with HIV).  \n\nStep 2: Note that an excisional lymph node biopsy has already been performed and confirms the most likely diagnosis (a lymphoma).  \n\u2022 In HIV-positive patients, Non-Hodgkin lymphoma (often diffuse large B-cell lymphoma) is common, and staging the disease is essential.  \n\u2022 Standard next steps after a confirmed lymphoma diagnosis include staging studies (such as imaging and bone marrow evaluation). In addition, before starting treatment (which may include regimens such as rituximab-based chemotherapy), it is important to screen for viral co-infections that can influence management.\n\nStep 3: Evaluate the answer choices.  \nA. Antinuclear antibody \u2013 This test is used for autoimmune conditions (e.g., systemic lupus erythematosus) and is not indicated in the workup of lymphoma.  \nB. Hepatitis C virus antibodies \u2013 Patients with lymphoma, especially those with HIV, are at increased risk for viral co-infections; screening for hepatitis viruses is important before initiating therapy, as hepatitis C (and B) can affect treatment decisions and risk of reactivation during immunosuppressive therapy.  \nC. JAK-2 mutation \u2013 This test is used to evaluate myeloproliferative disorders (e.g., polycythemia vera, essential thrombocythemia), which does not fit this patient\u2019s presentation.  \nD. Tartrate-resistant acid phosphatase (TRAP) test \u2013 This test is used in the evaluation of hairy cell leukemia; however, hairy cell leukemia typically presents with pancytopenia and massive splenomegaly but not usually with extensive lymphadenopathy as seen in this patient.\n\nStep 4: Choose the most appropriate next diagnostic evaluation.  \nSince the lymphoma diagnosis is confirmed histologically, the next step is to evaluate for co-infections (among other staging studies) that might affect treatment. Of the provided choices, screening for Hepatitis C virus antibodies is appropriate and should be performed prior to initiating therapy.\n\nFinal Answer: B. Hepatitis C virus antibodies.",
            "Step 1: Analyze the case. This 65\u2010year\u2010old man with HIV (poorly controlled) presents with B symptoms (intermittent fevers, severe night sweats, weight loss), generalized lymphadenopathy, splenomegaly, and laboratory findings including anemia, thrombocytopenia, leukocytosis, and an elevated lactate dehydrogenase (LDH). The excisional biopsy confirms the diagnosis of an aggressive lymphoid malignancy most consistent with a non-Hodgkin lymphoma (NHL), which is common in patients with HIV.\n\nStep 2: Consider the answer choices.  \n\u2022 Option A (Antinuclear antibody) is used to evaluate for autoimmune conditions like systemic lupus erythematosus; this is not indicated here.  \n\u2022 Option C (JAK-2 mutation) is most useful when evaluating myeloproliferative disorders such as polycythemia vera or primary myelofibrosis; these present with a different constellation of findings.  \n\u2022 Option D (Tartrate-resistant acid phosphatase [TRAP] test) is used in the workup of hairy cell leukemia. Hairy cell leukemia typically presents as an indolent process with pancytopenia and splenomegaly; however, the patient\u2019s leukocyte count is increased, and the overall findings fit better with an aggressive NHL rather than hairy cell leukemia.  \n\u2022 Option B (Hepatitis C virus antibodies) is the correct choice. There is an established association between chronic Hepatitis C infection and the development of certain B-cell lymphomas, and it is recommended to screen for Hepatitis C in patients with NHL. Additionally, in patients with HIV-associated lymphomas, coinfections (including Hepatitis C) can significantly affect treatment planning and prognosis.\n\nStep 3: Conclusion  \nGiven the confirmed diagnosis of NHL on histopathology and the known associations, the next best diagnostic step in the work\u2010up of this patient is to obtain Hepatitis C virus antibodies (Option B). \n\nFinal Answer: B. Hepatitis C virus antibodies"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the patient\u2019s presentation.  \n\u2022 The 65\u2010year\u2010old HIV\u2010positive man (with inconsistent antiretroviral therapy) presents with painless, generalized lymphadenopathy, B-symptoms (fever, night sweats, weight loss) and splenomegaly. His laboratory studies show anemia, thrombocytopenia, leukocytosis, and an elevated lactate dehydrogenase level\u2014all findings that raise concern for a hematologic malignancy such as a lymphoma (a known complication in patients with HIV).  \n\nStep 2: Note that an excisional lymph node biopsy has already been performed and confirms the most likely diagnosis (a lymphoma).  \n\u2022 In HIV-positive patients, Non-Hodgkin lymphoma (often diffuse large B-cell lymphoma) is common, and staging the disease is essential.  \n\u2022 Standard next steps after a confirmed lymphoma diagnosis include staging studies (such as imaging and bone marrow evaluation). In addition, before starting treatment (which may include regimens such as rituximab-based chemotherapy), it is important to screen for viral co-infections that can influence management.\n\nStep 3: Evaluate the answer choices.  \nA. Antinuclear antibody \u2013 This test is used for autoimmune conditions (e.g., systemic lupus erythematosus) and is not indicated in the workup of lymphoma.  \nB. Hepatitis C virus antibodies \u2013 Patients with lymphoma, especially those with HIV, are at increased risk for viral co-infections; screening for hepatitis viruses is important before initiating therapy, as hepatitis C (and B) can affect treatment decisions and risk of reactivation during immunosuppressive therapy.  \nC. JAK-2 mutation \u2013 This test is used to evaluate myeloproliferative disorders (e.g., polycythemia vera, essential thrombocythemia), which does not fit this patient\u2019s presentation.  \nD. Tartrate-resistant acid phosphatase (TRAP) test \u2013 This test is used in the evaluation of hairy cell leukemia; however, hairy cell leukemia typically presents with pancytopenia and massive splenomegaly but not usually with extensive lymphadenopathy as seen in this patient.\n\nStep 4: Choose the most appropriate next diagnostic evaluation.  \nSince the lymphoma diagnosis is confirmed histologically, the next step is to evaluate for co-infections (among other staging studies) that might affect treatment. Of the provided choices, screening for Hepatitis C virus antibodies is appropriate and should be performed prior to initiating therapy.\n\nFinal Answer: B. Hepatitis C virus antibodies."
    },
    {
        "realidx": 212,
        "question": "In order to assess the feasibility and evaluate the outcomes of cerclage wiring as a supportive approach to osteosynthesis in femur fractures, a group of orthopedic surgeons studied 14 patients with primary and periprosthetic fractures of the thigh bone. Parameters such as patient demographic, type of implant, number of wires used, fracture union rate, and potential complications were thoroughly recorded and analyzed in all the patients, with a mean duration of patient follow-up of 16 months. Union was achieved in all patients with a mean duration of 90 days, and there were no complications found in patients included in the study. The authors were satisfied with their findings and, due to the prospective nature of their research, submitted their study to a journal as a cohort study (which they noted in the study title as well). However, the journal editor returned the article, suggesting that it should be submitted as a case series instead. The editor made this suggestion to the authors for which of the following reasons?",
        "answer": "Lack of risk calculation",
        "options": {
            "A": "No prevalence assessment",
            "B": "Low number of patients",
            "C": "Ascertainment bias",
            "D": "Lack of risk calculation"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "order to assess",
            "evaluate",
            "outcomes",
            "cerclage wiring",
            "supportive approach",
            "osteosynthesis",
            "femur fractures",
            "a group",
            "orthopedic surgeons studied",
            "patients",
            "primary",
            "periprosthetic fractures of",
            "thigh bone",
            "Parameters",
            "as patient demographic",
            "type of implant",
            "number of wires used",
            "fracture union rate",
            "potential complications",
            "recorded",
            "analyzed",
            "patients",
            "mean duration",
            "patient follow-up",
            "months",
            "Union",
            "patients",
            "mean duration",
            "90 days",
            "complications found",
            "patients included",
            "study",
            "authors",
            "satisfied",
            "findings",
            "due to",
            "prospective nature",
            "research",
            "submitted",
            "study",
            "journal",
            "cohort study",
            "noted",
            "study title",
            "well",
            "journal editor returned",
            "article",
            "suggesting",
            "submitted",
            "case series",
            "editor made",
            "suggestion",
            "authors",
            "following reasons"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4023,
            "completion_tokens": 2856
        },
        "time_elapsed": 24.247705698013306,
        "raw_responses": [
            "The study in question followed 14 patients who all underwent the same intervention, with no comparator or control group provided. A cohort study typically involves identifying subjects based on their exposure or risk factor status and then comparing outcomes between different groups (e.g., exposed vs non-exposed). In the absence of a control group, one cannot calculate relative risk or assess the risk of developing an outcome compared to another group. Thus, the study design is more in keeping with a case series\u2014a descriptive study of a series of cases without a comparator.\n\nFinal answer: D. Lack of risk calculation",
            "The key detail is that a cohort study is typically defined by the comparison of outcomes between groups (for example, an exposed group versus a non-exposed group) and involves assessing the risk of an outcome, often calculating incidence, relative risk, or odds ratios. In the study described, the surgeons followed 14 patients all treated in a similar (prospective) manner without a separate control or comparison group. Because of that, they were only describing outcomes rather than calculating specific risks or comparative statistics.\n\nStep by step:\n1. The study does not have a comparator group that would allow for risk calculation (no exposed vs. unexposed groups).\n2. In a cohort study, the ability to calculate risks (like relative risk) is an essential component.\n3. Because the study only recorded outcomes in a series of cases (even if prospectively), it is descriptive rather than comparative.\n4. Thus, the journal editor recommended that the study be categorized as a case series due to the lack of risk calculation.\n\nThe final answer is: D. Lack of risk calculation.",
            "Let's examine the study design closely. The authors enrolled 14 patients and recorded various aspects of their outcomes after using cerclage wiring. However, there was no control group or comparison cohort. Without a comparator, no relative risk or risk calculation can be made, which is a mainstay of a cohort study. Instead, the study describes a series of cases with outcomes that are merely reported.\n\nThus, the study is more appropriately a case series rather than a cohort study. The journal editor suggested this reclassification because there was a lack of risk calculation.\n\nFinal Answer: D. Lack of risk calculation"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "The key detail is that a cohort study is typically defined by the comparison of outcomes between groups (for example, an exposed group versus a non-exposed group) and involves assessing the risk of an outcome, often calculating incidence, relative risk, or odds ratios. In the study described, the surgeons followed 14 patients all treated in a similar (prospective) manner without a separate control or comparison group. Because of that, they were only describing outcomes rather than calculating specific risks or comparative statistics.\n\nStep by step:\n1. The study does not have a comparator group that would allow for risk calculation (no exposed vs. unexposed groups).\n2. In a cohort study, the ability to calculate risks (like relative risk) is an essential component.\n3. Because the study only recorded outcomes in a series of cases (even if prospectively), it is descriptive rather than comparative.\n4. Thus, the journal editor recommended that the study be categorized as a case series due to the lack of risk calculation.\n\nThe final answer is: D. Lack of risk calculation."
    },
    {
        "realidx": 215,
        "question": "A 45-year-old man presents to the physician with complaints of increased urinary frequency and decreasing volumes for the past 2 months. He does not complain of any pain during urination. He is frustrated that he has to wake up 2 or 3 times per night to urinate even though he tried reducing the amount of water he consumes before bed and made some other dietary changes without any improvement. He has no family history of prostate disease. Physical examination is negative for any suprapubic mass or tenderness, and there is no costovertebral angle tenderness. Which of the following is the best next step in the management of this patient?",
        "answer": "Digital rectal examination",
        "options": {
            "A": "Urinalysis and serum creatinine",
            "B": "Reassurance",
            "C": "Digital rectal examination",
            "D": "Prostate-specific antigen"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old man presents",
            "physician",
            "complaints",
            "increased urinary frequency",
            "decreasing volumes",
            "past 2 months",
            "not",
            "pain",
            "urination",
            "frustrated",
            "to wake up",
            "3",
            "night to",
            "reducing",
            "amount",
            "water",
            "bed",
            "made",
            "dietary changes",
            "improvement",
            "family history of prostate disease",
            "Physical examination",
            "negative",
            "suprapubic mass",
            "tenderness",
            "costovertebral angle tenderness",
            "following",
            "best next step",
            "management",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4986,
            "completion_tokens": 4949
        },
        "time_elapsed": 37.15920352935791,
        "raw_responses": [
            "Step 1 \u2013 Evaluate the clinical scenario: A 45\u2010year\u2010old man presents with increasing urinary frequency, decreased volumes, and nocturia without dysuria or pain. While his symptoms are suggestive of a lower urinary tract issue (possibly early benign prostatic hyperplasia), he is still relatively young and his exam has not yet evaluated his prostate.\n\nStep 2 \u2013 Identify the appropriate initial evaluation: Whenever a patient presents with lower urinary tract symptoms, it is essential to rule out other causes, such as urinary tract infection, hematuria (which could suggest malignancy), or renal dysfunction secondary to urinary retention. The guidelines recommend initial workup with a focused history, physical exam including a digital rectal exam (DRE) to assess the prostate, as well as a urinalysis (UA) to help rule out infection, blood, or other abnormalities. A serum creatinine can also be helpful to evaluate renal function.\n\nStep 3 \u2013 Analyze the answer choices:\n\u2022 Option A (Urinalysis and serum creatinine): This is a noninvasive, routine initial evaluation, helping exclude infection and assess kidney function.\n\u2022 Option B (Reassurance): Inadequate since the patient\u2019s symptoms have been persistent despite lifestyle modifications, warranting further evaluation.\n\u2022 Option C (Digital rectal examination): Important in assessing prostate size and consistency, but while it should be part of the workup, ordering a UA is arguably a more universal and initial test in this scenario.\n\u2022 Option D (Prostate-specific antigen): Not indicated as the first step in a relatively young patient without a family history of prostate disease or any exam findings suggestive of malignancy.\n\nStep 4 \u2013 Final Answer: The best next step is noninvasive laboratory evaluation. The correct answer is Option A: Urinalysis and serum creatinine.\n\nFinal answer: A",
            "Step 1: Review the patient\u2019s presentation. The patient is a 45-year-old man with increased urinary frequency and decreasing urinary volumes over 2 months without pain. His history and exam do not suggest infection (no suprapubic tenderness or signs of upper tract involvement), and his family history does not indicate a predisposition to prostate disease.\n\nStep 2: Consider initial evaluation for lower urinary tract symptoms (LUTS). Even in the absence of pain or infection signs, it is important to evaluate for common causes of LUTS, including urinary tract infections, bladder outlet obstruction (such as benign prostatic hyperplasia), or other structural abnormalities. A urinalysis can help rule out infection or hematuria, while checking serum creatinine can assess renal function to ensure there is no obstructive pathology affecting the kidneys.\n\nStep 3: Compare answer options.\n\u2022 Option A (Urinalysis and serum creatinine) is the most appropriate initial step to evaluate for possible causes of his symptoms.\n\u2022 Option B (Reassurance) would be premature without ruling out treatable causes.\n\u2022 Option C (Digital rectal examination) might eventually be necessary to assess prostate size and texture; however, as part of an overall work-up, a urinalysis combined with serum creatinine is a better starting point.\n\u2022 Option D (Prostate-specific antigen) is not indicated in the initial evaluation for a patient of this age with these symptoms.\n\nFinal Answer: A. Urinalysis and serum creatinine.",
            "Step 1: Recognize that the patient is experiencing lower urinary tract symptoms (LUTS) such as urinary frequency, nocturia, and decreased urinary volume. Although his symptoms are concerning, his physical exam (which did not include a digital rectal exam) has not revealed any obvious masses or tenderness.\n\nStep 2: In patients with LUTS, the initial evaluation should include laboratory studies to rule out alternative causes (such as urinary tract infection or hematuria) that could mimic benign prostatic hyperplasia (BPH) or other obstructive processes. Therefore, a UA is an essential initial test. Serum creatinine is also obtained to assess kidney function given the potential for obstructive uropathy.\n\nStep 3: Although a digital rectal exam (DRE) is important in the evaluation of a man with suspected BPH, the initial step typically involves ruling out infection or other renal causes with laboratory testing.\n\nStep 4: Reassurance is not appropriate given his persistent symptoms, and PSA screening is not indicated as an initial step in the evaluation of LUTS.\n\nFinal answer: A. Urinalysis and serum creatinine"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Review the patient\u2019s presentation. The patient is a 45-year-old man with increased urinary frequency and decreasing urinary volumes over 2 months without pain. His history and exam do not suggest infection (no suprapubic tenderness or signs of upper tract involvement), and his family history does not indicate a predisposition to prostate disease.\n\nStep 2: Consider initial evaluation for lower urinary tract symptoms (LUTS). Even in the absence of pain or infection signs, it is important to evaluate for common causes of LUTS, including urinary tract infections, bladder outlet obstruction (such as benign prostatic hyperplasia), or other structural abnormalities. A urinalysis can help rule out infection or hematuria, while checking serum creatinine can assess renal function to ensure there is no obstructive pathology affecting the kidneys.\n\nStep 3: Compare answer options.\n\u2022 Option A (Urinalysis and serum creatinine) is the most appropriate initial step to evaluate for possible causes of his symptoms.\n\u2022 Option B (Reassurance) would be premature without ruling out treatable causes.\n\u2022 Option C (Digital rectal examination) might eventually be necessary to assess prostate size and texture; however, as part of an overall work-up, a urinalysis combined with serum creatinine is a better starting point.\n\u2022 Option D (Prostate-specific antigen) is not indicated in the initial evaluation for a patient of this age with these symptoms.\n\nFinal Answer: A. Urinalysis and serum creatinine."
    },
    {
        "realidx": 222,
        "question": "A 60-year-old woman presents to a physician for worsening shortness of breath and increasing abdominal distention over the last 3 months. She says that the shortness of breath is worse on exertion and improves with rest. While she could previously walk to the nearby store for her groceries, she now has to drive because she gets ''winded'' on the way. The patient was diagnosed with diabetes 5 years ago and is compliant with her medications. The medical history is otherwise unremarkable. The physical examination reveals gross ascites and visibly engorged periumbilical veins. Bilateral pitting edema is noted around the ankles. The finger-prick blood glucose level is 100 mg/dL. What is the mechanism of action of the anti-diabetic medication this patient is most likely taking?",
        "answer": "Increased gene expression of GLUT-4",
        "options": {
            "A": "Binding to the alpha subunit of the insulin receptor",
            "B": "Closure of ATP-sensitive K-channels in the pancreatic beta-cell",
            "C": "Increased gene expression of GLUT-4",
            "D": "Glucagon-like peptide-1 receptor agonist"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "60 year old woman presents",
            "physician",
            "worsening shortness of breath",
            "increasing abdominal distention",
            "months",
            "shortness of breath",
            "worse",
            "exertion",
            "improves",
            "rest",
            "walk",
            "store",
            "now",
            "to drive",
            "gets",
            "winded",
            "patient",
            "diagnosed",
            "diabetes",
            "years",
            "compliant",
            "medications",
            "medical history",
            "unremarkable",
            "physical examination reveals gross ascites",
            "engorged periumbilical veins",
            "Bilateral pitting edema",
            "noted",
            "ankles",
            "finger-prick blood glucose level",
            "100 mg/dL",
            "mechanism of action",
            "diabetic medication",
            "patient",
            "most likely"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5208,
            "completion_tokens": 3719
        },
        "time_elapsed": 29.962487936019897,
        "raw_responses": [
            "Step 1: Note that the patient has diabetes and is on an anti-diabetic medication. Her symptoms of worsening shortness of breath, ascites, and peripheral edema are signs of fluid retention and congestive heart failure. Among diabetic medications, thiazolidinediones (such as pioglitazone and rosiglitazone) are well known to cause fluid retention, which can exacerbate or precipitate heart failure.\n\nStep 2: Reviewing the options:\n\u2022 Option A (Binding to the alpha subunit of the insulin receptor) describes the action of insulin, not a thiazolidinedione.\n\u2022 Option B (Closure of ATP-sensitive K-channels in the pancreatic beta-cell) is the mechanism of sulfonylureas.\n\u2022 Option C (Increased gene expression of GLUT-4) corresponds to the effect of thiazolidinediones. These medications activate PPAR-\u03b3, which increases the transcription of insulin-sensitive genes (including GLUT-4) leading to improved insulin sensitivity; however, they are known for causing fluid retention.\n\u2022 Option D (Glucagon-like peptide-1 receptor agonist) refers to agents like exenatide or liraglutide, which are not associated with the heart failure and fluid retention seen in this patient.\n\nStep 3: The best match is option C.\n\nFinal answer: C. Increased gene expression of GLUT-4.",
            "Step 1: Identify the Key Clinical Findings\n\u2022 The patient is a 60-year-old woman with diabetes who presents with signs of fluid overload: shortness of breath on exertion, ascites, and peripheral edema.\n\u2022 Her blood glucose level is 100 mg/dL, suggesting her diabetic control is good.\n\nStep 2: Link the Clinical Picture with Medication Side Effects\n\u2022 One class of anti-diabetic medications is known to cause fluid retention, leading to edema and exacerbations of heart failure.\n\u2022 Thiazolidinediones (e.g., pioglitazone, rosiglitazone) work by reducing insulin resistance but have a well-known side effect of causing fluid retention, which can lead to or worsen heart failure.\n\nStep 3: Determine the Mechanism of Action of Thiazolidinediones\n\u2022 Thiazolidinediones bind to peroxisome proliferator-activated receptor-gamma (PPAR-\u03b3), a nuclear receptor.\n\u2022 This binding increases the transcription of insulin-sensitive genes, including those for GLUT-4, which helps improve insulin sensitivity.\n\nStep 4: Compare with the Answer Choices\nA. Binding to the alpha subunit of the insulin receptor \u2013 This is not the mechanism for thiazolidinediones.\nB. Closure of ATP-sensitive K-channels in the pancreatic beta-cell \u2013 This describes the action of sulfonylureas.\nC. Increased gene expression of GLUT-4 \u2013 This matches the mechanism of thiazolidinediones.\nD. Glucagon-like peptide-1 receptor agonist \u2013 This is the mechanism for GLP-1 receptor agonists.\n\nFinal Answer:\nC. Increased gene expression of GLUT-4",
            "Step 1: Recognize that the patient, who has diabetes, now presents with signs of fluid overload (ascites, engorged periumbilical veins, and peripheral edema), which suggests the development or worsening of congestive heart failure\u2014a known adverse effect of thiazolidinediones.\n\nStep 2: Recall that thiazolidinediones (such as pioglitazone) work by activating PPAR-\u03b3 receptors. This activation increases the transcription of insulin-sensitive genes and leads to increased expression of GLUT-4 transporters in adipocytes and skeletal muscle. However, one of the risks with this class of drugs is fluid retention, which can worsen or precipitate heart failure.\n\nStep 3: Compare the options:\n\u2022 Option A (Binding to the alpha subunit of the insulin receptor) does not match any anti-diabetic mechanism.\n\u2022 Option B (Closure of ATP-sensitive K-channels in the pancreatic beta-cell) is the mechanism for sulfonylureas, which do not typically cause marked fluid retention.\n\u2022 Option C (Increased gene expression of GLUT-4) is consistent with the thiazolidinedione mechanism.\n\u2022 Option D (Glucagon-like peptide-1 receptor agonist) does not cause this side effect profile.\n\nFinal answer: C. Increased gene expression of GLUT-4"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Identify the Key Clinical Findings\n\u2022 The patient is a 60-year-old woman with diabetes who presents with signs of fluid overload: shortness of breath on exertion, ascites, and peripheral edema.\n\u2022 Her blood glucose level is 100 mg/dL, suggesting her diabetic control is good.\n\nStep 2: Link the Clinical Picture with Medication Side Effects\n\u2022 One class of anti-diabetic medications is known to cause fluid retention, leading to edema and exacerbations of heart failure.\n\u2022 Thiazolidinediones (e.g., pioglitazone, rosiglitazone) work by reducing insulin resistance but have a well-known side effect of causing fluid retention, which can lead to or worsen heart failure.\n\nStep 3: Determine the Mechanism of Action of Thiazolidinediones\n\u2022 Thiazolidinediones bind to peroxisome proliferator-activated receptor-gamma (PPAR-\u03b3), a nuclear receptor.\n\u2022 This binding increases the transcription of insulin-sensitive genes, including those for GLUT-4, which helps improve insulin sensitivity.\n\nStep 4: Compare with the Answer Choices\nA. Binding to the alpha subunit of the insulin receptor \u2013 This is not the mechanism for thiazolidinediones.\nB. Closure of ATP-sensitive K-channels in the pancreatic beta-cell \u2013 This describes the action of sulfonylureas.\nC. Increased gene expression of GLUT-4 \u2013 This matches the mechanism of thiazolidinediones.\nD. Glucagon-like peptide-1 receptor agonist \u2013 This is the mechanism for GLP-1 receptor agonists.\n\nFinal Answer:\nC. Increased gene expression of GLUT-4"
    },
    {
        "realidx": 231,
        "question": "A 59-year-old man comes to the emergency department because of excruciating left knee pain for 4 days. He underwent a total knee arthroplasty of his left knee joint 4 months ago. He has hypertension and osteoarthritis. Current medications include glucosamine, amlodipine, and meloxicam. His temperature is 38.1\u00b0C (100.6\u00b0F), pulse is 97/min, and blood pressure is 118/71 mm Hg. Examination shows a tender, swollen left knee joint; range of motion is limited by pain. Analysis of the synovial fluid confirms septic arthritis, and the prosthesis is removed. Which of the following is the most likely causal organism?",
        "answer": "Staphylococcus epidermidis",
        "options": {
            "A": "Staphylococcus epidermidis",
            "B": "Escherichia coli",
            "C": "Staphylococcus aureus",
            "D": "Pseudomonas aeruginosa"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "59 year old man",
            "emergency department",
            "of excruciating left knee pain",
            "4 days",
            "total knee arthroplasty",
            "left",
            "joint",
            "months",
            "hypertension",
            "osteoarthritis",
            "Current medications include glucosamine",
            "amlodipine",
            "meloxicam",
            "temperature",
            "100",
            "pulse",
            "97 min",
            "blood pressure",
            "71 mm Hg",
            "Examination shows",
            "tender",
            "swollen left knee joint",
            "range of motion",
            "limited",
            "pain",
            "Analysis",
            "synovial fluid confirms septic arthritis",
            "prosthesis",
            "removed",
            "following",
            "most likely causal organism"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4431,
            "completion_tokens": 2430
        },
        "time_elapsed": 32.13821721076965,
        "raw_responses": [
            "Step 1: Identify Key Information\n\u2022 The patient has a prosthetic joint (total knee arthroplasty performed 4 months ago).\n\u2022 He presents with septic arthritis.\n\u2022 Prosthetic joint infections occurring months after surgery are often caused by organisms that form biofilms.\n\nStep 2: Analyze the Options\n\u2022 A. Staphylococcus epidermidis \u2013 This coagulase-negative organism is known for its ability to form biofilms on prosthetic devices, making it the most common cause of delayed prosthetic joint infections.\n\u2022 B. Escherichia coli \u2013 More commonly associated with urinary tract infections and intra-abdominal infections, not typically linked to prosthetic joint infections.\n\u2022 C. Staphylococcus aureus \u2013 A common cause of septic arthritis in native joints, but less typical in delayed prosthetic joint infections compared to S. epidermidis.\n\u2022 D. Pseudomonas aeruginosa \u2013 More often seen in infections involving burn wounds, cystic fibrosis, or intravenous drug use patients; not commonly linked to prosthetic joint infections in this context.\n\nStep 3: Final Answer\nThe most likely causal organism is: A. Staphylococcus epidermidis",
            "Step 1: Recognize that the patient has a prosthetic joint implanted 4 months ago. Prosthetic joint infections that occur in the delayed period (usually between 3 and 12 months after surgery) are most commonly associated with bacteria that form biofilms.\n\nStep 2: Staphylococcus epidermidis is a coagulase-negative Staphylococcus known for forming biofilms on indwelling medical devices, such as prosthetic joints. This makes it the most likely cause of the infection in this scenario.\n\nStep 3: Compare the choices:\n\u2022 Staphylococcus aureus is a common cause of septic arthritis in native joints but is less commonly connected with delayed prosthetic joint infections.\n\u2022 Escherichia coli typically causes urinary tract infections and is not commonly associated with prosthetic joint infections.\n\u2022 Pseudomonas aeruginosa, although capable of causing joint infections, is more often linked with specific risk factors (such as puncture wounds or immunocompromise), and is less likely in this setting.\n\nFinal answer: A. Staphylococcus epidermidis",
            "Step 1: Recognize that the patient has a prosthetic joint implanted 4 months ago and now presents with septic arthritis.\n\nStep 2: Recall that prosthetic joint infections are commonly caused by organisms that form biofilms on the prosthetic material. The most common of these is Staphylococcus epidermidis, a coagulase-negative staphylococcus.\n\nStep 3: Compare the available options:\n\u2022 Staphylococcus epidermidis \u2013 Frequently causes infections in prosthetic devices via biofilm formation.\n\u2022 Escherichia coli \u2013 Less common in prosthetic joint infections and more associated with urinary or gastrointestinal sources.\n\u2022 Staphylococcus aureus \u2013 While a common cause of septic arthritis in native joints, it is less typical in late prosthetic joint infections.\n\u2022 Pseudomonas aeruginosa \u2013 Typically associated with infections in immunocompromised patients, burns, or following puncture wounds, not as common in prosthetic joints.\n\nStep 4: Conclude that based on the patient\u2019s presentation and the nature of prosthetic joint infections, the most likely causal organism is Staphylococcus epidermidis.\n\nFinal Answer: A. Staphylococcus epidermidis"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Identify Key Information\n\u2022 The patient has a prosthetic joint (total knee arthroplasty performed 4 months ago).\n\u2022 He presents with septic arthritis.\n\u2022 Prosthetic joint infections occurring months after surgery are often caused by organisms that form biofilms.\n\nStep 2: Analyze the Options\n\u2022 A. Staphylococcus epidermidis \u2013 This coagulase-negative organism is known for its ability to form biofilms on prosthetic devices, making it the most common cause of delayed prosthetic joint infections.\n\u2022 B. Escherichia coli \u2013 More commonly associated with urinary tract infections and intra-abdominal infections, not typically linked to prosthetic joint infections.\n\u2022 C. Staphylococcus aureus \u2013 A common cause of septic arthritis in native joints, but less typical in delayed prosthetic joint infections compared to S. epidermidis.\n\u2022 D. Pseudomonas aeruginosa \u2013 More often seen in infections involving burn wounds, cystic fibrosis, or intravenous drug use patients; not commonly linked to prosthetic joint infections in this context.\n\nStep 3: Final Answer\nThe most likely causal organism is: A. Staphylococcus epidermidis"
    },
    {
        "realidx": 234,
        "question": "A 55-year-old man comes to the physician because of a 3-month history of a progressively growing mass in his axilla. During this period, he has had recurrent episodes of low-grade fever lasting for 7 to 10 days, and an 8-kg (18-lb) weight loss. His only medication is a multivitamin. Physical examination shows nontender, right axillary, cervical, and inguinal lymphadenopathy. His serum calcium concentration is 15.1 mg/dL and parathyroid hormone (PTH) concentration is 9 pg/mL. A lymph node biopsy shows granuloma formation and large CD15-positive, CD30-positive cells with bilobed nuclei. Which of the following is the most likely explanation for this patient's laboratory findings?",
        "answer": "Secretion of \u03b3-interferon by activated T-lymphocytes",
        "options": {
            "A": "Excessive intake of dietary ergocalciferol",
            "B": "Induction of focal osteolysis by tumor cells",
            "C": "Secretion of \u03b3-interferon by activated T-lymphocytes",
            "D": "Production of PTH-related peptide by malignant cells"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "55 year old man",
            "physician",
            "3 month history",
            "mass",
            "axilla",
            "period",
            "recurrent episodes of low-grade fever",
            "7",
            "10 days",
            "kg",
            "weight loss",
            "only medication",
            "multivitamin",
            "Physical examination shows nontender",
            "right axillary",
            "cervical",
            "inguinal lymphadenopathy",
            "serum concentration",
            "mg/dL",
            "parathyroid hormone",
            "concentration",
            "pg/mL",
            "lymph node biopsy shows granuloma formation",
            "large CD15 positive",
            "CD30-positive cells",
            "bilobed nuclei",
            "following",
            "most likely explanation",
            "patient's laboratory findings"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5910,
            "completion_tokens": 4872
        },
        "time_elapsed": 38.061890602111816,
        "raw_responses": [
            "Step 1: The patient\u2019s history of systemic \u201cB symptoms\u201d (fevers and weight loss), generalized lymphadenopathy, and the biopsy findings showing Reed-Sternberg cells (which are CD15-positive and CD30-positive with bilobed nuclei) point to Hodgkin lymphoma. In this subtype of lymphoma, granuloma formation and a reactive milieu of T-lymphocytes and macrophages are commonly seen.\n\nStep 2: The patient\u2019s laboratory results reveal hypercalcemia with a suppressed parathyroid hormone (PTH) level, indicating that the hypercalcemia is not due to primary hyperparathyroidism. In Hodgkin lymphoma (and other granulomatous diseases), activated T-lymphocytes and macrophages produce cytokines such as \u03b3-interferon. This cytokine can induce the enzyme 1\u03b1-hydroxylase in macrophages within the granulomatous tissue, leading to increased conversion of 25-hydroxyvitamin D to its active form (1,25-dihydroxyvitamin D or calcitriol). Elevated calcitriol then increases intestinal absorption of calcium, causing hypercalcemia.\n\nStep 3: Review of the options:\nA. Excessive intake of dietary ergocalciferol \u2013 There is no history or evidence of excessive vitamin D intake.\nB. Induction of focal osteolysis by tumor cells \u2013 This mechanism is more typical of conditions like multiple myeloma, not Hodgkin lymphoma.\nC. Secretion of \u03b3-interferon by activated T-lymphocytes \u2013 This is the most plausible explanation because it induces 1\u03b1-hydroxylase activity in macrophages, leading to increased calcitriol production and hypercalcemia.\nD. Production of PTH-related peptide by malignant cells \u2013 This mechanism is common in some nonhematologic malignancies (e.g., squamous cell carcinoma), but not in Hodgkin lymphoma.\n\nFinal Answer: C. Secretion of \u03b3-interferon by activated T-lymphocytes",
            "Let\u2019s review the case step by step:\n\n\u2022 The patient is a 55\u2010year\u2010old man with systemic \u201cB-symptoms\u201d (fever and weight loss) along with widespread nontender lymphadenopathy.\n\u2022 The lymph node biopsy shows Reed-Sternberg cells (large cells with bilobed nuclei that are CD15 and CD30 positive) and granuloma formation, which is diagnostic for Hodgkin lymphoma.\n\u2022 The patient\u2019s serum calcium is significantly elevated at 15.1 mg/dL, and the low parathyroid hormone concentration (9 pg/mL) indicates that the hypercalcemia is not mediated by PTH.\n\u2022 Hodgkin lymphoma is associated with hypercalcemia due to the granulomatous inflammatory response. In these lesions, activated T-lymphocytes (and macrophages) secrete cytokines such as \u03b3-interferon. \u03b3-Interferon then stimulates the enzyme 1\u03b1-hydroxylase in macrophages, converting vitamin D into its active form (1,25-dihydroxyvitamin D or calcitriol). The increased calcitriol enhances intestinal calcium absorption and bone resorption, leading to hypercalcemia.\n\nComparing answer choices:\n\u2013 Option A (excessive dietary ergocalciferol) is not applicable.\n\u2013 Option B (induction of focal osteolysis by tumor cells) is more characteristic of lesions in malignancies such as multiple myeloma.\n\u2013 Option D (production of PTH-related peptide) is commonly seen in squamous cell carcinomas, not Hodgkin lymphoma.\n\u2013 Option C (secretion of \u03b3-interferon by activated T-lymphocytes) fits the pathophysiology seen with Hodgkin lymphoma due to the granulomatous response.\n\nTherefore, the most likely explanation for this patient\u2019s laboratory findings is:\n\nFinal answer: C. Secretion of \u03b3-interferon by activated T-lymphocytes.",
            "Step 1: A 55-year-old man presents with constitutional symptoms (fevers, weight loss) and lymphadenopathy. The biopsy shows granulomas and Reed-Sternberg cells (CD15-positive, CD30-positive with bilobed nuclei), confirming Hodgkin lymphoma.\n\nStep 2: His laboratory studies show hypercalcemia with a low parathyroid hormone (PTH) level, suggesting a paraneoplastic process causing hypercalcemia rather than primary hyperparathyroidism. \n\nStep 3: In Hodgkin lymphoma, activated T-lymphocytes in the tumor microenvironment secrete \u03b3-interferon, which upregulates 1\u03b1-hydroxylase in macrophages. This enzyme converts inactive vitamin D (25-hydroxyvitamin D) to its active form (1,25-dihydroxyvitamin D), which increases calcium absorption in the gut, leading to hypercalcemia.\n\nStep 4: Now, we analyze the answer options:\n\u2022 Option A (Excessive intake of dietary ergocalciferol) is unlikely as the patient\u2019s history does not support excessive vitamin D intake.\n\u2022 Option B (Induction of focal osteolysis by tumor cells) is more typical of metastatic bone lesions or multiple myeloma.\n\u2022 Option C (Secretion of \u03b3-interferon by activated T-lymphocytes) directly explains the increased conversion to active vitamin D and subsequent hypercalcemia.\n\u2022 Option D (Production of PTH-related peptide by malignant cells) is typical of some solid tumors (e.g., squamous cell carcinoma) but not Hodgkin lymphoma.\n\nFinal Answer: C."
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "2"
        ],
        "final_solution": "Let\u2019s review the case step by step:\n\n\u2022 The patient is a 55\u2010year\u2010old man with systemic \u201cB-symptoms\u201d (fever and weight loss) along with widespread nontender lymphadenopathy.\n\u2022 The lymph node biopsy shows Reed-Sternberg cells (large cells with bilobed nuclei that are CD15 and CD30 positive) and granuloma formation, which is diagnostic for Hodgkin lymphoma.\n\u2022 The patient\u2019s serum calcium is significantly elevated at 15.1 mg/dL, and the low parathyroid hormone concentration (9 pg/mL) indicates that the hypercalcemia is not mediated by PTH.\n\u2022 Hodgkin lymphoma is associated with hypercalcemia due to the granulomatous inflammatory response. In these lesions, activated T-lymphocytes (and macrophages) secrete cytokines such as \u03b3-interferon. \u03b3-Interferon then stimulates the enzyme 1\u03b1-hydroxylase in macrophages, converting vitamin D into its active form (1,25-dihydroxyvitamin D or calcitriol). The increased calcitriol enhances intestinal calcium absorption and bone resorption, leading to hypercalcemia.\n\nComparing answer choices:\n\u2013 Option A (excessive dietary ergocalciferol) is not applicable.\n\u2013 Option B (induction of focal osteolysis by tumor cells) is more characteristic of lesions in malignancies such as multiple myeloma.\n\u2013 Option D (production of PTH-related peptide) is commonly seen in squamous cell carcinomas, not Hodgkin lymphoma.\n\u2013 Option C (secretion of \u03b3-interferon by activated T-lymphocytes) fits the pathophysiology seen with Hodgkin lymphoma due to the granulomatous response.\n\nTherefore, the most likely explanation for this patient\u2019s laboratory findings is:\n\nFinal answer: C. Secretion of \u03b3-interferon by activated T-lymphocytes."
    },
    {
        "realidx": 237,
        "question": "A 65-year-old man presents to his primary care physician with a neck mass. He first noticed a firm mass on the anterior aspect of his neck approximately 4 months ago. The mass is painless and has not increased in size since then. He has also noticed occasional fatigue and has gained 10 pounds in the past 4 months despite no change in his diet or exercise frequency. His past medical history is notable for gout for which he takes allopurinol. He denies any prior thyroid disorder. He runs 4 times per week and eats a balanced diet of mostly fruits and vegetables. He does not smoke and drinks a glass of wine with dinner. His family history is notable for medullary thyroid cancer in his maternal uncle. His temperature is 97.8\u00b0F (36.6\u00b0C), blood pressure is 127/72 mmHg, pulse is 87/min, and respirations are 19/min. On exam, he has a firm, symmetric, and stone-firm thyroid. A biopsy of this patient's lesion would most likely demonstrate which of the following findings?",
        "answer": "Dense fibroinflammatory infiltrate",
        "options": {
            "A": "Diffuse infiltrate of lymphoid cells destroying thyroid follicles",
            "B": "Dense fibroinflammatory infiltrate",
            "C": "Pleomorphic undifferentiated infiltrative cells with necrosis",
            "D": "Stromal amyloid deposition"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "65 year old man presents",
            "primary care physician",
            "neck mass",
            "first",
            "firm mass",
            "anterior aspect of",
            "neck approximately",
            "months",
            "mass",
            "painless",
            "not increased in size",
            "then",
            "occasional fatigue",
            "gained 10 pounds",
            "past",
            "months",
            "change in",
            "diet",
            "exercise frequency",
            "past medical history",
            "notable",
            "gout",
            "takes allopurinol",
            "denies",
            "prior thyroid disorder",
            "runs 4 times per week",
            "eats",
            "balanced diet",
            "mostly fruits",
            "vegetables",
            "not smoke",
            "drinks",
            "glass",
            "wine",
            "dinner",
            "family history",
            "notable",
            "medullary thyroid cancer",
            "maternal uncle",
            "temperature",
            "97",
            "36",
            "blood pressure",
            "72 mmHg",
            "pulse",
            "87 min",
            "respirations",
            "min",
            "exam",
            "firm",
            "symmetric",
            "stone firm thyroid",
            "biopsy",
            "patient's lesion",
            "most likely",
            "following findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5046,
            "completion_tokens": 2851
        },
        "time_elapsed": 70.68575763702393,
        "raw_responses": [
            "Step 1: The patient presents with a firm, \"stone-firm\" thyroid mass, weight gain, and fatigue. There is also a positive family history of medullary thyroid cancer.\n\nStep 2: Consider the pathology associated with different thyroid conditions:\n\u2022 Option A (Diffuse infiltrate of lymphoid cells destroying thyroid follicles) is most consistent with Hashimoto thyroiditis.\n\u2022 Option B (Dense fibroinflammatory infiltrate) fits Riedel thyroiditis.\n\u2022 Option C (Pleomorphic undifferentiated infiltrative cells with necrosis) is seen in anaplastic thyroid carcinoma.\n\u2022 Option D (Stromal amyloid deposition) is characteristic of medullary thyroid carcinoma, which is derived from parafollicular (C) cells that secrete calcitonin and lead to amyloid formation.\n\nStep 3: Given the clinical picture and family history, medullary thyroid carcinoma is the most likely diagnosis. Therefore, a biopsy would most likely show stromal amyloid deposition.\n\nFinal Answer: D. Stromal amyloid deposition",
            "Step 1: Analyze the patient's history and exam findings. The patient is a 65-year-old man with a 4-month history of a painless, firm neck mass. Notably, his maternal uncle had medullary thyroid cancer, which raises suspicion for a familial form of medullary thyroid carcinoma. The stone-firm thyroid on exam further supports this possibility.\n\nStep 2: Review the biopsy findings associated with various thyroid conditions:\n\u2022 Option A (Diffuse infiltrate of lymphoid cells destroying thyroid follicles) describes Hashimoto thyroiditis.\n\u2022 Option B (Dense fibroinflammatory infiltrate) is characteristic of Riedel thyroiditis.\n\u2022 Option C (Pleomorphic undifferentiated infiltrative cells with necrosis) is consistent with anaplastic thyroid carcinoma.\n\u2022 Option D (Stromal amyloid deposition) is the classic histopathologic finding in medullary thyroid carcinoma due to deposition of amyloid derived from calcitonin.\n\nStep 3: Eliminate the incorrect choices based on the patient\u2019s presentation and family history. The correct biopsy finding that aligns with medullary thyroid carcinoma is stromal amyloid deposition.\n\nFinal Answer: D. Stromal amyloid deposition",
            "Step 1: Analyze the Clinical Clues\n\u2022 The patient is a 65-year-old male with a firm, stone-firm thyroid mass.\n\u2022 His family history is significant for medullary thyroid cancer, which raises suspicion for a similar pathology.\n\u2022 Medullary thyroid carcinoma (MTC) is derived from parafollicular C cells, which produce calcitonin.\n\nStep 2: Understand the Histologic Findings of Medullary Thyroid Carcinoma\n\u2022 A key histologic hallmark of MTC is the deposition of amyloid in the stroma.\n\u2022 This amyloid is derived from the abnormal calcitonin produced by the neoplastic C cells.\n\nStep 3: Evaluate and Eliminate the Options\nA. Diffuse infiltrate of lymphoid cells destroying thyroid follicles \u2013 This description fits with Hashimoto's thyroiditis, an autoimmune condition typically presenting with a hypothyroid picture.\nB. Dense fibroinflammatory infiltrate \u2013 This is more consistent with subacute thyroiditis, which usually presents with a painful thyroid.\nC. Pleomorphic undifferentiated infiltrative cells with necrosis \u2013 This suggests an anaplastic thyroid carcinoma, which is highly aggressive and usually presents with rapidly enlarging mass and local invasion.\nD. Stromal amyloid deposition \u2013 This is characteristic of medullary thyroid carcinoma.\n\nFinal Answer:\nD. Stromal amyloid deposition"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Analyze the Clinical Clues\n\u2022 The patient is a 65-year-old male with a firm, stone-firm thyroid mass.\n\u2022 His family history is significant for medullary thyroid cancer, which raises suspicion for a similar pathology.\n\u2022 Medullary thyroid carcinoma (MTC) is derived from parafollicular C cells, which produce calcitonin.\n\nStep 2: Understand the Histologic Findings of Medullary Thyroid Carcinoma\n\u2022 A key histologic hallmark of MTC is the deposition of amyloid in the stroma.\n\u2022 This amyloid is derived from the abnormal calcitonin produced by the neoplastic C cells.\n\nStep 3: Evaluate and Eliminate the Options\nA. Diffuse infiltrate of lymphoid cells destroying thyroid follicles \u2013 This description fits with Hashimoto's thyroiditis, an autoimmune condition typically presenting with a hypothyroid picture.\nB. Dense fibroinflammatory infiltrate \u2013 This is more consistent with subacute thyroiditis, which usually presents with a painful thyroid.\nC. Pleomorphic undifferentiated infiltrative cells with necrosis \u2013 This suggests an anaplastic thyroid carcinoma, which is highly aggressive and usually presents with rapidly enlarging mass and local invasion.\nD. Stromal amyloid deposition \u2013 This is characteristic of medullary thyroid carcinoma.\n\nFinal Answer:\nD. Stromal amyloid deposition"
    },
    {
        "realidx": 238,
        "question": "A group of researchers decided to explore whether the estimates of incidence and prevalence rates of systemic lupus erythematosus (SLE) were influenced by the number of years it took to examine administrative data. These estimates were not only based on hospital discharges, but also on physician billing codes. For study purposes, the researchers labeled incident cases at the initial occurrence of SLE diagnosis in the hospital database, while prevalent cases were those that were coded as harboring SLE at any time, with patients maintaining their diagnosis until death. Which statement is true regarding the relationship between incidence and prevalence rates during the time period that might be chosen for this specific study?",
        "answer": "Incidence rates will be higher during shorter time periods than longer periods.",
        "options": {
            "A": "Incidence rates will be higher during shorter time periods than longer periods.",
            "B": "The prevalence of SLE during consecutively shorter time windows will be overestimated.",
            "C": "The inclusion of attack rates would increase incidence estimates in longer time periods.",
            "D": "The inclusion of attack rates would decrease incidence estimates in shorter time periods."
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "A group",
            "researchers",
            "to",
            "estimates",
            "incidence",
            "prevalence rates",
            "systemic lupus erythematosus",
            "influenced",
            "number",
            "years",
            "took to",
            "administrative data",
            "estimates",
            "not only based",
            "hospital discharges",
            "physician billing codes",
            "study purposes",
            "researchers labeled incident cases",
            "initial occurrence",
            "SLE diagnosis",
            "hospital database",
            "prevalent cases",
            "coded",
            "harboring SLE",
            "time",
            "patients maintaining",
            "diagnosis",
            "death",
            "statement",
            "true",
            "relationship",
            "incidence",
            "prevalence rates",
            "time period",
            "chosen",
            "specific study"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6081,
            "completion_tokens": 8098
        },
        "time_elapsed": 54.29154849052429,
        "raw_responses": [
            "Let\u2019s break down the thought\u2010process carefully.\n\nIn any disease that is largely chronic\u2014like systemic lupus erythematosus (SLE)\u2014there is a fundamental relationship between incidence (the \u201cflow\u201d of new cases over time) and prevalence (the \u201cstock\u201d of disease present at a particular point or period). Prevalence is roughly the product of incidence and the average duration of disease. In a situation where cases are \u201csticky\u201d (i.e. once diagnosed, patients remain \u201cprevalent\u201d until death), the longer you look back (or the longer your data\u2010capture window), the more likely you are to \u201caccumulate\u201d existing cases. That is why many epidemiologic studies use long look\u2010back periods to \u201cclear out\u201d prevalent cases from the pool so that incident cases truly represent the first recognized diagnosis.\n\nIn this study the researchers label an \u201cincident\u201d case as a patient\u2019s first appearance with an SLE diagnosis in their hospital database. However, if the observational window is short (say, using only 1 or 2 years of data), some patients who actually had longstanding SLE before the study period (i.e. true prevalent cases) might \u201cfirst\u201d appear in that short window. They would be mis\u2010classified as incident because there is not enough history to \u201cwash out\u201d their previous disease status. In contrast, a longer time window allows one to \u201cclear\u201d the backlog of prevalent cases so that only true new-onset cases are labeled as incident.\n\nThus, when one uses a shorter observational time period, the incident rate (number of new diagnoses divided by the time at risk) may be spuriously \u201cinflated\u201d by the inclusion of prevalent cases that are being coded for the first time in that window. In other words, if you look over a short period you are more likely to mis-classify some longstanding disease as \u201cincident.\u201d When using a longer time-frame, most patients who already had a diagnosis are recognized as prevalent and are not \u201cre\u2010diagnosed\u201d as new, so the calculated incidence rate is lower (and more accurate).\n\nReviewing the answer choices with that reasoning in mind:\n\nA. Incidence rates will be higher during shorter time periods than longer periods.\n\u2003\u2003\u2013 This is the correct statement because a short look\u2010back window leads to an inflation of \u201cincident\u201d cases (by mis\u2010classifying prevalent ones as incident), whereas extending the time period allows you to \u201cclear\u201d prevalent cases, resulting in lower incidence rates.\n\nB. The prevalence of SLE during consecutively shorter time windows will be overestimated.\n\u2003\u2003\u2013 This is not right. Prevalence is the accumulation over time and, in a very short window, you might even underestimate the actual stock of SLE cases if you miss ones that are not coded during that time.\n\nC. The inclusion of attack rates would increase incidence estimates in longer time periods.\n\u2003\u2003\u2013 \u201cAttack rate\u201d is a concept applied mostly to acute, time\u2010limited events (like infectious outbreaks) and is not typically used in measuring chronic diseases like SLE.\n\nD. The inclusion of attack rates would decrease incidence estimates in shorter time periods.\n\u2003\u2003\u2013 Again, attack rates are not particularly relevant for chronic conditions, and this statement does not represent the core issue of mis\u2010classification of incident vs prevalent cases under different look\u2010back durations.\n\nThus, following the step\u2010by\u2010step reasoning, the correct answer is:\n\nFinal Answer: A",
            "The key to answering this question is to understand that for a chronic disease like SLE, the estimates of incidence and prevalence can be affected by the \u201clook\u2010back\u201d period inherent in an administrative data study.\n\nIncidence rates are calculated as the number of new cases per unit time. When using a shorter time window to \u201ccapture\u201d incident cases, there is a risk that prevalent cases (which were diagnosed before the study period) might be mistakenly classified as incident because the available data does not extend far enough back in time to distinguish between longstanding cases and truly new ones. This misclassification artifact can lead to an artificially higher incidence rate when using a shorter time period. In contrast, if one uses a longer time frame (or ensures an adequate \u201cwash\u2010out\u201d period) then the chance of such misclassification is reduced. \n\nNone of the options referring to \u201cattack rates\u201d are particularly relevant to a chronic disease like SLE\u2014instead, the focus is on the effect of the observation window.\n\nTherefore, the correct answer is:\n\nA. Incidence rates will be higher during shorter time periods than longer periods.",
            "Step 1: Recognize the problem in study design. In studies using administrative data, a \u201cwash\u2010out\u201d period (or look\u2013back window) is needed to distinguish true incident cases from prevalent cases that have not been previously coded. If the period examined is very short, many cases detected as \u201cnew\u201d may have been diagnosed previously but not captured because of the limited look\u2013back time. This misclassification leads to an overestimation of the incidence rate over short observation windows.\n\nStep 2: Analyze the options.\n\n\u2022 Option A states that \u201cIncidence rates will be higher during shorter time periods than longer periods.\u201d This fits our reasoning\u2014when the look\u2013back period is insufficient, prevalent cases are misclassified as incident ones, thereby increasing the apparent incidence rate.\n\n\u2022 Option B discusses prevalence overestimation in short time windows. However, prevalence (the proportion with existing disease) in administrative data is less affected by the look\u2013back period since it typically includes anyone ever coded as having the disease until death. Thus, B is not accurate.\n\n\u2022 Options C and D refer to \u201cattack rates.\u201d Attack rates are measures used in outbreak settings to indicate the percentage of an at\u2013risk population that contracts the disease over a brief period. They are not applicable in the context of a chronic disease like SLE or this study design. Thus, both C and D can be eliminated.\n\nStep 3: Final Answer\n\nThe best answer is:\nA. Incidence rates will be higher during shorter time periods than longer periods."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Recognize the problem in study design. In studies using administrative data, a \u201cwash\u2010out\u201d period (or look\u2013back window) is needed to distinguish true incident cases from prevalent cases that have not been previously coded. If the period examined is very short, many cases detected as \u201cnew\u201d may have been diagnosed previously but not captured because of the limited look\u2013back time. This misclassification leads to an overestimation of the incidence rate over short observation windows.\n\nStep 2: Analyze the options.\n\n\u2022 Option A states that \u201cIncidence rates will be higher during shorter time periods than longer periods.\u201d This fits our reasoning\u2014when the look\u2013back period is insufficient, prevalent cases are misclassified as incident ones, thereby increasing the apparent incidence rate.\n\n\u2022 Option B discusses prevalence overestimation in short time windows. However, prevalence (the proportion with existing disease) in administrative data is less affected by the look\u2013back period since it typically includes anyone ever coded as having the disease until death. Thus, B is not accurate.\n\n\u2022 Options C and D refer to \u201cattack rates.\u201d Attack rates are measures used in outbreak settings to indicate the percentage of an at\u2013risk population that contracts the disease over a brief period. They are not applicable in the context of a chronic disease like SLE or this study design. Thus, both C and D can be eliminated.\n\nStep 3: Final Answer\n\nThe best answer is:\nA. Incidence rates will be higher during shorter time periods than longer periods."
    },
    {
        "realidx": 239,
        "question": "A 48-year-old Caucasian female presents to her primary care physician for evaluation of progressive weakness and shortness of breath. She has had progressive shortness of breath over the last year with an intermittent non-productive cough. In addition, she complains of difficulty raising her arms to brush her hair. Her temperature is 99.6\u00b0F (37.6\u00b0C), pulse is 80/min, blood pressure is 130/85 mmHg, respirations are 18/min, and oxygen saturation is 95% on room air. Neurologic exam shows 4/5 strength in the deltoid muscles bilaterally. Diffuse dry crackles are heard on lung auscultation. A faint erythematous rash is noted on the malar cheeks, periorbital areas, lateral proximal thighs, and the elbows. Which of the following tests is most likely to confirm the diagnosis?",
        "answer": "Muscle biopsy",
        "options": {
            "A": "Muscle biopsy",
            "B": "CT scan",
            "C": "Serum ANA titer",
            "D": "Skin biopsy"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "48 year old Caucasian female presents",
            "primary care physician",
            "evaluation",
            "progressive weakness",
            "shortness of breath",
            "progressive shortness of breath",
            "last year",
            "intermittent non-productive cough",
            "addition",
            "difficulty",
            "arms to brush",
            "hair",
            "temperature",
            "99",
            "pulse",
            "80 min",
            "blood pressure",
            "85 mmHg",
            "respirations",
            "min",
            "oxygen saturation",
            "95",
            "room",
            "Neurologic exam shows 4/5 strength",
            "deltoid muscles",
            "Diffuse dry crackles",
            "heard",
            "lung auscultation",
            "faint erythematous rash",
            "noted",
            "malar",
            "periorbital areas",
            "lateral proximal thighs",
            "elbows",
            "following tests",
            "most likely to confirm",
            "diagnosis"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5139,
            "completion_tokens": 3049
        },
        "time_elapsed": 27.19412636756897,
        "raw_responses": [
            "Step 1: Integrate the clinical picture. This patient is a 48-year-old Caucasian female presenting with progressive muscle weakness\u2014most notably proximal weakness, as seen in difficulty raising her arms\u2014as well as respiratory complaints and characteristic skin findings (malar rash, periorbital rash, and involvement of the lateral proximal thighs and elbows). Together, these findings strongly point toward dermatomyositis.\n\nStep 2: Analyze the diagnostic options. For dermatomyositis:\n\u2003\u2022 Muscle biopsy (Option A) is considered the gold standard for diagnosis as it allows direct visualization of muscle inflammation, perifascicular atrophy, and other characteristic histologic changes.\n\u2003\u2022 CT scan (Option B) is not used for muscle pathology confirmation.\n\u2003\u2022 Serum ANA titer (Option C) may be positive in many autoimmune conditions, including dermatomyositis, but it is not specific enough to confirm the disease.\n\u2003\u2022 Skin biopsy (Option D) might help delineate the rash pathology but does not confirm the underlying muscle involvement.\n\nStep 3: Eliminate incorrect choices and choose the best confirmatory test. Given that muscle biopsy provides a definitive diagnosis by revealing specific findings associated with dermatomyositis, it is the most appropriate choice.\n\nFinal answer: A. Muscle biopsy.",
            "Step 1: Gather critical aspects of the case.  \n\u2022 The patient is a 48-year-old Caucasian female presenting with progressive shortness of breath, non-productive cough, and proximal muscle weakness (difficulty raising her arms).  \n\u2022 The physical exam reveals muscle weakness (4/5 strength in the deltoids), diffuse dry crackles on lung auscultation, and a faint erythematous rash present on areas such as the malar region, periorbital areas, lateral proximal thighs, and elbows.\n\nStep 2: Consider the likely diagnosis.  \nThe combination of proximal muscle weakness and the characteristic rash (notably the malar and periorbital involvement) strongly suggests dermatomyositis.\n\nStep 3: Identify the test that confirms the diagnosis.  \nWhile various tests (serum enzymes, autoantibodies like anti-Mi-2, and imaging studies) can support the diagnosis, the gold standard for definitively confirming dermatomyositis is a muscle biopsy.  \n\u2022 Option A (Muscle biopsy) is the best choice because it can reveal characteristic inflammatory infiltrates and muscle fiber damage.  \n\u2022 Option B (CT scan) is not beneficial for diagnosing an inflammatory myopathy.  \n\u2022 Option C (Serum ANA titer) is nonspecific and would not confirm dermatomyositis by itself.  \n\u2022 Option D (Skin biopsy) might reveal dermal changes but is less definitive for diagnosing dermatomyositis, which primarily involves muscle pathology with associated skin findings.\n\nFinal Answer: A. Muscle biopsy",
            "Step 1: Recognize the Clinical Picture\n\u2022 The patient is a middle-aged woman with progressive proximal muscle weakness (difficulty raising her arms), shortness of breath, an intermittent cough, and diffuse dry crackles on lung auscultation.\n\u2022 There is also an erythematous rash noted over the cheeks, periorbital areas, lateral proximal thighs, and elbows.\n\u2022 These findings are highly suggestive of dermatomyositis, an inflammatory myopathy characterized by skin findings and muscle weakness.\n\nStep 2: Evaluate the Diagnostic Options\nA. Muscle biopsy \u2013 This is considered the gold standard for diagnosing inflammatory myopathies such as dermatomyositis. It would reveal characteristic inflammatory infiltrates, muscle fiber necrosis, and perifascicular atrophy.\nB. CT scan \u2013 This imaging modality is not useful for diagnosing dermatomyositis.\nC. Serum ANA titer \u2013 While an elevated ANA can be seen in dermatomyositis, it is nonspecific and not definitive for the diagnosis.\nD. Skin biopsy \u2013 Although it can show characteristic changes in the skin, it is less definitive compared to a muscle biopsy for confirming the diagnosis of dermatomyositis.\n\nStep 3: Make the Final Decision\nGiven the clinical scenario and diagnostic options, a muscle biopsy (Option A) is the most specific test to confirm the diagnosis of dermatomyositis.\n\nFinal Answer: A. Muscle biopsy"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Gather critical aspects of the case.  \n\u2022 The patient is a 48-year-old Caucasian female presenting with progressive shortness of breath, non-productive cough, and proximal muscle weakness (difficulty raising her arms).  \n\u2022 The physical exam reveals muscle weakness (4/5 strength in the deltoids), diffuse dry crackles on lung auscultation, and a faint erythematous rash present on areas such as the malar region, periorbital areas, lateral proximal thighs, and elbows.\n\nStep 2: Consider the likely diagnosis.  \nThe combination of proximal muscle weakness and the characteristic rash (notably the malar and periorbital involvement) strongly suggests dermatomyositis.\n\nStep 3: Identify the test that confirms the diagnosis.  \nWhile various tests (serum enzymes, autoantibodies like anti-Mi-2, and imaging studies) can support the diagnosis, the gold standard for definitively confirming dermatomyositis is a muscle biopsy.  \n\u2022 Option A (Muscle biopsy) is the best choice because it can reveal characteristic inflammatory infiltrates and muscle fiber damage.  \n\u2022 Option B (CT scan) is not beneficial for diagnosing an inflammatory myopathy.  \n\u2022 Option C (Serum ANA titer) is nonspecific and would not confirm dermatomyositis by itself.  \n\u2022 Option D (Skin biopsy) might reveal dermal changes but is less definitive for diagnosing dermatomyositis, which primarily involves muscle pathology with associated skin findings.\n\nFinal Answer: A. Muscle biopsy"
    },
    {
        "realidx": 241,
        "question": "A 41-year-old man presents to his primary care provider with abdominal pain. He says that the pain \u201ccomes and goes\u201d throughout the day and usually lasts 20-30 minutes per episode. He can point to the spot 1-2 inches above the umbilicus where he feels the pain. He denies any feeling of regurgitation or nighttime cough but endorses nausea. He reports that he used to eat three large meals per day but has found that eating more frequently improves his pain. He tried a couple pills of ibuprofen with food over the past couple days and thinks it helped. He has gained four pounds since his past appointment three months ago. The patient denies any diarrhea or change in his stools. He has no past medical history. He drinks 5-6 beers on the weekend and has a 20 pack-year smoking history. He denies any family history of cancer. On physical exam, he is tender to palpation above the umbilicus. Bowel sounds are present. A stool guaiac test is positive. The patient undergoes endoscopy with biopsy to diagnose his condition.\n\nWhich of the following is most likely to be found on histology?",
        "answer": "Urease-producing organism in the small intestine",
        "options": {
            "A": "Mucosal defect in the stomach",
            "B": "Urease-producing organism in the small intestine",
            "C": "PAS-positive material in the small intestine",
            "D": "Crypt abscesses in the large intestine"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old man presents",
            "primary care provider",
            "abdominal pain",
            "pain",
            "goes",
            "day",
            "usually lasts 20",
            "episode",
            "point",
            "spot",
            "inches",
            "umbilicus",
            "feels",
            "pain",
            "denies",
            "feeling",
            "regurgitation",
            "nighttime cough",
            "nausea",
            "reports",
            "used to eat three large meals",
            "day",
            "found",
            "eating",
            "frequently improves",
            "pain",
            "couple pills",
            "ibuprofen",
            "food",
            "past couple days",
            "thinks",
            "helped",
            "gained four pounds",
            "past appointment three months",
            "patient denies",
            "diarrhea",
            "change in",
            "stools",
            "past medical history",
            "drinks 5-6 beers",
            "weekend",
            "20 smoking history",
            "denies",
            "family history of cancer",
            "physical exam",
            "tender",
            "palpation",
            "umbilicus",
            "Bowel sounds",
            "present",
            "stool guaiac test",
            "positive",
            "patient",
            "endoscopy",
            "biopsy to diagnose",
            "condition",
            "following",
            "most likely to",
            "found",
            "histology"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 6144,
            "completion_tokens": 4940
        },
        "time_elapsed": 35.86466836929321,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s clinical presentation. The man\u2019s episodic epigastric pain (located about 1\u20132 inches above the umbilicus) that improves with frequent, smaller meals is characteristic of a duodenal ulcer. The positive stool guaiac test indicates gastrointestinal bleeding, and his history of occasional ibuprofen use is also relevant.\n\nStep 2: Identify the underlying etiology. The most common cause of duodenal ulcers is Helicobacter pylori infection, a gram\u2010negative, urease\u2010producing bacterium. Although NSAID use can contribute to ulcer formation, the clinical picture fits more closely with H. pylori\u2013induced ulcer disease.\n\nStep 3: Evaluate the answer choices:\n\u2022 Option A (Mucosal defect in the stomach) would be more characteristic of a gastric ulcer rather than a duodenal ulcer.\n\u2022 Option B (Urease-producing organism in the small intestine) describes H. pylori, which is known to colonize the duodenal mucosa in duodenal ulcer cases.\n\u2022 Option C (PAS-positive material in the small intestine) is associated with conditions like Whipple disease.\n\u2022 Option D (Crypt abscesses in the large intestine) is seen in inflammatory conditions such as ulcerative colitis.\n\nStep 4: Final Answer. The best histologic finding on biopsy in this case is Option B: a urease-producing organism in the small intestine (indicative of Helicobacter pylori infection).",
            "Step 1: Analyze the clinical presentation. The patient is a 41-year-old man with recurrent, intermittent epigastric pain that lasts 20-30 minutes per episode. The pain improves when he eats smaller, more frequent meals\u2014a classic presentation for a duodenal ulcer. The use of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), could contribute, but the feature of relief with food is more characteristic of a duodenal ulcer. Additionally, the positive stool guaiac test suggests bleeding at the ulcer site.\n\nStep 2: Consider the likely cause. Two common causes of duodenal ulcers are Helicobacter pylori infection and NSAID use. The patient\u2019s history (including smoking and alcohol use) supports the possibility of H. pylori infection, which is known to produce urease\u2014a key enzyme that helps the bacteria neutralize stomach acid by converting urea into ammonia.\n\nStep 3: Review the answer choices.\nA. Mucosal defect in the stomach \u2013 This is more indicative of a gastric ulcer, and his pain pattern (relief with food) points toward a duodenal ulcer.\nB. Urease-producing organism in the small intestine \u2013 This fits with H. pylori infection, which is typically found in the duodenum (part of the small intestine) in cases of duodenal ulcers.\nC. PAS-positive material in the small intestine \u2013 PAS positivity suggests a different pathology (like certain infections or Whipple disease), which is not consistent with his presentation.\nD. Crypt abscesses in the large intestine \u2013 These are seen in inflammatory bowel diseases such as ulcerative colitis, which does not match the patient\u2019s symptoms.\n\nStep 4: Final answer. Based on the clinical scenario and the process of elimination, the histologic finding most likely to be found on biopsy is that of a urease-producing organism in the small intestine (H. pylori infection).\n\nFinal answer: B.",
            "Step 1: Review the clinical features.\n\u2022 The patient describes epigastric pain (\"1-2 inches above the umbilicus\") that \u201ccomes and goes\u201d and lasts 20\u201330 minutes.\n\u2022 Also noted is that he finds relief by eating more frequent, smaller meals\u2014a classic presentation seen in duodenal ulcers.\n\u2022 The positive stool guaiac test suggests occult gastrointestinal bleeding, which can be seen in peptic ulcer disease.\n\nStep 2: Consider the likely causes.\n\u2022 Duodenal ulcers are most often associated with Helicobacter pylori infection. H. pylori is a gram\u2010negative, urease\u2010producing bacterium.\n\u2022 Although ibuprofen (an NSAID) is known to predispose to ulcer formation, the pain pattern fits more with a duodenal ulcer from H. pylori rather than NSAID-induced gastric ulcer.\n\u2022 Other options like PAS-positive material and crypt abscesses are associated with entirely different conditions (Whipple disease and ulcerative colitis, respectively).\n\nStep 3: Eliminate the incorrect choices.\nA. Mucosal defect in the stomach \u2013 While this could represent a peptic ulcer, the clinical picture aligns better with a duodenal ulcer, and the biopsy would specifically reveal evidence of H. pylori.\nC. PAS-positive material in the small intestine \u2013 This is indicative of Whipple disease, which does not fit this presentation.\nD. Crypt abscesses in the large intestine \u2013 These are characteristic of ulcerative colitis, not peptic ulcer disease.\n\nStep 4: Final answer.\nSince Helicobacter pylori is a urease-producing organism commonly found in duodenal ulcers, the biopsy is most likely to reveal this organism.\n\nFinal Answer: B. Urease-producing organism in the small intestine"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation. The patient is a 41-year-old man with recurrent, intermittent epigastric pain that lasts 20-30 minutes per episode. The pain improves when he eats smaller, more frequent meals\u2014a classic presentation for a duodenal ulcer. The use of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), could contribute, but the feature of relief with food is more characteristic of a duodenal ulcer. Additionally, the positive stool guaiac test suggests bleeding at the ulcer site.\n\nStep 2: Consider the likely cause. Two common causes of duodenal ulcers are Helicobacter pylori infection and NSAID use. The patient\u2019s history (including smoking and alcohol use) supports the possibility of H. pylori infection, which is known to produce urease\u2014a key enzyme that helps the bacteria neutralize stomach acid by converting urea into ammonia.\n\nStep 3: Review the answer choices.\nA. Mucosal defect in the stomach \u2013 This is more indicative of a gastric ulcer, and his pain pattern (relief with food) points toward a duodenal ulcer.\nB. Urease-producing organism in the small intestine \u2013 This fits with H. pylori infection, which is typically found in the duodenum (part of the small intestine) in cases of duodenal ulcers.\nC. PAS-positive material in the small intestine \u2013 PAS positivity suggests a different pathology (like certain infections or Whipple disease), which is not consistent with his presentation.\nD. Crypt abscesses in the large intestine \u2013 These are seen in inflammatory bowel diseases such as ulcerative colitis, which does not match the patient\u2019s symptoms.\n\nStep 4: Final answer. Based on the clinical scenario and the process of elimination, the histologic finding most likely to be found on biopsy is that of a urease-producing organism in the small intestine (H. pylori infection).\n\nFinal answer: B."
    },
    {
        "realidx": 243,
        "question": " A 61-year-old man was started on rosuvastatin 40 mg 8 weeks ago and presents today for a follow-up. He complains of pain in his legs and general weakness. On physical exam, he has full range of motion of his extremities but complains of pain. His blood pressure is 126/84 mm Hg and heart rate is 74/min. The decision is made to stop the statin and return to the clinic in 2 weeks to assess any changes in symptoms. After stopping the statin, his muscular symptoms resolve. What is the next best course of action to take regarding his LDL control?",
        "answer": "Restart rosuvastatin at a lower dose",
        "options": {
            "A": "Restart rosuvastatin at a lower dose",
            "B": "Initiate fenofibrate",
            "C": "Initiate a different statin",
            "D": "Initiate fish oils"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "61 year old man",
            "started",
            "rosuvastatin 40 mg",
            "weeks",
            "presents today",
            "follow-up",
            "pain",
            "legs",
            "general weakness",
            "physical exam",
            "full range of motion",
            "extremities",
            "pain",
            "blood pressure",
            "84 mm Hg",
            "heart rate",
            "74 min",
            "decision",
            "made to stop",
            "statin",
            "return",
            "clinic",
            "2 weeks to assess",
            "changes",
            "symptoms",
            "stopping",
            "statin",
            "muscular symptoms resolve",
            "next best course",
            "action to take",
            "control"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4767,
            "completion_tokens": 3720
        },
        "time_elapsed": 28.298009634017944,
        "raw_responses": [
            "Step 1. Analysis of the case:\n\u2022 A 61-year-old man was started on rosuvastatin 40 mg and now has developed leg pain and general weakness.\n\u2022 His exam is otherwise unremarkable, and his symptoms resolve upon stopping the statin, suggesting statin-induced myopathy.\n\u2022 Given his cardiovascular risk factors, continued LDL management is essential.\n\nStep 2. Considering the options:\nA. Restart rosuvastatin at a lower dose \u2013 Reducing the dose may alleviate myopathy symptoms while maintaining LDL control; statin-induced side effects are often dose-related.\nB. Initiate fenofibrate \u2013 Fibrates are typically used for hypertriglyceridemia, not for primary LDL reduction; they also carry a risk of myopathy, especially when combined with statins.\nC. Initiate a different statin \u2013 While switching statins can be considered, typically the first step is to lower the dose of the current statin, which is often effective in minimizing side effects.\nD. Initiate fish oils \u2013 Fish oils mainly lower triglycerides and have limited effect on LDL levels.\n\nStep 3. Final decision:\nGiven the need for effective LDL management and the dose-dependent nature of statin-induced myopathy, the best approach is to restart rosuvastatin at a lower dose.\n\nFinal answer: A. Restart rosuvastatin at a lower dose.",
            "Step 1: Recognize that the patient developed statin-associated myopathy (muscle pain and weakness) from high-intensity rosuvastatin (40 mg), which resolved after discontinuing the medication.\n\nStep 2: The clinical goal is to maintain LDL control given his elevated cardiovascular risk profile while also minimizing adverse effects. Guidelines recommend that when a patient experiences statin-induced myopathy, one should consider restarting statin therapy at a lower dose or, if necessary, switching to another statin with a lower risk profile.\n\nStep 3: Examine the options:\n\u2022 Option A \u2013 Restart rosuvastatin at a lower dose: Lowering the dose may reduce the incidence of myopathy while still providing some LDL control benefits.\n\u2022 Option B \u2013 Initiate fenofibrate: Fenofibrate is primarily used for hypertriglyceridemia and is not the first choice for LDL control.\n\u2022 Option C \u2013 Initiate a different statin: While this is a reasonable alternative if one statin is not tolerated, the initial approach is to see if a lower dose of the same statin is tolerated.\n\u2022 Option D \u2013 Initiate fish oils: Fish oils do not have robust LDL-lowering effects and are not appropriate in this situation.\n\nStep 4: Given that his symptoms resolved after stopping the statin, the next best step is to attempt to re-establish statin therapy to achieve LDL control. Restarting rosuvastatin at a lower dose is appropriate and in line with evidence-based guidelines.\n\nFinal Answer: A. Restart rosuvastatin at a lower dose.",
            "Step-by-Step Reasoning:\n\n1. The patient\u2019s muscular symptoms developed on a high dose of rosuvastatin (40 mg) and resolved after discontinuing the statin, which strongly suggests statin-induced myopathy\u2014a dose-dependent adverse effect.\n\n2. The primary goal is to manage his LDL levels while minimizing side effects. Since his symptoms improved after stopping the medication, it is reasonable to try reintroducing a statin at a lower dose.\n\n3. Among the options provided:\n\u2003\u2022 Option A (Restart rosuvastatin at a lower dose) is appropriate since a lower dose can help reduce the risk of myopathy while still providing LDL control.\n\u2003\u2022 Option B (Initiate fenofibrate) is more suited for controlling hypertriglyceridemia, not LDL cholesterol.\n\u2003\u2022 Option C (Initiate a different statin) might be considered, but the more straightforward approach is to lower the dose of the current statin.\n\u2003\u2022 Option D (Initiate fish oils) primarily benefit triglyceride levels and are not first-line for LDL management.\n\nFinal Answer: A. Restart rosuvastatin at a lower dose."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Recognize that the patient developed statin-associated myopathy (muscle pain and weakness) from high-intensity rosuvastatin (40 mg), which resolved after discontinuing the medication.\n\nStep 2: The clinical goal is to maintain LDL control given his elevated cardiovascular risk profile while also minimizing adverse effects. Guidelines recommend that when a patient experiences statin-induced myopathy, one should consider restarting statin therapy at a lower dose or, if necessary, switching to another statin with a lower risk profile.\n\nStep 3: Examine the options:\n\u2022 Option A \u2013 Restart rosuvastatin at a lower dose: Lowering the dose may reduce the incidence of myopathy while still providing some LDL control benefits.\n\u2022 Option B \u2013 Initiate fenofibrate: Fenofibrate is primarily used for hypertriglyceridemia and is not the first choice for LDL control.\n\u2022 Option C \u2013 Initiate a different statin: While this is a reasonable alternative if one statin is not tolerated, the initial approach is to see if a lower dose of the same statin is tolerated.\n\u2022 Option D \u2013 Initiate fish oils: Fish oils do not have robust LDL-lowering effects and are not appropriate in this situation.\n\nStep 4: Given that his symptoms resolved after stopping the statin, the next best step is to attempt to re-establish statin therapy to achieve LDL control. Restarting rosuvastatin at a lower dose is appropriate and in line with evidence-based guidelines.\n\nFinal Answer: A. Restart rosuvastatin at a lower dose."
    },
    {
        "realidx": 246,
        "question": "A 43-year-old man with a history of hepatitis C and current intravenous drug use presents with 5 days of fever, chills, headache, and severe back pain. On physical exam, temperature is 100.6 deg F (38.1 deg C), blood pressure is 109/56 mmHg, pulse is 94/min, and respirations are 18/min. He is thin and diaphoretic with pinpoint pupils, poor dentition, and track marks on his arms and legs. A high-pitched systolic murmur is heard, loudest in the left sternal border and with inspiration. He is admitted to the hospital and started on broad-spectrum antibiotics. One of the blood cultures drawn 12 hours ago returns positive for Staphylococcus aureus. Which of the following is the most appropriate next step to confirm the diagnosis?",
        "answer": "Repeat blood cultures now",
        "options": {
            "A": "Repeat blood cultures now",
            "B": "Repeat blood cultures 24 hours after initial cultures were drawn",
            "C": "Repeat blood cultures 48 hours after initial cultures were drawn",
            "D": "Do not repeat blood cultures"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "history of hepatitis C",
            "current intravenous drug use presents",
            "5 days",
            "fever",
            "chills",
            "headache",
            "severe back pain",
            "physical exam",
            "temperature",
            "100",
            "deg F",
            "blood pressure",
            "mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "thin",
            "diaphoretic",
            "pinpoint pupils",
            "poor dentition",
            "track marks",
            "arms",
            "legs",
            "high-pitched systolic murmur",
            "heard",
            "loudest",
            "left sternal border",
            "inspiration",
            "admitted",
            "hospital",
            "started",
            "broad spectrum antibiotics",
            "One of",
            "blood cultures drawn 12 hours",
            "returns positive",
            "Staphylococcus aureus",
            "following",
            "most appropriate next step to confirm",
            "diagnosis"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4779,
            "completion_tokens": 8816
        },
        "time_elapsed": 60.84351563453674,
        "raw_responses": [
            "Step 1: Recognize that this patient\u2019s presentation and risk factors (intravenous drug use, positive blood culture for Staphylococcus aureus, and a murmur heard along the left sternal border on inspiration) are highly concerning for infective endocarditis.\n\nStep 2: According to the Duke criteria for infective endocarditis, one of the major criteria is persistent bacteremia with a typical organism, with the necessity of having multiple blood culture sets. Although one culture has returned positive, additional cultures are required to confirm persistent bacteremia and to strengthen the diagnosis.\n\nStep 3: The correct approach is to repeat the blood cultures as soon as possible (i.e., now) rather than waiting 24 or 48 hours. Delaying repeat cultures could postpone confirmation of the diagnosis and correct management.\n\nFinal Answer: A. Repeat blood cultures now.",
            "We have a 43-year-old man with IV drug use and hepatitis C who presents with signs consistent with infective endocarditis (eg, dirty needles, track marks, and a new murmur that is best heard along the left sternal border with inspiration, suggesting tricuspid involvement). One blood culture drawn 12 hours ago is positive for Staphylococcus aureus.\n\nWhen considering the Duke criteria for endocarditis, one of the major criteria is persistently positive blood cultures. In suspected cases of endocarditis, after initiating antibiotics, it is standard practice to repeat blood cultures to ensure that the bacteremia is persistent (or, in treated cases, that it is cleared). The recommended timing for repeat blood cultures in suspected infective endocarditis is around 48 hours after the initial cultures were drawn. This allows time for the treatment to have an effect and also to see if the positive culture is persistent, which would support the diagnosis of endocarditis.\n\nNow, let\u2019s briefly consider the answer options:\n\n\u2022\u2003Repeating blood cultures now (option A) may be too early to identify if the bacteremia is persistent.\n\u2022\u2003Repeating them 24 hours after (option B) is still early.\n\u2022\u2003Repeating them 48 hours after (option C) is the recommended interval.\n\u2022\u2003Not repeating blood cultures (option D) would not help provide the needed diagnostic confirmation.\n\nThus, the most appropriate next step is to repeat blood cultures 48 hours after the initial cultures were drawn, making option C the best answer.\n\nFinal Answer: C. Repeat blood cultures 48 hours after initial cultures were drawn.",
            "Step 1: The patient\u2019s history of IV drug use, the physical exam findings (including track marks and a new systolic murmur), and the blood culture growing Staphylococcus aureus strongly suggest infective endocarditis.\n\nStep 2: One of the major criteria of the Duke criteria for endocarditis is persistent bacteremia with a typical organism (such as S. aureus). Documentation of persistent bacteremia is usually done by repeating blood cultures after starting antibiotics.\n\nStep 3: The current guidelines suggest that, after initiating appropriate antibiotic therapy, follow\u2010up blood cultures should be obtained about 48 hours after the initial cultures. This timing is most useful in confirming persistent bacteremia, which supports the diagnosis of infective endocarditis, as opposed to transient bacteremia which might be seen with other sources of infection or contaminants.\n\nStep 4: Option A (repeat cultures immediately) and Option B (repeat cultures 24 hours later) are too soon to reliably evaluate for clearance of bacteremia. Option D (do not repeat) would forgo an important diagnostic step.\n\nFinal Answer: C. Repeat blood cultures 48 hours after initial cultures were drawn"
        ],
        "ensemble_raw_responses": [
            "The best answer is provided by candidate solution 1.",
            "1",
            "1"
        ],
        "final_solution": "We have a 43-year-old man with IV drug use and hepatitis C who presents with signs consistent with infective endocarditis (eg, dirty needles, track marks, and a new murmur that is best heard along the left sternal border with inspiration, suggesting tricuspid involvement). One blood culture drawn 12 hours ago is positive for Staphylococcus aureus.\n\nWhen considering the Duke criteria for endocarditis, one of the major criteria is persistently positive blood cultures. In suspected cases of endocarditis, after initiating antibiotics, it is standard practice to repeat blood cultures to ensure that the bacteremia is persistent (or, in treated cases, that it is cleared). The recommended timing for repeat blood cultures in suspected infective endocarditis is around 48 hours after the initial cultures were drawn. This allows time for the treatment to have an effect and also to see if the positive culture is persistent, which would support the diagnosis of endocarditis.\n\nNow, let\u2019s briefly consider the answer options:\n\n\u2022\u2003Repeating blood cultures now (option A) may be too early to identify if the bacteremia is persistent.\n\u2022\u2003Repeating them 24 hours after (option B) is still early.\n\u2022\u2003Repeating them 48 hours after (option C) is the recommended interval.\n\u2022\u2003Not repeating blood cultures (option D) would not help provide the needed diagnostic confirmation.\n\nThus, the most appropriate next step is to repeat blood cultures 48 hours after the initial cultures were drawn, making option C the best answer.\n\nFinal Answer: C. Repeat blood cultures 48 hours after initial cultures were drawn."
    },
    {
        "realidx": 258,
        "question": "A 36-year-old nursing home worker presents to the clinic with the complaints of breathlessness, cough, and night sweats for the past 2 months. She further expresses her concerns about the possibility of contracting tuberculosis as one of the patients under her care is being treated for tuberculosis. A PPD skin test is done and reads 11 mm on day 3. Chest X-ray demonstrates a cavitary lesion in the right upper lobe. The standard anti-tuberculosis medication regimen is started. At a follow-up appointment 3 months later the patient presents with fatigue. She has also been experiencing occasional dizziness, weakness, and numbness in her feet. Physical exam is positive for conjunctival pallor. Lab work is significant for a hemoglobin level of 10 g/dL and mean corpuscular volume of 68 fl. What is the most likely cause of her current symptoms?",
        "answer": "Decreased ALA synthesis",
        "options": {
            "A": "Inhibition of ferrochelatase",
            "B": "Increased homocysteine degradation",
            "C": "Increased GABA production",
            "D": "Decreased ALA synthesis"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "36 year old nursing presents",
            "clinic",
            "complaints",
            "breathlessness",
            "cough",
            "night sweats",
            "past 2 months",
            "further",
            "concerns",
            "possibility",
            "contracting tuberculosis",
            "one",
            "patients",
            "care",
            "treated",
            "tuberculosis",
            "PPD skin test",
            "reads",
            "mm",
            "day 3",
            "Chest X-ray demonstrates",
            "lesion",
            "right upper lobe",
            "standard",
            "tuberculosis medication regimen",
            "started",
            "follow-up appointment",
            "months later",
            "patient presents",
            "fatigue",
            "experiencing occasional dizziness",
            "weakness",
            "numbness in",
            "feet",
            "Physical exam",
            "positive",
            "conjunctival pallor",
            "Lab work",
            "significant",
            "a hemoglobin level",
            "10 g/dL",
            "mean corpuscular volume",
            "68 fl",
            "most likely cause",
            "current symptoms"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5172,
            "completion_tokens": 4041
        },
        "time_elapsed": 34.03849935531616,
        "raw_responses": [
            "Step 1: The patient is on standard anti-tuberculosis therapy, which usually includes isoniazid. Isoniazid is known to cause pyridoxine (vitamin B6) deficiency.\n\nStep 2: Pyridoxine is a required cofactor for delta-aminolevulinic acid (ALA) synthase, the rate-limiting enzyme in heme synthesis. Without enough pyridoxine, ALA synthesis is impaired, leading to inadequate heme production. The resulting anemia is typically microcytic (low MCV) and hypochromic. Furthermore, pyridoxine deficiency also explains the patient\u2019s neurological symptoms such as numbness in her feet.\n\nStep 3: Evaluating the options:\n\u2003A. Inhibition of ferrochelatase \u2013 This is more characteristic of lead poisoning, not isoniazid-induced issues.\n\u2003B. Increased homocysteine degradation \u2013 Not related to the effects of isoniazid.\n\u2003C. Increased GABA production \u2013 Unrelated to the effects of isoniazid.\n\u2003D. Decreased ALA synthesis \u2013 This reflects the impaired function of ALA synthase due to pyridoxine deficiency.\n\nFinal Answer: D. Decreased ALA synthesis",
            "Step 1: Recognize the clinical scenario. The patient was started on a standard TB regimen that includes isoniazid. Isoniazid is known to cause vitamin B6 (pyridoxine) deficiency.\n\nStep 2: Understand the consequences of pyridoxine deficiency. Pyridoxine is a cofactor required for the enzyme \u03b4-aminolevulinate (ALA) synthase, which catalyzes the first step in heme synthesis. A deficiency in vitamin B6 results in decreased activity of this enzyme, leading to decreased ALA synthesis. This impairment in heme synthesis predisposes the patient to a microcytic anemia, as evidenced by her low hemoglobin and low mean corpuscular volume.\n\nStep 3: Evaluate the answer choices:\n\u2022 A. Inhibition of ferrochelatase \u2013 This is not associated with isoniazid treatment; rather, ferrochelatase inhibition is seen in cases like lead poisoning.\n\u2022 B. Increased homocysteine degradation \u2013 Not relevant to the mechanism of isoniazid.\n\u2022 C. Increased GABA production \u2013 This is not related to the development of anemia in this setting.\n\u2022 D. Decreased ALA synthesis \u2013 This accurately describes the effect of pyridoxine deficiency (due to isoniazid) on heme synthesis, leading to microcytic anemia.\n\nFinal Answer: D. Decreased ALA synthesis",
            "Step 1: Identify the clinical scenario. The patient is on standard antituberculosis treatment, which includes isoniazid. Isoniazid is known to cause pyridoxine (vitamin B6) deficiency.\n\nStep 2: Recognize the consequences of pyridoxine deficiency. Pyridoxine is a crucial cofactor for the enzyme delta-aminolevulinic acid (ALA) synthase, which is the first enzyme in the heme synthesis pathway. A deficiency results in decreased ALA synthesis, which in turn leads to decreased heme production, manifesting as a microcytic anemia. Additionally, pyridoxine deficiency can also cause peripheral neuropathy, which explains her symptoms of dizziness, weakness, and numbness in her feet.\n\nStep 3: Compare and eliminate the provided options:\n\u2022 Option A \u2013 Inhibition of ferrochelatase: This enzyme is involved in the final step of heme synthesis and is typically inhibited by substances like lead, not isoniazid.\n\u2022 Option B \u2013 Increased homocysteine degradation: This is not related to the mechanism of isoniazid-induced anemia.\n\u2022 Option C \u2013 Increased GABA production: Isoniazid can decrease GABA levels (not increase them) leading to seizures, not anemia.\n\u2022 Option D \u2013 Decreased ALA synthesis: This directly results from a deficiency of pyridoxine due to isoniazid therapy and is the correct mechanism leading to sideroblastic anemia and neurological symptoms in this patient.\n\nFinal answer: D. Decreased ALA synthesis"
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Identify the clinical scenario. The patient is on standard antituberculosis treatment, which includes isoniazid. Isoniazid is known to cause pyridoxine (vitamin B6) deficiency.\n\nStep 2: Recognize the consequences of pyridoxine deficiency. Pyridoxine is a crucial cofactor for the enzyme delta-aminolevulinic acid (ALA) synthase, which is the first enzyme in the heme synthesis pathway. A deficiency results in decreased ALA synthesis, which in turn leads to decreased heme production, manifesting as a microcytic anemia. Additionally, pyridoxine deficiency can also cause peripheral neuropathy, which explains her symptoms of dizziness, weakness, and numbness in her feet.\n\nStep 3: Compare and eliminate the provided options:\n\u2022 Option A \u2013 Inhibition of ferrochelatase: This enzyme is involved in the final step of heme synthesis and is typically inhibited by substances like lead, not isoniazid.\n\u2022 Option B \u2013 Increased homocysteine degradation: This is not related to the mechanism of isoniazid-induced anemia.\n\u2022 Option C \u2013 Increased GABA production: Isoniazid can decrease GABA levels (not increase them) leading to seizures, not anemia.\n\u2022 Option D \u2013 Decreased ALA synthesis: This directly results from a deficiency of pyridoxine due to isoniazid therapy and is the correct mechanism leading to sideroblastic anemia and neurological symptoms in this patient.\n\nFinal answer: D. Decreased ALA synthesis"
    },
    {
        "realidx": 265,
        "question": "A 76-year-old man with chronic obstructive pulmonary disease (COPD) presents complaining of 3 weeks of cough and progressive dyspnea on exertion in the setting of a 20 pound weight loss. He is a 60 pack-year smoker, worked as a shipbuilder 30 years ago, and recently traveled to Ohio to visit family. Chest radiograph shows increased bronchovascular markings, reticular parenchymal opacities, and multiple pleural plaques. Labs are unremarkable except for a slight anemia. Which of the following is the most likely finding on this patient's chest CT?",
        "answer": "Lower lobe cavitary mass",
        "options": {
            "A": "Nodular mass spreading along pleural surfaces",
            "B": "Honeycombing",
            "C": "Air bronchogram",
            "D": "Lower lobe cavitary mass"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "76 year old man",
            "chronic obstructive pulmonary disease",
            "presents complaining of",
            "weeks",
            "cough",
            "progressive dyspnea on exertion",
            "setting",
            "20 pound weight loss",
            "60 pack-year smoker",
            "worked",
            "30 years",
            "recently traveled",
            "Ohio to visit family",
            "Chest radiograph shows increased",
            "markings",
            "reticular parenchymal opacities",
            "multiple pleural plaques",
            "Labs",
            "unremarkable",
            "slight anemia",
            "following",
            "most likely finding",
            "patient's chest CT"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4419,
            "completion_tokens": 5798
        },
        "time_elapsed": 40.476579666137695,
        "raw_responses": [
            "Step 1: Identify Key Details\n\u2022 The patient is a 76-year-old man with COPD and a significant smoking history.\n\u2022 He worked as a shipbuilder, which is associated with asbestos exposure.\n\u2022 The radiograph shows increased bronchovascular markings, reticular parenchymal opacities, and multiple pleural plaques\u2014findings that raise suspicion for asbestos-related disease.\n\u2022 His weight loss adds to the concern for a malignancy.\n\nStep 2: Narrow the Differential Diagnosis\n\u2022 Asbestos exposure in shipbuilders is well known to increase the risk of mesothelioma.\n\u2022 Mesothelioma typically presents with diffuse pleural thickening, often appearing as nodular masses spreading along the pleural surfaces on CT.\n\u2022 Other options such as honeycombing (seen in idiopathic pulmonary fibrosis), air bronchogram (common in pneumonia or lung consolidation), or a lower lobe cavitary mass (suggesting certain types of lung cancer or infections) do not fit the clinical picture supported by his history and radiographic findings.\n\nStep 3: Compare Options & Conclude\n\u2022 Option A: \"Nodular mass spreading along pleural surfaces\" is the classic CT appearance of mesothelioma, particularly in patients with asbestos exposure.\n\u2022 Options B, C, and D are less consistent with the history of asbestos exposure and the described radiographic and clinical findings.\n\nFinal Answer: A. Nodular mass spreading along pleural surfaces",
            "Step 1: Recognize that the patient's history of shipbuilding indicates asbestos exposure. The chest radiograph findings (reticular opacities, increased bronchovascular markings, and pleural plaques) also support an asbestos-related lung disease.\n\nStep 2: Differentiate the choices:\n\u2013 Option A (Nodular mass spreading along pleural surfaces) suggests mesothelioma, which can be asbestos-related, but the radiograph findings here are more consistent with interstitial fibrosis.\n\u2013 Option B (Honeycombing) is a typical CT finding seen in asbestosis due to interstitial fibrosis, particularly in the lower lobes.\n\u2013 Option C (Air bronchogram) is usually associated with consolidation (e.g., pneumonia).\n\u2013 Option D (Lower lobe cavitary mass) would be more characteristic of an infectious process, such as tuberculosis.\n\nStep 3: Given the asbestos exposure history and radiographic evidence, the most likely CT finding would be interstitial fibrosis with honeycombing.\n\nFinal answer: B. Honeycombing",
            "Step 1: The patient is a 76\u2010year\u2010old man with a significant smoking history and COPD who worked as a shipbuilder, suggesting asbestos exposure. His weight loss and respiratory symptoms raise concern for a malignancy.\n\nStep 2: The chest radiograph findings describe pleural plaques, which are strongly associated with asbestos exposure. Patients with asbestos exposure have an increased risk of developing mesothelioma, which typically presents as a nodular mass spreading diffusely along the pleural surfaces.\n\nStep 3: Evaluating the choices:\n\u2022 A. Nodular mass spreading along pleural surfaces \u2013 This would be the expected CT finding in a patient with mesothelioma due to asbestos exposure.\n\u2022 B. Honeycombing \u2013 This is typically seen in idiopathic pulmonary fibrosis, not in asbestos-related disease.\n\u2022 C. Air bronchogram \u2013 This finding is commonly associated with lung consolidation (e.g., pneumonia) rather than asbestos-related malignancy.\n\u2022 D. Lower lobe cavitary mass \u2013 This might suggest an infectious process or cavitating neoplasm, but does not fit with the pleural plaques.\n\nFinal Answer: A. Nodular mass spreading along pleural surfaces"
        ],
        "ensemble_raw_responses": [
            "1",
            "0\n\nAnalyzing the patient\u2019s presentation and imaging findings, the evidence favors an asbestos-induced parenchymal fibrosis (asbestosis) rather than mesothelioma. The radiograph shows reticular parenchymal opacities and increased bronchovascular markings, indicating interstitial fibrosis\u2014which on chest CT is classically seen as honeycombing in the lower lobes. Although the patient's weight loss and asbestos exposure might raise concern for mesothelioma, the described reticular pattern is more consistent with asbestosis. Therefore, candidate solution 0, which selects honeycombing as the CT finding, is the best final answer.",
            "1"
        ],
        "final_solution": "Step 1: Identify Key Details\n\u2022 The patient is a 76-year-old man with COPD and a significant smoking history.\n\u2022 He worked as a shipbuilder, which is associated with asbestos exposure.\n\u2022 The radiograph shows increased bronchovascular markings, reticular parenchymal opacities, and multiple pleural plaques\u2014findings that raise suspicion for asbestos-related disease.\n\u2022 His weight loss adds to the concern for a malignancy.\n\nStep 2: Narrow the Differential Diagnosis\n\u2022 Asbestos exposure in shipbuilders is well known to increase the risk of mesothelioma.\n\u2022 Mesothelioma typically presents with diffuse pleural thickening, often appearing as nodular masses spreading along the pleural surfaces on CT.\n\u2022 Other options such as honeycombing (seen in idiopathic pulmonary fibrosis), air bronchogram (common in pneumonia or lung consolidation), or a lower lobe cavitary mass (suggesting certain types of lung cancer or infections) do not fit the clinical picture supported by his history and radiographic findings.\n\nStep 3: Compare Options & Conclude\n\u2022 Option A: \"Nodular mass spreading along pleural surfaces\" is the classic CT appearance of mesothelioma, particularly in patients with asbestos exposure.\n\u2022 Options B, C, and D are less consistent with the history of asbestos exposure and the described radiographic and clinical findings.\n\nFinal Answer: A. Nodular mass spreading along pleural surfaces"
    },
    {
        "realidx": 267,
        "question": "A 34-year-old male suffers from inherited hemophilia A. He and his wife have three unaffected daughters. What is the probability that the second daughter is a carrier of the disease?",
        "answer": "100%",
        "options": {
            "A": "0%",
            "B": "25%",
            "C": "50%",
            "D": "100%"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old male suffers",
            "inherited hemophilia A",
            "wife",
            "three unaffected daughters",
            "probability",
            "second daughter",
            "carrier of",
            "disease"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 3222,
            "completion_tokens": 2757
        },
        "time_elapsed": 23.63439655303955,
        "raw_responses": [
            "Step 1: Hemophilia A is an X-linked recessive disorder. This means that males (XY) with the affected X will show the disease, while females (XX) with one affected X typically are carriers, because they have another normal allele on the other X.\n\nStep 2: The affected male (with genotype X\u02b0Y) will pass on his affected X chromosome to each of his daughters (since daughters always receive the father's X chromosome). Therefore, all of his daughters will inherit the affected X allele from him.\n\nStep 3: Given that the daughters receive an affected X from their father and a normal X from their unaffected mother, each daughter will be a carrier regardless of being symptomatic or not.\n\nStep 4: Since the question asks for the probability that the second daughter is a carrier\u2014and the logic applies equally to all daughters\u2014this probability is 100%.\n\nFinal Answer: 100%",
            "Step 1: Recognize that hemophilia A is an X-linked recessive disorder. Affected males have the mutant allele on their only X chromosome.\n\nStep 2: When an affected male (with a mutated X) has daughters with an unaffected female (who likely has two normal X chromosomes), each daughter gets one X chromosome from each parent. The daughter always inherits the affected X from her father, making her an obligate carrier, although she does not manifest the disease because the normal allele from the mother compensates.\n\nStep 3: Since every daughter will inherit the affected X chromosome from the father, the probability that any daughter\u2014including the second daughter\u2014is a carrier is 100%.\n\nFinal answer: 100%",
            "Step 1: Understand the inheritance pattern. Hemophilia A is an X-linked recessive disease. A hemophiliac male has the mutation on his only X chromosome while his Y chromosome is normal.\n\nStep 2: Determine the genetics for a daughter. Every daughter receives one X chromosome from her father and one from her mother. Since the father\u2019s only X chromosome is mutated, every daughter will inherit the mutation.\n\nStep 3: Consider the mother's contribution. Since the daughter is unaffected (as stated, the daughters are unaffected), the mother must provide a normal X chromosome. Thus, each daughter ends up with one mutated (from the father) and one normal (from the mother) X chromosome, making her a carrier.\n\nStep 4: Apply the conclusion to the second daughter. Regardless of birth order, every daughter in this scenario will be a carrier.\n\nFinal Answer: 100%"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Understand the inheritance pattern. Hemophilia A is an X-linked recessive disease. A hemophiliac male has the mutation on his only X chromosome while his Y chromosome is normal.\n\nStep 2: Determine the genetics for a daughter. Every daughter receives one X chromosome from her father and one from her mother. Since the father\u2019s only X chromosome is mutated, every daughter will inherit the mutation.\n\nStep 3: Consider the mother's contribution. Since the daughter is unaffected (as stated, the daughters are unaffected), the mother must provide a normal X chromosome. Thus, each daughter ends up with one mutated (from the father) and one normal (from the mother) X chromosome, making her a carrier.\n\nStep 4: Apply the conclusion to the second daughter. Regardless of birth order, every daughter in this scenario will be a carrier.\n\nFinal Answer: 100%"
    },
    {
        "realidx": 271,
        "question": "A 22-year-old primigravida presents for a regular prenatal visit at 16 weeks gestation. She is concerned about the results of a dipstick test she performed at home, which showed 1+ glucose. She does not know  if her liquid consumption has increased, but she urinates more frequently than before. The course of her pregnancy has been unremarkable and she has no significant co-morbidities. The BMI is 25.6 kg/cm2 and she has gained 3 kg (6.72 lb) during the pregnancy. The blood pressure is 110/80 mm Hg, the heart rate is 82/min, the respiratory rate is 14/min, and the temperature is 36.6\u2103 (97.9\u2109). The lungs are clear to auscultation, the heart sounds are normal with no murmurs, and there is no abdominal or costovertebral angle tenderness. The laboratory tests show the following results:\nFasting glucose 97 mg/L\nALT 12 IU/L\nAST 14 IU/L\nTotal bilirubin 0.8 mg/dL(15 \u00b5mol/L)\nPlasma creatinine 0.7 mg/dL (61.9 \u00b5mol/L)\nWhich of the following tests are indicated to determine the cause of the abnormal dipstick test results?",
        "answer": "No tests required",
        "options": {
            "A": "HbA1c measurement",
            "B": "No tests required",
            "C": "Urinalysis",
            "D": "Oral glucose tolerance test"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old primigravida presents",
            "regular prenatal visit",
            "weeks gestation",
            "concerned",
            "results",
            "dipstick test",
            "performed at home",
            "showed 1",
            "glucose",
            "not",
            "liquid consumption",
            "increased",
            "more frequently",
            "course",
            "pregnancy",
            "unremarkable",
            "significant co-morbidities",
            "BMI",
            "kg/cm2",
            "gained 3 kg",
            "72",
            "pregnancy",
            "blood pressure",
            "80 mm Hg",
            "heart rate",
            "min",
            "respiratory rate",
            "min",
            "temperature",
            "36",
            "97",
            "lungs",
            "clear",
            "auscultation",
            "heart sounds",
            "normal",
            "murmurs",
            "abdominal",
            "costovertebral angle tenderness",
            "laboratory tests show",
            "following results",
            "Fasting glucose 97 mg/L ALT 12 IU",
            "AST",
            "Total bilirubin 0 8 mg dL",
            "mol/L",
            "Plasma creatinine 0.7 mg/dL",
            "61",
            "mol/L",
            "following tests",
            "indicated to",
            "cause",
            "abnormal dipstick"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5646,
            "completion_tokens": 3542
        },
        "time_elapsed": 29.858588933944702,
        "raw_responses": [
            "Step 1: Identify the salient facts. The 22\u2010year\u2010old primigravida is at 16 weeks gestation. Although she noticed 1+ glucose on an at-home dipstick and has increased urinary frequency, her fasting blood glucose is normal at 97 mg/dL, and her other laboratory values are within normal limits.\n\nStep 2: Understand pregnancy physiology. Pregnancy normally increases glomerular filtration rate, which can lower the renal threshold for glucose reabsorption. Consequently, low levels of glucosuria (glucose in the urine) can be a normal finding during pregnancy, even in the absence of hyperglycemia.\n\nStep 3: Evaluate the answer options.  \n\u2022 Option A (HbA1c measurement): This is not appropriate here because HbA1c reflects average glucose levels over the prior 3 months. In this early stage of pregnancy and with a normal fasting glucose, there is no suspicion of diabetes requiring such evaluation.  \n\u2022 Option C (Urinalysis): While a formal urinalysis could be used to confirm findings, the clinical context (normal blood glucose and typical pregnancy-induced glucosuria) suggests that an abnormal dipstick for glucose is benign and does not warrant further investigation.  \n\u2022 Option D (Oral glucose tolerance test): Screening for gestational diabetes is usually performed later in pregnancy (typically between 24\u201328 weeks) and isn\u2019t indicated at 16 weeks in a patient with normal blood glucose and no high-risk factors.  \n\u2022 Option B (No tests required): Given that mild glucosuria is physiologically common in pregnancy and there are no other concerns, further testing is unnecessary.\n\nStep 4: Conclusion. The most appropriate approach is to provide reassurance and not pursue additional testing for the abnormal dipstick results.\n\nFinal Answer: B. No tests required.",
            "Step 1: The patient is a 22-year-old primigravida at 16 weeks gestation who noted 1+ glucose on a home dipstick test but has a normal fasting blood glucose level (97 mg/L) on a subsequent test. In pregnant women, increased renal blood flow and glomerular filtration rate can commonly result in physiologic glycosuria, much like the situation seen here.\n\nStep 2: \n\u2022 HbA1c measurement is used to assess long-term glycemic control but is not indicated in this setting of an isolated dipstick finding.\n\u2022 An oral glucose tolerance test is used to evaluate for gestational diabetes, especially around 24\u201328 weeks gestation, and is not warranted at 16 weeks in an asymptomatic patient with normal blood work.\n\u2022 A urinalysis would simply confirm the presence of glucose and does not add new diagnostic insight if the cause of glycosuria is already explained by normal physiologic changes in pregnancy.\n\u2022 No tests required: Given that the patient\u2019s symptoms and laboratory studies are consistent with normal physiologic glycosuria in pregnancy, no further workup is indicated.\n\nStep 3: The final answer is: B. No tests required.",
            "Step 1: Recognize that glycosuria (glucose in urine) can be a normal finding in pregnancy due to increased renal blood flow and glomerular filtration rate, leading to a lower renal threshold for glucose.\n\nStep 2: Note that the patient\u2019s fasting glucose is normal (97 mg/dL), and she displays no other signs or symptoms of gestational diabetes. There is also no evidence of any infection or kidney pathology.\n\nStep 3: Analyze the answer choices:\n\u2022 HbA1c measurement (Option A) is not typically used in pregnancy to evaluate gestational diabetes, especially in the context of normal fasting glucose.\n\u2022 No tests required (Option B) is appropriate here as the glycosuria is likely a normal physiological phenomenon in pregnancy.\n\u2022 Urinalysis (Option C) would confirm the presence of glucose but wouldn\u2019t provide additional useful information since the dipstick already showed 1+ glucose.\n\u2022 Oral glucose tolerance test (Option D) is used to screen for gestational diabetes, but there is no indication for it given the normal fasting glucose and absence of clinical concern.\n\nFinal Answer: B. No tests required"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Identify the salient facts. The 22\u2010year\u2010old primigravida is at 16 weeks gestation. Although she noticed 1+ glucose on an at-home dipstick and has increased urinary frequency, her fasting blood glucose is normal at 97 mg/dL, and her other laboratory values are within normal limits.\n\nStep 2: Understand pregnancy physiology. Pregnancy normally increases glomerular filtration rate, which can lower the renal threshold for glucose reabsorption. Consequently, low levels of glucosuria (glucose in the urine) can be a normal finding during pregnancy, even in the absence of hyperglycemia.\n\nStep 3: Evaluate the answer options.  \n\u2022 Option A (HbA1c measurement): This is not appropriate here because HbA1c reflects average glucose levels over the prior 3 months. In this early stage of pregnancy and with a normal fasting glucose, there is no suspicion of diabetes requiring such evaluation.  \n\u2022 Option C (Urinalysis): While a formal urinalysis could be used to confirm findings, the clinical context (normal blood glucose and typical pregnancy-induced glucosuria) suggests that an abnormal dipstick for glucose is benign and does not warrant further investigation.  \n\u2022 Option D (Oral glucose tolerance test): Screening for gestational diabetes is usually performed later in pregnancy (typically between 24\u201328 weeks) and isn\u2019t indicated at 16 weeks in a patient with normal blood glucose and no high-risk factors.  \n\u2022 Option B (No tests required): Given that mild glucosuria is physiologically common in pregnancy and there are no other concerns, further testing is unnecessary.\n\nStep 4: Conclusion. The most appropriate approach is to provide reassurance and not pursue additional testing for the abnormal dipstick results.\n\nFinal Answer: B. No tests required."
    },
    {
        "realidx": 273,
        "question": "A 57-year-old man comes to the physician because of a 3-week history of abdominal bloating and increased frequency of stools. He describes the stools as bulky, foul-smelling, and difficult to flush. He also has a 4-month history of recurrent dull upper abdominal pain that usually lasts for a few days, worsens after meals, and is not relieved with antacids. He has had a 10-kg (22-lb) weight loss in the past 4 months. He has no personal or family history of serious illness. He has smoked 1 pack of cigarettes daily for 37 years. He has a 12-year history of drinking 6 to 8 beers daily. He is 160 cm (5 ft 3 in) tall and weighs 52 kg (115 lb); BMI is 20 kg/m2. His vital signs are within normal limits. Abdominal examination shows mild epigastric tenderness without rebound or guarding. Bowel sounds are normal. The remainder of the examination shows no abnormalities. Which of the following is the most appropriate next step in diagnosis?",
        "answer": "Abdominal CT scan",
        "options": {
            "A": "Abdominal CT scan",
            "B": "Endoscopic ultrasonography",
            "C": "Abdominal ultrasound",
            "D": "Upper gastrointestinal endoscopy"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "57 year old man",
            "physician",
            "3 week history",
            "abdominal bloating",
            "increased frequency of stools",
            "stools",
            "bulky",
            "foul-smelling",
            "difficult to flush",
            "4 month history",
            "recurrent dull upper",
            "usually",
            "days",
            "worsens",
            "meals",
            "not relieved with antacids",
            "a 10 kg",
            "weight loss",
            "past",
            "months",
            "personal",
            "family history",
            "serious illness",
            "smoked 1 pack",
            "cigarettes daily",
            "years",
            "12 year history",
            "drinking 6",
            "beers daily",
            "5 ft",
            "tall",
            "kg",
            "BMI",
            "20 kg/m2",
            "vital signs",
            "normal limits",
            "Abdominal examination shows mild epigastric tenderness",
            "guarding",
            "Bowel sounds",
            "normal",
            "examination shows",
            "abnormalities",
            "following",
            "most appropriate next step",
            "diagnosis"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4917,
            "completion_tokens": 3268
        },
        "time_elapsed": 28.315207719802856,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s presentation. The patient is a 57-year-old man with a history of chronic alcohol use and smoking who presents with a 3-week history of steatorrhea (bulky, foul-smelling stools) and a 4-month history of recurrent upper abdominal pain that worsens after meals along with significant weight loss. These symptoms are suggestive of pancreatic dysfunction, such as chronic pancreatitis, especially in the context of his alcohol use.\n\nStep 2: Determine the best diagnostic test. In patients with suspected chronic pancreatitis, imaging is essential to assess for structural changes in the pancreas (such as calcifications or ductal irregularities). An abdominal CT scan is considered the initial, most appropriate imaging modality given its ability to provide detailed information on pancreatic anatomy and detect chronic changes related to pancreatitis. Although endoscopic ultrasonography may be useful in certain scenarios, it is typically reserved for cases where CT is inconclusive or when further detailed evaluation is necessary.\n\nStep 3: Eliminate less appropriate options. \n\u2022 Abdominal ultrasound is less sensitive for pancreatic pathology compared to CT.\n\u2022 Upper gastrointestinal endoscopy evaluates the luminal mucosa and is not the best modality for assessing pancreatic structure.\n\u2022 Endoscopic ultrasonography, while sensitive, is more invasive and generally not the first-line investigation.\n\nFinal Answer: A. Abdominal CT scan",
            "Step 1: Identify key clinical features.\n\u2022 The patient has steatorrhea (bulky, foul-smelling stools), recurrent epigastric pain worsening after meals, and significant weight loss.\n\u2022 He has a history of heavy alcohol use, a known risk factor for chronic pancreatitis.\n\nStep 2: Develop the differential.\n\u2022 Chronic pancreatitis is likely given his history and symptoms. It causes pancreatic exocrine insufficiency (leading to steatorrhea) and abdominal pain.\n\u2022 Other processes like pancreatic cancer could be considered, but his history and presentation are more indicative of chronic pancreatitis.\n\nStep 3: Choose the appropriate diagnostic test.\n\u2022 Abdominal CT scan is the initial imaging study to evaluate patients suspected of having chronic pancreatitis. It can identify pancreatic calcifications, ductal changes, and other characteristic findings.\n\u2022 Endoscopic ultrasonography is a more sensitive test but is usually reserved as a follow\u2010up if CT results are inconclusive or for early disease.\n\u2022 Abdominal ultrasound is less sensitive for pancreatic parenchymal changes.\n\u2022 Upper gastrointestinal endoscopy is not the first-line diagnostic tool for pancreatic pathology.\n\nFinal Answer: A. Abdominal CT scan",
            "Step 1: The patient\u2019s symptoms include steatorrhea (bulky, foul-smelling, oily stools), postprandial upper abdominal pain, and significant weight loss\u2014all of which point toward malabsorption due to pancreatic insufficiency. His history of heavy alcohol use further supports the likelihood of chronic pancreatitis.\n\nStep 2: An abdominal CT scan is the most useful initial diagnostic test for chronic pancreatitis because it helps evaluate pancreatic calcifications, ductal changes, and other structural abnormalities. Endoscopic ultrasonography (EUS) is useful in certain cases but is more invasive and generally not the initial study. Abdominal ultrasound is less sensitive for detailed pancreatic pathology, and upper gastrointestinal endoscopy is not indicated in this scenario.\n\nStep 3: The most appropriate next step in diagnosis is an Abdominal CT scan.\n\nFinal Answer: A. Abdominal CT scan"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1"
        ],
        "final_solution": "Step 1: The patient\u2019s symptoms include steatorrhea (bulky, foul-smelling, oily stools), postprandial upper abdominal pain, and significant weight loss\u2014all of which point toward malabsorption due to pancreatic insufficiency. His history of heavy alcohol use further supports the likelihood of chronic pancreatitis.\n\nStep 2: An abdominal CT scan is the most useful initial diagnostic test for chronic pancreatitis because it helps evaluate pancreatic calcifications, ductal changes, and other structural abnormalities. Endoscopic ultrasonography (EUS) is useful in certain cases but is more invasive and generally not the initial study. Abdominal ultrasound is less sensitive for detailed pancreatic pathology, and upper gastrointestinal endoscopy is not indicated in this scenario.\n\nStep 3: The most appropriate next step in diagnosis is an Abdominal CT scan.\n\nFinal Answer: A. Abdominal CT scan"
    },
    {
        "realidx": 284,
        "question": "An elderly man presents to his physician with complaints of difficulty breathing, easy fatigability, and bilateral leg swelling which began 2 months ago. His breathlessness worsens while walking, climbing the stairs, and lying flat on his back. He also finds it difficult to sleep well at night, as he often wakes up to catch his breath. His pulse is 98/min and blood pressure is 114/90 mm Hg. On examination, he has mild respiratory distress, distended neck veins, and bilateral pitting edema is evident on the lower third of his legs. His respiratory rate is 33/min, SpO2 is 93% in room air, and coarse crepitations are heard over the lung bases. On auscultation, the P2 component of his second heart sound is heard loudest at the second left intercostal space, and an S3 gallop rhythm is heard at the apex. Medication is prescribed for his symptoms which changes his cardiac physiology as depicted with the dashed line recorded post-medication. What is the mechanism of action of the prescribed medication?",
        "answer": "Decrease in transmembrane sodium gradient",
        "options": {
            "A": "Decrease in transmembrane sodium gradient",
            "B": "Preferential dilatation of capacitance vessels",
            "C": "Inhibition of aldosterone-mediated sodium reabsorption",
            "D": "Reduction in myocardial contractility"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "elderly man presents",
            "physician",
            "complaints",
            "difficulty breathing",
            "easy fatigability",
            "bilateral leg swelling",
            "began 2 months",
            "breathlessness worsens",
            "walking",
            "climbing",
            "stairs",
            "lying flat on",
            "back",
            "finds",
            "difficult to sleep well",
            "night",
            "often wakes up",
            "catch",
            "breath",
            "pulse",
            "98 min",
            "blood pressure",
            "90 mm Hg",
            "examination",
            "mild respiratory distress",
            "distended neck",
            "bilateral pitting edema",
            "evident",
            "lower third",
            "legs",
            "respiratory rate",
            "min",
            "room air",
            "coarse crepitations",
            "heard",
            "lung bases",
            "auscultation",
            "P2 component",
            "second heart",
            "heard loudest",
            "second left intercostal space",
            "S3",
            "heard",
            "apex",
            "Medication",
            "prescribed",
            "symptoms",
            "changes",
            "cardiac physiology",
            "dashed line recorded post medication",
            "mechanism of action",
            "prescribed medication"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 7701,
            "completion_tokens": 17050
        },
        "time_elapsed": 109.75664615631104,
        "raw_responses": [
            "We can reason through the case as follows:\n\n\u2022 The patient\u2019s symptoms \u2013 worsening dyspnea (especially on exertion and when supine), orthopnea (waking at night to \u201ccatch his breath\u201d), jugular venous distention, pulmonary crackles, and bilateral lower\u2010extremity edema \u2013 are all classic findings in heart failure with volume overload.\n\n\u2022 In clinical practice, the main initial treatment to relieve these congestive symptoms is a loop diuretic. Loop diuretics (such as furosemide) work by blocking the Na\u207a\u2010K\u207a\u20102Cl\u207b cotransporter in the thick ascending limb of the loop of Henle. This inhibition decreases sodium (and chloride) reabsorption, resulting in increased excretion of sodium with water (natriuresis and diuresis) and thus a reduction in the preload (the end\u2010diastolic volume) on the heart. In a pressure\u2013volume diagram (the Frank\u2013Starling curve), reducing the preload moves the operating point down along the same curve, which is often depicted by a dashed line after medication administration.\n\n\u2022 Looking at the answer options:\n\u2003\u2013 Option A (\u201cDecrease in transmembrane sodium gradient\u201d) is our best approximation for the effect of loop diuretics. By blocking the Na\u207a reabsorption process, the normal transmembrane sodium gradient along the tubular cells is altered, which is a key step in preventing water reabsorption.\n\u2003\u2013 Option B (\u201cPreferential dilatation of capacitance vessels\u201d) describes the action of nitrates, which reduce preload by venodilation. Although nitrates are sometimes used (especially in the setting of myocardial ischemia or acute pulmonary edema), they are not the mainstay for chronic symptomatic volume overload.\n\u2003\u2013 Option C (\u201cInhibition of aldosterone-mediated sodium reabsorption\u201d) is the mechanism of aldosterone antagonists (like spironolactone), which are used as adjunctive therapy in heart failure but are not the primary agent used for the acute relief of congestion.\n\u2003\u2013 Option D (\u201cReduction in myocardial contractility\u201d) would be harmful in a patient with heart failure (and is the opposite of what a positive inotrope would do).\n\n\u2022 Therefore, the medication prescribed was most likely a loop diuretic (e.g., furosemide) whose principal action is to block sodium (and chloride) reabsorption in the thick ascending limb \u2013 effectively \u201cdecreasing the transmembrane sodium gradient.\u201d This action reduces preload and improves the patient\u2019s symptoms.\n\nFinal Answer: A. Decrease in transmembrane sodium gradient.",
            "We can solve the problem by working through the details. This  elderly man presents with classic features of congestive heart failure\u2014shortness of breath that worsens when lying flat (orthopnea), pulmonary crackles (from pulmonary edema), an S3 gallop, jugular venous distention, and bilateral leg edema. In the setting of fluid overload, one of the main therapeutic goals is to reduce the \u201cpreload\u201d (the volume of blood returning to the heart) so that the left\u2010ventricular filling pressures drop and the pulmonary edema lessens.\n\nOne method to accomplish this is by using agents that preferentially dilate the venous (capacitance) vessels. When the veins dilate, more blood is stored in the venous system (increased venous capacitance), which reduces the amount of blood returning to the heart. This results in a leftward shift of the operating point in the pressure\u2013volume loop (as shown by the dashed line in the figure), thereby alleviating symptoms caused by fluid overload.\n\nLet\u2019s review the answer choices step by step:\n\n\u2022 Option A (\u201cDecrease in transmembrane sodium gradient\u201d) is the mechanism by which cardiac glycosides (eg, digoxin) work. Inhibition of the Na+/K+-ATPase increases intracellular calcium (resulting in increased contractility). Although digoxin is used in heart failure, it is not a first\u2010line agent for relieving volume overload, and its primary effect is not on venous capacitance.\n\n\u2022 Option B (\u201cPreferential dilatation of capacitance vessels\u201d) describes the mechanism of nitrates (eg, nitroglycerin). By dilating the venous system, nitrates reduce preload, decrease left\u2010ventricular filling pressures, and quickly relieve symptoms of pulmonary edema. This is the mechanism that most directly accounts for the depicted change in the heart\u2019s pressure\u2010volume relationship.\n\n\u2022 Option C (\u201cInhibition of aldosterone-mediated sodium reabsorption\u201d) is how aldosterone antagonists (eg, spironolactone) work. While these drugs are used in chronic heart failure and have proven mortality benefit by reducing maladaptive remodeling and decreasing volume retention, their mechanism doesn\u2019t match the immediate preload reduction suggested by the altered pressure\u2013volume loop.\n\n\u2022 Option D (\u201cReduction in myocardial contractility\u201d) is the mechanism of beta blockers. Although beta blockers are an important part of long\u2010term heart failure therapy, they initially decrease contractility and are not used for immediate symptomatic relief in decompensated heart failure.\n\nSince the goal in this patient is to relieve symptoms produced by volume overload and the pressure\u2013volume loop shows changes consistent with a decreased preload, the best answer is:\n\nB. Preferential dilatation of capacitance vessels.",
            "Let\u2019s work through the reasoning step\u2010by\u2010step:\n\nStep 1. Identify the patient\u2019s presentation.  \nThe 2\u2010month history of difficulty breathing, easy fatigability, orthopnea (waking at night to catch his breath), neck vein distension, bi\u2010leg pitting edema, pulmonary crackles, a loud P2, and an S3 gallop all point toward congestive (systolic) heart failure with signs of pulmonary and systemic fluid overload.\n\nStep 2. Consider how medications affect cardiac physiology.  \nFor someone with heart failure and volume overload the first goal is to reduce the \u201cpreload\u201d (the volume the heart must handle at the end of diastole) to reduce the work of the failing heart and relieve symptoms. One of the primary treatments for symptomatic relief is the use of diuretics.\n\nStep 3. Match the medication to its mechanism.  \nLoop diuretics (eg, furosemide) are typically prescribed to rapidly reduce volume overload. Their mechanism of action is by inhibiting the Na+/K+/2Cl\u2013 cotransporter in the thick ascending limb of the loop of Henle. This inhibition leads to decreased reabsorption of sodium (and chloride and potassium), which in turn reduces the transmembrane sodium gradient that drives water reabsorption. The net effect is a reduction in blood volume (and preload), thereby alleviating pulmonary congestion and edema.  \n\nStep 4. Review the options and eliminate those that do not fit.  \n\u2022 Option B (\u201cPreferential dilatation of capacitance vessels\u201d) describes the effect of nitrates, which benefit patients by causing venodilation (reducing preload) but are not the first\u2010line symptomatic relief in a chronic heart failure setting with established volume overload.  \n\u2022 Option C (\u201cInhibition of aldosterone-mediated sodium reabsorption\u201d) describes aldosterone antagonists (like spironolactone) which are used in heart failure for mortality benefit and remodeling prevention rather than for immediate symptom relief.  \n\u2022 Option D (\u201cReduction in myocardial contractility\u201d) is not therapeutic in the setting of heart failure and would likely worsen the patient\u2019s status.  \n\nStep 5. Arrive at the final answer.  \nSince the primary goal is to reduce preload by promoting sodium (and water) loss, the medication prescribed is most consistent with a loop diuretic. While the classic description of loop diuretics is \u201cblocking the NKCC2 cotransporter\u201d, the option that best approximates this effect is \u201cDecrease in transmembrane sodium gradient.\u201d\n\nFinal Answer: A. Decrease in transmembrane sodium gradient"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "We can reason through the case as follows:\n\n\u2022 The patient\u2019s symptoms \u2013 worsening dyspnea (especially on exertion and when supine), orthopnea (waking at night to \u201ccatch his breath\u201d), jugular venous distention, pulmonary crackles, and bilateral lower\u2010extremity edema \u2013 are all classic findings in heart failure with volume overload.\n\n\u2022 In clinical practice, the main initial treatment to relieve these congestive symptoms is a loop diuretic. Loop diuretics (such as furosemide) work by blocking the Na\u207a\u2010K\u207a\u20102Cl\u207b cotransporter in the thick ascending limb of the loop of Henle. This inhibition decreases sodium (and chloride) reabsorption, resulting in increased excretion of sodium with water (natriuresis and diuresis) and thus a reduction in the preload (the end\u2010diastolic volume) on the heart. In a pressure\u2013volume diagram (the Frank\u2013Starling curve), reducing the preload moves the operating point down along the same curve, which is often depicted by a dashed line after medication administration.\n\n\u2022 Looking at the answer options:\n\u2003\u2013 Option A (\u201cDecrease in transmembrane sodium gradient\u201d) is our best approximation for the effect of loop diuretics. By blocking the Na\u207a reabsorption process, the normal transmembrane sodium gradient along the tubular cells is altered, which is a key step in preventing water reabsorption.\n\u2003\u2013 Option B (\u201cPreferential dilatation of capacitance vessels\u201d) describes the action of nitrates, which reduce preload by venodilation. Although nitrates are sometimes used (especially in the setting of myocardial ischemia or acute pulmonary edema), they are not the mainstay for chronic symptomatic volume overload.\n\u2003\u2013 Option C (\u201cInhibition of aldosterone-mediated sodium reabsorption\u201d) is the mechanism of aldosterone antagonists (like spironolactone), which are used as adjunctive therapy in heart failure but are not the primary agent used for the acute relief of congestion.\n\u2003\u2013 Option D (\u201cReduction in myocardial contractility\u201d) would be harmful in a patient with heart failure (and is the opposite of what a positive inotrope would do).\n\n\u2022 Therefore, the medication prescribed was most likely a loop diuretic (e.g., furosemide) whose principal action is to block sodium (and chloride) reabsorption in the thick ascending limb \u2013 effectively \u201cdecreasing the transmembrane sodium gradient.\u201d This action reduces preload and improves the patient\u2019s symptoms.\n\nFinal Answer: A. Decrease in transmembrane sodium gradient."
    },
    {
        "realidx": 285,
        "question": "A 30-year-old man presents to his primary care physician with complaints of excessive fatigue and weakness for the last several weeks. He also complains of abdominal pain and constipation for the same duration. On further questioning, he reports that he has lost 8 pounds in the last 2 weeks. Past medical history and family history are insignificant. His temperature is 37.3\u00b0 C (99.2\u00b0 F), respirations are 21/min, pulse is 63/min, and blood pressure is 99/70 mm Hg. On physical examination, he is a tired-appearing, thin male. He has a bronze discoloration to his skin, but he denies being outside in the sun or any history of laying in tanning beds. What is the next best step in the management of this patient?",
        "answer": "Start him on both hydrocortisone and fludrocortisone therapy",
        "options": {
            "A": "Administer intravenous fludrocortisone",
            "B": "Start him on androgen replacement treatment",
            "C": "Start him on both hydrocortisone and fludrocortisone therapy",
            "D": "Order an ACTH stimulation test"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "30 year old man presents",
            "primary care physician",
            "complaints",
            "excessive fatigue",
            "weakness",
            "weeks",
            "abdominal pain",
            "constipation",
            "same duration",
            "further questioning",
            "reports",
            "lost",
            "pounds",
            "2 weeks",
            "Past medical history",
            "family history",
            "temperature",
            "99",
            "F",
            "respirations",
            "min",
            "pulse",
            "63 min",
            "blood pressure",
            "99 70 mm Hg",
            "physical examination",
            "tired appearing",
            "thin male",
            "bronze discoloration",
            "skin",
            "denies",
            "outside",
            "sun",
            "history",
            "laying",
            "tanning beds",
            "next best step",
            "management",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5247,
            "completion_tokens": 3353
        },
        "time_elapsed": 28.041799783706665,
        "raw_responses": [
            "Step 1: Interpretation of the Clinical Scenario\n\u2022 The patient\u2019s symptoms (excessive fatigue, weakness, abdominal pain, constipation, weight loss) along with physical findings (bronze discoloration of the skin, hypotension) are classic for primary adrenal insufficiency (Addison's disease). The hyperpigmentation results from high levels of ACTH stimulating melanocyte receptors.\n  \nStep 2: Analyzing the Management Options\n\u2022 Option A (Administer intravenous fludrocortisone) would be used for mineralocorticoid replacement, but starting treatment immediately is not appropriate without confirming the diagnosis.\n\u2022 Option B (Start him on androgen replacement treatment) does not address the primary issue of adrenal insufficiency.\n\u2022 Option C (Start him on both hydrocortisone and fludrocortisone therapy) would be proper once the diagnosis of Addison\u2019s disease is confirmed; however, initiating treatment before testing might obscure diagnostic accuracy.\n\u2022 Option D (Order an ACTH stimulation test) is the correct diagnostic step to confirm primary adrenal insufficiency. This test helps establish the deficiency in glucocorticoid (and often mineralocorticoid) production, which leads to follow-up hormone replacement therapy.\n\nStep 3: Final Answer\nThe next best step in management is to order an ACTH stimulation test.\n\nFinal answer: D. Order an ACTH stimulation test.",
            "Step 1: The patient\u2019s presentation, including fatigue, weakness, abdominal pain, constipation, weight loss, hypotension, and a bronze discoloration of the skin, is highly suggestive of primary adrenal insufficiency (Addison's disease). In primary adrenal insufficiency, the adrenal glands fail to produce sufficient cortisol (and often aldosterone), leading to compensatory overproduction of ACTH. The elevated ACTH can stimulate melanocytes, causing hyperpigmentation.\n\nStep 2: Before initiating treatment (such as glucocorticoid or mineralocorticoid replacement), it is essential to confirm the diagnosis. The best test to evaluate adrenal insufficiency is the ACTH stimulation test, which assesses the adrenal glands\u2019 ability to produce cortisol in response to ACTH.\n\nStep 3: The answer choices:\nA. Administer intravenous fludrocortisone \u2013 This is inappropriate without confirming the diagnosis.\nB. Start him on androgen replacement treatment \u2013 Not indicated as the initial step.\nC. Start him on both hydrocortisone and fludrocortisone therapy \u2013 Although treatment of confirmed primary adrenal insufficiency would include both, the diagnosis must first be verified.\nD. Order an ACTH stimulation test \u2013 This is the appropriate next step for confirming the diagnosis.\n\nFinal answer: D. Order an ACTH stimulation test.",
            "Step 1: Identify the key clinical features. The patient is a 30-year-old male with several weeks of fatigue, weakness, abdominal pain, and constipation. Notably, he also has unintentional weight loss and a low blood pressure reading (99/70 mm Hg). Additionally, his skin shows a bronze discoloration, which raises suspicion for hyperpigmentation due to increased ACTH levels, a common finding in primary adrenal insufficiency (Addison's disease).\n\nStep 2: Narrow the differential diagnosis. The combination of hypotension, weight loss, and hyperpigmentation is highly suggestive of Addison's disease. This condition results from the adrenal cortex's inability to produce adequate cortisol (and often aldosterone), leading to an increase in ACTH production. The elevated ACTH levels stimulate melanocytes, causing the bronze pigmentation.\n\nStep 3: Consider the next best step in management. In suspected Addison's disease, the appropriate next step is to confirm the diagnosis. The ACTH stimulation test is the standard confirmatory test. This test helps determine whether the adrenal glands can produce cortisol in response to synthetic ACTH. \n\nStep 4: Compare the options:\n\u2022 Option A - Administer intravenous fludrocortisone is part of treatment for adrenal insufficiency, particularly its mineralocorticoid deficiency, but should not be initiated before confirming the diagnosis.\n\u2022 Option B - Start him on androgen replacement treatment is not indicated in this scenario.\n\u2022 Option C - Start him on both hydrocortisone and fludrocortisone therapy is a treatment for confirmed Addison's disease, but again, treatment should follow diagnostic confirmation.\n\u2022 Option D - Order an ACTH stimulation test is the appropriate next diagnostic step to confirm primary adrenal insufficiency.\n\nFinal Answer: D. Order an ACTH stimulation test."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify the key clinical features. The patient is a 30-year-old male with several weeks of fatigue, weakness, abdominal pain, and constipation. Notably, he also has unintentional weight loss and a low blood pressure reading (99/70 mm Hg). Additionally, his skin shows a bronze discoloration, which raises suspicion for hyperpigmentation due to increased ACTH levels, a common finding in primary adrenal insufficiency (Addison's disease).\n\nStep 2: Narrow the differential diagnosis. The combination of hypotension, weight loss, and hyperpigmentation is highly suggestive of Addison's disease. This condition results from the adrenal cortex's inability to produce adequate cortisol (and often aldosterone), leading to an increase in ACTH production. The elevated ACTH levels stimulate melanocytes, causing the bronze pigmentation.\n\nStep 3: Consider the next best step in management. In suspected Addison's disease, the appropriate next step is to confirm the diagnosis. The ACTH stimulation test is the standard confirmatory test. This test helps determine whether the adrenal glands can produce cortisol in response to synthetic ACTH. \n\nStep 4: Compare the options:\n\u2022 Option A - Administer intravenous fludrocortisone is part of treatment for adrenal insufficiency, particularly its mineralocorticoid deficiency, but should not be initiated before confirming the diagnosis.\n\u2022 Option B - Start him on androgen replacement treatment is not indicated in this scenario.\n\u2022 Option C - Start him on both hydrocortisone and fludrocortisone therapy is a treatment for confirmed Addison's disease, but again, treatment should follow diagnostic confirmation.\n\u2022 Option D - Order an ACTH stimulation test is the appropriate next diagnostic step to confirm primary adrenal insufficiency.\n\nFinal Answer: D. Order an ACTH stimulation test."
    },
    {
        "realidx": 303,
        "question": "A 16-year-old female presents to her primary care physician due to lack of menstruation. She has never had a period and is anxious that she is not \u201ckeeping up\u201d with her friends. She states that her breasts began developing when she was 13, and she had a growth spurt around the same time. Review of systems reveals that she has also been getting headaches every few months over the last year with some photosensitivity and nausea each time. Ibuprofen relieves her symptoms. The patient is a competitive ice skater and has never been sexually active. Her mother has a history of migraine headaches, and her older sister has a history of bipolar disorder. Both underwent menarche at age 15. At this visit, the patient\u2019s temperature is 98.6\u00b0F (37.0\u00b0C), pulse is 70/min, blood pressure is 118/65 mmHg, and respirations are 13/min. Her body mass index is 23.8 kg/m^2. Cardiopulmonary and abdominal exams are unremarkable. Both breasts are Tanner IV with no expressable discharge. Pelvic and axillary hair growth is also Tanner IV. The patient is unable to tolerate a full pelvic exam, but the part of the vaginal canal that is examined is unremarkable. Laboratory studies are ordered and are below:\n\nSerum:\nNa+: 139 mEq/L\nK+: 4.1 mEq/L\nCl-: 100 mEq/L\nHCO3-: 24 mEq/L\nUrea nitrogen: 12 mg/dL\nGlucose: 73 mg/dL\nCreatinine: 0.9 mg/dL\nCa2+: 9.7 mg/dL\nMg2+: 1.7 mEq/L\nAST: 11 U/L\nALT: 11 U/L\nFollicle Stimulating Hormone (FSH): 16.2 mIU/mL (4.7-21.5 mIU/ml)\nEstrogen: 240 pg/mL (64-357 pg/mL)\n\nAbdominal ultrasound is performed and shows a normal uterus and ovaries. Which of the following is the most likely diagnosis?",
        "answer": "Vaginal septum",
        "options": {
            "A": "Hyperprolactinemia",
            "B": "Imperforate hymen",
            "C": "Vaginal septum",
            "D": "Normal development"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old female presents",
            "primary care physician due to lack of menstruation",
            "never",
            "period",
            "anxious",
            "not keeping",
            "friends",
            "states",
            "breasts began",
            "growth spurt",
            "same time",
            "Review of systems reveals",
            "getting headaches",
            "few months",
            "year",
            "photosensitivity",
            "nausea",
            "time",
            "Ibuprofen relieves",
            "symptoms",
            "patient",
            "competitive ice",
            "never",
            "sexually active",
            "mother",
            "history of migraine headaches",
            "older sister",
            "history of bipolar disorder",
            "menarche at age",
            "visit",
            "patients temperature",
            "98",
            "pulse",
            "70 min",
            "blood pressure",
            "65 mmHg",
            "respirations",
            "min",
            "body mass index",
            "23",
            "kg/m",
            "Cardiopulmonary",
            "abdominal exams",
            "unremarkable",
            "breasts",
            "Tanner IV",
            "discharge",
            "Pelvic",
            "axillary",
            "Tanner IV",
            "patient",
            "unable to",
            "full pelvic exam",
            "part of",
            "vaginal canal",
            "examined",
            "unremarkable",
            "Laboratory studies",
            "ordered",
            "Serum",
            "Na",
            "mEq/L K",
            "4.1 mEq/L Cl",
            "100 mEq/L HCO3",
            "mEq/L Urea nitrogen",
            "mg/dL Glucose",
            "mg/dL Creatinine",
            "0.9 mg/dL Ca2",
            "9",
            "mg dL Mg2",
            "1.7 mEq/L AST",
            "U/L ALT",
            "U/L Follicle Stimulating Hormone",
            "mIU mL",
            "ml",
            "Estrogen",
            "pg/mL",
            "64",
            "pg/mL",
            "Abdominal ultrasound",
            "performed",
            "shows",
            "normal uterus",
            "ovaries",
            "following",
            "most likely diagnosis"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 7500,
            "completion_tokens": 4950
        },
        "time_elapsed": 37.09200096130371,
        "raw_responses": [
            "Step 1: Gather important information.\n\u2022 The patient is a 16\u2010year\u2010old female with no history of menses (primary amenorrhea).\n\u2022 She exhibits normal secondary sexual characteristics, with Tanner stage IV breasts and pubic/axillary hair.\n\u2022 Her uterus and ovaries are visualized on ultrasound.\n\u2022 Laboratory studies (FSH, estrogen levels) are within normal limits for her age.\n\u2022 She experiences occasional headaches with photosensitivity, which are likely migraines\u2014a side note unlikely related to her amenorrhea.\n\nStep 2: Consider each option.\nA. Hyperprolactinemia \u2013 Typically presents with amenorrhea and galactorrhea and may have low estrogen levels. Here, estrogen levels are normal and there is no mention of nipple discharge.\nB. Imperforate hymen \u2013 Would cause an obstruction, usually presenting with cyclic pelvic pain and a bulging, bluish membrane on exam (\u201cblue bulging hymen\u201d), which was not noted.\nC. Vaginal septum \u2013 This can also cause outflow obstruction, resulting in cyclic pain and sometimes a partially obstructed exam. However, the limited pelvic exam did not reveal abnormal findings, and the ultrasound shows normal uterus.\nD. Normal development \u2013 Considering her age, the onset of secondary sexual characteristics, and that her mother had menarche at age 15, primary amenorrhea at 16 can be within the spectrum of normal variation.\n\nStep 3: Identify the most likely diagnosis.\nGiven the normal secondary sexual development, normal pelvic ultrasound, and appropriate hormone levels, the absence of menstruation in this patient is most consistent with normal developmental variation. The headaches are likely unrelated.\n\nFinal answer: [D. Normal development]",
            "Step 1: Review the patient\u2019s history and exam findings.\n\u2022 She is a 16\u2010year\u2010old female with no menstrual periods (primary amenorrhea).\n\u2022 She has developed secondary sexual characteristics normally (Tanner stage IV breasts and pubic/axillary hair), and her uterus and ovaries are normal on ultrasound.\n\u2022 She experiences occasional headaches with photosensitivity, which are more consistent with migraines (especially given her family history) than with a central pituitary disorder.\n\u2022 Her laboratory hormone levels (FSH and estrogen) are within normal ranges.\n\nStep 2: Compare and eliminate the choices.\nA. Hyperprolactinemia \u2013 This usually presents with amenorrhea plus galactorrhea and low gonadotropin levels. There is no report of unexpected breast discharge, and her FSH and estrogen are normal.\nB. Imperforate Hymen \u2013 This would obstruct menstrual blood outflow and often cause cyclic pelvic pain along with a bulging, tense hymenal membrane on exam. The exam findings do not support an obstructive lesion.\nC. Vaginal Septum \u2013 This is another form of outflow tract obstruction that can delay menstruation. However, with a vaginal septum, there is often history and exam findings (such as pelvic pain or a palpable septum) that are not present here.\nD. Normal Development \u2013 Despite her age, her hormonal profile, development of secondary sexual characteristics, and normal pelvic ultrasound indicate that her reproductive system is functioning normally. Her occasional headaches are consistent with migraines rather than a disorder of the hypothalamic-pituitary-ovarian axis.\n\nStep 3: Final Answer\nThe most likely diagnosis is: D. Normal development.",
            "Step 1: Review key details from the vignette.\n\u2022 The 16\u2010year-old female has never had a period (primary amenorrhea).\n\u2022 Secondary sexual characteristics are well developed (breasts Tanner IV, pubic/axillary hair Tanner IV), and she had a normal growth spurt.\n\u2022 An ultrasound shows a normal uterus and ovaries.\n\u2022 She has occasional headaches with photosensitivity and nausea, which are more suggestive of migraine rather than any endocrine disorder.\n\u2022 Laboratory studies reveal a normal FSH (16.2 mIU/mL) and estrogen (240 pg/mL).\n\nStep 2: Consider and eliminate the options.\nA. Hyperprolactinemia \u2013 Typically causes amenorrhea and galactorrhea. There is no mention of nipple discharge; the menstrual cycle is affected due to high prolactin\u2019s inhibition of GnRH, but her FSH and estrogen levels are within normal limits.\nB. Imperforate hymen \u2013 Would usually lead to obstructive symptoms such as cyclic pelvic pain, abdominal distension from collected menstrual blood (hematocolpos), and possibly a bulging introitus on exam. This is not found here.\nC. Vaginal septum \u2013 Similar to an imperforate hymen, a transverse vaginal septum may obstruct menstrual flow, leading to cyclical pain and blood accumulation. Again, these findings are absent.\nD. Normal development \u2013 In the context of primary amenorrhea, a girl with normal secondary sexual characteristics, normal internal genitalia, and appropriate hormone levels may simply have a normal variant of pubertal development. Although menarche typically occurs by 15 in most girls, some variation can be normal, and her occasional headaches are more consistent with migraines (which can run in families) than a disorder affecting her reproductive system.\n\nStep 3: Conclusion\nGiven the normal physical exam of the reproductive tract, appropriate hormone values, and the absence of findings suggestive of structural or endocrine abnormalities, the most likely diagnosis is normal variant development.\n\nFinal answer: D. Normal development"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review the patient\u2019s history and exam findings.\n\u2022 She is a 16\u2010year\u2010old female with no menstrual periods (primary amenorrhea).\n\u2022 She has developed secondary sexual characteristics normally (Tanner stage IV breasts and pubic/axillary hair), and her uterus and ovaries are normal on ultrasound.\n\u2022 She experiences occasional headaches with photosensitivity, which are more consistent with migraines (especially given her family history) than with a central pituitary disorder.\n\u2022 Her laboratory hormone levels (FSH and estrogen) are within normal ranges.\n\nStep 2: Compare and eliminate the choices.\nA. Hyperprolactinemia \u2013 This usually presents with amenorrhea plus galactorrhea and low gonadotropin levels. There is no report of unexpected breast discharge, and her FSH and estrogen are normal.\nB. Imperforate Hymen \u2013 This would obstruct menstrual blood outflow and often cause cyclic pelvic pain along with a bulging, tense hymenal membrane on exam. The exam findings do not support an obstructive lesion.\nC. Vaginal Septum \u2013 This is another form of outflow tract obstruction that can delay menstruation. However, with a vaginal septum, there is often history and exam findings (such as pelvic pain or a palpable septum) that are not present here.\nD. Normal Development \u2013 Despite her age, her hormonal profile, development of secondary sexual characteristics, and normal pelvic ultrasound indicate that her reproductive system is functioning normally. Her occasional headaches are consistent with migraines rather than a disorder of the hypothalamic-pituitary-ovarian axis.\n\nStep 3: Final Answer\nThe most likely diagnosis is: D. Normal development."
    },
    {
        "realidx": 307,
        "question": "A 67-year-old man is brought to the emergency department with sudden onset of slurred speech. The patient\u2019s eldest daughter says that he couldn\u2019t move his arm during the episode. Past medical history is significant for hypertension and a hemorrhagic stroke 6 years ago, which was treated surgically. After admission, the patient gets increasingly worse and loses consciousness. A noncontrast CT of the head shows a subarachnoid hemorrhage (SAH). The patient is taken to the operating room, where the SAH evacuated, and the vessel is repaired. Postoperatively, the patient is unresponsive. Several days later, a repeat CT of the head shows an enlarging aneurysm in a different vessel in the brain. The patient\u2019s daughter is asked to consent to a non-emergent, life-saving operation since the patient is in a comatose state. She does not consent to the operation even though the physician stresses it would be life-saving. Upon further discussion, the physician finds out that the patient was abusive and neglectful to his children, and the daughter wants \u201cto live in peace.\u201d The patient has no written advanced directive. Which of the following is the most appropriate course of action?",
        "answer": "Contact another family member for consent",
        "options": {
            "A": "Follow the daughter\u2019s wishes to withhold the operation",
            "B": "Refer this case to the court",
            "C": "Contact another family member for consent",
            "D": "Report the daughter to the police"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "67 year old man",
            "brought",
            "emergency department",
            "sudden onset",
            "slurred speech",
            "patients",
            "daughter",
            "move",
            "arm",
            "episode",
            "Past medical history",
            "significant",
            "hypertension",
            "hemorrhagic stroke",
            "years",
            "treated surgically",
            "admission",
            "patient gets",
            "worse",
            "consciousness",
            "CT of",
            "head shows",
            "subarachnoid hemorrhage",
            "patient",
            "taken",
            "operating room",
            "SAH",
            "vessel",
            "repaired",
            "patient",
            "unresponsive",
            "days later",
            "repeat CT of",
            "head shows",
            "enlarging aneurysm",
            "different vessel",
            "brain",
            "patients daughter",
            "to consent",
            "non-emergent",
            "life saving operation",
            "patient",
            "comatose state",
            "not consent",
            "operation",
            "physician stresses",
            "life saving",
            "further discussion",
            "physician finds out",
            "patient",
            "neglectful",
            "children",
            "daughter",
            "to live",
            "peace",
            "patient",
            "written advanced directive",
            "following",
            "most appropriate course",
            "action"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5775,
            "completion_tokens": 3385
        },
        "time_elapsed": 77.50043940544128,
        "raw_responses": [
            "Step 1: Review the Essential Details\n\u2022 The patient is comatose with a life\u2010threatening condition requiring a non\u2010emergent, but life\u2010saving, intervention.\n\u2022 There is no written advanced directive.\n\u2022 The patient\u2019s daughter is the designated surrogate decision-maker.\n\u2022 The daughter\u2019s decision to withhold treatment is influenced by her personal negative history with her father (he was abusive and neglectful), not necessarily by what is in his best medical interest.\n\nStep 2: Understand the Ethical Conflict\nEven though the daughter is the legal surrogate, surrogate decision-making should be based on the patient\u2019s best interests or previously expressed wishes. Her refusal is likely being colored by personal emotions rather than an objective reflection of what the patient would have wanted.\n\nStep 3: Evaluate the Options\nA. Follow the daughter\u2019s wishes to withhold the operation.\n\u2003\u2013 This option would mean following a decision that may be ethically invalid because her motivations are conflicted, potentially harming the patient\u2019s right to life\u2010saving treatment.\nB. Refer this case to the court.\n\u2003\u2013 In disputes where a surrogate\u2019s decision appears to be compromised by conflicting personal interests, it is appropriate to have the decision reviewed by the court to determine the best course of action.\nC. Contact another family member for consent.\n\u2003\u2013 The daughter is the legally authorized surrogate; contacting another family member might not override her legal authority, even if their opinions differ.\nD. Report the daughter to the police.\n\u2003\u2013 There is no legal basis for criminal action in this context simply because of her personal grievances.\n\nStep 4: Conclusion and Final Answer\nThe most appropriate course of action is to refer the case to the court for further review to ensure that the patient\u2019s best interests are protected.\n\nFinal Answer: B. Refer this case to the court.",
            "Step 1: Identify the clinical situation and decision-making dilemma.\n\u2022 A 67-year-old man is comatose after complications from a subarachnoid hemorrhage and subsequent surgery.\n\u2022 He now requires a non-emergent life-saving operation for an enlarging aneurysm.\n\u2022 The patient does not have an advanced directive, so decision-making falls to his next of kin.\n\u2022 His daughter, who is legally his surrogate decision-maker, refuses consent\u2014even though the operation is life-saving.\n\u2022 Additional context shows that the patient was abusive and neglectful to his children, which might bias her decision.\n\nStep 2: Evaluate the answer options.\nA. Follow the daughter\u2019s wishes to withhold the operation.\n\u2003\u2022 This ignores the possibility of a conflict of interest that might compromise her decision-making. The surrogate\u2019s refusal, based solely on personal feelings, may not represent the patient\u2019s best interest.\nB. Refer this case to the court.\n\u2003\u2022 When there is potential conflict of interest or abuse history making a surrogate\u2019s decision questionable, legal intervention (court involvement) is warranted to appoint an impartial decision-maker.\nC. Contact another family member for consent.\n\u2003\u2022 While consulting another family member is possible, it is not standard practice if the legal surrogate (in this case, the daughter) is already designated. Moreover, given the history and the conflict, seeking another surrogate wouldn\u2019t resolve the ethical dilemma.\nD. Report the daughter to the police.\n\u2003\u2022 Reporting to law enforcement is not appropriate in this context. This is not a criminal matter but an ethical and legal dispute regarding medical decision-making.\n\nStep 3: Conclusion.\nGiven the conflict of interest evident by the daughter\u2019s abusive history and her refusal of care that would be life-saving for her father, it is most appropriate to refer the case to the court so that an unbiased decision-maker can be assigned.\n\nFinal Answer: B. Refer this case to the court.",
            "Step 1: The patient is incapacitated and has no written advanced directive, so a surrogate decision-maker must act on his behalf. Typically, the daughter would serve this role as next-of-kin.\n\nStep 2: However, the daughter has a known history of abuse and neglect toward the patient, which creates a conflict of interest as her decision may not align with the patient\u2019s best interests.\n\nStep 3: Given that the surgery is life-saving and non-emergent, the physician should seek an alternative to the conflicted decision-maker\u2019s refusal.\n\nStep 4: In cases where the designated surrogate\u2019s decision is potentially influenced by personal conflicts and may not represent the patient\u2019s wishes or best interests, it is appropriate to refer the matter to the court for evaluation and appointment of an impartial decision-maker.\n\nFinal Answer: B. Refer this case to the court."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review the Essential Details\n\u2022 The patient is comatose with a life\u2010threatening condition requiring a non\u2010emergent, but life\u2010saving, intervention.\n\u2022 There is no written advanced directive.\n\u2022 The patient\u2019s daughter is the designated surrogate decision-maker.\n\u2022 The daughter\u2019s decision to withhold treatment is influenced by her personal negative history with her father (he was abusive and neglectful), not necessarily by what is in his best medical interest.\n\nStep 2: Understand the Ethical Conflict\nEven though the daughter is the legal surrogate, surrogate decision-making should be based on the patient\u2019s best interests or previously expressed wishes. Her refusal is likely being colored by personal emotions rather than an objective reflection of what the patient would have wanted.\n\nStep 3: Evaluate the Options\nA. Follow the daughter\u2019s wishes to withhold the operation.\n\u2003\u2013 This option would mean following a decision that may be ethically invalid because her motivations are conflicted, potentially harming the patient\u2019s right to life\u2010saving treatment.\nB. Refer this case to the court.\n\u2003\u2013 In disputes where a surrogate\u2019s decision appears to be compromised by conflicting personal interests, it is appropriate to have the decision reviewed by the court to determine the best course of action.\nC. Contact another family member for consent.\n\u2003\u2013 The daughter is the legally authorized surrogate; contacting another family member might not override her legal authority, even if their opinions differ.\nD. Report the daughter to the police.\n\u2003\u2013 There is no legal basis for criminal action in this context simply because of her personal grievances.\n\nStep 4: Conclusion and Final Answer\nThe most appropriate course of action is to refer the case to the court for further review to ensure that the patient\u2019s best interests are protected.\n\nFinal Answer: B. Refer this case to the court."
    },
    {
        "realidx": 321,
        "question": "A 55-year-old man recovering from knee replacement surgery complains of breathlessness in the postoperative ward. He has been confined to bed for the past 5 days and is under observation. He felt a sudden difficulty in breathing and called for the ward nurse. He says that he is unable to take deep breaths and has a sharp pain on the right side of his chest with each inspiration. His temperature is 37.5\u00b0C (99.8\u00b0F), the pulse is 111/min, the respirations are 31/min, and the blood pressure is 85/55 mm Hg. He experiences pain in his right calf on dorsiflexion. There are no other prominent findings on physical examination. His chest X-ray does not show anything significant. The ECG reveals sinus tachycardia. Which of the following is the best course of management at this time?",
        "answer": "Subcutaneous fondaparinux",
        "options": {
            "A": "Subcutaneous fondaparinux",
            "B": "Inferior vena cava filter",
            "C": "Ventilation-perfusion scan",
            "D": "Lower extremity doppler"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "55 year old man recovering from knee surgery",
            "breathlessness",
            "postoperative ward",
            "confined to bed",
            "past",
            "days",
            "observation",
            "felt",
            "sudden difficulty",
            "breathing",
            "called",
            "ward nurse",
            "unable to take deep breaths",
            "pain",
            "right side",
            "chest",
            "inspiration",
            "temperature",
            "99",
            "pulse",
            "min",
            "respirations",
            "31 min",
            "blood pressure",
            "85 55 mm Hg",
            "experiences pain in",
            "right calf",
            "prominent findings",
            "physical examination",
            "chest X-ray",
            "not show",
            "significant",
            "ECG reveals sinus tachycardia",
            "following",
            "best course",
            "management",
            "time"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6696,
            "completion_tokens": 7735
        },
        "time_elapsed": 55.97944450378418,
        "raw_responses": [
            "Step 1: Recognize the clinical picture. This 55\u2010year\u2010old postoperative patient, who has been immobile, presents with sudden onset dyspnea, pleuritic chest pain, hypotension, tachypnea, and tachycardia. Additionally, he has a positive sign for deep vein thrombosis (DVT) on his right calf. These findings are highly suggestive of a pulmonary embolism (PE) secondary to a DVT.\n\nStep 2: Examine the management options. In suspected PE with evidence of DVT, confirming the diagnosis promptly is key:\n\n\u2022 Option A (Subcutaneous fondaparinux) is an anticoagulant that could be used as part of the management of venous thromboembolism. However, in a hemodynamically unstable patient with a massive PE, treatment is more aggressive (usually with thrombolytic therapy), and you would first confirm the diagnosis before starting treatment if the diagnosis is not yet definitive.\n\n\u2022 Option B (Inferior vena cava filter) is reserved for patients with contraindications to anticoagulation or recurrent emboli despite adequate anticoagulation, not for initial management.\n\n\u2022 Option C (Ventilation-perfusion scan) is a diagnostic test for PE but may not be ideal in a hemodynamically unstable patient where time is critical. It also has limitations if the chest x-ray is normal or if the patient is too unstable to go to the scanner.\n\n\u2022 Option D (Lower extremity doppler) is a rapid, noninvasive test that can identify the source of the embolism (a DVT). In a patient with signs of DVT and high suspicion for PE, a positive doppler can be used to justify initiating treatment, especially when further imaging might delay care.\n\nStep 3: Decide on the best course of management. Given the patient\u2019s hemodynamic instability and classic signs of DVT, performing a lower extremity doppler is the most appropriate next step. It can quickly confirm the presence of DVT, thereby supporting the diagnosis of pulmonary embolism, so that immediate treatment can be instituted.\n\nFinal Answer: D. Lower extremity doppler",
            "Step 1: Review the clinical picture. This 55-year-old man, recovering from surgery and with prolonged immobilization, acutely develops sudden-onset shortness of breath, pleuritic chest pain, tachypnea, tachycardia, and hypotension. In addition, he complains of right calf pain on dorsiflexion\u2014a finding that raises suspicion for deep venous thrombosis (DVT), which is frequently the source of pulmonary embolism (PE).\n\nStep 2: Consider the diagnostic and management options.\n\u2022 Subcutaneous fondaparinux is an anticoagulant used for treating and preventing DVT/PE, but in a patient with hemodynamic instability (e.g., hypotension), the management of massive PE is more aggressive and typically involves immediate thrombolytic therapy rather than initiating subcutaneous anticoagulation alone.\n\u2022 An inferior vena cava (IVC) filter is reserved for patients who have contraindications to anticoagulation or recurrent embolism despite proper therapy\u2014not appropriate at this immediate time.\n\u2022 A ventilation-perfusion (V/Q) scan is a diagnostic tool for PE. Although his chest X-ray is normal (making a V/Q scan feasible), his unstable hemodynamics make moving him to perform a V/Q scan less ideal.\n\u2022 A lower extremity doppler ultrasound is a bedside, noninvasive test that can quickly identify a DVT. In a patient with high clinical suspicion for PE and unstable hemodynamics, finding a DVT can provide enough evidence to initiate treatment without waiting for further testing like CT pulmonary angiography or V/Q scanning.\n\nStep 3: Compare and eliminate incorrect choices.\n\u2022 Fondaparinux (Option A) would not be sufficient treatment given his hemodynamic instability.\n\u2022 An IVC filter (Option B) is not indicated in this setting.\n\u2022 A V/Q scan (Option C) would be less practical in a hemodynamically unstable patient.\n\u2022 Lower extremity doppler (Option D) is rapid, can be performed at the bedside, and will help confirm a source of embolism in this high-risk situation.\n\nFinal Answer: D. Lower extremity doppler",
            "Step 1: Summarize the Case\n\u2022 The patient is a 55\u2010year\u2010old man post knee replacement who\u2019s been relatively immobile for 5 days.\n\u2022 He suddenly develops breathlessness, pleuritic right\u2010sided chest pain, tachycardia (111/min), tachypnea (31/min), and hypotension (85/55 mm Hg), which are concerning for a pulmonary embolism (PE).\n\u2022 He also notes right calf pain on dorsiflexion, suggesting a deep venous thrombosis (DVT) as the potential embolic source.\n\u2022 His chest X\u2010ray is unremarkable and his ECG shows only sinus tachycardia.\n  \nStep 2: Consider the Differential and Likely Diagnosis\n\u2022 The clinical picture strongly suggests a massive pulmonary embolism originating from a DVT, especially given his recent surgery and immobilization.\n\u2022 In a patient with such hemodynamic instability and a high clinical suspicion of PE, rapid confirmation of a thromboembolic source is vital.\n\nStep 3: Evaluate the Options\nA. Subcutaneous fondaparinux \u2013 This is an anticoagulant used for treatment of DVT/PE. However, in the setting of hemodynamic instability (shock), immediate diagnosis and potential escalation (such as thrombolytic therapy) is required rather than solely starting routine anticoagulation.\n  \nB. Inferior vena cava filter \u2013 This is considered when there are contraindications to anticoagulation or recurrent emboli despite adequate therapy\u2014not the first-line treatment in an acute massive PE.\n  \nC. Ventilation-perfusion (V/Q) scan \u2013 While this test can diagnose a PE, it may be less readily available and takes time to perform and interpret. In a hemodynamically unstable patient, delays in diagnosis are dangerous.\n  \nD. Lower extremity doppler \u2013 This is a bedside ultrasound examination to detect a DVT. Given the patient\u2019s calf pain and the high likelihood of DVT as the source of his PE, a positive study would strongly support the diagnosis and allow prompt initiation of treatment without waiting for more complicated imaging.\n\nStep 4: Conclude the Best Management\nIn a hemodynamically unstable patient with strong clinical suspicion of PE, the fastest and least invasive step is to perform a lower extremity doppler study to rapidly identify a DVT. A confirmed DVT in this clinical context is enough to confirm the presumed diagnosis of PE, prompting immediate treatment.\n\nFinal Answer: D. Lower extremity doppler"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Summarize the Case\n\u2022 The patient is a 55\u2010year\u2010old man post knee replacement who\u2019s been relatively immobile for 5 days.\n\u2022 He suddenly develops breathlessness, pleuritic right\u2010sided chest pain, tachycardia (111/min), tachypnea (31/min), and hypotension (85/55 mm Hg), which are concerning for a pulmonary embolism (PE).\n\u2022 He also notes right calf pain on dorsiflexion, suggesting a deep venous thrombosis (DVT) as the potential embolic source.\n\u2022 His chest X\u2010ray is unremarkable and his ECG shows only sinus tachycardia.\n  \nStep 2: Consider the Differential and Likely Diagnosis\n\u2022 The clinical picture strongly suggests a massive pulmonary embolism originating from a DVT, especially given his recent surgery and immobilization.\n\u2022 In a patient with such hemodynamic instability and a high clinical suspicion of PE, rapid confirmation of a thromboembolic source is vital.\n\nStep 3: Evaluate the Options\nA. Subcutaneous fondaparinux \u2013 This is an anticoagulant used for treatment of DVT/PE. However, in the setting of hemodynamic instability (shock), immediate diagnosis and potential escalation (such as thrombolytic therapy) is required rather than solely starting routine anticoagulation.\n  \nB. Inferior vena cava filter \u2013 This is considered when there are contraindications to anticoagulation or recurrent emboli despite adequate therapy\u2014not the first-line treatment in an acute massive PE.\n  \nC. Ventilation-perfusion (V/Q) scan \u2013 While this test can diagnose a PE, it may be less readily available and takes time to perform and interpret. In a hemodynamically unstable patient, delays in diagnosis are dangerous.\n  \nD. Lower extremity doppler \u2013 This is a bedside ultrasound examination to detect a DVT. Given the patient\u2019s calf pain and the high likelihood of DVT as the source of his PE, a positive study would strongly support the diagnosis and allow prompt initiation of treatment without waiting for more complicated imaging.\n\nStep 4: Conclude the Best Management\nIn a hemodynamically unstable patient with strong clinical suspicion of PE, the fastest and least invasive step is to perform a lower extremity doppler study to rapidly identify a DVT. A confirmed DVT in this clinical context is enough to confirm the presumed diagnosis of PE, prompting immediate treatment.\n\nFinal Answer: D. Lower extremity doppler"
    },
    {
        "realidx": 329,
        "question": "A 57-year-old woman is brought to the emergency department by ambulance for dysarthria and left-sided facial droop. She is accompanied by her son, who states that the patient had just returned home an hour ago from walking the dog when suddenly the patient stated she felt \u201cstrange.\u201d When her son asked her what was wrong, her speech was slurred and her \"face looked funny.\u201d The son quickly called an ambulance. The paramedic upon arrival noted that the patient had left-sided facial droop. Her medical history includes asthma and sickle cell disease. She takes hydroxyurea, uses oxycodone as needed for pain, and an albuterol inhaler as needed for shortness of breath. The patient\u2019s temperature is 97\u00b0F (36.1\u00b0C), blood pressure is 145/72 mmHg, pulse is 93/min, and respirations are 14/min with an oxygen saturation of 96% on room air. On physical examination, a left-sided facial droop is appreciated. She has trouble articulating her words, and her speech is garbled. She is put on 2 L of oxygen by nasal cannula. Labs are obtained and pending. Which of the following therapies is most likely indicated?",
        "answer": "Exchange transfusion",
        "options": {
            "A": "Alteplase",
            "B": "Exchange transfusion",
            "C": "Hydralazine",
            "D": "Warfarin"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "57 year old woman",
            "brought",
            "emergency department",
            "ambulance",
            "dysarthria",
            "left-sided facial droop",
            "son",
            "states",
            "patient",
            "returned home",
            "hour",
            "walking",
            "dog",
            "patient stated",
            "felt",
            "son",
            "wrong",
            "speech",
            "slurred",
            "face looked",
            "son",
            "called",
            "ambulance",
            "paramedic",
            "arrival noted",
            "patient",
            "left-sided facial droop",
            "medical history includes asthma",
            "sickle cell disease",
            "takes hydroxyurea",
            "uses oxycodone as needed",
            "pain",
            "albuterol inhaler as needed",
            "shortness of breath",
            "patients temperature",
            "36",
            "blood pressure",
            "72 mmHg",
            "pulse",
            "min",
            "respirations",
            "14 min",
            "oxygen saturation",
            "96",
            "room air",
            "physical examination",
            "left-sided facial droop",
            "words",
            "speech",
            "put",
            "2",
            "oxygen",
            "nasal cannula",
            "Labs",
            "obtained",
            "following therapies",
            "most likely indicated"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5859,
            "completion_tokens": 8141
        },
        "time_elapsed": 54.30461001396179,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s presentation.  \n\u2022 The 57\u2010year-old woman has sudden onset dysarthria (difficulty speaking) and left\u2010sided facial droop. These are signs consistent with an acute ischemic stroke.  \n\u2022 The symptoms started about an hour ago, placing her within the therapeutic window for stroke intervention.\n\nStep 2: Consider her medical history.  \n\u2022 Although she has sickle cell disease (SCD) and is on hydroxyurea, her current presentation resembles a classic ischemic stroke rather than a sickle cell crisis.  \n\u2022 In patients with SCD who have neurological events, exchange transfusion may be considered if the event is primarily due to sickling. However, in an acute ischemic stroke within the tPA window and without other contraindications, the standard of care remains thrombolytic therapy (i.e., alteplase).\n\nStep 3: Evaluate the answer choices.  \nA. Alteplase \u2013 This is a tissue plasminogen activator used for acute ischemic stroke if given within the appropriate time window (usually 3\u20134.5 hours from symptom onset). Her presentation fits this treatment.  \nB. Exchange transfusion \u2013 While used in SCD patients when neurological complications arise specifically from sickling, her presentation is more consistent with a typical thrombotic stroke, making tPA the more appropriate therapy.  \nC. Hydralazine \u2013 This is an antihypertensive medication; her blood pressure is moderately elevated but not at levels that necessitate acute management in the context of stroke.  \nD. Warfarin \u2013 This anticoagulant is not used acutely for ischemic stroke management and is more commonly employed in conditions like atrial fibrillation for stroke prevention.\n\nStep 4: Provide the final answer.  \nThe best therapy indicated in this scenario is Alteplase.\n\nFinal answer: A. Alteplase.",
            "Step 1: This patient presents with acute onset neurologic deficits (dysarthria and left-sided facial droop) that began about an hour ago, a classic presentation of an ischemic stroke. The time window is crucial for acute ischemic stroke management.\n\nStep 2: Alteplase (tPA) is the treatment of choice for acute ischemic stroke if the patient presents within the recommended time window (typically within 3-4.5 hours from symptom onset). Although the patient has a history of sickle cell disease, the acute management of her stroke symptoms in the given time frame focuses on recanalization of the occluded vessel via thrombolytic therapy. The other options\u2014exchange transfusion (used for sickle cell crises), hydralazine (used for hypertensive emergencies), and warfarin (anticoagulation for conditions like atrial fibrillation)\u2014are not appropriate for immediate therapy in this scenario.\n\nStep 3: Therefore, the most appropriate treatment for this patient is Alteplase.\n\nFinal answer: A. Alteplase",
            "Step 1: Analyze the patient\u2019s presentation. The patient has acute-onset neurological deficits (dysarthria, left-sided facial droop) that began about an hour ago, which is consistent with an ischemic stroke. Her vital signs and exam further support this diagnosis.\n\nStep 2: Consider her past medical history. The patient has sickle cell disease, a known risk factor for stroke due to vaso-occlusive events caused by sickled red blood cells. Although standard treatment for acute ischemic stroke is thrombolysis with alteplase if the patient is within the therapeutic window, stroke management in patients with sickle cell disease often requires an additional targeted therapy.\n\nStep 3: Review the treatment options.  \n\u2022 Option A, Alteplase, is the standard thrombolytic treatment for acute ischemic stroke in the appropriate time window, but in patients with sickle cell disease, the pathophysiology involves sickled cells leading to vascular occlusion rather than a typical thromboembolic clot.  \n\u2022 Option B, Exchange transfusion, is indicated in patients with sickle cell disease experiencing an acute ischemic stroke. By rapidly reducing the percentage of sickled hemoglobin (HbS), exchange transfusion improves oxygen delivery and reduces further vaso-occlusion.  \n\u2022 Options C (Hydralazine) and D (Warfarin) are not indicated for the acute management of an ischemic stroke in this context.\n\nStep 4: Compare and eliminate. Given the patient\u2019s sickle cell disease background, the most appropriate management strategy is to rapidly reduce the sickled hemoglobin level and reverse the vaso-occlusion; therefore, exchange transfusion is the appropriate therapy rather than immediate treatment with alteplase.\n\nFinal Answer: B. Exchange transfusion"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Analyze the patient\u2019s presentation. The patient has acute-onset neurological deficits (dysarthria, left-sided facial droop) that began about an hour ago, which is consistent with an ischemic stroke. Her vital signs and exam further support this diagnosis.\n\nStep 2: Consider her past medical history. The patient has sickle cell disease, a known risk factor for stroke due to vaso-occlusive events caused by sickled red blood cells. Although standard treatment for acute ischemic stroke is thrombolysis with alteplase if the patient is within the therapeutic window, stroke management in patients with sickle cell disease often requires an additional targeted therapy.\n\nStep 3: Review the treatment options.  \n\u2022 Option A, Alteplase, is the standard thrombolytic treatment for acute ischemic stroke in the appropriate time window, but in patients with sickle cell disease, the pathophysiology involves sickled cells leading to vascular occlusion rather than a typical thromboembolic clot.  \n\u2022 Option B, Exchange transfusion, is indicated in patients with sickle cell disease experiencing an acute ischemic stroke. By rapidly reducing the percentage of sickled hemoglobin (HbS), exchange transfusion improves oxygen delivery and reduces further vaso-occlusion.  \n\u2022 Options C (Hydralazine) and D (Warfarin) are not indicated for the acute management of an ischemic stroke in this context.\n\nStep 4: Compare and eliminate. Given the patient\u2019s sickle cell disease background, the most appropriate management strategy is to rapidly reduce the sickled hemoglobin level and reverse the vaso-occlusion; therefore, exchange transfusion is the appropriate therapy rather than immediate treatment with alteplase.\n\nFinal Answer: B. Exchange transfusion"
    },
    {
        "realidx": 336,
        "question": "A 39-year-old man is brought to the emergency department unconscious following 2 episodes of generalized tonic-clonic seizures. According to the attendants, he has complained of recurrent headaches for the past 2 weeks. There is no history of fever, head trauma, or a seizure disorder. The patient does not smoke cigarettes but reportedly drinks 2 glasses of wine daily. He has multiple sexual partners and history regarding the contraceptive use is unavailable. The patient\u2019s vitals include: blood pressure 137/88 mm Hg, temperature 37.2\u00b0C (99.0\u00b0F). On physical examination, he is obtunded. He grimaces on pain and localizes in response to pain in both upper extremities. Pupils are bilateral 3-mm in diameter and equally round and reactive. Laboratory tests are within normal limits. An MRI of the brain with contrast is shown in the exhibit (see image). A brain biopsy is performed that reveals perivascular clusters of lymphocytes. Which of the following is most associated with this patient\u2019s condition?",
        "answer": "Epstein-Barr virus",
        "options": {
            "A": "Epstein-Barr virus",
            "B": "Human herpes virus",
            "C": "Human papilloma virus",
            "D": "Schistosoma haematobium"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "brought",
            "emergency department unconscious following 2 episodes of generalized tonic-clonic seizures",
            "attendants",
            "recurrent headaches",
            "past 2 weeks",
            "history",
            "fever",
            "head trauma",
            "seizure disorder",
            "patient",
            "not smoke cigarettes",
            "drinks 2 glasses",
            "wine daily",
            "multiple sexual partners",
            "history",
            "contraceptive use",
            "unavailable",
            "patients",
            "include",
            "blood pressure",
            "88 mm Hg",
            "temperature",
            "99",
            "physical examination",
            "obtunded",
            "grimaces",
            "pain",
            "localizes",
            "response",
            "pain",
            "upper extremities",
            "Pupils",
            "bilateral",
            "mm",
            "diameter",
            "round",
            "reactive",
            "Laboratory tests",
            "normal limits",
            "MRI of",
            "brain",
            "contrast",
            "shown",
            "exhibit",
            "see image",
            "brain biopsy",
            "performed",
            "reveals perivascular clusters",
            "lymphocytes",
            "following",
            "most associated with",
            "patients condition"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5541,
            "completion_tokens": 4146
        },
        "time_elapsed": 32.428401470184326,
        "raw_responses": [
            "Step 1: Recognize that the patient\u2019s clinical picture\u2014seizures, progressive headaches, and risk factors from his sexual history\u2014raises concern for an intracranial mass, possibly in an immunocompromised host (e.g., undiagnosed HIV).\n\nStep 2: The brain MRI (not shown but implied) likely demonstrated a ring-enhancing lesion, which in an immunocompromised individual along with his age and profile points toward primary CNS lymphoma.\n\nStep 3: Primary CNS lymphoma in patients with immunocompromise, especially those with HIV, is strongly associated with Epstein-Barr virus (EBV). The biopsy finding of perivascular clusters of lymphocytes further supports the diagnosis.\n\nStep 4: Now comparing the options:\n\u2022 Epstein-Barr virus \u2013 Commonly associated with primary CNS lymphoma in immunocompromised patients.\n\u2022 Human herpes virus \u2013 While certain HHVs are linked to other CNS conditions (e.g., HHV-6 with encephalitis), they are not typically associated with primary CNS lymphoma.\n\u2022 Human papilloma virus \u2013 Associated with cervical and other anogenital cancers, not with brain lymphoma.\n\u2022 Schistosoma haematobium \u2013 Associated with bladder pathology and squamous cell carcinoma of the bladder, not with CNS lesions.\n\nFinal Answer: Epstein-Barr virus",
            "Step 1: Identify patient risk factors and presentation.\n\u2022 The patient is a 39\u2010year\u2010old male with multiple sexual partners and uncertain contraceptive use. This raises concern for sexually transmitted infections\u2014including HIV.\n\u2022 He has been experiencing recurrent headaches for 2 weeks and now presents with seizures. In an immunocompromised individual (as HIV patients may be), neurological lesions are common.\n\nStep 2: Evaluate imaging and histologic findings.\n\u2022 The MRI of the brain with contrast (although not directly viewable here) most likely shows a lesion suggestive of a mass effect or ring-enhancement.\n\u2022 The brain biopsy reveals perivascular clusters of lymphocytes, a finding that is characteristic of primary central nervous system (CNS) lymphoma\u2014a condition that frequently occurs in immunocompromised patients.\n\nStep 3: Link the condition to an associated infectious agent.\n\u2022 Primary CNS lymphoma in immunocompromised individuals (especially those with HIV/AIDS) is strongly associated with Epstein-Barr virus (EBV).\n\u2022 Although EBV is a type of human herpesvirus (specifically HHV-4), the answer choice specifically listing Epstein-Barr virus is the most appropriate association.\n\nStep 4: Compare and eliminate incorrect choices.\n\u2022 Option B (\"Human herpes virus\") is too nonspecific since EBV (HHV-4) is the particular herpesvirus linked to primary CNS lymphoma.\n\u2022 Options C (Human papilloma virus) and D (Schistosoma haematobium) have no known association with this type of CNS lesion.\n\nFinal Answer: Epstein-Barr virus",
            "Step 1: Analyze the Clinical Scenario\n\n\u2022 The patient is a 39-year-old man with new-onset generalized tonic-clonic seizures and a 2-week history of headaches.  \n\u2022 His history includes multiple sexual partners, raising the possibility of an immunocompromised state, such as HIV infection, even if it's not explicitly stated.  \n\u2022 The MRI (as described) likely shows findings consistent with an intracranial mass lesion.  \n\u2022 The brain biopsy reveals perivascular clusters of lymphocytes, which is a feature seen in primary central nervous system (CNS) lymphoma.\n\nStep 2: Correlate with Known Associations\n\n\u2022 In immunocompromised patients, particularly those with HIV/AIDS, primary CNS lymphoma is commonly associated with Epstein-Barr virus (EBV).  \n\u2022 The typical presentation of primary CNS lymphoma in such patients includes neurological symptoms like headaches and seizures.\n  \nStep 3: Compare the Options\n\nA. Epstein-Barr virus \u2013 Strongly associated with primary CNS lymphoma in immunocompromised individuals.  \nB. Human herpes virus \u2013 Although herpes viruses (e.g., HSV) cause encephalitis, especially involving the temporal lobes, they are not linked with this pattern of perivascular lymphocytic infiltration seen in CNS lymphoma.  \nC. Human papilloma virus \u2013 Not associated with CNS lymphoma or brain lesions.  \nD. Schistosoma haematobium \u2013 Associated with bladder pathology and certain cancers of the urinary system, not CNS involvement.\n\nStep 4: Final Answer\n\nThe condition described is primary CNS lymphoma, and the virus most commonly associated with this condition in immunocompromised patients is Epstein-Barr virus.\n\nFinal answer: A. Epstein-Barr virus."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Analyze the Clinical Scenario\n\n\u2022 The patient is a 39-year-old man with new-onset generalized tonic-clonic seizures and a 2-week history of headaches.  \n\u2022 His history includes multiple sexual partners, raising the possibility of an immunocompromised state, such as HIV infection, even if it's not explicitly stated.  \n\u2022 The MRI (as described) likely shows findings consistent with an intracranial mass lesion.  \n\u2022 The brain biopsy reveals perivascular clusters of lymphocytes, which is a feature seen in primary central nervous system (CNS) lymphoma.\n\nStep 2: Correlate with Known Associations\n\n\u2022 In immunocompromised patients, particularly those with HIV/AIDS, primary CNS lymphoma is commonly associated with Epstein-Barr virus (EBV).  \n\u2022 The typical presentation of primary CNS lymphoma in such patients includes neurological symptoms like headaches and seizures.\n  \nStep 3: Compare the Options\n\nA. Epstein-Barr virus \u2013 Strongly associated with primary CNS lymphoma in immunocompromised individuals.  \nB. Human herpes virus \u2013 Although herpes viruses (e.g., HSV) cause encephalitis, especially involving the temporal lobes, they are not linked with this pattern of perivascular lymphocytic infiltration seen in CNS lymphoma.  \nC. Human papilloma virus \u2013 Not associated with CNS lymphoma or brain lesions.  \nD. Schistosoma haematobium \u2013 Associated with bladder pathology and certain cancers of the urinary system, not CNS involvement.\n\nStep 4: Final Answer\n\nThe condition described is primary CNS lymphoma, and the virus most commonly associated with this condition in immunocompromised patients is Epstein-Barr virus.\n\nFinal answer: A. Epstein-Barr virus."
    },
    {
        "realidx": 337,
        "question": "A 22-year-old woman from a rural area who recently discovered she was pregnant is referred for a cardiology consultation due to cyanosis, dyspnea, and a cardiac murmur revealed at the initial prenatal visit. She is gravida 1, para 0 with an estimated gestational age of 19 weeks. She says that the murmur was found in her childhood, and the doctor at that time placed her under observation only. However, she has been lost to follow-up and has not had proper follow up in years. Currently, she complains of dizziness and occasional dyspnea on exertion which has gradually increased during her pregnancy. Prior to her pregnancy, she did not have any symptoms. The vital signs are as follows: blood pressure 125/60 mm Hg, heart rate 81/min, respiratory rate 13/min, and temperature 36.7\u00b0C (98.0\u00b0F). Her examination is significant for acrocyanosis and a fixed splitting of S2 and grade 3/6 midsystolic murmur best heard over the left upper sternal border. Which of the following physiological pregnancy changes is causing the change in this patient\u2019s condition?",
        "answer": "Decrease in systemic vascular resistance",
        "options": {
            "A": "Increase in heart rate",
            "B": "Decrease in systemic vascular resistance",
            "C": "Increase in cardiac output",
            "D": "Increase in blood volume"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman",
            "rural area",
            "recently discovered",
            "pregnant",
            "referred",
            "cardiology consultation",
            "cyanosis",
            "dyspnea",
            "cardiac murmur revealed",
            "initial prenatal visit",
            "gravida 1",
            "para 0",
            "estimated gestational age",
            "19 weeks",
            "murmur",
            "found",
            "childhood",
            "doctor",
            "time placed",
            "observation only",
            "lost to follow-up",
            "not",
            "follow up",
            "years",
            "Currently",
            "dizziness",
            "occasional dyspnea on exertion",
            "increased",
            "pregnancy",
            "pregnancy",
            "not",
            "symptoms",
            "vital signs",
            "follows",
            "blood pressure",
            "60 mm Hg",
            "heart rate 81 min",
            "respiratory rate",
            "min",
            "temperature 36",
            "98",
            "examination",
            "significant",
            "acrocyanosis",
            "fixed splitting",
            "S2",
            "grade",
            "6 midsystolic murmur best heard",
            "left upper sternal border",
            "following physiological pregnancy changes",
            "causing",
            "change",
            "patients condition"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5772,
            "completion_tokens": 4239
        },
        "time_elapsed": 33.63654947280884,
        "raw_responses": [
            "Step 1: Recognize that the patient has an atrial septal defect (ASD), as suggested by her fixed splitting of S2 and the murmur along the left upper sternal border. Patients with ASD may be asymptomatic until the hemodynamic changes of pregnancy worsen their symptoms.\n\nStep 2: In pregnancy, several vital cardiovascular changes occur. Although increased heart rate and increased cardiac output are notable, the pronounced increase in blood volume drives much of the increase in cardiac output. This increased volume loads the right side of the heart and increases the left-to-right shunting through the ASD, leading to her symptoms of dyspnea and dizziness.\n\nStep 3: By eliminating the less directly relevant options:\n\u2022 Option A (Increase in heart rate): While heart rate does increase, it does not directly account for the worsened shunting.\n\u2022 Option B (Decrease in systemic vascular resistance): Although this change is significant in pregnancy, it plays a less crucial role in accentuating the shunt in ASD.\n\u2022 Option C (Increase in cardiac output): This is true but is largely a consequence of the increase in blood volume.\n\u2022 Option D (Increase in blood volume): This is the primary change that increases preload and exacerbates the left-to-right shunt.\n\nFinal answer: D. Increase in blood volume",
            "Step 1: The patient\u2019s history and physical exam (notably fixed splitting of S2 and a midsystolic murmur at the left upper sternal border) are most consistent with an atrial septal defect (ASD). During pregnancy, physiological changes can lead to an increase in the left-to-right shunt through the ASD, resulting in symptoms such as dyspnea and cyanosis.\n\nStep 2: Let\u2019s review the options:\n\u2022 A. Increase in heart rate \u2013 Although heart rate does increase in pregnancy, this change alone would not directly worsen the shunt.\n\u2022 B. Decrease in systemic vascular resistance \u2013 This occurs in pregnancy but its effect is more significant in conditions with significant left-to-right or right-to-left shunting due to pressure changes in the ventricles, not the fixed atrial defect.\n\u2022 C. Increase in cardiac output \u2013 Cardiac output does increase in pregnancy. However, the increase in cardiac output is primarily a result of another underlying change.\n\u2022 D. Increase in blood volume \u2013 During pregnancy, blood volume expands significantly, increasing venous return. In a patient with an ASD, this increase in blood volume leads to increased shunting of blood from the left atrium to the right atrium, which can exacerbate symptoms like dyspnea and cyanosis.\n\nStep 3: The underlying physiological pregnancy change that most directly worsens this patient\u2019s cardiac condition is the increase in blood volume.\n\nFinal answer: D. Increase in blood volume",
            "Step 1: Recognize that this patient\u2019s presentation is consistent with an atrial septal defect (ASD). Key findings such as a fixed splitting of S2 and a systolic murmur over the left upper sternal border point toward this diagnosis. A patient with an ASD can tolerate the defect for years with minimal symptoms until pregnancy-related changes increase the volume load on the heart.\n\nStep 2: Identify the significant physiologic changes in pregnancy. Pregnancy causes many cardiovascular adaptations including an increase in heart rate, a decrease in systemic vascular resistance, an increase in cardiac output, and a significant increase in blood volume. These changes are designed to meet the greater metabolic demands of the mother and the developing fetus.\n\nStep 3: Relate the physiologic changes to the patient\u2019s condition. In patients with an ASD, a larger blood volume leads to an increased amount of blood shunting from the left atrium to the right atrium. This increased volume load can exacerbate symptoms like dyspnea and cyanosis even if the defect was relatively benign before pregnancy. Although an increase in cardiac output is also seen in pregnancy, it is the marked increase in blood volume (which drives the rise in preload) that most significantly worsens the left-to-right shunt.\n\nStep 4: Eliminate incorrect options. \n\u2022 An increase in heart rate (Option A) occurs in pregnancy, but its effect on her condition is less pronounced.\n\u2022 A decrease in systemic vascular resistance (Option B) is characteristic of pregnancy but does not directly increase the volume shunting in an ASD.\n\u2022 An increase in cardiac output (Option C) is indeed part of the normal changes, but this is in large part due to the increase in blood volume rather than being the primary culprit itself.\n\nStep 5: Provide the final answer.\nThe physiological change responsible for the worsening of her condition is the increase in blood volume.\n\nFinal Answer: D. Increase in blood volume"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Recognize that this patient\u2019s presentation is consistent with an atrial septal defect (ASD). Key findings such as a fixed splitting of S2 and a systolic murmur over the left upper sternal border point toward this diagnosis. A patient with an ASD can tolerate the defect for years with minimal symptoms until pregnancy-related changes increase the volume load on the heart.\n\nStep 2: Identify the significant physiologic changes in pregnancy. Pregnancy causes many cardiovascular adaptations including an increase in heart rate, a decrease in systemic vascular resistance, an increase in cardiac output, and a significant increase in blood volume. These changes are designed to meet the greater metabolic demands of the mother and the developing fetus.\n\nStep 3: Relate the physiologic changes to the patient\u2019s condition. In patients with an ASD, a larger blood volume leads to an increased amount of blood shunting from the left atrium to the right atrium. This increased volume load can exacerbate symptoms like dyspnea and cyanosis even if the defect was relatively benign before pregnancy. Although an increase in cardiac output is also seen in pregnancy, it is the marked increase in blood volume (which drives the rise in preload) that most significantly worsens the left-to-right shunt.\n\nStep 4: Eliminate incorrect options. \n\u2022 An increase in heart rate (Option A) occurs in pregnancy, but its effect on her condition is less pronounced.\n\u2022 A decrease in systemic vascular resistance (Option B) is characteristic of pregnancy but does not directly increase the volume shunting in an ASD.\n\u2022 An increase in cardiac output (Option C) is indeed part of the normal changes, but this is in large part due to the increase in blood volume rather than being the primary culprit itself.\n\nStep 5: Provide the final answer.\nThe physiological change responsible for the worsening of her condition is the increase in blood volume.\n\nFinal Answer: D. Increase in blood volume"
    },
    {
        "realidx": 340,
        "question": "A 67-year-old man is brought to the physician because of increasing forgetfulness, unsteadiness, and falls over the past year. He reports that these symptoms seem to worsen with each fall. Initially, he could not remember directions to his home but now cannot remember recent conversations or appointments he has made. He often repeats questions that he asked shortly before. He has long-standing hypertension, coronary artery disease, and hypercholesterolemia. Current medications include aspirin, carvedilol, enalapril, and atorvastatin. Examination shows a bruise over the left temple and an unsteady gait. On mental status examination, he is oriented to place and person only. Short-term memory is impaired; he can recall 0 out of 5 objects after 10 minutes. Long-term memory is intact. He has no delusions or hallucinations. Muscle strength is decreased in the left lower extremity. The Babinski sign is present on the left. A CT scan of the head is shown. Which of the following is the most appropriate next step in management?",
        "answer": "Cognitive training",
        "options": {
            "A": "Warfarin therapy",
            "B": "Vitamin E therapy",
            "C": "Tetrabenazine therapy",
            "D": "Cognitive training"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "67 year old man",
            "brought",
            "physician",
            "increasing forgetfulness",
            "unsteadiness",
            "falls",
            "past year",
            "reports",
            "symptoms",
            "to worsen",
            "fall",
            "Initially",
            "not remember directions",
            "home",
            "now",
            "remember recent conversations",
            "appointments",
            "made",
            "often repeats questions",
            "long standing hypertension",
            "coronary artery disease",
            "hypercholesterolemia",
            "Current medications include aspirin",
            "carvedilol",
            "enalapril",
            "atorvastatin",
            "Examination shows",
            "bruise",
            "left temple",
            "unsteady gait",
            "mental",
            "oriented to place",
            "person only",
            "Short-term memory",
            "impaired",
            "recall 0 out",
            "5 objects",
            "10 minutes",
            "Long-term memory",
            "intact",
            "delusions",
            "hallucinations",
            "Muscle strength",
            "decreased",
            "left lower extremity",
            "Babinski sign",
            "present",
            "left",
            "CT scan of",
            "head",
            "shown",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6450,
            "completion_tokens": 12341
        },
        "time_elapsed": 83.78934168815613,
        "raw_responses": [
            "Step 1. Summarize the Case\n\n\u2022 A 67\u2010year\u2010old man has had gradually worsening cognitive impairment (short\u2010term memory loss), unsteady gait with falls, and now focal neurological signs (decreased strength and a positive Babinski sign on the left).  \n\u2022 There is a bruise over the left temple, and his history of falls in an elderly patient raises concern for head trauma.  \n\u2022 A CT scan of the head is provided. Although we cannot see it, the clinical picture strongly suggests an intracranial bleed.\n\nStep 2. Consider the Differential\n\nIn an elderly patient with a history of falls and gradual cognitive decline plus focal deficits, the most likely diagnosis is a chronic subdural hematoma. Its classic features include:\n\u2003\u2013 A history of minor head trauma or repeated falls\n\u2003\u2013 Gradual onset of cognitive or personality changes (e.g., memory impairment)\n\u2003\u2013 Focal neurologic deficits (e.g., weakness, abnormal reflexes)\n\u2003\u2013 CT imaging typically showing a crescent\u2010shaped collection tracking along the convexity\n\nStep 3. Relate to the Answer Options\n\nThe available answer options are:  \nA. Warfarin therapy  \nB. Vitamin E therapy  \nC. Tetrabenazine therapy  \nD. Cognitive training  \n\nExamine each choice:\n\u2022 Warfarin: An anticoagulant that would worsen bleeding risk in someone with a subdural hematoma.  \n\u2022 Vitamin E: An antioxidant that has been studied in Alzheimer\u2019s disease but is not useful in managing intracranial hemorrhage.  \n\u2022 Tetrabenazine: A drug used to treat chorea (as in Huntington\u2019s disease), not indicated here.  \n\u2022 Cognitive training: An adjunct for neurodegenerative disorders but not an appropriate treatment for a structural lesion causing the symptoms.\n\nNone of these options corresponds to the standard treatment for a chronic subdural hematoma, which is urgent neurosurgical evaluation for evacuation (often via burr hole drainage).\n\nStep 4. Final Answer\n\nBased on the patient\u2019s presentation and the likely CT findings consistent with a chronic subdural hematoma, the most appropriate next step is not any of the listed medical therapies but rather neurosurgical intervention.\n\nFinal Answer: None of the above \u2013 the patient requires an urgent neurosurgical evaluation for surgical evacuation of his chronic subdural hematoma.",
            "Step 1: Analyze the patient\u2019s history and exam findings. This 67\u2010year\u2010old man has had a year of progressively worsening cognition (especially short-term memory), unsteadiness, and falls. In addition, he now demonstrates focal neurological deficits (left lower extremity weakness with a positive Babinski sign) and a bruise over his left temple, suggesting previous head trauma. His vascular risk factors (hypertension, hypercholesterolemia, coronary artery disease) predispose him to cerebrovascular disease.\n\nStep 2: Consider the differential diagnoses. The stepwise cognitive decline and focal deficits may suggest vascular dementia from multiple infarcts. Although chronic subdural hematoma is in the differential (especially with a history of falls and head trauma), his slowly progressive decline over a year along with focal findings and vascular risk factors is most consistent with vascular dementia. The CT scan (not shown here) likely supports a vascular process with evidence of infarcts or white matter changes rather than an acute/subacute hemorrhage.\n\nStep 3: Evaluate the management options provided.\n\u2022 Option A (Warfarin therapy) is an anticoagulant and is not used to treat dementia; indeed, in the setting of brain vascular pathology, it could be harmful.\n\u2022 Option B (Vitamin E therapy) has been studied for Alzheimer\u2019s disease but does not have a proven benefit in the management of vascular dementia.\n\u2022 Option C (Tetrabenazine therapy) is used to treat hyperkinetic movement disorders (such as Huntington\u2019s chorea), which this patient does not exhibit.\n\u2022 Option D (Cognitive training) is a supportive management strategy that is used in patients with dementia (including vascular dementia) to help improve cognitive function or slow decline.\n\nStep 4: Final decision. Given that protective measures and risk factor modification are already in place for his vascular disease and that there is no established curative treatment for vascular dementia, the best next step is supportive management. Cognitive training is most appropriate among the options provided.\n\nFinal answer: D. Cognitive training",
            "This man\u2019s history and examination point to a gradually progressive cognitive decline with focal neurologic deficits in the setting of vascular risk factors. His presentation \u2013 with stepwise worsening of memory and gait after documented head trauma (i.e. bruising over the temple with falls) coupled with short\u2010term memory loss but preserved long\u2010term memory \u2013 is most consistent with a vascular dementia picture (such as can be seen in multi\u2010infarct dementia). His CT study (not shown here, but provided in the question) likely demonstrates findings supporting this clinical scenario. \n\nThe mainstay of management in vascular cognitive impairment is to reduce further vascular insults by optimizing blood pressure, lipids, and other risk factors. In addition, nonpharmacologic interventions such as cognitive training may help support function, especially since there is no single proven \u201ccure\u201d for vascular dementia. \n\nLet\u2019s briefly review why the other options are not correct:\n\n\u2022\u2003Warfarin therapy is an anticoagulant used for stroke prevention in settings like atrial fibrillation; however, there is no indication for anticoagulation here and it might even increase bleeding risk if there were any hemorrhagic tendencies.\n\n\u2022\u2003Vitamin E therapy has been studied as an antioxidant treatment in Alzheimer disease, but it is not standard therapy for a patient with this clinical picture.\n\n\u2022\u2003Tetrabenazine is used to treat the chorea seen in Huntington disease and is not applicable in this case.\n\nThus, among the provided options, the most appropriate next step in management is to employ nonpharmacologic interventions \u2013 such as cognitive training \u2013 alongside risk factor modification.\n\nFinal Answer: Cognitive training (Option D)."
        ],
        "ensemble_raw_responses": [
            "0",
            "0\n\nAnalyzing the case, the patient\u2019s history of repeated falls with a bruise over his temple, focal neurologic deficits (left\u2010sided weakness and a positive Babinski sign), and the CT scan (which is described but not shown) all point toward a chronic subdural hematoma. This lesion often presents in older adults after even minor head trauma and can lead to progressive, sometimes fluctuating, cognitive decline. Although some of the other candidate solutions leaned toward a diagnosis of vascular dementia, the presence of head trauma and focal neurological findings (in combination with the CT appearance) makes chronic subdural hematoma the more likely diagnosis. Appropriate management is urgent neurosurgical consultation for evacuation of the hematoma rather than any of the therapies listed in the answer options.\n\nThus, the best answer corresponds to candidate solution 0.",
            "2"
        ],
        "final_solution": "Step 1. Summarize the Case\n\n\u2022 A 67\u2010year\u2010old man has had gradually worsening cognitive impairment (short\u2010term memory loss), unsteady gait with falls, and now focal neurological signs (decreased strength and a positive Babinski sign on the left).  \n\u2022 There is a bruise over the left temple, and his history of falls in an elderly patient raises concern for head trauma.  \n\u2022 A CT scan of the head is provided. Although we cannot see it, the clinical picture strongly suggests an intracranial bleed.\n\nStep 2. Consider the Differential\n\nIn an elderly patient with a history of falls and gradual cognitive decline plus focal deficits, the most likely diagnosis is a chronic subdural hematoma. Its classic features include:\n\u2003\u2013 A history of minor head trauma or repeated falls\n\u2003\u2013 Gradual onset of cognitive or personality changes (e.g., memory impairment)\n\u2003\u2013 Focal neurologic deficits (e.g., weakness, abnormal reflexes)\n\u2003\u2013 CT imaging typically showing a crescent\u2010shaped collection tracking along the convexity\n\nStep 3. Relate to the Answer Options\n\nThe available answer options are:  \nA. Warfarin therapy  \nB. Vitamin E therapy  \nC. Tetrabenazine therapy  \nD. Cognitive training  \n\nExamine each choice:\n\u2022 Warfarin: An anticoagulant that would worsen bleeding risk in someone with a subdural hematoma.  \n\u2022 Vitamin E: An antioxidant that has been studied in Alzheimer\u2019s disease but is not useful in managing intracranial hemorrhage.  \n\u2022 Tetrabenazine: A drug used to treat chorea (as in Huntington\u2019s disease), not indicated here.  \n\u2022 Cognitive training: An adjunct for neurodegenerative disorders but not an appropriate treatment for a structural lesion causing the symptoms.\n\nNone of these options corresponds to the standard treatment for a chronic subdural hematoma, which is urgent neurosurgical evaluation for evacuation (often via burr hole drainage).\n\nStep 4. Final Answer\n\nBased on the patient\u2019s presentation and the likely CT findings consistent with a chronic subdural hematoma, the most appropriate next step is not any of the listed medical therapies but rather neurosurgical intervention.\n\nFinal Answer: None of the above \u2013 the patient requires an urgent neurosurgical evaluation for surgical evacuation of his chronic subdural hematoma."
    },
    {
        "realidx": 367,
        "question": "A 22-year-old gravida 1 presents to her physician at 15 weeks gestation for a prenatal appointment. She complains of a rash involving her chest, face, and arms, a watery nasal discharge, and mild bilateral knee pain. She has had these symptoms for about 5 days. The symptoms do not seem to bother her too much, but she is concerned for the baby. She had contact with her younger sister, who also had a rash and was diagnosed with rubella infection about 10 days ago at a family gathering. She cannot confirm her vaccination history. Her vital signs are as follows: blood pressure, 110/70 mmHg; heart rate, 89/min; respiratory rate, 12/min; and temperature, 37.6\u2103 (99.7\u2109). Examination shows a moderately dense maculopapular lacy rash spread over the patient\u2019s trunk, extremities, and face. No lymph node, liver, or spleen enlargement is noted. The knee joints appear normal.\nSerology performed 1 year ago Current serology\nRubella IgM - negative Rubella IgM - negative\nRubella IgG - 1:128 Rubella IgG - 1:64\nRubella IgG avidity - high Rubella IgG avidity - high\nWhat is the proper next step in the management of this woman?",
        "answer": "Recommend additional serologic testing for parvovirus B19",
        "options": {
            "A": "Reassure and recommend vaccination against rubella postpartum",
            "B": "Recommend pregnancy termination",
            "C": "Arrange a chorionic villus sampling",
            "D": "Recommend additional serologic testing for parvovirus B19"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old gravida 1 presents",
            "physician",
            "weeks gestation",
            "prenatal appointment",
            "rash involving",
            "chest",
            "face",
            "arms",
            "watery nasal discharge",
            "mild bilateral knee pain",
            "symptoms",
            "5 days",
            "symptoms",
            "not",
            "to",
            "too much",
            "concerned",
            "baby",
            "contact with",
            "younger sister",
            "rash",
            "diagnosed",
            "rubella infection",
            "10 days",
            "family",
            "confirm",
            "vaccination history",
            "vital signs",
            "follows",
            "blood pressure",
            "70 mmHg",
            "heart rate",
            "min",
            "respiratory rate",
            "min",
            "temperature",
            "99",
            "Examination shows",
            "moderately dense maculopapular lacy rash spread",
            "patients trunk",
            "extremities",
            "face",
            "lymph node",
            "liver",
            "spleen enlargement",
            "noted",
            "knee joints appear normal",
            "Serology performed 1 year",
            "Current serology Rubella IgM",
            "negative",
            "1",
            "Rubella",
            "64 Rubella",
            "avidity",
            "high",
            "next step",
            "management",
            "woman"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6381,
            "completion_tokens": 2831
        },
        "time_elapsed": 59.37731599807739,
        "raw_responses": [
            "Step 1: Review the case details.\n\u2022 The patient is a 22-year-old pregnant woman at 15 weeks gestation.\n\u2022 She presents with a maculopapular, lacy rash on her trunk, face, and extremities, along with mild nasal symptoms and knee pain.\n\u2022 She had contact with her sister, who was diagnosed with rubella.\n\u2022 Her rubella serologic tests show: \n\u2003 \u2013 Rubella IgM remains negative (both current and from 1 year ago).\n\u2003 \u2013 Rubella IgG is positive (though it decreased from 1:128 to 1:64) and shows high avidity, indicating past exposure/immunization.\n  \nStep 2: Analyze the serologic results.\n\u2022 Negative Rubella IgM and high-avidity IgG suggest that she is not experiencing an acute rubella infection.\n\u2022 The presence of Rubella IgG signifies prior immunity (from vaccination or a previous infection).\n\u2022 The high IgG avidity reinforces that the antibodies are from a past immune response rather than a recent infection.\n\nStep 3: Compare the options.\nA. Reassure and recommend vaccination against rubella postpartum.\n\u2003\u2013 This is appropriate because she is immune, and rubella vaccination is contraindicated during pregnancy but should be offered postpartum if she is not up to date.\nB. Recommend pregnancy termination.\n\u2003\u2013 This is not indicated because there is no evidence of an acute rubella infection.\nC. Arrange a chorionic villus sampling.\n\u2003\u2013 This invasive testing is unnecessary as there is no suspected congenital rubella syndrome.\nD. Recommend additional serologic testing for parvovirus B19.\n\u2003\u2013 Although parvovirus B19 can cause rash and joint pains in adults, the serologic picture fits rubella immunity, not an acute parvovirus infection.\n\nStep 4: Final Answer\nThe proper next step in management is to reassure the patient and recommend that she receive rubella vaccination postpartum.\n\nFinal Answer: A. Reassure and recommend vaccination against rubella postpartum.",
            "Step 1: Review the Patient's History and Presentation\n\u2022 The patient is 15 weeks pregnant and exposed to rubella from her sister, who was recently diagnosed.\n\u2022 She currently has mild symptoms (rash, nasal discharge, mild knee pain) which could be suggestive of a viral illness, but the physical exam and vital signs are unremarkable.\n\nStep 2: Analyze the Rubella Serologic Studies\n\u2022 The negative rubella IgM on both tests indicates no current acute infection.\n\u2022 The rubella IgG is present at significant titers (1:128 previously, 1:64 currently) and has high avidity. High IgG avidity indicates a remote infection or established immunity, not a recent seroconversion.\n\u2022 These results confirm that the patient has preexisting immunity to rubella.\n\nStep 3: Consider the Management Options\n\u2022 Option A (Reassure and recommend vaccination against rubella postpartum) is the correct approach because she already has immunity and should be vaccinated postpartum to ensure protection for future pregnancies.\n\u2022 Option B (Recommend pregnancy termination) is not warranted, as there is no evidence of acute rubella infection or fetal risk.\n\u2022 Option C (Arrange a chorionic villus sampling) is unnecessary since there is no indication of fetal abnormality or rubella-related complications.\n\u2022 Option D (Recommend additional serologic testing for parvovirus B19) is not indicated, as the presentation and serology are consistent with past rubella immunity rather than parvovirus B19 infection.\n\nFinal Answer: A. Reassure and recommend vaccination against rubella postpartum.",
            "Step 1: We note that while the patient reported rubella-like symptoms and recent contact with someone diagnosed with rubella, her serologic testing tells a different story. Her current rubella IgM is negative, which indicates that there is no evidence of an acute infection. Additionally, the presence of rubella IgG (even though the titer has decreased slightly, likely due to natural variation) coupled with high IgG avidity implies a past infection or immunization rather than a recent primary exposure. High-avidity IgG antibodies mean that the infection occurred long enough ago for the antibodies to mature, thereby excluding a recent primary rubella infection during pregnancy.\n\nStep 2: The other options serve different purposes:\n\u2022 Option B (Recommend pregnancy termination) would be considered only in confirmed cases of primary rubella infection with a high risk of congenital rubella syndrome, which is not the case here.\n\u2022 Option C (Arrange a chorionic villus sampling) is used for genetic or structural fetal abnormalities and is not indicated based on these findings.\n\u2022 Option D (Recommend additional serologic testing for parvovirus B19) is unrelated, as the patient\u2019s clinical picture and exposures are not suggestive of parvovirus; she has a rubella exposure history.\n\nStep 3: Therefore, the proper management is to reassure the patient that she is not at risk for congenital rubella syndrome given the serologic evidence of past immunity. Vaccination against rubella should be deferred until the postpartum period due to its contraindication during pregnancy.\n\nFinal Answer: A. Reassure and recommend vaccination against rubella postpartum."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Review the case details.\n\u2022 The patient is a 22-year-old pregnant woman at 15 weeks gestation.\n\u2022 She presents with a maculopapular, lacy rash on her trunk, face, and extremities, along with mild nasal symptoms and knee pain.\n\u2022 She had contact with her sister, who was diagnosed with rubella.\n\u2022 Her rubella serologic tests show: \n\u2003 \u2013 Rubella IgM remains negative (both current and from 1 year ago).\n\u2003 \u2013 Rubella IgG is positive (though it decreased from 1:128 to 1:64) and shows high avidity, indicating past exposure/immunization.\n  \nStep 2: Analyze the serologic results.\n\u2022 Negative Rubella IgM and high-avidity IgG suggest that she is not experiencing an acute rubella infection.\n\u2022 The presence of Rubella IgG signifies prior immunity (from vaccination or a previous infection).\n\u2022 The high IgG avidity reinforces that the antibodies are from a past immune response rather than a recent infection.\n\nStep 3: Compare the options.\nA. Reassure and recommend vaccination against rubella postpartum.\n\u2003\u2013 This is appropriate because she is immune, and rubella vaccination is contraindicated during pregnancy but should be offered postpartum if she is not up to date.\nB. Recommend pregnancy termination.\n\u2003\u2013 This is not indicated because there is no evidence of an acute rubella infection.\nC. Arrange a chorionic villus sampling.\n\u2003\u2013 This invasive testing is unnecessary as there is no suspected congenital rubella syndrome.\nD. Recommend additional serologic testing for parvovirus B19.\n\u2003\u2013 Although parvovirus B19 can cause rash and joint pains in adults, the serologic picture fits rubella immunity, not an acute parvovirus infection.\n\nStep 4: Final Answer\nThe proper next step in management is to reassure the patient and recommend that she receive rubella vaccination postpartum.\n\nFinal Answer: A. Reassure and recommend vaccination against rubella postpartum."
    },
    {
        "realidx": 380,
        "question": "A 70-year-old obese male presents to the emergency department with shortness of breath and cough of sudden onset. The patient states that his symptoms came on while he was sleeping. The patient has a past medical history of type II diabetes and is currently taking lisinopril, metformin, insulin, and fish oil. On physical exam, you note bipedal edema and jugular venous distention (JVD). An EKG and chest radiographs are obtained (Figures A and B). The patient is started on BIPAP and medical therapy and his symptoms improve rapidly. Lab values are as follows.\n\nSerum:\nNa+: 137 mEq/L\nK+: 3.2 mEq/L\nCl-: 100 mEq/L\nHCO3-: 31 mEq/L\nBUN: 20 mg/dL\nGlucose: 120 mg/dL\nCreatinine: 1.2 mg/dL\nCa2+: 10.9 mg/dL\n\nWhich of the following is the best explanation of this patient's current presentation?",
        "answer": "Hydrochlorothiazide",
        "options": {
            "A": "Furosemide",
            "B": "Hydrochlorothiazide",
            "C": "Renal tubular acidosis type II",
            "D": "Renal tubular acidosis type IV"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "70 year old obese male presents",
            "emergency department",
            "shortness of breath",
            "cough",
            "sudden onset",
            "patient states",
            "symptoms",
            "sleeping",
            "patient",
            "a past medical type II diabetes",
            "currently taking lisinopril",
            "metformin",
            "insulin",
            "fish oil",
            "physical exam",
            "note",
            "edema",
            "jugular venous distention",
            "EKG",
            "chest radiographs",
            "obtained",
            "patient",
            "started",
            "BIPAP",
            "medical therapy",
            "symptoms",
            "rapidly",
            "Lab values",
            "follows",
            "Serum",
            "Na",
            "137 mEq L K",
            "3.2 mEq/L Cl",
            "100 mEq/L HCO3",
            "31 mEq/L",
            "20 mg/dL Glucose",
            "mg/dL Creatinine",
            "1.2 mg/dL Ca2",
            "10 9 mg dL",
            "following",
            "best explanation",
            "patient's current presentation"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6057,
            "completion_tokens": 5121
        },
        "time_elapsed": 39.73515868186951,
        "raw_responses": [
            "Step 1: Recognize that this elderly patient with obesity, diabetes, and physical exam findings of bipedal edema and JVD has signs suggestive of congestive heart failure. His acute onset of shortness of breath, especially occurring while sleeping, is consistent with paroxysmal nocturnal dyspnea\u2014a feature of heart failure exacerbation.\n\nStep 2: Review the laboratory values. The potassium is low at 3.2 mEq/L and there is a high bicarbonate at 31 mEq/L, suggesting a metabolic alkalosis. One common cause of metabolic alkalosis with hypokalemia is the use of loop diuretics that lead to contraction alkalosis.\n\nStep 3: Evaluate the answer choices. \n\u2022 Choice A (Furosemide): As a loop diuretic, it is the mainstay treatment for acute decompensated heart failure. It causes loss of potassium, leading to hypokalemia and can cause metabolic alkalosis due to contraction alkalosis.\n\u2022 Choice B (Hydrochlorothiazide): While thiazide diuretics can also cause similar electrolyte disturbances, they are not favored in the setting of acute decompensated heart failure.\n\u2022 Choices C and D (Renal tubular acidosis type II and IV): Both of these conditions typically present with a metabolic acidosis (and in type IV, often with hyperkalemia), which does not match the lab findings in this patient.\n\nStep 4: Therefore, the best explanation for this patient's current presentation and lab findings (in the context of acute decompensated heart failure being managed in the emergency setting) is the use of Furosemide.\n\nFinal answer: A. Furosemide",
            "Step 1: Note the patient\u2019s clinical presentation. The 70\u2010year-old male presents with sudden onset shortness of breath and cough, combined with signs of volume overload (bipedal edema and JVD), suggesting acute decompensated heart failure. Treatment with BIPAP and rapid symptomatic improvement, along with his past history, also align with an acute heart failure event.\n\nStep 2: Examine the laboratory values. The labs show:\n\u2022 Potassium: 3.2 mEq/L (low, indicating hypokalemia)\n\u2022 Bicarbonate: 31 mEq/L (elevated, indicating metabolic alkalosis)\nThese findings are classic for the effects of diuretic therapy, particularly with loop diuretics.\n\nStep 3: Compare the options:\nA. Furosemide \u2013 A loop diuretic known to cause contraction alkalosis and hypokalemia as it promotes loss of sodium, chloride, and water, with a secondary increase in bicarbonate and loss of potassium.\nB. Hydrochlorothiazide \u2013 A thiazide diuretic can also cause hypokalemia and metabolic alkalosis, but loop diuretics are more commonly used in acute heart failure settings.\nC. Renal tubular acidosis type II \u2013 Typically causes a metabolic acidosis (with bicarbonate wasting), not alkalosis.\nD. Renal tubular acidosis type IV \u2013 Usually associated with hyperkalemia and metabolic acidosis, not hypokalemia and alkalosis.\n\nStep 4: Conclude based on the clinical scenario. In the context of acute decompensated heart failure, a loop diuretic like furosemide is commonly used to relieve volume overload. The lab abnormalities (metabolic alkalosis and hypokalemia) that are seen here are most consistent with furosemide use.\n\nFinal answer: A. Furosemide",
            "Step 1: Recognize that the patient\u2019s presentation (sudden shortness of breath, cough, bipedal edema, and JVD) is consistent with acute heart failure exacerbation. The rapid improvement with BIPAP and medical therapy supports this diagnosis.\n\nStep 2: Look at the labs: The serum potassium is low at 3.2 mEq/L (hypokalemia) and the bicarbonate is elevated at 31 mEq/L (metabolic alkalosis). These laboratory abnormalities are both seen as side effects of certain diuretics.\n\nStep 3: Consider the options:\n\u2022 Furosemide is a loop diuretic that is commonly used in the treatment of acute heart failure. It can cause hypokalemia and metabolic alkalosis due to increased renal excretion of potassium and contraction alkalosis.\n\u2022 Hydrochlorothiazide, a thiazide diuretic, can also cause similar electrolyte abnormalities, but it is less frequently used in the setting of acute heart failure exacerbations.\n\u2022 Renal tubular acidosis (RTA) type II causes metabolic acidosis along with hypokalemia, not alkalosis.\n\u2022 RTA type IV typically presents with hyperkalemia and metabolic acidosis.\n\nStep 4: Eliminate the conditions that conflict with the lab findings:\n\u2022 RTA types II and IV do not match the pattern of metabolic alkalosis and hypokalemia.\n\u2022 While hydrochlorothiazide can cause hypokalemia and metabolic alkalosis, it is not the typical choice in an acute decompensated heart failure scenario.\n\nFinal Answer: Furosemide\n\nThus, the best explanation for the patient\u2019s current lab abnormalities and presentation is related to his likely treatment with furosemide."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Recognize that this elderly patient with obesity, diabetes, and physical exam findings of bipedal edema and JVD has signs suggestive of congestive heart failure. His acute onset of shortness of breath, especially occurring while sleeping, is consistent with paroxysmal nocturnal dyspnea\u2014a feature of heart failure exacerbation.\n\nStep 2: Review the laboratory values. The potassium is low at 3.2 mEq/L and there is a high bicarbonate at 31 mEq/L, suggesting a metabolic alkalosis. One common cause of metabolic alkalosis with hypokalemia is the use of loop diuretics that lead to contraction alkalosis.\n\nStep 3: Evaluate the answer choices. \n\u2022 Choice A (Furosemide): As a loop diuretic, it is the mainstay treatment for acute decompensated heart failure. It causes loss of potassium, leading to hypokalemia and can cause metabolic alkalosis due to contraction alkalosis.\n\u2022 Choice B (Hydrochlorothiazide): While thiazide diuretics can also cause similar electrolyte disturbances, they are not favored in the setting of acute decompensated heart failure.\n\u2022 Choices C and D (Renal tubular acidosis type II and IV): Both of these conditions typically present with a metabolic acidosis (and in type IV, often with hyperkalemia), which does not match the lab findings in this patient.\n\nStep 4: Therefore, the best explanation for this patient's current presentation and lab findings (in the context of acute decompensated heart failure being managed in the emergency setting) is the use of Furosemide.\n\nFinal answer: A. Furosemide"
    },
    {
        "realidx": 413,
        "question": "A 56-year-old man with a history of pancreatic cancer presents to the surgical intensive care unit following a pancreaticoduodenectomy. Over the next 3 days, the patient's drainage output is noted to exceed 1 liter per day. In the early morning of postoperative day 4, the nurse states that the patient is difficult to arouse. His temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 107/88 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. His skin and mucous membranes are dry on physical exam. Laboratory values are ordered as seen below.\n\nSerum:\nNa+: 154 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 27 mEq/L\nBUN: 20 mg/dL\nGlucose: 99 mg/dL\nCreatinine: 1.1 mg/dL\n\nWhich of the following is the best next step in management?",
        "answer": "0.9% saline IV",
        "options": {
            "A": "0.9% saline IV",
            "B": "5% dextrose IV",
            "C": "5% dextrose IV with 0.45% saline IV",
            "D": "Oral free water replacement"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "history of pancreatic cancer presents",
            "surgical intensive care unit following",
            "pancreaticoduodenectomy",
            "next",
            "days",
            "patient's drainage output",
            "noted to",
            "1 liter per day",
            "early morning",
            "postoperative day 4",
            "nurse states",
            "patient",
            "difficult",
            "temperature",
            "99",
            "blood pressure",
            "88 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "skin",
            "mucous membranes",
            "dry",
            "physical exam",
            "Laboratory values",
            "ordered",
            "seen",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4",
            "mEq/L HCO3",
            "27 mEq/L",
            "20 mg/dL Glucose",
            "99 mg/dL Creatinine",
            "1.1 mg/dL",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5688,
            "completion_tokens": 4726
        },
        "time_elapsed": 35.3632071018219,
        "raw_responses": [
            "Step 1: Recognize the clinical scenario.\n\u2022 The patient, post\u2013pancreaticoduodenectomy, has high output from his surgical drains (>1 liter per day) which can lead to significant fluid loss.\n\u2022 On postoperative day 4, the patient is minimally responsive with signs of dehydration (dry mucous membranes, tachycardia) and elevated serum sodium (154 mEq/L), consistent with hypernatremia.\n\nStep 2: Understand the implications.\n\u2022 The hypernatremia is due to an excess loss of free water relative to sodium\u2014a common occurrence with high-output drains.\n\u2022 The patient is likely hypovolemic and has a relative deficit of free water. Oral replacement isn\u2019t feasible since the patient is difficult to arouse.\n\nStep 3: Compare the management options.\nA. 0.9% saline IV \u2013 This isotonic fluid does not provide free water; it would not correct the hypernatremia and may further sustain the relative free water deficit.\nB. 5% dextrose IV \u2013 5% dextrose essentially becomes free water once the dextrose is metabolized; however, if the patient is also hypovolemic, using only free water might not adequately restore intravascular volume.\nC. 5% dextrose IV with 0.45% saline IV \u2013 This combination provides hypotonic fluid, which supplies free water to help correct hypernatremia while also contributing some sodium to support the intravascular volume.\nD. Oral free water replacement \u2013 Given the patient\u2019s altered mental status, oral administration isn\u2019t safe or feasible.\n\nStep 4: Final Answer.\nThe best next step in management is to administer 5% dextrose IV with 0.45% saline IV.\n\nFinal Answer: C. 5% dextrose IV with 0.45% saline IV",
            "Step 1: Recognize that the patient is exhibiting signs of dehydration (dry mucous membranes, tachycardia) in the setting of significant postoperative drainage (>1 L/day), which is causing a free water deficit. His hypernatremia (Na\u207a 154 mEq/L) confirms this.\n\nStep 2: Identify that free water loss should be replaced with hypotonic fluids to gradually lower his serum sodium. Although 0.9% saline is isotonic, it would not correct his deficit in free water and could worsen his hypernatremia. Oral free water replacement (Option D) is not advisable in an obtunded patient. Combining 5% dextrose with 0.45% saline (Option C) provides some free water but is unnecessary when pure free water via IV (5% dextrose) is both effective and appropriate.\n\nStep 3: The best choice is therefore 5% dextrose IV, which delivers free water once the dextrose is metabolized, allowing for a gradual correction of the hypernatremia.\n\nFinal Answer: 5% dextrose IV (Option B).",
            "Step-by-Step Reasoning:\n\n1. The patient is postoperative day 4 after a pancreaticoduodenectomy with high output from the drainage (>1 liter per day). This significant loss of fluids, which likely contain electrolytes and water, has led to dehydration.\n\n2. The laboratory results show hypernatremia (Na+: 154 mEq/L), which indicates a deficit of free water relative to sodium. This scenario is consistent with dehydration causing hypertonic hypernatremia.\n\n3. The patient\u2019s physical exam (dry skin and mucous membranes) and altered mental status (difficult to arouse) further support the diagnosis of dehydration.\n\n4. Considering fluid replacement options:\n\u2003\u2022 Option A (0.9% saline) is isotonic and does not provide free water; in fact, it could worsen hypernatremia.\n\u2003\u2022 Option B (5% dextrose IV) provides free water after dextrose metabolism but might not be sufficient for the volume deficit.\n\u2003\u2022 Option C (5% dextrose IV with 0.45% saline infusion) provides a hypotonic solution, which delivers free water to correct the hypernatremia while also partially replacing electrolytes. This option helps gradually correct the hypernatremia.\n\u2003\u2022 Option D (oral free water replacement) is not ideal due to the patient's altered mental status, which poses a risk for aspiration.\n\n5. Therefore, the best next step in management is to start intravenous hypotonic fluids to replace the free water deficit while addressing the electrolyte imbalance.\n\nFinal Answer: C. 5% dextrose IV with 0.45% saline IV"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Recognize the clinical scenario.\n\u2022 The patient, post\u2013pancreaticoduodenectomy, has high output from his surgical drains (>1 liter per day) which can lead to significant fluid loss.\n\u2022 On postoperative day 4, the patient is minimally responsive with signs of dehydration (dry mucous membranes, tachycardia) and elevated serum sodium (154 mEq/L), consistent with hypernatremia.\n\nStep 2: Understand the implications.\n\u2022 The hypernatremia is due to an excess loss of free water relative to sodium\u2014a common occurrence with high-output drains.\n\u2022 The patient is likely hypovolemic and has a relative deficit of free water. Oral replacement isn\u2019t feasible since the patient is difficult to arouse.\n\nStep 3: Compare the management options.\nA. 0.9% saline IV \u2013 This isotonic fluid does not provide free water; it would not correct the hypernatremia and may further sustain the relative free water deficit.\nB. 5% dextrose IV \u2013 5% dextrose essentially becomes free water once the dextrose is metabolized; however, if the patient is also hypovolemic, using only free water might not adequately restore intravascular volume.\nC. 5% dextrose IV with 0.45% saline IV \u2013 This combination provides hypotonic fluid, which supplies free water to help correct hypernatremia while also contributing some sodium to support the intravascular volume.\nD. Oral free water replacement \u2013 Given the patient\u2019s altered mental status, oral administration isn\u2019t safe or feasible.\n\nStep 4: Final Answer.\nThe best next step in management is to administer 5% dextrose IV with 0.45% saline IV.\n\nFinal Answer: C. 5% dextrose IV with 0.45% saline IV"
    },
    {
        "realidx": 423,
        "question": "A 27-year-old woman presents to the emergency department with acute onset bloody diarrhea. The patient has had severe abdominal pain throughout her entire life with occasional episodes of bloody diarrhea. She has recently lost 7 pounds and has felt generally ill for the past 2 days. She has a past medical history of generalized seizures with her most recent one having occurred 5 days ago. One month ago, the patient was treated for impetigo. The patient admits to occasional cocaine use and binge drinking. Her temperature is 98.7\u00b0F (37.1\u00b0C), blood pressure is 107/58 mmHg, pulse is 127/min, respirations are 16/min, and oxygen saturation is 99% on room air. Physical exam is notable for diffuse abdominal tenderness and guaiac positive stools. Laboratory values are ordered as seen below.\n\nHemoglobin: 9 g/dL\nHematocrit: 30%\nLeukocyte count: 9,400/mm^3 with normal differential\nPlatelet count: 199,000/mm^3\n\nSerum:\nNa+: 139 mEq/L\nCl-: 101 mEq/L\nK+: 4.9 mEq/L\nHCO3-: 25 mEq/L\nBUN: 37 mg/dL\nGlucose: 99 mg/dL\nCreatinine: 1.8 mg/dL\nAST: 62 U/L\nALT: 80 U/L\nBlood alcohol: .15 g/dL\n\nUrine:\nColor: Yellow\nProtein: Positive\nCocaine: Positive\nMarijuana: Positive\n\nWhich of the following is the best explanation for this patient's laboratory findings?",
        "answer": "Protein deposition",
        "options": {
            "A": "Alcohol-induced liver injury",
            "B": "Immune response to streptococcal infection",
            "C": "Intestinal IgA deficiency",
            "D": "Protein deposition"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "27 year old woman presents",
            "emergency department",
            "acute onset bloody diarrhea",
            "patient",
            "severe abdominal",
            "entire life",
            "occasional episodes of bloody diarrhea",
            "recently lost",
            "pounds",
            "felt",
            "ill",
            "past 2 days",
            "past medical generalized seizures",
            "most recent one",
            "occurred 5 days",
            "One month",
            "patient",
            "treated",
            "impetigo",
            "patient admits",
            "occasional cocaine use",
            "binge drinking",
            "temperature",
            "98",
            "blood pressure",
            "58 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "99",
            "room air",
            "Physical exam",
            "notable",
            "diffuse abdominal tenderness",
            "guaiac positive stools",
            "Laboratory values",
            "ordered",
            "seen",
            "Hemoglobin",
            "g/dL Hematocrit",
            "30",
            "Leukocyte count",
            "400 mm",
            "normal differential Platelet count",
            "mm",
            "Serum",
            "Na",
            "mEq/L Cl",
            "mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L",
            "mg/dL Glucose",
            "99 mg/dL Creatinine",
            "1.8 mg/dL AST",
            "62 U/L ALT",
            "80 U/L Blood alcohol",
            "g/dL",
            "Urine",
            "Color",
            "Yellow Protein",
            "Positive Cocaine",
            "Positive Marijuana",
            "Positive",
            "following",
            "best explanation",
            "patient's laboratory findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 7986,
            "completion_tokens": 13189
        },
        "time_elapsed": 86.66539597511292,
        "raw_responses": [
            "Step 1: Identify the Key Historical and Laboratory Clues\n\u2022 The patient reports lifelong episodes of severe abdominal pain with occasional bloody diarrhea and recent weight loss. These clues point to a longstanding inflammatory bowel process.\n\u2022 Her laboratory findings include anemia, elevated BUN and creatinine, and protein in her urine\u2014all of which indicate renal dysfunction.\n\u2022 Notably, she had impetigo about 1 month ago and a history of seizures, but these are red herrings compared to her chronic gastrointestinal complaints.\n\nStep 2: Consider How Chronic Inflammation Can Affect the Kidneys\n\u2022 Inflammatory bowel diseases (IBD) such as ulcerative colitis (or Crohn\u2019s disease) frequently present with recurrent bloody diarrhea and abdominal pain.\n\u2022 A well\u2010recognized complication of long-standing inflammatory conditions is secondary (AA) amyloidosis. In this process, chronic inflammation leads to overproduction of serum amyloid A protein, which eventually misfolds and deposits as amyloid fibrils in various organs, most notably the kidneys. This deposition manifests as proteinuria and progressive renal dysfunction.\n\nStep 3: Evaluate the Answer Choices\nA. Alcohol-induced liver injury \n\u2003\u2003\u2013 Although her blood alcohol level is elevated, the liver enzyme abnormalities are only mildly elevated and do not explain the kidney injury or chronic GI symptoms.\nB. Immune response to streptococcal infection \n\u2003\u2003\u2013 While post\u2013streptococcal glomerulonephritis occurs after infections like impetigo, the timing, age, and clinical picture (especially chronic GI issues) are not typical. Also, PSGN usually presents with hypertension and hypocomplementemia.\nC. Intestinal IgA deficiency \n\u2003\u2003\u2013 This condition predisposes to infections but does not account for kidney injury or a chronic history of bloody diarrhea.\nD. Protein deposition \n\u2003\u2003\u2013 This refers to the deposition of misfolded proteins such as amyloid in tissues. In patients with long-standing inflammatory diseases (like ulcerative colitis), secondary amyloidosis (AA amyloid deposition) can develop, resulting in renal proteinuria and kidney dysfunction.\n\nStep 4: Final Answer\nThe best explanation for her laboratory findings is chronic inflammation from her likely inflammatory bowel disease leading to AA amyloidosis (protein deposition) affecting the kidneys.\n\nFinal Answer: D. Protein deposition",
            "Step 1: Look at the patient\u2019s history and presentation.\n\u2022 The patient is a 27\u2010year\u2010old woman with a lifelong history of severe abdominal pain and episodes of bloody diarrhea. This pattern strongly suggests an underlying chronic inflammatory bowel disease (IBD), such as ulcerative colitis.\n\u2022 She now presents with acute onset bloody diarrhea, weight loss, and malaise\u2014likely a flare of her chronic condition.\n\u2022 In addition, her labs show anemia (hemoglobin 9 g/dL) consistent with chronic blood loss, and signs of renal dysfunction (elevated BUN and creatinine) with protein present in the urine.\n\nStep 2: Examine the laboratory abnormalities.\n\u2022 The elevated BUN (37 mg/dL) and creatinine (1.8 mg/dL) denote kidney injury.\n\u2022 The protein-positive urine indicates a proteinuric process.\n\u2022 These findings, in the setting of a chronic inflammatory disease, are suggestive of a renal complication from the underlying disorder.\n\nStep 3: Integrate the chronic inflammatory state with the renal findings.\n\u2022 Chronic inflammatory conditions (such as IBD) can give rise to secondary (AA) amyloidosis. With prolonged inflammation, serum amyloid A protein is overproduced, and it may deposit in various tissues. In the kidney, amyloid deposition leads to proteinuria and progressive renal dysfunction.\n\u2022 This \u201cprotein deposition\u201d best explains the findings of protein-positive urine and renal impairment in a patient with a history consistent with chronic IBD.\n\nStep 4: Evaluate the answer choices.\nA. Alcohol-induced liver injury \u2013 Not consistent because the patient\u2019s liver enzymes, while slightly elevated, do not match the pattern expected (and her clinical picture centers on chronic abdominal issues and renal impairment).\nB. Immune response to streptococcal infection \u2013 Although she had impetigo one month ago, post-streptococcal glomerulonephritis generally presents with hypertension, edema, and is less plausible in the context of a lifelong history of bloody diarrhea.\nC. Intestinal IgA deficiency \u2013 Not associated with the renal findings and chronic bloody diarrhea described in this patient.\nD. Protein deposition \u2013 This choice refers to the deposition of amyloid protein in the kidneys (secondary amyloidosis) as a complication of a chronic inflammatory process, which matches her clinical scenario.\n\nFinal Answer: D. Protein deposition",
            "Step 1: Key Points from the Clinical Presentation\n\u2022 The patient is a 27\u2010year\u2010old woman with a history of lifelong, severe abdominal pain and episodic bloody diarrhea. This chronic gastrointestinal history raises suspicion for an underlying inflammatory process.\n\u2022 She now presents with acute onset bloody diarrhea, weight loss, and signs of systemic illness.\n\u2022 She has laboratory evidence of kidney impairment (elevated BUN at 37 mg/dL and creatinine at 1.8 mg/dL) and protein on urine analysis.\n\u2022 Relevant past history includes a recent impetigo infection and generalized seizures.\n\nStep 2: Interpreting the Laboratory Findings in Context\n\u2022 The findings of proteinuria and kidney dysfunction suggest a glomerular pathology.\n\u2022 In patients with chronic gastrointestinal inflammation (e.g., inflammatory bowel disease), one known kidney complication is IgA nephropathy. This condition is characterized by the deposition of IgA immune complexes (proteins) in the mesangium of the kidneys.\n\u2022 The mention of a prior skin infection (impetigo) might lead one to consider post-streptococcal glomerulonephritis. However, the patient\u2019s lifelong GI symptoms and the laboratory picture do not fit the classic presentation of post-streptococcal glomerulonephritis.\n\nStep 3: Analyzing the Options\nA. Alcohol-induced liver injury \u2013 Although the patient has a positive blood alcohol level, alcohol-induced liver injury doesn\u2019t account for her kidney findings (proteinuria and elevated creatinine).\nB. Immune response to streptococcal infection \u2013 While a recent impetigo could potentially trigger a post-streptococcal process, the clinical presentation (lifelong GI issues) and laboratory data are not typical for post-streptococcal glomerulonephritis.\nC. Intestinal IgA deficiency \u2013 IgA deficiency is associated with recurrent sinopulmonary infections and certain gastrointestinal disorders, but it does not lead to protein deposition in the kidneys.\nD. Protein deposition \u2013 This option represents the mechanism underlying IgA nephropathy (Berger disease), where IgA immune complexes deposit in the glomeruli. Given the patient\u2019s history of chronic abdominal pain and bloody diarrhea (suggesting an inflammatory gastrointestinal process) combined with new kidney findings, this is the most likely explanation.\n\nStep 4: Final Answer\nThe best explanation for her laboratory findings is immune complex deposition in the kidney, as seen with IgA nephropathy. Therefore, the answer is:\n\nD. Protein deposition"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify the Key Historical and Laboratory Clues\n\u2022 The patient reports lifelong episodes of severe abdominal pain with occasional bloody diarrhea and recent weight loss. These clues point to a longstanding inflammatory bowel process.\n\u2022 Her laboratory findings include anemia, elevated BUN and creatinine, and protein in her urine\u2014all of which indicate renal dysfunction.\n\u2022 Notably, she had impetigo about 1 month ago and a history of seizures, but these are red herrings compared to her chronic gastrointestinal complaints.\n\nStep 2: Consider How Chronic Inflammation Can Affect the Kidneys\n\u2022 Inflammatory bowel diseases (IBD) such as ulcerative colitis (or Crohn\u2019s disease) frequently present with recurrent bloody diarrhea and abdominal pain.\n\u2022 A well\u2010recognized complication of long-standing inflammatory conditions is secondary (AA) amyloidosis. In this process, chronic inflammation leads to overproduction of serum amyloid A protein, which eventually misfolds and deposits as amyloid fibrils in various organs, most notably the kidneys. This deposition manifests as proteinuria and progressive renal dysfunction.\n\nStep 3: Evaluate the Answer Choices\nA. Alcohol-induced liver injury \n\u2003\u2003\u2013 Although her blood alcohol level is elevated, the liver enzyme abnormalities are only mildly elevated and do not explain the kidney injury or chronic GI symptoms.\nB. Immune response to streptococcal infection \n\u2003\u2003\u2013 While post\u2013streptococcal glomerulonephritis occurs after infections like impetigo, the timing, age, and clinical picture (especially chronic GI issues) are not typical. Also, PSGN usually presents with hypertension and hypocomplementemia.\nC. Intestinal IgA deficiency \n\u2003\u2003\u2013 This condition predisposes to infections but does not account for kidney injury or a chronic history of bloody diarrhea.\nD. Protein deposition \n\u2003\u2003\u2013 This refers to the deposition of misfolded proteins such as amyloid in tissues. In patients with long-standing inflammatory diseases (like ulcerative colitis), secondary amyloidosis (AA amyloid deposition) can develop, resulting in renal proteinuria and kidney dysfunction.\n\nStep 4: Final Answer\nThe best explanation for her laboratory findings is chronic inflammation from her likely inflammatory bowel disease leading to AA amyloidosis (protein deposition) affecting the kidneys.\n\nFinal Answer: D. Protein deposition"
    },
    {
        "realidx": 448,
        "question": "A 69-year-old male with a longstanding history of hypertension and high cholesterol presents with abdominal pain and \u2018bruising on his feet\u2019. The patient states that his symptoms started about a week ago and have steadily worsened. He describes the abdominal pain as mild to moderate, dull, and deeply localized to the umbilical region. Past medical history is significant for 2 transient ischemic attacks 6 months prior, characterized by a sudden right-sided weakness and trouble speaking but recovered fully within 30 minutes. Current medications are sildenafil 100 mg orally as needed. Patient reports a 30-pack-year smoking history and heavy alcohol use on the weekends. Review of systems is significant for decreased appetite and feeling easily full. Vitals are temperature 37\u00b0C (98.6\u00b0F), blood pressure 155/89 mm Hg, pulse 89/min, respirations 16/min, and oxygen saturation 98% on room air. On physical examination, the patient is alert and cooperative. The cardiac exam is normal. Lungs are clear to auscultation. Carotid bruit present on the right. The abdomen is soft and nontender. Bowel sounds present. A pulsatile abdominal mass is felt in the lower umbilical region. Patient\u2019s feet have the following appearance seen in the picture. Abdominal ultrasound reveals the presence of an abdominal aortic aneurysm (AAA). Contrast CT reveals a small, unruptured AAA (diameter 4.1 cm). High flow supplemental oxygen and fluid resuscitation are initiated. Morphine sulfate and metoprolol are administered. Which of the following is the best course of treatment for this patient?\n ",
        "answer": "Emergency open surgical repair",
        "options": {
            "A": "Discharge with clinical surveillance and ultrasound every 6 months",
            "B": "Elective endovascular repair",
            "C": "Elective open surgical repair",
            "D": "Emergency open surgical repair"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "69 year old male",
            "history of hypertension",
            "high cholesterol presents",
            "abdominal pain",
            "bruising",
            "feet",
            "patient states",
            "symptoms started",
            "week",
            "worsened",
            "abdominal",
            "mild to moderate",
            "dull",
            "deeply localized",
            "umbilical region",
            "Past medical history",
            "significant",
            "transient ischemic attacks",
            "months prior",
            "characterized",
            "sudden right-sided weakness",
            "speaking",
            "recovered",
            "30 minutes",
            "Current medications",
            "sildenafil 100 mg orally",
            "needed",
            "Patient reports",
            "30 pack-year smoking history",
            "heavy alcohol use",
            "weekends",
            "Review of systems",
            "significant",
            "decreased appetite",
            "feeling easily full",
            "temperature",
            "98",
            "blood pressure",
            "mm Hg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation 98",
            "room air",
            "physical examination",
            "patient",
            "alert",
            "cooperative",
            "cardiac exam",
            "normal",
            "Lungs",
            "clear",
            "auscultation",
            "Carotid bruit present",
            "right",
            "abdomen",
            "soft",
            "nontender",
            "Bowel sounds present",
            "pulsatile abdominal mass",
            "felt",
            "lower umbilical region",
            "Patients feet",
            "following appearance seen",
            "picture",
            "Abdominal ultrasound reveals",
            "presence of",
            "abdominal aortic aneurysm",
            "Contrast CT reveals",
            "small",
            "diameter",
            "High flow supplemental oxygen",
            "fluid resuscitation",
            "initiated",
            "Morphine sulfate",
            "metoprolol",
            "administered",
            "following",
            "best course",
            "treatment",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5922,
            "completion_tokens": 3767
        },
        "time_elapsed": 71.51071381568909,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s presentation and workup. The 69\u2010year\u2010old man with abdominal pain has a palpable pulsatile abdominal mass, and imaging studies (ultrasound followed by contrast CT) reveal an abdominal aortic aneurysm (AAA) measuring 4.1 cm in diameter. His symptoms are relatively mild, with no evidence of rupture.\n\nStep 2: Consider standard management guidelines for AAAs. In men, elective repair of an asymptomatic abdominal aortic aneurysm is generally recommended when the diameter exceeds 5.5 cm. Since his aneurysm is 4.1 cm, it falls below the threshold for surgical intervention, making surveillance the appropriate choice. The patient\u2019s foot findings (bruising) are noted but do not change the management of a small, stable AAA.\n\nStep 3: Evaluate the treatment options:\n\u2022 Option A \u2013 Discharge with clinical surveillance and ultrasound every 6 months: This is the proper management for an AAA <5.5 cm in a male patient, as serial imaging is used to monitor the aneurysm for expansion.\n\u2022 Option B \u2013 Elective endovascular repair: This is reserved for aneurysms meeting size criteria or if the aneurysm is symptomatic in a concerning manner.\n\u2022 Option C \u2013 Elective open surgical repair: Similarly, this is for larger or symptomatic aneurysms requiring repair.\n\u2022 Option D \u2013 Emergency open surgical repair: This is indicated only in the setting of a ruptured or acutely unstable aneurysm.\n\nStep 4: Decide the best course of action. With a 4.1 cm AAA and no features suggesting imminent rupture, the correct management is surveillance.\n\nFinal answer: A. Discharge with clinical surveillance and ultrasound every 6 months.",
            "Step 1: Recognize that the patient has an abdominal aortic aneurysm (AAA) with a measured diameter of 4.1 cm, which is below the surgical threshold. In men, surgical repair is generally recommended for AAAs that are larger than 5.5 cm in diameter or if they are rapidly expanding.\n\nStep 2: Evaluate the management options:\n\u2022 Option A (Discharge with clinical surveillance and ultrasound every 6 months) is appropriate since the AAA is small and unruptured.\n\u2022 Options B (Elective endovascular repair), C (Elective open surgical repair), and D (Emergency open surgical repair) are reserved for larger aneurysms (typically >5.5 cm) or ruptured aneurysms.\n\nStep 3: Therefore, the best course of treatment for this patient is to discharge him with clinical surveillance and periodic ultrasound evaluations.\n\nFinal Answer: A. Discharge with clinical surveillance and ultrasound every 6 months",
            "Step 1: Evaluate the patient's presentation and imaging findings. The patient is a 69-year-old male with risk factors, and his imaging reveals an abdominal aortic aneurysm (AAA) measuring 4.1 cm in diameter. Although he has some symptoms (abdominal pain and \u201cbruising on his feet\u201d), these are not indicative of a ruptured aneurysm, and the aneurysm is considered small according to current guidelines (elective repair is typically reserved for AAAs >5.5 cm in men).\n\nStep 2: Compare the treatment options.\n\u2022 Option A: Discharge with clinical surveillance and ultrasound every 6 months \u2013 This is the standard management for a small, unruptured AAA (<5.5 cm) in men.\n\u2022 Option B and C: Elective endovascular repair or elective open surgical repair \u2013 These interventions are generally reserved for larger AAAs where the rupture risk is higher.\n\u2022 Option D: Emergency open surgical repair \u2013 This is indicated in the case of a ruptured AAA, which is not the scenario here.\n\nStep 3: Final Answer.\nBased on the above reasoning, the best course of treatment for this patient is:\n\nAnswer: A. Discharge with clinical surveillance and ultrasound every 6 months."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Recognize that the patient has an abdominal aortic aneurysm (AAA) with a measured diameter of 4.1 cm, which is below the surgical threshold. In men, surgical repair is generally recommended for AAAs that are larger than 5.5 cm in diameter or if they are rapidly expanding.\n\nStep 2: Evaluate the management options:\n\u2022 Option A (Discharge with clinical surveillance and ultrasound every 6 months) is appropriate since the AAA is small and unruptured.\n\u2022 Options B (Elective endovascular repair), C (Elective open surgical repair), and D (Emergency open surgical repair) are reserved for larger aneurysms (typically >5.5 cm) or ruptured aneurysms.\n\nStep 3: Therefore, the best course of treatment for this patient is to discharge him with clinical surveillance and periodic ultrasound evaluations.\n\nFinal Answer: A. Discharge with clinical surveillance and ultrasound every 6 months"
    },
    {
        "realidx": 452,
        "question": "A 37-year-old man comes to the emergency department with the chief complaint of a high fever for several days. In addition to the fever, he has had malaise, chest pain, and a dry cough. He recently went on vacation to South America but has returned to his job delivering packages. He has several friends who recently had influenza. Hi temperature is 102.8\u00b0F (39.3 \u00b0C), blood pressure is 137/80 mmHg, pulse is 104/min, respirations are 19/min, and oxygen saturation is 98%. Chest exam reveals a deep noise found bilaterally in the lung bases. Chest radiograph reveals a wider area of opacity near the heart and bilateral lung infiltrates. Which of the following is characteristic of the most likely organism responsible for this patient's symptoms?",
        "answer": "D-glutamate capsule",
        "options": {
            "A": "Cultured on charcoal and yeast",
            "B": "D-glutamate capsule",
            "C": "Found in desert sand",
            "D": "Polyribosyl-ribitol-phosphate capsule"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old man",
            "emergency department",
            "chief complaint",
            "high fever",
            "several days",
            "fever",
            "malaise",
            "chest pain",
            "dry cough",
            "recently",
            "vacation",
            "South America",
            "returned",
            "job delivering packages",
            "several friends",
            "recently",
            "influenza",
            "Hi temperature",
            "blood pressure",
            "80 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "Chest exam reveals",
            "deep noise found",
            "lung bases",
            "Chest radiograph reveals",
            "wider area",
            "opacity",
            "heart",
            "bilateral lung infiltrates",
            "following",
            "characteristic",
            "likely organism responsible",
            "patient's symptoms"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5709,
            "completion_tokens": 7097
        },
        "time_elapsed": 54.031938314437866,
        "raw_responses": [
            "Step 1: Analyze the clinical picture.  \n\u2022 The patient presents with a high fever, malaise, chest pain, and a dry cough.  \n\u2022 His chest radiograph shows an opacity near the heart and bilateral lung infiltrates, which is suggestive of an atypical pneumonia rather than the classic lobar pneumonia picture.  \n\u2022 His history of recent travel to South America and contact with friends who have had influenza raise the possibility of an atypical pathogen.  \n\nStep 2: Consider the potential etiologic agents.  \n\u2022 Atypical pneumonia is commonly caused by organisms such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila.  \n\u2022 Legionella is known for causing a pneumonia with high fever and bilateral infiltrates. Although gastrointestinal symptoms sometimes accompany Legionella infection, they are not always present.  \n\nStep 3: Evaluate the answer choices.  \nA. Cultured on charcoal and yeast  \n\u2003\u2003\u2013 This description refers to Legionella pneumophila, which is cultured on buffered charcoal yeast extract (BCYE) agar.  \nB. D-glutamate capsule  \n\u2003\u2003\u2013 This capsule composition characterizes Bacillus anthracis.  \nC. Found in desert sand  \n\u2003\u2003\u2013 This clue points toward organisms like Coccidioides immitis, which is endemic to desert regions (primarily in the southwestern U.S.), not typical for South America travel.  \nD. Polyribosyl-ribitol-phosphate capsule  \n\u2003\u2003\u2013 This capsule is characteristic of Haemophilus influenzae type b.\n\nStep 4: Determine the correct answer.  \nGiven the clinical findings and the specific culture medium clue, the most likely organism is Legionella pneumophila, which is best cultured on charcoal and yeast extract medium.\n\nFinal answer: A. Cultured on charcoal and yeast.",
            "Step 1: Review the clinical scenario.  \n\u2022 The patient is a 37\u2010year\u2010old man with several days of high fever (102.8\u00b0F/39.3\u00b0C), malaise, chest pain, and a dry cough.  \n\u2022 He recently traveled to South America, suggesting possible exposure to environmental pathogens from hotels or contaminated water sources.  \n\u2022 His exam is notable for bilateral lung findings and a chest radiograph showing an opacity in the perihilar region with bilateral infiltrates.  \n\nStep 2: Analyze the options based on known microbiologic characteristics.  \n\u2022 Option A: \u201cCultured on charcoal and yeast\u201d refers to an organism that grows on buffered charcoal yeast extract agar \u2013 the classic culture medium for Legionella pneumophila. Legionella is known to cause pneumonia (often with high fever and a dry cough) and is associated with recent travel and hotel stays.  \n\u2022 Option B: \u201cD-glutamate capsule\u201d is characteristic of Bacillus anthracis, which typically causes inhalational anthrax with mediastinal widening and a rapidly severe course\u2014not fitting this patient\u2019s presentation.  \n\u2022 Option C: \u201cFound in desert sand\u201d is suggestive of an organism like Coccidioides immitis, which is endemic to certain desert areas of the Southwestern United States and parts of Central America, but the clinical presentation and travel history here are more supportive of another diagnosis.  \n\u2022 Option D: \u201cPolyribosyl\u2010ribitol\u2010phosphate capsule\u201d is the capsule of Haemophilus influenzae type b, an organism that is less likely to cause pneumonia in a healthy 37\u2010year\u2010old.\n\nStep 3: Compare and eliminate.  \n\u2022 Option B is inconsistent with the clinical picture of inhalational anthrax.  \n\u2022 Option C does not match the typical geography or presentation.  \n\u2022 Option D describes a pathogen usually involving pediatric infections (or adults with compromised immune status) rather than this patient.  \n\u2022 Option A appropriately describes Legionella pneumophila, which is cultured on charcoal yeast extract agar.\n\nFinal Answer: Option A \u2013 Cultured on charcoal and yeast.",
            "Step 1: Recognize that the patient\u2019s presentation is consistent with an atypical pneumonia. The symptoms (high fever, malaise, chest pain, dry cough) along with the radiograph finding of bilateral infiltrates with a perihilar distribution suggest an atypical pathogen.\n\nStep 2: Note the travel history to South America, which can be associated with exposures to various environmental pathogens. However, the key detail in the answer choices is option A: \"Cultured on charcoal and yeast.\" This is a hallmark of Legionella pneumophila, which is classically grown on buffered charcoal yeast extract (BCYE) agar.\n\nStep 3: Compare the other choices:\n\u2022 D. \"Polyribosyl-ribitol-phosphate capsule\" is characteristic of Haemophilus influenzae type b.\n\u2022 B. \"D\u2010glutamate capsule\" is seen in Bacillus anthracis.\n\u2022 C. \"Found in desert sand\" is more suggestive of organisms like Coccidioides immitis.\nThus, they do not match the clinical picture.\n\nStep 4: Conclude that the most likely organism is Legionella pneumophila, which is best characterized by its growth on buffered charcoal yeast extract agar.\n\nFinal Answer: A. Cultured on charcoal and yeast"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Review the clinical scenario.  \n\u2022 The patient is a 37\u2010year\u2010old man with several days of high fever (102.8\u00b0F/39.3\u00b0C), malaise, chest pain, and a dry cough.  \n\u2022 He recently traveled to South America, suggesting possible exposure to environmental pathogens from hotels or contaminated water sources.  \n\u2022 His exam is notable for bilateral lung findings and a chest radiograph showing an opacity in the perihilar region with bilateral infiltrates.  \n\nStep 2: Analyze the options based on known microbiologic characteristics.  \n\u2022 Option A: \u201cCultured on charcoal and yeast\u201d refers to an organism that grows on buffered charcoal yeast extract agar \u2013 the classic culture medium for Legionella pneumophila. Legionella is known to cause pneumonia (often with high fever and a dry cough) and is associated with recent travel and hotel stays.  \n\u2022 Option B: \u201cD-glutamate capsule\u201d is characteristic of Bacillus anthracis, which typically causes inhalational anthrax with mediastinal widening and a rapidly severe course\u2014not fitting this patient\u2019s presentation.  \n\u2022 Option C: \u201cFound in desert sand\u201d is suggestive of an organism like Coccidioides immitis, which is endemic to certain desert areas of the Southwestern United States and parts of Central America, but the clinical presentation and travel history here are more supportive of another diagnosis.  \n\u2022 Option D: \u201cPolyribosyl\u2010ribitol\u2010phosphate capsule\u201d is the capsule of Haemophilus influenzae type b, an organism that is less likely to cause pneumonia in a healthy 37\u2010year\u2010old.\n\nStep 3: Compare and eliminate.  \n\u2022 Option B is inconsistent with the clinical picture of inhalational anthrax.  \n\u2022 Option C does not match the typical geography or presentation.  \n\u2022 Option D describes a pathogen usually involving pediatric infections (or adults with compromised immune status) rather than this patient.  \n\u2022 Option A appropriately describes Legionella pneumophila, which is cultured on charcoal yeast extract agar.\n\nFinal Answer: Option A \u2013 Cultured on charcoal and yeast."
    },
    {
        "realidx": 454,
        "question": "A 42-year-old man presents to a neurologist for evaluation of severe headache. He started experiencing episodic headaches and palpitations 3 months ago; however, he thought that these symptoms were simply related to the stress of moving and starting a new job. He has continued to experience these intermittent headaches and has also noticed that he sweats profusely during these episodes. On presentation his temperature is 99.1\u00b0F (37.3\u00b0C), blood pressure is 163/112 mmHg, pulse is 112/min, and respirations are 15/min. Physical exam reveals pallor and perspiration but is otherwise unremarkable. The most likely cause of this patient's symptoms is produced by cells located in which region of the histology slide shown in figure A?",
        "answer": "E",
        "options": {
            "A": "A",
            "B": "B",
            "C": "C",
            "D": "E"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man presents",
            "neurologist",
            "evaluation",
            "severe headache",
            "started experiencing episodic headaches",
            "palpitations",
            "months",
            "thought",
            "symptoms",
            "related",
            "stress",
            "moving",
            "starting",
            "new job",
            "continued to experience",
            "intermittent headaches",
            "sweats",
            "episodes",
            "presentation",
            "temperature",
            "99",
            "3C",
            "blood pressure",
            "mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "Physical exam reveals pallor",
            "perspiration",
            "unremarkable",
            "most likely cause",
            "patient's symptoms",
            "cells",
            "region",
            "histology slide shown"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 3735,
            "completion_tokens": 5058
        },
        "time_elapsed": 62.02895212173462,
        "raw_responses": [
            "Step 1: The patient\u2019s symptoms\u2014episodic headaches, palpitations, profuse sweating, hypertension, and pallor\u2014are classic for pheochromocytoma, a catecholamine\u2010secreting tumor.\n\nStep 2: Pheochromocytomas arise from chromaffin cells, which are derived from neural crest cells and reside in the adrenal medulla.\n\nStep 3: In the provided histology slide (Figure A), the region that corresponds to the adrenal medulla is labeled as option C.\n\nFinal answer: C",
            "This patient\u2019s symptoms (episodic headaches, palpitations, diaphoresis, and hypertension) strongly point to a pheochromocytoma\u2014a catecholamine\u2010secreting tumor that originates from chromaffin cells in the adrenal medulla. In the provided histologic slide (Figure A), the region that corresponds to the adrenal medulla is labeled as \u201cE.\u201d \n\nStep\u2010by\u2010step reasoning:\n1. The patient\u2019s clinical presentation (paroxysmal headaches, palpitations, sweating, and high blood pressure) is classic for pheochromocytoma.\n2. Pheochromocytomas arise from the chromaffin cells found in the adrenal medulla.\n3. In the histologic slide, the region that represents the adrenal medulla is marked \u201cE.\u201d\n\nFinal answer: E.",
            "Step 1: Recognize the clinical picture. The patient\u2019s episodic headaches, palpitations, diaphoresis, and hypertension are classic for a pheochromocytoma, a catecholamine\u2010secreting tumor.\n\nStep 2: Recall the origin of the cells. Pheochromocytomas arise from chromaffin cells, which are specialized neuroendocrine cells derived from neural crest cells.\n\nStep 3: Link the histology slide. In an image of the adrenal gland, the chromaffin cells are located in the adrenal medulla (the inner portion of the gland).\n\nStep 4: Identify the correct option. Based on the provided options (A, B, C, D, E), the region that represents the adrenal medulla is labeled as Option C.\n\nFinal Answer: C"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "This patient\u2019s symptoms (episodic headaches, palpitations, diaphoresis, and hypertension) strongly point to a pheochromocytoma\u2014a catecholamine\u2010secreting tumor that originates from chromaffin cells in the adrenal medulla. In the provided histologic slide (Figure A), the region that corresponds to the adrenal medulla is labeled as \u201cE.\u201d \n\nStep\u2010by\u2010step reasoning:\n1. The patient\u2019s clinical presentation (paroxysmal headaches, palpitations, sweating, and high blood pressure) is classic for pheochromocytoma.\n2. Pheochromocytomas arise from the chromaffin cells found in the adrenal medulla.\n3. In the histologic slide, the region that represents the adrenal medulla is marked \u201cE.\u201d\n\nFinal answer: E."
    },
    {
        "realidx": 461,
        "question": "A 58-year-old man comes to the physician because he is unable to achieve erections during sexual intercourse. He first noticed the problem 8 months ago, when he became sexually active with a new girlfriend. He states that his relationship with his girlfriend is good, but his inability to engage in sexual intercourse has been frustrating. He has hyperlipidemia and was diagnosed with major depressive disorder 3 years ago. He works as a lawyer and enjoys his job, but he has had a great deal of stress lately. He had not been sexually active for the previous 3 years, since the death of his wife. He does not smoke. He drinks 4\u20136 beers on weekends. Current medications include simvastatin and citalopram. His temperature is 37.5\u00b0C (99.5\u00b0F), pulse is 80/min, and blood pressure is 135/82 mm Hg. BMI is 30 kg/m2. Pedal pulses are difficult to palpate. The remainder of the physical examination shows no abnormalities. Which of the following is the most appropriate next step in management?",
        "answer": "Nocturnal penile tumescence testing",
        "options": {
            "A": "Psychotherapy",
            "B": "Penile prosthesis insertion",
            "C": "Nocturnal penile tumescence testing",
            "D": "Switch citalopram to bupropion"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "58 year old man",
            "physician",
            "unable to",
            "erections",
            "sexual intercourse",
            "first",
            "problem",
            "months",
            "sexually active",
            "new girlfriend",
            "states",
            "relationship",
            "girlfriend",
            "good",
            "sexual intercourse",
            "hyperlipidemia",
            "diagnosed",
            "major depressive disorder",
            "years",
            "works",
            "lawyer",
            "job",
            "great",
            "stress",
            "not",
            "sexually active",
            "previous",
            "years",
            "death",
            "wife",
            "not smoke",
            "drinks",
            "beers",
            "weekends",
            "Current medications include simvastatin",
            "citalopram",
            "temperature",
            "99",
            "pulse",
            "80 min",
            "blood pressure",
            "mm Hg",
            "BMI",
            "30 kg/m2",
            "Pedal pulses",
            "difficult to palpate",
            "physical examination shows",
            "abnormalities",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 6123,
            "completion_tokens": 6857
        },
        "time_elapsed": 137.6460645198822,
        "raw_responses": [
            "Step 1: Review the patient\u2019s history and exam.\n\u2022 The patient is a 58\u2010year\u2010old man with hyperlipidemia, obesity (BMI 30), and signs of possible peripheral vascular disease (difficult-to-palpate pedal pulses), all of which raise concern for organic, vascular ED.\n\u2022 He also has major depressive disorder and is taking citalopram; however, while SSRIs can cause sexual dysfunction, his physical exam findings suggest an underlying vascular cause rather than solely a medication side effect.\n\u2022 The fact that his erectile difficulties began 8 months ago, when reinitiating sexual activity after a long hiatus, supports the possibility of an organic cause rather than predominantly psychological factors.\n\nStep 2: Evaluate the answer choices.\nA. Psychotherapy \u2013 Typically used for psychogenic ED, but his exam findings and risk factors point to an organic etiology.\nB. Penile prosthesis insertion \u2013 This is reserved for refractory cases that have not responded to less invasive treatments.\nC. Nocturnal penile tumescence testing \u2013 This diagnostic test can differentiate between organic and psychogenic causes by evaluating whether spontaneous erections occur during REM sleep.\nD. Switch citalopram to bupropion \u2013 Although bupropion is less likely to cause sexual dysfunction, switching his antidepressant would not address his vascular risk factors, which are likely contributing to his ED.\n\nStep 3: Select the best next step in management.\nGiven the concerning physical findings (suggesting vascular insufficiency) and the need to distinguish organic from psychogenic causes, the most appropriate next step is to conduct nocturnal penile tumescence testing.\n\nFinal Answer: C. Nocturnal penile tumescence testing",
            "Step 1: Recognize the patient\u2019s risk factors and clinical presentation. This 58\u2010year\u2010old man has hyperlipidemia, obesity, possible peripheral vascular disease (as evidenced by his difficult-to-palpate pedal pulses), and a history of major depressive disorder treated with citalopram. While SSRIs like citalopram can cause sexual dysfunction, his vascular risk factors and physical examination point toward an organic (vasculogenic) cause.\n\nStep 2: Narrow down the options by evaluating each:\n\u2022 Option A \u2013 Psychotherapy: This is more useful if the cause were primarily psychogenic (e.g., performance anxiety), but his exam findings and risk factors suggest an organic cause.\n\u2022 Option B \u2013 Penile prosthesis insertion: This is a more invasive treatment reserved for refractory cases that have not responded to medical management, so it is premature.\n\u2022 Option C \u2013 Nocturnal penile tumescence (NPT) testing: This test helps differentiate between organic and psychogenic erectile dysfunction by assessing whether he has spontaneous nocturnal erections. Given the mix of potential causes, NPT is an appropriate next step to confirm that his ED is organic in nature.\n\u2022 Option D \u2013 Switching citalopram to bupropion: Although citalopram can contribute to sexual dysfunction, the presence of significant vascular disease signs suggests that the primary issue is organic rather than medication-induced.\n\nStep 3: Since his clinical picture is ambiguous (with both potential medication and organic causes) but weighted towards organic etiology, performing nocturnal penile tumescence testing (Option C) is the most appropriate next step in management. This test will help clarify whether his ED is due to vascular problems rather than a psychogenic or medication-induced cause.\n\nFinal answer: C. Nocturnal penile tumescence testing",
            "Step 1: Review the details of the case. We have a 58-year-old man complaining of an 8-month history of erectile dysfunction. Although he is on citalopram for major depressive disorder\u2014a medication known to potentially cause sexual dysfunction\u2014he also has several risk factors that predispose him to organic (vasculogenic) ED, including hyperlipidemia, obesity (BMI 30 kg/m\u00b2), and diminished pedal pulses on exam, suggesting underlying atherosclerotic disease. Additionally, although he experienced a significant emotional loss (his wife's death), his new sexual relationship and recent change in sexual activity pattern raise the question of whether this ED is organic or psychogenic (or possibly medication-induced).\n\nStep 2: Consider the answer options.\n\u2022 Option A (Psychotherapy) would be more appropriate if his dysfunction were primarily psychogenic; however, his physical exam and risk factors strongly suggest an organic component.\n\u2022 Option B (Penile prosthesis insertion) is an invasive treatment reserved for patients who have failed less invasive therapies.\n\u2022 Option D (Switch citalopram to bupropion) is considered in patients where antidepressant-induced sexual dysfunction is the suspected etiology. In this case, while his depression treatment could contribute to his symptoms, his significant cardiovascular risk factors make an organic cause more likely.\n\u2022 Option C (Nocturnal penile tumescence testing) is used to differentiate between an organic and psychogenic cause of ED by assessing whether spontaneous erections during sleep are present.\n\nStep 3: Determining the next step in management.\nBecause the patient has mixed potential contributing factors and an unclear etiology\u2014while his risk factors suggest a vascular cause, his medication could also contribute\u2014the most appropriate next step is to determine whether the erectile mechanism is physiologically intact. Nocturnal penile tumescence testing is the ideal test to distinguish between organic and psychogenic causes.\n\nFinal Answer: C. Nocturnal penile tumescence testing"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review the patient\u2019s history and exam.\n\u2022 The patient is a 58\u2010year\u2010old man with hyperlipidemia, obesity (BMI 30), and signs of possible peripheral vascular disease (difficult-to-palpate pedal pulses), all of which raise concern for organic, vascular ED.\n\u2022 He also has major depressive disorder and is taking citalopram; however, while SSRIs can cause sexual dysfunction, his physical exam findings suggest an underlying vascular cause rather than solely a medication side effect.\n\u2022 The fact that his erectile difficulties began 8 months ago, when reinitiating sexual activity after a long hiatus, supports the possibility of an organic cause rather than predominantly psychological factors.\n\nStep 2: Evaluate the answer choices.\nA. Psychotherapy \u2013 Typically used for psychogenic ED, but his exam findings and risk factors point to an organic etiology.\nB. Penile prosthesis insertion \u2013 This is reserved for refractory cases that have not responded to less invasive treatments.\nC. Nocturnal penile tumescence testing \u2013 This diagnostic test can differentiate between organic and psychogenic causes by evaluating whether spontaneous erections occur during REM sleep.\nD. Switch citalopram to bupropion \u2013 Although bupropion is less likely to cause sexual dysfunction, switching his antidepressant would not address his vascular risk factors, which are likely contributing to his ED.\n\nStep 3: Select the best next step in management.\nGiven the concerning physical findings (suggesting vascular insufficiency) and the need to distinguish organic from psychogenic causes, the most appropriate next step is to conduct nocturnal penile tumescence testing.\n\nFinal Answer: C. Nocturnal penile tumescence testing"
    },
    {
        "realidx": 477,
        "question": "A 32-year-old man comes to the physician because of a 2-day history of a tingling sensation in his right forearm. He reports that his symptoms started after he lifted heavy weights at the gym. Physical examination shows loss of sensation on the lateral side of the right forearm. Sensation over the thumb is intact. Range of motion of the neck is normal. His symptoms do not worsen with axial compression or distraction of the neck. Further examination of this patient is most likely to show weakness of which of the following actions?",
        "answer": "Elbow flexion",
        "options": {
            "A": "Elbow flexion",
            "B": "Forearm pronation",
            "C": "Index finger flexion",
            "D": "Wrist extension"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "physician",
            "2-day history",
            "tingling sensation",
            "right forearm",
            "reports",
            "symptoms started",
            "lifted heavy weights",
            "Physical examination shows loss of sensation",
            "lateral side",
            "right forearm",
            "Sensation",
            "thumb",
            "intact",
            "Range of motion",
            "neck",
            "normal",
            "symptoms",
            "not worsen",
            "axial compression",
            "distraction of",
            "neck",
            "Further examination",
            "patient",
            "most likely to show weakness",
            "following actions"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4785,
            "completion_tokens": 3470
        },
        "time_elapsed": 33.25357127189636,
        "raw_responses": [
            "Step 1: Recognize the affected sensory area. The lateral forearm is innervated by the lateral antebrachial cutaneous nerve, which is a terminal branch of the musculocutaneous nerve.\n\nStep 2: Determine the nerve\u2019s motor function. The musculocutaneous nerve primarily provides motor innervation to the biceps brachii and brachialis, muscles that are responsible for elbow flexion.\n\nStep 3: Evaluate the options:\n\u2022 Elbow flexion \u2013 This function is mediated by the biceps brachii and brachialis, which are innervated by the musculocutaneous nerve. An injury affecting this nerve (and its sensory branch) would likely weaken elbow flexion.\n\u2022 Forearm pronation \u2013 This is mainly controlled by muscles innervated by the median nerve (pronator teres and pronator quadratus).\n\u2022 Index finger flexion \u2013 Typically involves the median nerve (flexor digitorum superficialis/profundus).\n\u2022 Wrist extension \u2013 Controlled primarily by the radial nerve.\n\nStep 4: Conclude. Since the presentation indicates injury to the musculocutaneous nerve, the weakness would most likely be seen in elbow flexion.\n\nFinal answer: A. Elbow flexion",
            "Step 1: Analyze the patient\u2019s presentation. The 32\u2010year-old man has a 2\u2010day history of tingling on the lateral side of his right forearm after heavy weightlifting. There is no neck involvement, and thumb sensation is intact.\n\nStep 2: Identify the nerve involved. The lateral side of the forearm\u2019s sensation is mediated by the lateral antebrachial cutaneous nerve, which is the sensory branch of the musculocutaneous nerve. \n\nStep 3: Determine the motor functions of the musculocutaneous nerve. This nerve provides motor innervation to muscles responsible for elbow flexion (such as the biceps brachii and brachialis) and also aids in forearm supination.\n\nStep 4: Compare the options:\n\u2022 A. Elbow flexion \u2013 Weakness in this action would be consistent with injury to the musculocutaneous nerve.\n\u2022 B. Forearm pronation \u2013 This is mainly governed by the median nerve (pronator teres) and is not associated with the lateral forearm sensory distribution.\n\u2022 C. Index finger flexion \u2013 Also mediated by muscles innervated by the median nerve, not the musculocutaneous nerve.\n\u2022 D. Wrist extension \u2013 Controlled by the radial nerve, unrelated to the lateral forearm sensation loss.\n\nStep 5: Conclusion. The patient\u2019s presentation is most consistent with an injury to the musculocutaneous nerve, which would most likely result in weakness of elbow flexion.\n\nFinal answer: A. Elbow flexion",
            "Step 1: Relevant information from the examples shows that clinical questions provide key symptoms and physical findings to guide you toward the correct diagnosis and treatment. In this case, the patient has a tingling sensation on the lateral side of his right forearm after lifting heavy weights, and his thumb sensation is intact. Range of motion in the neck is normal and his symptoms do not change with neck movements, helping to rule out cervical radiculopathy.\n\nStep 2: The lateral forearm's sensation is provided by the lateral antebrachial cutaneous nerve, which is the sensory continuation of the musculocutaneous nerve. Given the history of heavy lifting, it is likely that the musculocutaneous nerve has been injured or irritated. The musculocutaneous nerve also innervates the biceps brachii, which is responsible for elbow flexion.\n\nComparing the options:\n\u2022 Option A (Elbow flexion) \u2013 This action is primarily mediated by muscles innervated by the musculocutaneous nerve.\n\u2022 Option B (Forearm pronation) \u2013 This action is mainly mediated by the pronator teres and pronator quadratus (median nerve).\n\u2022 Option C (Index finger flexion) \u2013 This is largely mediated by the flexor digitorum superficialis and profundus (median/ulnar nerve).\n\u2022 Option D (Wrist extension) \u2013 This is controlled by muscles innervated by the radial nerve.\n\nStep 3: The most likely finding on further examination would be weakness of elbow flexion.\n\nFinal answer: A. Elbow flexion"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Analyze the patient\u2019s presentation. The 32\u2010year-old man has a 2\u2010day history of tingling on the lateral side of his right forearm after heavy weightlifting. There is no neck involvement, and thumb sensation is intact.\n\nStep 2: Identify the nerve involved. The lateral side of the forearm\u2019s sensation is mediated by the lateral antebrachial cutaneous nerve, which is the sensory branch of the musculocutaneous nerve. \n\nStep 3: Determine the motor functions of the musculocutaneous nerve. This nerve provides motor innervation to muscles responsible for elbow flexion (such as the biceps brachii and brachialis) and also aids in forearm supination.\n\nStep 4: Compare the options:\n\u2022 A. Elbow flexion \u2013 Weakness in this action would be consistent with injury to the musculocutaneous nerve.\n\u2022 B. Forearm pronation \u2013 This is mainly governed by the median nerve (pronator teres) and is not associated with the lateral forearm sensory distribution.\n\u2022 C. Index finger flexion \u2013 Also mediated by muscles innervated by the median nerve, not the musculocutaneous nerve.\n\u2022 D. Wrist extension \u2013 Controlled by the radial nerve, unrelated to the lateral forearm sensation loss.\n\nStep 5: Conclusion. The patient\u2019s presentation is most consistent with an injury to the musculocutaneous nerve, which would most likely result in weakness of elbow flexion.\n\nFinal answer: A. Elbow flexion"
    },
    {
        "realidx": 480,
        "question": "A 17-year-old girl is brought to the pediatrician by her father for evaluation. He is concerned that she has not undergone puberty yet, while all of her classmates at school have. The patient herself feels well overall, with no specific complaints. Examination shows vital signs of T 98.9, HR 71, and BP 137/92. The physician notes undeveloped breasts and normal external and internal female genitalia in Tanner I stage of development. Her body mass index is within normal limits, she is in the 40th percentile for height, and she is agreeable and pleasant during the interview. Which of the following additional findings is likely present in this patient?",
        "answer": "Hypokalemia",
        "options": {
            "A": "Aromatase enzyme deficiency",
            "B": "Hypokalemia",
            "C": "XY karyotype",
            "D": "Hypercortisolism"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old girl",
            "brought",
            "pediatrician",
            "father",
            "evaluation",
            "concerned",
            "not",
            "puberty",
            "classmates",
            "school",
            "patient",
            "feels well overall",
            "specific complaints",
            "Examination shows vital signs",
            "98",
            "71",
            "BP",
            "physician notes",
            "breasts",
            "normal external",
            "internal",
            "Tanner",
            "development",
            "body mass index",
            "normal limits",
            "percentile",
            "height",
            "pleasant",
            "interview",
            "following additional findings",
            "likely present",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5232,
            "completion_tokens": 6705
        },
        "time_elapsed": 83.56281423568726,
        "raw_responses": [
            "Step 1: Review the patient's presentation. A 17\u2010year\u2010old girl with normal female genitalia and normal BMI has not undergone any secondary sexual development (Tanner stage I) and has elevated blood pressure. These findings indicate primary amenorrhea due to estrogen deficiency despite the presence of normal female reproductive anatomy.\n\nStep 2: Evaluate the answer options.\n\u2022 Option A \u2013 Aromatase enzyme deficiency: In aromatase deficiency, the body cannot convert androgens to estrogens. This lack of estrogen prevents breast development and can lead to primary amenorrhea. Additionally, excess androgens may lead to hypertension. It is also associated with maternal virilization during pregnancy.\n\u2022 Option B \u2013 Hypokalemia: This finding is not typically associated with failure to initiate puberty and is more related to conditions like hyperaldosteronism.\n\u2022 Option C \u2013 XY karyotype: This would be seen with complete androgen insensitivity syndrome, but these patients usually develop breasts due to peripheral conversion of testosterone to estrogen.\n\u2022 Option D \u2013 Hypercortisolism: Cushing syndrome (hypercortisolism) does not typically present with a primary lack of pubertal development in this manner.\n\nStep 3: Conclusion.\nThe patient\u2019s presentation is most consistent with aromatase enzyme deficiency. An additional finding often seen with this condition is maternal virilization during pregnancy. \n\nFinal answer: Aromatase enzyme deficiency.",
            "Step 1: The patient is a 17\u2010year\u2010old girl with primary amenorrhea and a complete lack of secondary sexual development (Tanner stage I breasts) despite having normal internal and external female genitalia. Additionally, her blood pressure is elevated for her age (137/92 mm Hg).\n\nStep 2: Considering the options:\n\u2003\u2022 Aromatase enzyme deficiency (Option A) results in an inability to convert androgens to estrogens. In a genetic female (46,XX), this leads to absent estrogen effects (lack of breast development, primary amenorrhea) while allowing the presence of a normal uterus. The excess androgens can also lead to virilization signs and are associated with hypertension (due to increased mineralocorticoid precursors). Even if subtle, these clues support aromatase deficiency.\n\u2003\u2022 Hypokalemia (Option B) is not typically associated with delayed puberty.\n\u2003\u2022 An XY karyotype (Option C) is seen in complete androgen insensitivity syndrome, where patients have female external genitalia, but they develop breasts due to peripheral aromatization of testosterone into estrogen and lack a uterus\u2014this contradicts the finding of normal internal female genitalia.\n\u2003\u2022 Hypercortisolism (Option D) is not known to cause absent pubertal development in this context.\n\nStep 3: By process of elimination and matching the clinical findings (lack of estrogen effects, normal internal female organs, and hypertension), aromatase enzyme deficiency is the most likely cause.\n\nFinal Answer: A. Aromatase enzyme deficiency.",
            "Step 1: Review the patient's case. A 17\u2010year\u2010old girl presents with a lack of pubertal development (Tanner I, no breast development) despite normal internal and external female genitalia, a normal BMI, and a slightly elevated blood pressure.\n\nStep 2: Analyze the answer choices.\n\n\u2022 Aromatase enzyme deficiency (Option A) leads to an inability to convert androgens to estrogens. In genetic females, this results in low estrogen levels (which may explain the lack of breast development) and accumulation of androgens. A characteristic additional finding in patients with aromatase deficiency is maternal virilization during pregnancy (due to placental lack of aromatization), along with potential issues such as hypertension.\n\n\u2022 Hypokalemia (Option B) is not typically associated with delayed puberty in females and is more suggestive of electrolyte disturbances from conditions like hyperaldosteronism.\n\n\u2022 XY karyotype (Option C) would be seen in individuals with complete androgen insensitivity syndrome; however, those individuals usually develop breasts (due to peripheral aromatization) despite scant pubic hair, which does not fit our patient\u2019s presentation.\n\n\u2022 Hypercortisolism (Option D) (Cushing syndrome) presents with clinical features (such as truncal obesity, striae, and other physical stigmata) that are absent in this patient.\n\nStep 3: Identify the likely additional finding. Among the options, aromatase enzyme deficiency best explains the lack of secondary sexual characteristics. In patients with aromatase deficiency, the inability to produce estrogen by converting androgens often results in failure of breast development. Additionally, a key associated finding is maternal virilization during pregnancy due to excess androgens crossing the placenta.\n\nFinal Answer: Aromatase enzyme deficiency."
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review the patient's case. A 17\u2010year\u2010old girl presents with a lack of pubertal development (Tanner I, no breast development) despite normal internal and external female genitalia, a normal BMI, and a slightly elevated blood pressure.\n\nStep 2: Analyze the answer choices.\n\n\u2022 Aromatase enzyme deficiency (Option A) leads to an inability to convert androgens to estrogens. In genetic females, this results in low estrogen levels (which may explain the lack of breast development) and accumulation of androgens. A characteristic additional finding in patients with aromatase deficiency is maternal virilization during pregnancy (due to placental lack of aromatization), along with potential issues such as hypertension.\n\n\u2022 Hypokalemia (Option B) is not typically associated with delayed puberty in females and is more suggestive of electrolyte disturbances from conditions like hyperaldosteronism.\n\n\u2022 XY karyotype (Option C) would be seen in individuals with complete androgen insensitivity syndrome; however, those individuals usually develop breasts (due to peripheral aromatization) despite scant pubic hair, which does not fit our patient\u2019s presentation.\n\n\u2022 Hypercortisolism (Option D) (Cushing syndrome) presents with clinical features (such as truncal obesity, striae, and other physical stigmata) that are absent in this patient.\n\nStep 3: Identify the likely additional finding. Among the options, aromatase enzyme deficiency best explains the lack of secondary sexual characteristics. In patients with aromatase deficiency, the inability to produce estrogen by converting androgens often results in failure of breast development. Additionally, a key associated finding is maternal virilization during pregnancy due to excess androgens crossing the placenta.\n\nFinal Answer: Aromatase enzyme deficiency."
    },
    {
        "realidx": 483,
        "question": "A 40-year-old man presents to the emergency department with altered mental status. He has a history of cirrhosis of the liver secondary to alcoholism. He started becoming more confused a few days ago and it has been getting gradually worse. His temperature is 98.8\u00b0F (37.1\u00b0C), blood pressure is 134/90 mmHg, pulse is 83/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals a distended abdomen that is non-tender. Neurological exam is notable for a confused patient and asterixis. Laboratory values are ordered as seen below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 3.3 mEq/L\nHCO3-: 22 mEq/L\nBUN: 20 mg/dL\nGlucose: 59 mg/dL\nCreatinine: 1.1 mg/dL\nCa2+: 10.2 mg/dL\n\nWhich of the following is the best next treatment for this patient?",
        "answer": "Potassium",
        "options": {
            "A": "Dextrose",
            "B": "Lactulose",
            "C": "Potassium",
            "D": "Rifaximin"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "40 year old man presents",
            "emergency department",
            "altered mental status",
            "history of cirrhosis",
            "liver secondary to alcoholism",
            "started",
            "more confused",
            "few days",
            "getting",
            "worse",
            "temperature",
            "98",
            "blood pressure",
            "90 mmHg",
            "pulse",
            "83 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "Physical exam reveals",
            "distended abdomen",
            "non-tender",
            "Neurological exam",
            "notable",
            "confused patient",
            "asterixis",
            "Laboratory values",
            "ordered",
            "seen",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "3.3 mEq/L HCO3",
            "mEq/L",
            "20 mg/dL Glucose",
            "59 mg/dL Creatinine",
            "1.1 mg/dL Ca2",
            "10",
            "mg/dL",
            "following",
            "best next treatment",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5151,
            "completion_tokens": 2760
        },
        "time_elapsed": 22.444433450698853,
        "raw_responses": [
            "Step 1: Recognize that the patient with cirrhosis presents with altered mental status and asterixis\u2014classic signs of hepatic encephalopathy.\n\nStep 2: Review the laboratory data. Although his glucose is slightly low (59 mg/dL) and his potassium is a bit low (3.3 mEq/L), these abnormalities are not severe enough to solely account for his neurological symptoms. The main concern, given his presentation and history, is hepatic encephalopathy.\n\nStep 3: Evaluate treatment options:\n\u2022 Dextrose (Option A) would be used to treat severe hypoglycemia, but his glucose level is only mildly low.\n\u2022 Lactulose (Option B) is the first-line treatment for hepatic encephalopathy as it helps lower ammonia levels.\n\u2022 Potassium (Option C) would address the hypokalemia, but it is not directly treating the encephalopathy.\n\u2022 Rifaximin (Option D) is an adjunct treatment to lactulose for hepatic encephalopathy but is not the initial therapy.\n\nStep 4: The best next treatment is lactulose.\n\nFinal Answer: B. Lactulose",
            "Step 1: The patient's presentation\u2014cirrhosis, gradual worsening mental status, altered sensorium, and asterixis\u2014is most consistent with hepatic encephalopathy.\n\nStep 2: Among the treatment options:\n\u2022 Dextrose: Although his blood glucose is slightly low (59 mg/dL), it\u2019s not the primary issue here.\n\u2022 Lactulose: This is the first-line treatment for hepatic encephalopathy as it helps reduce blood ammonia levels.\n\u2022 Potassium: His mild hypokalemia (3.3 mEq/L) would require correction eventually, but it is not the immediate priority.\n\u2022 Rifaximin: This may be used as adjunctive therapy for hepatic encephalopathy but is not the initial treatment.\n\nStep 3: Therefore, the best next treatment for this patient is Lactulose.\n\nFinal answer: B. Lactulose",
            "Step 1: Identify Key Points in the Clinical Vignette\n\u2022 The patient is a 40-year-old man with a known history of cirrhosis secondary to alcoholism.\n\u2022 He presents with altered mental status that has been gradually worsening over several days.\n\u2022 On exam, he exhibits asterixis\u2014a flapping tremor highly suggestive of hepatic encephalopathy\u2014along with a distended, non-tender abdomen.\n\u2022 Laboratory values show no significant metabolic derangements that would explain his mental status change (e.g., normal sodium, only mildly low potassium, and a glucose at the lower end of normal).\n\nStep 2: Analyze and Compare the Treatment Options\nA. Dextrose \u2013 While his glucose is 59 mg/dL, which is at the lower borderline, the clinical picture and classic sign of asterixis point strongly towards hepatic encephalopathy rather than hypoglycemia. Immediate dextrose administration isn\u2019t the primary treatment focus here.\nB. Lactulose \u2013 This is the treatment of choice for hepatic encephalopathy. Lactulose helps by reducing serum ammonia levels through acidification of the gut lumen and trapping ammonia, thereby decreasing its absorption.\nC. Potassium \u2013 Although his potassium is slightly low (3.3 mEq/L), correcting low potassium is not the immediate management priority in a cirrhotic patient with signs of hepatic encephalopathy.\nD. Rifaximin \u2013 This antibiotic is used as an adjunct therapy in hepatic encephalopathy, but lactulose remains the first-line treatment.\n\nStep 3: Selecting the Best Next Treatment\nGiven the patient\u2019s presentation (cirrhosis, confusion, presence of asterixis) and the laboratory findings, the most appropriate next step in treatment is to initiate lactulose therapy for hepatic encephalopathy.\n\nFinal Answer: Lactulose"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Identify Key Points in the Clinical Vignette\n\u2022 The patient is a 40-year-old man with a known history of cirrhosis secondary to alcoholism.\n\u2022 He presents with altered mental status that has been gradually worsening over several days.\n\u2022 On exam, he exhibits asterixis\u2014a flapping tremor highly suggestive of hepatic encephalopathy\u2014along with a distended, non-tender abdomen.\n\u2022 Laboratory values show no significant metabolic derangements that would explain his mental status change (e.g., normal sodium, only mildly low potassium, and a glucose at the lower end of normal).\n\nStep 2: Analyze and Compare the Treatment Options\nA. Dextrose \u2013 While his glucose is 59 mg/dL, which is at the lower borderline, the clinical picture and classic sign of asterixis point strongly towards hepatic encephalopathy rather than hypoglycemia. Immediate dextrose administration isn\u2019t the primary treatment focus here.\nB. Lactulose \u2013 This is the treatment of choice for hepatic encephalopathy. Lactulose helps by reducing serum ammonia levels through acidification of the gut lumen and trapping ammonia, thereby decreasing its absorption.\nC. Potassium \u2013 Although his potassium is slightly low (3.3 mEq/L), correcting low potassium is not the immediate management priority in a cirrhotic patient with signs of hepatic encephalopathy.\nD. Rifaximin \u2013 This antibiotic is used as an adjunct therapy in hepatic encephalopathy, but lactulose remains the first-line treatment.\n\nStep 3: Selecting the Best Next Treatment\nGiven the patient\u2019s presentation (cirrhosis, confusion, presence of asterixis) and the laboratory findings, the most appropriate next step in treatment is to initiate lactulose therapy for hepatic encephalopathy.\n\nFinal Answer: Lactulose"
    },
    {
        "realidx": 485,
        "question": "A 35-year-old woman presents to the physician because of episodes of difficulty swallowing for the past 3 months. She feels solid food getting stuck in her chest behind the sternum. She does not have any issues with liquids. She has no coughing or nasal regurgitation. She has no hoarseness or weight loss. She reports occasional heartburn that has lasted for about a year. Her past medical history is significant for asthma and eczema. She has no history of any serious illness and takes no medications. Her vital signs are within normal limits. Physical examination shows no abnormal findings. An endoscopic image of the esophagus is shown. Mucosal biopsy shows eosinophilic infiltration. Which of the following is the most appropriate pharmacotherapy at this time?",
        "answer": "Omeprazole",
        "options": {
            "A": "Budesonide",
            "B": "Fluconazole",
            "C": "Nitroglycerin",
            "D": "Omeprazole"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "35 year old woman presents",
            "physician",
            "of episodes",
            "difficulty swallowing",
            "past 3 months",
            "feels solid food getting",
            "chest",
            "sternum",
            "not",
            "issues",
            "liquids",
            "coughing",
            "nasal regurgitation",
            "hoarseness",
            "weight loss",
            "reports occasional heartburn",
            "lasted",
            "year",
            "past medical history",
            "significant",
            "asthma",
            "eczema",
            "history",
            "serious illness",
            "takes",
            "medications",
            "vital signs",
            "normal",
            "Physical examination shows",
            "abnormal findings",
            "endoscopic image of",
            "esophagus",
            "shown",
            "Mucosal biopsy shows eosinophilic infiltration",
            "following",
            "most appropriate pharmacotherapy",
            "time"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5061,
            "completion_tokens": 4351
        },
        "time_elapsed": 48.29897117614746,
        "raw_responses": [
            "Step 1: Identify the Key Clinical Features\n\u2022 The patient is a 35\u2010year-old woman with intermittent dysphagia to solids, a history of atopy (asthma and eczema), and occasional heartburn lasting about 1 year.\n\u2022 The endoscopic image (not shown here) along with mucosal biopsy showing eosinophilic infiltration strongly suggests eosinophilic esophagitis (EoE).\n\nStep 2: Understand the Differential Diagnoses and Corresponding Treatments\n\u2022 EoE is associated with atopic diseases and typically presents with solid food dysphagia. The biopsy confirms the diagnosis.\n\u2022 Fluconazole is used for candida esophagitis, which generally presents with odynophagia and white plaques on endoscopy\u2014findings absent here.\n\u2022 Nitroglycerin is used to treat esophageal spasms and chest pain of vascular origin, which is not indicated in this scenario.\n\u2022 Omeprazole (a proton pump inhibitor) might be used to treat GERD, which can sometimes overlap with EoE; however, in a confirmed case of EoE with typical findings, a PPI may not be sufficient as definitive therapy.\n\u2022 Swallowed topical corticosteroids such as budesonide are considered an appropriate treatment for EoE.\n\nStep 3: Choose the Most Appropriate Pharmacotherapy\nGiven the biopsy findings showing eosinophilic infiltration and the clinical picture consistent with EoE, the best pharmacotherapy at this time is a topical corticosteroid. The correct answer is Budesonide.\n\nFinal Answer: A. Budesonide",
            "Step 1: Recognize Key Findings\n\u2022 The patient is a 35-year-old woman with intermittent solid food dysphagia (solids getting stuck behind the sternum) and a history of atopy (asthma and eczema).\n\u2022 She experiences occasional heartburn that has persisted for about a year.\n\u2022 Endoscopy and biopsy reveal eosinophilic infiltration of the esophageal mucosa.\n\u2022 These features are classic for eosinophilic esophagitis (EoE).\n\nStep 2: Evaluate Treatment Options\n\u2022 Budesonide \u2013 A topical corticosteroid used in the treatment of EoE. Inhaled (swallowed) budesonide is commonly used to reduce eosinophilic inflammation in the esophagus.\n\u2022 Fluconazole \u2013 An antifungal, appropriate for treating candida esophagitis, which is typically seen in immunocompromised patients and would not show eosinophilic infiltration.\n\u2022 Nitroglycerin \u2013 Used for relieving chest pain from coronary issues or esophageal spasm; it is not indicated in this scenario.\n\u2022 Omeprazole \u2013 A proton pump inhibitor used for gastroesophageal reflux disease (GERD). Although GERD can be associated with eosinophilic infiltration (in PPI-responsive esophageal eosinophilia), the patient\u2019s history of atopy and the typical findings on endoscopy and biopsy point to EoE rather than pure GERD.\n\nStep 3: Conclusion\nGiven the clinical context of suspected eosinophilic esophagitis, the appropriate pharmacotherapy is a swallowed corticosteroid.\n\nFinal Answer: Budesonide",
            "Step 1: Assess the clinical presentation. The patient, a 35-year-old woman with a history of atopy (asthma and eczema), presents with dysphagia to solids and occasional heartburn. Endoscopic findings along with the biopsy showing eosinophilic infiltration point toward a diagnosis of eosinophilic esophagitis.\n\nStep 2: Review the treatment options. In eosinophilic esophagitis, the first-line therapy is the use of topical glucocorticoids to reduce inflammation, typically administered as a swallowed formulation. Budesonide is the medication used in this context. \n\nStep 3: Eliminate the other options. Fluconazole (an antifungal) is used for esophageal candidiasis, which is not indicated here. Nitroglycerin is used for esophageal spasm, which doesn\u2019t correlate with the biopsy findings. Omeprazole (a proton pump inhibitor) is useful for acid reflux; however, in the presence of eosinophilic infiltration characteristic of eosinophilic esophagitis, topical steroids remain the primary treatment.\n\nFinal Answer: A. Budesonide"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify the Key Clinical Features\n\u2022 The patient is a 35\u2010year-old woman with intermittent dysphagia to solids, a history of atopy (asthma and eczema), and occasional heartburn lasting about 1 year.\n\u2022 The endoscopic image (not shown here) along with mucosal biopsy showing eosinophilic infiltration strongly suggests eosinophilic esophagitis (EoE).\n\nStep 2: Understand the Differential Diagnoses and Corresponding Treatments\n\u2022 EoE is associated with atopic diseases and typically presents with solid food dysphagia. The biopsy confirms the diagnosis.\n\u2022 Fluconazole is used for candida esophagitis, which generally presents with odynophagia and white plaques on endoscopy\u2014findings absent here.\n\u2022 Nitroglycerin is used to treat esophageal spasms and chest pain of vascular origin, which is not indicated in this scenario.\n\u2022 Omeprazole (a proton pump inhibitor) might be used to treat GERD, which can sometimes overlap with EoE; however, in a confirmed case of EoE with typical findings, a PPI may not be sufficient as definitive therapy.\n\u2022 Swallowed topical corticosteroids such as budesonide are considered an appropriate treatment for EoE.\n\nStep 3: Choose the Most Appropriate Pharmacotherapy\nGiven the biopsy findings showing eosinophilic infiltration and the clinical picture consistent with EoE, the best pharmacotherapy at this time is a topical corticosteroid. The correct answer is Budesonide.\n\nFinal Answer: A. Budesonide"
    },
    {
        "realidx": 497,
        "question": "A 29-year-old woman presents to the physician with a blurred vision of her right eye for 2 days. She has pain around her right eye during eye movement. She takes no medications. At the clinic, her blood pressure is 110/70 mm Hg, the pulse is 72/min, respirations are 15/min, and the temperature is 36.5\u2103 (97.7\u2109). On physical examination, illumination of the left eye results in bilateral pupillary constriction while illumination of the right eye results in a mild bilateral pupillary dilation. Fundoscopic examination shows optic disk swelling in the right eye. The color vision test shows decreased perception in the right eye. The remainder of the physical examination shows no abnormalities. Specific additional history should be obtained regarding which of the following?",
        "answer": "Sensory loss",
        "options": {
            "A": "Dry eyes",
            "B": "High-risk sexual behaviour",
            "C": "Oral ulcers",
            "D": "Sensory loss"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "29 year old woman presents",
            "physician",
            "blurred vision",
            "right eye",
            "2 days",
            "pain around",
            "right eye",
            "eye movement",
            "takes",
            "medications",
            "clinic",
            "blood pressure",
            "70 mm Hg",
            "pulse",
            "72 min",
            "respirations",
            "min",
            "temperature",
            "36",
            "97",
            "physical examination",
            "illumination",
            "left eye results",
            "bilateral pupillary constriction",
            "illumination",
            "right eye results",
            "mild bilateral pupillary",
            "Fundoscopic examination shows optic disk swelling",
            "right eye",
            "color vision test shows decreased perception",
            "right eye",
            "physical examination shows",
            "abnormalities",
            "Specific additional history",
            "obtained",
            "following"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4215,
            "completion_tokens": 2837
        },
        "time_elapsed": 48.388343334198,
        "raw_responses": [
            "Step 1: The patient presents with blurred vision, pain during eye movement, and decreased color perception on the right side. The unilateral optic disk swelling along with a relative afferent pupillary defect (evident by the abnormal pupillary response) point to optic neuritis.\n\nStep 2: Optic neuritis is most frequently associated with multiple sclerosis (MS), a demyelinating disorder in which patients often experience sensory deficits (such as numbness or tingling) along with motor symptoms over time.\n\nStep 3: Among the answer choices, obtaining additional history regarding sensory loss (Option D) is most pertinent. This could reveal previous episodes of numbness, tingling, or other neurological symptoms that would further support a diagnosis of MS.\n\nFinal answer: D. Sensory loss",
            "Step 1: Recognize that the patient\u2019s symptoms (blurred vision, pain with eye movement, decreased color perception, relative afferent pupillary defect, and optic disk swelling) are classic for optic neuritis.\n\nStep 2: Note that optic neuritis is commonly associated with multiple sclerosis (MS), particularly in young women. In MS, patients might experience additional neurological symptoms, such as sensory disturbances (numbness or tingling) or motor deficits.\n\nStep 3: Examine the options and eliminate choices that are not typically linked with MS:\n\u2022 A. Dry eyes \u2013 More suggestive of conditions like Sj\u00f6gren\u2019s syndrome.\n\u2022 B. High-risk sexual behavior \u2013 Could point to infections such as syphilis (which can also cause optic issues), but the clinical picture is more consistent with optic neuritis from MS.\n\u2022 C. Oral ulcers \u2013 Might be seen in autoimmune conditions like Beh\u00e7et\u2019s disease, not primarily associated with optic neuritis.\n\u2022 D. Sensory loss \u2013 Consistent with neurological findings often seen in MS.\n\nStep 4: Given the association between optic neuritis and multiple sclerosis, specific additional history should be obtained regarding any episodes of sensory loss.\n\nFinal answer: D. Sensory loss",
            "Step 1: Recognize that the patient\u2019s presentation\u2014blurred vision with pain on eye movement, an afferent pupillary defect (signified by the abnormal pupillary response when light is shone in the affected eye), decreased color vision, and optic disk swelling\u2014is highly suggestive of optic neuritis.\n\nStep 2: Optic neuritis is most commonly associated with multiple sclerosis (MS). Given that this patient is a young woman, MS is high on the differential diagnosis list. MS is characterized by episodes of demyelination that can manifest with sensory loss, motor weakness, or coordination issues, among other neurological symptoms.\n\nStep 3: Among the answer choices provided, asking about \"Sensory loss\" would be most relevant. This could uncover additional symptoms consistent with MS, such as numbness or tingling, which would support the diagnosis.\n\nFinal Answer: D. Sensory loss"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Recognize that the patient\u2019s symptoms (blurred vision, pain with eye movement, decreased color perception, relative afferent pupillary defect, and optic disk swelling) are classic for optic neuritis.\n\nStep 2: Note that optic neuritis is commonly associated with multiple sclerosis (MS), particularly in young women. In MS, patients might experience additional neurological symptoms, such as sensory disturbances (numbness or tingling) or motor deficits.\n\nStep 3: Examine the options and eliminate choices that are not typically linked with MS:\n\u2022 A. Dry eyes \u2013 More suggestive of conditions like Sj\u00f6gren\u2019s syndrome.\n\u2022 B. High-risk sexual behavior \u2013 Could point to infections such as syphilis (which can also cause optic issues), but the clinical picture is more consistent with optic neuritis from MS.\n\u2022 C. Oral ulcers \u2013 Might be seen in autoimmune conditions like Beh\u00e7et\u2019s disease, not primarily associated with optic neuritis.\n\u2022 D. Sensory loss \u2013 Consistent with neurological findings often seen in MS.\n\nStep 4: Given the association between optic neuritis and multiple sclerosis, specific additional history should be obtained regarding any episodes of sensory loss.\n\nFinal answer: D. Sensory loss"
    },
    {
        "realidx": 499,
        "question": "A 30-year-old male presents to his primary care physician complaining of infertility. He and his wife have been trying to get pregnant for the past two years. They have used fertility monitors and other aids without success. A hysterosalpingogram in his wife was normal. The patient has a history of cleft lip and recurrent upper respiratory infections as a child. He was briefly hospitalized for severe pneumonia when he was 9-years-old. His temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 120/85 mmHg, pulse is 90/min, and respirations are 18/min. On examination, he is a healthy-appearing male in no acute distress with fully developed reproductive organs. Notably, cardiac auscultation is silent in the left 5th intercostal space at the midclavicular line. This patient most likely has a mutation in which of the following classes of proteins?",
        "answer": "Retrograde cytoskeletal motor protein",
        "options": {
            "A": "Microtubule monomeric protein",
            "B": "Transmembrane ion channel protein",
            "C": "Retrograde cytoskeletal motor protein",
            "D": "Anterograde cytoskeletal motor protein"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "30 year old male presents",
            "primary care physician",
            "infertility",
            "wife",
            "to",
            "pregnant",
            "past two years",
            "used fertility monitors",
            "aids",
            "success",
            "hysterosalpingogram",
            "wife",
            "normal",
            "patient",
            "history of cleft lip",
            "recurrent upper respiratory infections",
            "child",
            "hospitalized",
            "severe pneumonia",
            "years old",
            "temperature",
            "98",
            "blood pressure",
            "85 mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "examination",
            "healthy appearing male",
            "acute distress",
            "reproductive organs",
            "cardiac auscultation",
            "silent",
            "left 5th intercostal space",
            "midclavicular line",
            "patient",
            "likely",
            "a mutation",
            "following classes",
            "proteins"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4638,
            "completion_tokens": 3219
        },
        "time_elapsed": 53.4454562664032,
        "raw_responses": [
            "Step 1: Recognize key clues. This patient presents with infertility, a history of recurrent respiratory infections, and a cleft lip, along with the absence of cardiac sounds at the typical left-sided location. These findings are consistent with primary ciliary dyskinesia (Kartagener syndrome), which often includes dextrocardia (hence the silent left 5th intercostal space) and infertility due to immotile sperm.\n\nStep 2: Understand the underlying defect. Kartagener syndrome is due to a defect in the dynein arms of cilia. Dynein arms are motor proteins that allow cilia to move; they are responsible for retrograde movement along microtubules.\n\nStep 3: Analyze the options.\nA. Microtubule monomeric protein \u2013 This refers to tubulin, which forms microtubules, but not to the motor function.\nB. Transmembrane ion channel protein \u2013 Not related to ciliary motion.\nC. Retrograde cytoskeletal motor protein \u2013 Dynein, the protein affected in Kartagener syndrome, is a motor protein that works in the retrograde direction (toward the minus end of microtubules).\nD. Anterograde cytoskeletal motor protein \u2013 This describes kinesin, the motor protein that moves toward the plus end of microtubules, which is not implicated here.\n\nStep 4: Final Answer. Given that the defect is in the dynein arms (a retrograde motor protein), the correct answer is:\n\nFinal answer: C. Retrograde cytoskeletal motor protein",
            "Step 1: The patient\u2019s history of recurrent respiratory infections, cleft lip, and the finding of absent heart sounds in the usual left-sided location (suggesting dextrocardia) point toward Kartagener syndrome (primary ciliary dyskinesia).\n\nStep 2: Kartagener syndrome involves defective motility of cilia, which is due to a defect in the dynein arms. Dynein proteins are cytoskeletal motor proteins that normally provide retrograde movement along microtubules.\n\nStep 3: Among the options, Option C describes a retrograde cytoskeletal motor protein, which best fits the description of dynein.\n\nFinal Answer: C. Retrograde cytoskeletal motor protein",
            "Step 1: The patient's presentation includes infertility, recurrent respiratory infections, and a history of a cleft lip. On exam, the lack of heart sounds in the left 5th intercostal space suggests dextrocardia. This combination is characteristic of Kartagener's syndrome, a subset of primary ciliary dyskinesia, which is caused by a defect in the dynein arms essential for ciliary movement.\n\nStep 2: Dynein arms are retrograde cytoskeletal motor proteins. Defects in these proteins lead to the impaired function of cilia and flagella, explaining the respiratory issues and infertility (due to immotile sperm) in this patient.\n\nStep 3: Among the given options, the defect most consistent with dynein arm dysfunction is found in the retrograde cytoskeletal motor proteins.\n\nFinal Answer: C. Retrograde cytoskeletal motor protein"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Recognize key clues. This patient presents with infertility, a history of recurrent respiratory infections, and a cleft lip, along with the absence of cardiac sounds at the typical left-sided location. These findings are consistent with primary ciliary dyskinesia (Kartagener syndrome), which often includes dextrocardia (hence the silent left 5th intercostal space) and infertility due to immotile sperm.\n\nStep 2: Understand the underlying defect. Kartagener syndrome is due to a defect in the dynein arms of cilia. Dynein arms are motor proteins that allow cilia to move; they are responsible for retrograde movement along microtubules.\n\nStep 3: Analyze the options.\nA. Microtubule monomeric protein \u2013 This refers to tubulin, which forms microtubules, but not to the motor function.\nB. Transmembrane ion channel protein \u2013 Not related to ciliary motion.\nC. Retrograde cytoskeletal motor protein \u2013 Dynein, the protein affected in Kartagener syndrome, is a motor protein that works in the retrograde direction (toward the minus end of microtubules).\nD. Anterograde cytoskeletal motor protein \u2013 This describes kinesin, the motor protein that moves toward the plus end of microtubules, which is not implicated here.\n\nStep 4: Final Answer. Given that the defect is in the dynein arms (a retrograde motor protein), the correct answer is:\n\nFinal answer: C. Retrograde cytoskeletal motor protein"
    },
    {
        "realidx": 501,
        "question": "A 36-year-old man undergoes open reduction and internal fixation of a left femur fracture sustained after a motor vehicle collision. Three days after the surgery, he develops fever and redness around the surgical site. His temperature is 39.5\u00b0C (103.1\u00b0F). Physical examination shows purulent discharge from the wound with erythema of the surrounding skin. Wound culture of the purulent discharge shows gram-positive cocci in clusters. Treatment with oral dicloxacillin is initiated. Four days later, the patient continues to have high-grade fever, pain, and purulent discharge. Which of the following characteristics of the infecting organism best explains the failure to improve with antibiotic therapy?",
        "answer": "Adaptation in binding proteins",
        "options": {
            "A": "Presence of an impenetrable outer membrane",
            "B": "Ability to cleave \u03b2-lactam rings",
            "C": "Development of efflux pumps",
            "D": "Adaptation in binding proteins"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "36 year old man",
            "open reduction",
            "internal fixation of",
            "left femur fracture sustained",
            "motor vehicle collision",
            "Three days",
            "surgery",
            "fever",
            "redness",
            "surgical site",
            "temperature",
            "Physical examination shows purulent discharge from",
            "wound",
            "erythema of",
            "surrounding skin",
            "Wound culture",
            "purulent discharge shows gram-positive cocci in clusters",
            "Treatment",
            "oral dicloxacillin",
            "initiated",
            "Four days later",
            "patient continues to",
            "high-grade fever",
            "pain",
            "purulent discharge",
            "following characteristics",
            "infecting organism best",
            "failure to",
            "antibiotic therapy"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4812,
            "completion_tokens": 3382
        },
        "time_elapsed": 53.1652774810791,
        "raw_responses": [
            "Step 1: The organism is a gram\u2010positive coccus in clusters, which indicates Staphylococcus aureus. Dicloxacillin is a penicillinase-resistant penicillin that is effective against methicillin-sensitive S. aureus (MSSA).\n\nStep 2: The patient\u2019s lack of response to dicloxacillin suggests that the infecting organism might be methicillin-resistant S. aureus (MRSA). The primary mechanism for MRSA resistance is the alteration (adaptation) of penicillin-binding proteins (specifically, the production of PBP2a encoded by the mecA gene), which prevents effective binding of beta\u2010lactam antibiotics.\n\nStep 3: Evaluating the options:\n\u2022 Option A (impenetrable outer membrane) is a mechanism seen with gram\u2010negative bacteria.\n\u2022 Option B (ability to cleave \u03b2\u2010lactam rings) refers to beta\u2010lactamase production; however, dicloxacillin is resistant to standard beta\u2010lactamases.\n\u2022 Option C (development of efflux pumps) is not the typical mechanism of resistance for S. aureus in this context.\n\u2022 Option D (adaptation in binding proteins) correctly describes the mechanism behind MRSA\u2019s resistance to beta\u2010lactam antibiotics.\n\nFinal Answer: D. Adaptation in binding proteins.",
            "Step 1: The organism is described as gram-positive cocci in clusters, which is characteristic of Staphylococcus aureus.\n\nStep 2: Dicloxacillin is a beta-lactam antibiotic that is resistant to beta-lactamase produced by many strains of S. aureus. However, the patient\u2019s failure to improve suggests that the organism is resistant despite this resistance to beta-lactamase degradation.\n\nStep 3: The primary mechanism of resistance in methicillin-resistant Staphylococcus aureus (MRSA) is the modification of penicillin-binding proteins, particularly the acquisition of PBP2a, which has a low affinity for beta-lactam antibiotics. This adaptation prevents drugs like dicloxacillin from effectively inhibiting bacterial cell wall synthesis.\n\nStep 4: Comparing the answer options:\n\u2022 Option A (Presence of an impenetrable outer membrane) is characteristic of gram-negative bacteria.\n\u2022 Option B (Ability to cleave \u03b2-lactam rings) describes beta-lactamase activity, which dicloxacillin is designed to overcome.\n\u2022 Option C (Development of efflux pumps) is a resistance mechanism more common in other bacteria or for other classes of antibiotics.\n\u2022 Option D (Adaptation in binding proteins) directly correlates with the altered penicillin-binding proteins seen in MRSA.\n\nFinal Answer: D. Adaptation in binding proteins",
            "Step 1: The patient underwent surgery and subsequently developed an infection at the surgical site. The culture shows gram-positive cocci in clusters, which is characteristic of Staphylococcus aureus.\n\nStep 2: Dicloxacillin is a penicillinase-resistant penicillin used to treat methicillin-sensitive Staphylococcus aureus (MSSA). However, the patient\u2019s lack of improvement suggests the infecting organism may be methicillin-resistant Staphylococcus aureus (MRSA).\n\nStep 3: MRSA\u2019s resistance is primarily due to an alteration in penicillin-binding proteins (specifically, production of PBP2a), which prevents \u03b2-lactam antibiotics from effectively binding and inhibiting cell wall synthesis.\n\nStep 4: Evaluating the answer choices:\n\u2022 Option A (Presence of an impenetrable outer membrane) applies to gram-negative bacteria.\n\u2022 Option B (Ability to cleave \u03b2-lactam rings) is a mechanism of resistance seen with \u03b2-lactamase production; however, dicloxacillin is designed to resist degradation by \u03b2-lactamases.\n\u2022 Option C (Development of efflux pumps) is not the primary mechanism of resistance seen in MRSA.\n\u2022 Option D (Adaptation in binding proteins) accurately describes MRSA\u2019s mechanism of resistance.\n\nFinal Answer: D. Adaptation in binding proteins"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: The organism is a gram\u2010positive coccus in clusters, which indicates Staphylococcus aureus. Dicloxacillin is a penicillinase-resistant penicillin that is effective against methicillin-sensitive S. aureus (MSSA).\n\nStep 2: The patient\u2019s lack of response to dicloxacillin suggests that the infecting organism might be methicillin-resistant S. aureus (MRSA). The primary mechanism for MRSA resistance is the alteration (adaptation) of penicillin-binding proteins (specifically, the production of PBP2a encoded by the mecA gene), which prevents effective binding of beta\u2010lactam antibiotics.\n\nStep 3: Evaluating the options:\n\u2022 Option A (impenetrable outer membrane) is a mechanism seen with gram\u2010negative bacteria.\n\u2022 Option B (ability to cleave \u03b2\u2010lactam rings) refers to beta\u2010lactamase production; however, dicloxacillin is resistant to standard beta\u2010lactamases.\n\u2022 Option C (development of efflux pumps) is not the typical mechanism of resistance for S. aureus in this context.\n\u2022 Option D (adaptation in binding proteins) correctly describes the mechanism behind MRSA\u2019s resistance to beta\u2010lactam antibiotics.\n\nFinal Answer: D. Adaptation in binding proteins."
    },
    {
        "realidx": 514,
        "question": "A 3-year-old girl is brought to the physician because of a 3-day history of fever, cough, purulent nasal discharge. She has experienced 7 similar episodes, each lasting 2\u20135 days in the previous 2 years. She has also had intermittent abdominal cramps and recurrent episodes of foul-smelling greasy diarrhea in the past year. She is at the 55th percentile for height and 35th percentile for weight. Her temperature is 38.9\u00b0C (102\u00b0F), pulse is 100/min, respirations are 24/min, and blood pressure is 110/60 mm Hg. Physical examination shows an erythematous oropharynx without exudate and tenderness over the frontoethmoidal sinuses. The abdomen is distended, nontender, and tympanitic to percussion. Bowel sounds are increased. Stool microscopy shows pear-shaped multi-flagellated organisms. This patient is at increased risk for which of the following?",
        "answer": "Anaphylactic transfusion reactions",
        "options": {
            "A": "Anaphylactic transfusion reactions",
            "B": "Cutaneous granulomas",
            "C": "Non-Hodgkin lymphoma",
            "D": "Disseminated tuberculosis"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "3 year old girl",
            "brought",
            "physician",
            "3-day history",
            "fever",
            "cough",
            "purulent nasal discharge",
            "experienced",
            "similar episodes",
            "lasting",
            "days",
            "previous 2 years",
            "intermittent abdominal cramps",
            "recurrent episodes of",
            "smelling greasy diarrhea",
            "past year",
            "percentile",
            "height",
            "percentile",
            "weight",
            "temperature",
            "pulse",
            "100 min",
            "respirations",
            "min",
            "blood pressure",
            "60 mm Hg",
            "Physical examination shows",
            "erythematous oropharynx",
            "exudate",
            "tenderness",
            "sinuses",
            "abdomen",
            "distended",
            "nontender",
            "tympanitic",
            "percussion",
            "Bowel sounds",
            "increased",
            "Stool microscopy shows pear-shaped multi flagellated organisms",
            "patient",
            "increased risk",
            "following"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5658,
            "completion_tokens": 4409
        },
        "time_elapsed": 99.3309497833252,
        "raw_responses": [
            "Step 1: Analyze the clinical presentation.  \n\u2022 The patient, a 3\u2010year\u2010old girl, has a history of recurrent sinus and respiratory infections and recurrent episodes of foul-smelling, greasy diarrhea.  \n\u2022 Stool microscopy reveals pear-shaped, multi-flagellated organisms, which are characteristic of Giardia lamblia.  \n\nStep 2: Recognize the likely underlying disorder.  \n\u2022 Recurrent respiratory infections along with giardiasis suggest selective IgA deficiency. This condition is the most common primary immunodeficiency and predisposes patients to sinopulmonary infections and gastrointestinal infections (Giardia is commonly seen).  \n\nStep 3: Identify associated complications of selective IgA deficiency.  \n\u2022 Patients with selective IgA deficiency can develop anti-IgA antibodies.  \n\u2022 This predisposes them to anaphylactic transfusion reactions when they are exposed to blood products containing IgA.  \n\nStep 4: Compare the answer choices.  \nA. Anaphylactic transfusion reactions \u2013 This is a known risk in patients with IgA deficiency.  \nB. Cutaneous granulomas \u2013 Not classically linked with IgA deficiency.  \nC. Non-Hodgkin lymphoma \u2013 While some immunodeficiencies increase the risk of lymphoma (commonly seen in common variable immunodeficiency), this is not the primary complication of selective IgA deficiency.  \nD. Disseminated tuberculosis \u2013 There is no direct association with IgA deficiency.\n\nStep 5: Provide the final answer.  \nFinal Answer: A. Anaphylactic transfusion reactions",
            "Step 1: Identify the key clinical features.  \n\u2022 The patient is a 3-year-old girl with recurrent sinopulmonary infections (fever, cough, purulent nasal discharge, sinus tenderness) and gastrointestinal symptoms (abdominal cramps, foul-smelling greasy diarrhea).  \n\u2022 Stool microscopy reveals pear-shaped, multi-flagellated organisms, which are characteristic of Giardia lamblia.\n\nStep 2: Establish a likely diagnosis.  \n\u2022 The combination of recurrent mucosal infections (in the respiratory and gastrointestinal tracts) and Giardia infection strongly suggests selective IgA deficiency. IgA plays a crucial role in protecting mucosal surfaces, and its deficiency predisposes patients to recurrent sinopulmonary infections and gastrointestinal infections (like giardiasis).\n\nStep 3: Evaluate the options.  \nA. Anaphylactic transfusion reactions \u2013 Patients with IgA deficiency can develop anti-IgA antibodies. When they receive blood products that contain IgA, they may experience anaphylaxis.  \nB. Cutaneous granulomas \u2013 These are not typically associated with selective IgA deficiency; they are more aligned with other immune disorders.  \nC. Non-Hodgkin lymphoma \u2013 While some primary immunodeficiencies (like common variable immunodeficiency) are associated with increased lymphoma risk, this is not the most characteristic risk in selective IgA deficiency.  \nD. Disseminated tuberculosis \u2013 There is no direct association between selective IgA deficiency and an increased risk for disseminated tuberculosis.\n\nStep 4: Arriving at the final answer.  \nConsidering the classic presentation of selective IgA deficiency and its known complication of anti-IgA antibodies triggering anaphylactic reactions upon exposure to IgA in blood products, the correct answer is: A. Anaphylactic transfusion reactions.\n\nFinal Answer: A.",
            "Step 1: Analyze the clinical presentation. This 3-year-old girl has recurrent episodes of upper respiratory tract infections (fever, cough, sinus tenderness) and gastrointestinal symptoms (abdominal cramps, foul-smelling greasy diarrhea). Her stool microscopy shows pear-shaped, multi-flagellated organisms, which is diagnostic for Giardia lamblia infection.\n\nStep 2: Recognize the association with an immunodeficiency. Recurrent sinopulmonary infections and Giardia infections are classic for selective IgA deficiency\u2014the most common primary immunodeficiency. Patients with IgA deficiency are predisposed to mucosal infections because IgA plays a crucial role in defending mucosal surfaces.\n\nStep 3: Link the immunodeficiency to increased risks. One important complication in patients with selective IgA deficiency is an increased risk for anaphylactic reactions during blood transfusions. This is due to the formation of anti-IgA antibodies that can react to IgA in transfused blood products, potentially causing severe, life-threatening allergic reactions.\n\nStep 4: Evaluate the answer choices:\nA. Anaphylactic transfusion reactions \u2013 Correct, as described above.\nB. Cutaneous granulomas \u2013 Not typically associated with IgA deficiency.\nC. Non-Hodgkin lymphoma \u2013 While some immunodeficiencies like common variable immunodeficiency have an associated increased risk of lymphoma, this is not the primary concern in IgA deficiency.\nD. Disseminated tuberculosis \u2013 Not specifically linked to IgA deficiency.\n\nFinal Answer: A. Anaphylactic transfusion reactions"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation.  \n\u2022 The patient, a 3\u2010year\u2010old girl, has a history of recurrent sinus and respiratory infections and recurrent episodes of foul-smelling, greasy diarrhea.  \n\u2022 Stool microscopy reveals pear-shaped, multi-flagellated organisms, which are characteristic of Giardia lamblia.  \n\nStep 2: Recognize the likely underlying disorder.  \n\u2022 Recurrent respiratory infections along with giardiasis suggest selective IgA deficiency. This condition is the most common primary immunodeficiency and predisposes patients to sinopulmonary infections and gastrointestinal infections (Giardia is commonly seen).  \n\nStep 3: Identify associated complications of selective IgA deficiency.  \n\u2022 Patients with selective IgA deficiency can develop anti-IgA antibodies.  \n\u2022 This predisposes them to anaphylactic transfusion reactions when they are exposed to blood products containing IgA.  \n\nStep 4: Compare the answer choices.  \nA. Anaphylactic transfusion reactions \u2013 This is a known risk in patients with IgA deficiency.  \nB. Cutaneous granulomas \u2013 Not classically linked with IgA deficiency.  \nC. Non-Hodgkin lymphoma \u2013 While some immunodeficiencies increase the risk of lymphoma (commonly seen in common variable immunodeficiency), this is not the primary complication of selective IgA deficiency.  \nD. Disseminated tuberculosis \u2013 There is no direct association with IgA deficiency.\n\nStep 5: Provide the final answer.  \nFinal Answer: A. Anaphylactic transfusion reactions"
    },
    {
        "realidx": 524,
        "question": "A 6-month-old boy is brought to the physician by his parents for difficulty breathing and bluish discoloration of the lips for the past hour. During the past 3 months, the patient has had several upper respiratory tract infections and poor weight gain. Physical examination shows crackles over both lung fields and enlargement of the tonsils and cervical lymph nodes. His serum IgA, IgE, and IgG titers are decreased. An x-ray of the chest shows bilateral interstitial infiltrates. Methenamine silver staining of bronchial lavage fluid shows disc-shaped cysts. A defect in which of the following is the most likely underlying cause of this patient's condition?",
        "answer": "T-cell receptor signaling",
        "options": {
            "A": "Actin filament assembly",
            "B": "T-cell receptor signaling",
            "C": "Microtubule polymerization",
            "D": "B-cell maturation"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "month old boy",
            "brought",
            "physician",
            "parents",
            "difficulty breathing",
            "discoloration",
            "lips",
            "past hour",
            "past 3 months",
            "patient",
            "several upper respiratory tract infections",
            "poor weight gain",
            "Physical examination shows crackles",
            "lung fields",
            "enlargement of",
            "tonsils",
            "cervical lymph nodes",
            "serum IgA",
            "titers",
            "decreased",
            "x-ray of",
            "chest shows bilateral interstitial",
            "Methenamine silver staining of bronchial lavage fluid shows disc-shaped cysts",
            "defect",
            "following",
            "most likely underlying cause",
            "patient's condition"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5739,
            "completion_tokens": 4737
        },
        "time_elapsed": 118.98209285736084,
        "raw_responses": [
            "Step 1: Key clinical findings include:\n\u2022 The patient is a 6\u2010month\u2010old boy with recurrent infections (multiple URIs), poor weight gain, and pneumonia with bilateral infiltrates.\n\u2022 The chest imaging and methenamine silver stain findings (disc\u2010shaped cysts) are consistent with Pneumocystis jirovecii pneumonia.\n\u2022 Laboratory studies show decreased serum IgA, IgE, and IgG titers (with IgM not mentioned, likely preserved or elevated), which fits a diagnosis of hyper\u2010IgM syndrome.\n\nStep 2: Hyper\u2010IgM syndrome typically occurs due to a defect in the CD40 ligand (found on T cells) that is needed for class switch recombination during B-cell maturation. Failure of this process results in normal or elevated IgM with decreased IgG, IgA, and IgE levels.\n\nStep 3: Considering the options:\nA. Actin filament assembly \u2013 Not relevant to class switching; defects here are seen in disorders like Wiskott-Aldrich syndrome, which has additional features (thrombocytopenia, eczema).\nB. T-cell receptor signaling \u2013 While T-cell function is important, the defect in hyper-IgM is specifically in the CD40 ligand, not in the overall T-cell receptor signaling.\nC. Microtubule polymerization \u2013 Associated with issues like ciliary dyskinesia, not immunoglobulin class switching.\nD. B-cell maturation \u2013 This option is correct because defective CD40L prevents proper B-cell maturation (class switch recombination) leading to low levels of IgG, IgA, and IgE.\n\nFinal Answer: D. B-cell maturation",
            "Step 1: Evaluate the clinical presentation. The 6\u2010month\u2010old boy has recurrent upper respiratory infections, poor weight gain, and now presents with respiratory distress and cyanosis. The imaging shows bilateral interstitial infiltrates, and the methenamine silver stain reveals disc\u2010shaped cysts, which is characteristic of Pneumocystis jirovecii pneumonia.\n\nStep 2: Interpret the immunoglobulin findings. The serum levels of IgA, IgE, and IgG are decreased. This laboratory profile is typical for hyper-IgM syndrome, where patients are unable to undergo immunoglobulin class switching. In hyper-IgM syndrome, while IgM levels are either normal or elevated, the other isotypes are very low due to an inability of B cells to mature and switch immunoglobulin classes.\n\nStep 3: Link the underlying defect. Hyper-IgM syndrome most commonly results from a defect in the CD40 ligand on T cells, which is crucial for signaling to B cells to initiate class switching. Although the defect originates in T-cell signaling (specifically CD40L-CD40 interaction), the ultimate consequence is impaired B-cell maturation and class switching.\n\nStep 4: Evaluate the answer choices:\n\u2022 Option A (Actin filament assembly) is associated with conditions like Wiskott-Aldrich syndrome, which presents with eczema and thrombocytopenia rather than isolated immunoglobulin class deficits.\n\u2022 Option B (T-cell receptor signaling) suggests a defect in T-cell activation overall, but the specific defect in hyper-IgM syndrome lies in the CD40L-mediated signal rather than the T-cell receptor itself.\n\u2022 Option C (Microtubule polymerization) is seen in disorders such as Ch\u00e9diak-Higashi syndrome, which presents with recurrent infections but also features albinism and neurological issues.\n\u2022 Option D (B-cell maturation) directly addresses the inability of B cells to undergo class switching, resulting in decreased IgA, IgE, and IgG, which is the hallmark of hyper-IgM syndrome.\n\nStep 5: Final Answer.\nThe best answer, given the underlying defect leading to impaired immunoglobulin class switching (a failure in B-cell maturation), is:\n\nFinal Answer: D. B-cell maturation",
            "Step 1: The patient is a 6\u2010month\u2010old boy with recurrent respiratory infections and poor weight gain. His clinical picture, combined with the finding of bilateral interstitial infiltrates on x\u2010ray and disc-shaped cysts on methenamine silver staining (suggestive of Pneumocystis jirovecii pneumonia), raises concern for an immunodeficiency.\n\nStep 2: The laboratory findings show decreased titers of IgA, IgE, and IgG. This pattern is consistent with hyper\u2010IgM syndrome, a disorder in which patients cannot class switch immunoglobulins. In this condition, IgM levels are typically normal or high, while the other immunoglobulin classes are low. The underlying defect in hyper\u2010IgM syndrome often results from a mutation affecting the CD40 ligand on T cells, thereby impairing the interaction between T cells and B cells, which is crucial for B\u2010cell maturation and isotype switching.\n\nStep 3: Evaluating the answer choices:\n\u2022 Option A (Actin filament assembly) is related to disorders like Wiskott-Aldrich syndrome, which does not fit with the immunoglobulin findings here.\n\u2022 Option B (T-cell receptor signaling) would affect T-cell activation broadly, but the specific immunoglobulin pattern points toward a class switching defect.\n\u2022 Option C (Microtubule polymerization) is not associated with the immunodeficiency seen in this patient.\n\u2022 Option D (B-cell maturation) correctly identifies the process that is impaired in hyper\u2010IgM syndrome, where a failure of class-switch recombination due to defective CD40/CD40 ligand interaction leads to low IgA, IgE, and IgG levels.\n\nFinal Answer: D. B-cell maturation"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Key clinical findings include:\n\u2022 The patient is a 6\u2010month\u2010old boy with recurrent infections (multiple URIs), poor weight gain, and pneumonia with bilateral infiltrates.\n\u2022 The chest imaging and methenamine silver stain findings (disc\u2010shaped cysts) are consistent with Pneumocystis jirovecii pneumonia.\n\u2022 Laboratory studies show decreased serum IgA, IgE, and IgG titers (with IgM not mentioned, likely preserved or elevated), which fits a diagnosis of hyper\u2010IgM syndrome.\n\nStep 2: Hyper\u2010IgM syndrome typically occurs due to a defect in the CD40 ligand (found on T cells) that is needed for class switch recombination during B-cell maturation. Failure of this process results in normal or elevated IgM with decreased IgG, IgA, and IgE levels.\n\nStep 3: Considering the options:\nA. Actin filament assembly \u2013 Not relevant to class switching; defects here are seen in disorders like Wiskott-Aldrich syndrome, which has additional features (thrombocytopenia, eczema).\nB. T-cell receptor signaling \u2013 While T-cell function is important, the defect in hyper-IgM is specifically in the CD40 ligand, not in the overall T-cell receptor signaling.\nC. Microtubule polymerization \u2013 Associated with issues like ciliary dyskinesia, not immunoglobulin class switching.\nD. B-cell maturation \u2013 This option is correct because defective CD40L prevents proper B-cell maturation (class switch recombination) leading to low levels of IgG, IgA, and IgE.\n\nFinal Answer: D. B-cell maturation"
    },
    {
        "realidx": 531,
        "question": "A 24-year-old woman is brought to the emergency room (ER) by her co-workers after they found her unconscious in her cubicle when they returned from lunch. They tell you that she has diabetes but do not know anything more about her condition. The woman\u2019s vital signs include: pulse 110/min, respiratory rate 24/min, temperature 36.7\u00b0C (98.0\u00b0F), and blood pressure 90/60 mm Hg. On physical examination, the patient is breathing heavily and gives irrelevant responses to questions. The skin and mucous membranes appear dry. Examination of the abdomen reveals mild diffuse tenderness to palpation. Deep tendon reflexes in the extremities are 1+ bilaterally. Laboratory studies show:\nFinger stick glucose 630 mg/dL\nArterial blood gas analysis:\npH 7.1\nPO2 90 mm Hg\nPCO2 33 mm Hg\nHCO3 8 mEq/L\nSerum:\nSodium 135 mEq/L\nPotassium 3.1 mEq/L\nChloride 136 mEq/L\nBlood urea nitrogen 20 mg/dL\nSerum creatinine 1.2 mg/dL\nUrine examination shows:\nGlucose Positive\nKetones Positive\nLeukocytes Negative\nNitrite Negative\nRBCs Negative\nCasts Negative\nThe patient is immediately started on a bolus of intravenous (IV) 0.9% sodium chloride (NaCl). Which of the following is the next best step in the management of this patient?",
        "answer": "Replace potassium intravenously",
        "options": {
            "A": "Infuse NaHCO3 slowly",
            "B": "Switch fluids to 0.45% NaCl",
            "C": "Start IV insulin infusion",
            "D": "Replace potassium intravenously"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old woman",
            "brought",
            "emergency room",
            "co workers",
            "found",
            "unconscious",
            "returned",
            "lunch",
            "diabetes",
            "not",
            "more",
            "condition",
            "vital signs include",
            "pulse",
            "min",
            "respiratory rate",
            "min",
            "temperature 36",
            "98",
            "blood pressure 90 60 mm Hg",
            "physical examination",
            "patient",
            "breathing",
            "gives",
            "responses",
            "questions",
            "skin",
            "mucous membranes appear dry",
            "Examination of",
            "abdomen reveals mild diffuse tenderness",
            "palpation",
            "Deep tendon reflexes",
            "extremities",
            "1",
            "Laboratory studies show",
            "Finger stick glucose",
            "mg/dL Arterial blood gas analysis",
            "pH",
            "PO2 90 mm Hg PCO2",
            "HCO3",
            "mEq/L Serum",
            "Sodium",
            "mEq",
            "dL Serum",
            "Urine examination shows",
            "Glucose Positive Ketones",
            "Leukocytes Negative Nitrite",
            "RBCs",
            "Casts Negative",
            "patient",
            "immediately started",
            "bolus",
            "intravenous",
            "0.9",
            "sodium chloride",
            "NaCl",
            "following",
            "next best step",
            "management",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5991,
            "completion_tokens": 3116
        },
        "time_elapsed": 63.348498582839966,
        "raw_responses": [
            "Step 1: This patient presents with classic signs of diabetic ketoacidosis (DKA): high blood glucose (630 mg/dL), metabolic acidosis (pH 7.1, HCO\u2083 8 mEq/L) with an anion gap, as well as ketonuria and dehydration.\n\nStep 2: The initial management of DKA includes fluid resuscitation, which has already been started with 0.9% NaCl. Next, it is crucial to address electrolyte imbalances\u2014especially potassium\u2014because insulin therapy will drive potassium into cells and can precipitate severe hypokalemia if the serum level is low.\n\nStep 3: The laboratory studies show a potassium level of 3.1 mEq/L. Guidelines advise that if the serum potassium is less than 3.3 mEq/L, potassium must be replaced before starting insulin infusion to prevent life-threatening hypokalemia.\n\nStep 4: Evaluating the options:\n\u2022 Option A (Infuse NaHCO\u2083 slowly) is reserved for cases with a pH typically <6.9 and is not indicated here.\n\u2022 Option B (Switch fluids to 0.45% NaCl) is not appropriate at this point as the patient is still hypovolemic.\n\u2022 Option C (Start IV insulin infusion) would be the next step if the potassium level were adequate, but given the current level, it could worsen hypokalemia.\n\u2022 Option D (Replace potassium intravenously) is the correct next step to safely initiate subsequent insulin therapy.\n\nFinal Answer: D. Replace potassium intravenously.",
            "Step 1: The clinical picture is consistent with diabetic ketoacidosis (DKA) given the patient\u2019s history of diabetes, severe hyperglycemia (630 mg/dL), metabolic acidosis (pH 7.1, HCO3 of 8 mEq/L), and the presence of ketones in the urine.\n\nStep 2: In the management of DKA, after the initial fluid resuscitation with isotonic saline (0.9% NaCl), the next steps include checking and correcting electrolyte imbalances\u2014most importantly potassium\u2014before starting insulin therapy. Insulin drives potassium into cells and can worsen hypokalemia.\n\nStep 3: The patient\u2019s serum potassium is 3.1 mEq/L, which is below the recommended threshold (3.3 mEq/L) for initiating insulin therapy. Starting an insulin infusion at this point could lead to life-threatening cardiac arrhythmias due to further decreases in serum potassium.\n\nStep 4: Evaluating the options:\n\u2003A. Infuse NaHCO\u2083 slowly \u2013 Bicarbonate therapy is reserved for severe acidosis (typically pH <6.9) and is not indicated here.\n\u2003B. Switch fluids to 0.45% NaCl \u2013 This is not appropriate at this stage; fluid management with normal saline is continued until blood sugar reaches a safer level.\n\u2003C. Start IV insulin infusion \u2013 Insulin should be delayed until potassium is corrected due to the current hypokalemia.\n\u2003D. Replace potassium intravenously \u2013 This is the correct step, as the low potassium level must be corrected before starting insulin therapy.\n\nFinal answer: D. Replace potassium intravenously.",
            "Step 1: The patient shows signs of diabetic ketoacidosis (DKA) as evidenced by a high blood glucose level (630 mg/dL), positive ketones in the urine, a low pH (7.1), and a low serum bicarbonate (8 mEq/L). She has also been started on IV 0.9% NaCl, which is the appropriate initial fluid resuscitation.\n\nStep 2: Although starting IV insulin is an essential part of DKA management, it must be delayed if the potassium level is too low (in this case, 3.1 mEq/L). Insulin drives potassium into cells, which could further lower the serum potassium level, leading to dangerous hypokalemia and arrhythmias.\n\nStep 3: Therefore, before initiating an insulin infusion, it is crucial to first replace potassium intravenously to bring the level above 3.3 mEq/L.\n\nFinal Answer: D. Replace potassium intravenously."
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: The clinical picture is consistent with diabetic ketoacidosis (DKA) given the patient\u2019s history of diabetes, severe hyperglycemia (630 mg/dL), metabolic acidosis (pH 7.1, HCO3 of 8 mEq/L), and the presence of ketones in the urine.\n\nStep 2: In the management of DKA, after the initial fluid resuscitation with isotonic saline (0.9% NaCl), the next steps include checking and correcting electrolyte imbalances\u2014most importantly potassium\u2014before starting insulin therapy. Insulin drives potassium into cells and can worsen hypokalemia.\n\nStep 3: The patient\u2019s serum potassium is 3.1 mEq/L, which is below the recommended threshold (3.3 mEq/L) for initiating insulin therapy. Starting an insulin infusion at this point could lead to life-threatening cardiac arrhythmias due to further decreases in serum potassium.\n\nStep 4: Evaluating the options:\n\u2003A. Infuse NaHCO\u2083 slowly \u2013 Bicarbonate therapy is reserved for severe acidosis (typically pH <6.9) and is not indicated here.\n\u2003B. Switch fluids to 0.45% NaCl \u2013 This is not appropriate at this stage; fluid management with normal saline is continued until blood sugar reaches a safer level.\n\u2003C. Start IV insulin infusion \u2013 Insulin should be delayed until potassium is corrected due to the current hypokalemia.\n\u2003D. Replace potassium intravenously \u2013 This is the correct step, as the low potassium level must be corrected before starting insulin therapy.\n\nFinal answer: D. Replace potassium intravenously."
    },
    {
        "realidx": 560,
        "question": "A 55-year-old man presents to his primary care physician for a general checkup. The patient has a past medical history of diabetes, hypertension, and atrial fibrillation and is currently taking warfarin, insulin, lisinopril, and metoprolol. The patient\u2019s brother recently died from a heart attack and he has switched to an all vegetarian diet in order to improve his health. His temperature is 98.6\u00b0F (37.0\u00b0C), blood pressure is 167/108 mmHg, pulse is 90/min, respirations are 17/min, and oxygen saturation is 98% on room air. The patient\u2019s physical exam is unremarkable. His laboratory values are ordered as seen below.\n\nHemoglobin: 12 g/dL\nHematocrit: 36%\nLeukocyte count: 7,550/mm^3 with normal differential\nPlatelet count: 197,000/mm^3\nINR: 1.0\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 25 mEq/L\nBUN: 20 mg/dL\nGlucose: 99 mg/dL\nCreatinine: 1.1 mg/dL\nCa2+: 10.2 mg/dL\n\nWhich of the following is the best explanation for this patient\u2019s laboratory values?",
        "answer": "Dietary changes",
        "options": {
            "A": "Dietary changes",
            "B": "Increased hepatic metabolism",
            "C": "Increased renal clearance",
            "D": "Medication noncompliance"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "55 year old man presents",
            "primary care physician",
            "general checkup",
            "patient",
            "past medical diabetes",
            "hypertension",
            "atrial fibrillation",
            "currently taking warfarin",
            "insulin",
            "lisinopril",
            "metoprolol",
            "patients brother recently died",
            "heart attack",
            "switched",
            "vegetarian diet",
            "order to",
            "health",
            "temperature",
            "98",
            "blood pressure",
            "mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "patients physical exam",
            "unremarkable",
            "laboratory values",
            "ordered",
            "seen",
            "Hemoglobin",
            "g/dL Hematocrit",
            "36",
            "Leukocyte count",
            "7 550 mm",
            "normal differential Platelet count",
            "mm",
            "INR",
            "1 0",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L",
            "20 mg/dL Glucose",
            "99 mg/dL Creatinine",
            "1.1 mg/dL Ca2",
            "10",
            "mg/dL",
            "following",
            "best explanation",
            "patients laboratory values"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5319,
            "completion_tokens": 4288
        },
        "time_elapsed": 29.533108949661255,
        "raw_responses": [
            "Step 1: Recognize that the patient is on warfarin for atrial fibrillation and should have a therapeutic INR (typically 2.0\u20133.0), yet his current INR is 1.0, which is subtherapeutic.\n\nStep 2: Note the patient recently switched to an all\u2010vegetarian diet. Many vegetables (especially leafy greens) are high in vitamin K. Increased dietary vitamin K antagonizes the effects of warfarin, thereby lowering the INR.\n\nStep 3: Review the answer choices:\n\u2003A. Dietary changes \u2013 indicates increased vitamin K intake from his new diet interfering with warfarin.\n\u2003B. Increased hepatic metabolism \u2013 there\u2019s no indication of enzyme inducers affecting warfarin.\n\u2003C. Increased renal clearance \u2013 warfarin is not renally cleared, and there\u2019s no evidence of this.\n\u2003D. Medication noncompliance \u2013 while possible, the recent dietary change is a more direct explanation given the context.\n\nFinal Answer: A. Dietary changes",
            "Step 1: The patient is on warfarin, which works by inhibiting vitamin K-dependent clotting factors and is monitored using the INR. An expected therapeutic INR for patients on warfarin is generally between 2.0 and 3.0.\n\nStep 2: His laboratory value shows an INR of 1.0, which is subtherapeutic. This means that the warfarin effect is being diminished.\n\nStep 3: The patient recently switched to an all-vegetarian diet, which likely includes more green leafy vegetables that are high in vitamin K. Increased vitamin K intake antagonizes the effects of warfarin, leading to a lower than expected INR.\n\nStep 4: Options B (increased hepatic metabolism) and C (increased renal clearance) are not likely explanations given that warfarin\u2019s metabolism is not significantly altered by the factors mentioned and the lab findings point to an interaction with vitamin K. Option D (medication noncompliance) is a possibility, but the key change noted in the patient's history is his switch to a vegetarian diet.\n\nFinal Answer: A. Dietary changes",
            "Step 1: The patient is on warfarin for atrial fibrillation, and the goal INR for most indications with warfarin is usually around 2.0 to 3.0. His INR of 1.0 suggests that his warfarin effect is lower than desired.\n\nStep 2: Considering his recent switch to an all vegetarian diet, it is important to remember that green leafy vegetables, which are common in such diets, are high in vitamin K. Vitamin K is a cofactor necessary for the synthesis of clotting factors, and a high intake of vitamin K can counteract the anticoagulant effect of warfarin. This would lead to a lower-than-expected INR.\n\nStep 3: The available options are:\nA. Dietary changes \u2013 Likely explanation, as increased vitamin K intake from his vegetarian diet would decrease warfarin\u2019s effect.\nB. Increased hepatic metabolism \u2013 There is no indication of liver enzyme induction or liver function alteration here.\nC. Increased renal clearance \u2013 This does not affect INR as warfarin is metabolized in the liver.\nD. Medication noncompliance \u2013 While possible, the recent dietary change provides a more direct and likely explanation.\n\nFinal Answer: A. Dietary changes"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Recognize that the patient is on warfarin for atrial fibrillation and should have a therapeutic INR (typically 2.0\u20133.0), yet his current INR is 1.0, which is subtherapeutic.\n\nStep 2: Note the patient recently switched to an all\u2010vegetarian diet. Many vegetables (especially leafy greens) are high in vitamin K. Increased dietary vitamin K antagonizes the effects of warfarin, thereby lowering the INR.\n\nStep 3: Review the answer choices:\n\u2003A. Dietary changes \u2013 indicates increased vitamin K intake from his new diet interfering with warfarin.\n\u2003B. Increased hepatic metabolism \u2013 there\u2019s no indication of enzyme inducers affecting warfarin.\n\u2003C. Increased renal clearance \u2013 warfarin is not renally cleared, and there\u2019s no evidence of this.\n\u2003D. Medication noncompliance \u2013 while possible, the recent dietary change is a more direct explanation given the context.\n\nFinal Answer: A. Dietary changes"
    },
    {
        "realidx": 564,
        "question": "A 35-year-old man visits your office for his annual health checkup. He was diagnosed with generalized anxiety disorder 6 months ago, which is being treated with citalopram. He comments that his symptoms have improved since initiating the prescribed therapy; however, in the past 2 months, he has been unable to have sexual intercourse due to weak tumescence and low libido. His blood pressure is 122/74 mm Hg, heart rate is 75/min, and respiratory rate is 16/min. Physical examination reveals regular heart and lung sounds. What is the appropriate step in the management of this patient?",
        "answer": "Lowering citalopram dose",
        "options": {
            "A": "Lowering citalopram dose",
            "B": "Addition of bupropion",
            "C": "Switch to fluoxetine",
            "D": "Switch to selegiline"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "35 year old man visits",
            "office",
            "annual health",
            "diagnosed",
            "generalized anxiety disorder",
            "months",
            "treated with citalopram",
            "comments",
            "symptoms",
            "improved since initiating",
            "prescribed therapy",
            "past",
            "months",
            "unable to",
            "sexual intercourse due to weak tumescence",
            "low libido",
            "blood pressure",
            "74 mm Hg",
            "heart rate",
            "75 min",
            "respiratory rate",
            "min",
            "Physical examination reveals regular heart",
            "lung sounds",
            "appropriate step",
            "management",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4626,
            "completion_tokens": 3290
        },
        "time_elapsed": 27.244747161865234,
        "raw_responses": [
            "Step 1: Review the Patient\u2019s Presentation\n\u2022 The patient is a 35\u2010year\u2010old man with generalized anxiety disorder (GAD) who is being treated with citalopram, an SSRI.\n\u2022 Although his anxiety symptoms have improved, he is experiencing sexual dysfunction characterized by weak tumescence and low libido, which is a well-known side effect of SSRI therapy.\n\nStep 2: Evaluate the Management Options\nA. Lowering the citalopram dose \u2013 While decreasing the dose might reduce sexual side effects, it could also result in a relapse of his effective anxiety control.\nB. Addition of bupropion \u2013 Bupropion is known to counteract SSRI-induced sexual dysfunction and is sometimes used as an adjunct to maintain therapeutic efficacy while alleviating side effects.\nC. Switch to fluoxetine \u2013 Fluoxetine is another SSRI and shares similar risks for sexual dysfunction, so switching is unlikely to mitigate his symptoms.\nD. Switch to selegiline \u2013 Selegiline is a monoamine oxidase inhibitor (MAOI) used in other conditions (e.g., Parkinson\u2019s disease) but is not a standard treatment for GAD and would not address the sexual side effects.\n\nStep 3: Choose the Appropriate Management\nGiven that his anxiety is well-managed, and the primary issue is SSRI-induced sexual dysfunction, the best strategy is to add bupropion. This approach targets the specific side effect while allowing the patient to maintain his current effective anxiety treatment without compromising efficacy.\n\nFinal Answer: B. Addition of bupropion",
            "Step 1: Recognize that the patient, a 35-year-old man with generalized anxiety disorder, is being treated with citalopram and is now experiencing sexual dysfunction (weak tumescence and low libido), which is a well-known side effect of SSRIs.\n\nStep 2: Evaluate the given options:\n\u2003\u2022 Option A \u2013 Lowering the citalopram dose could potentially reduce sexual side effects, but it might also reduce the therapeutic benefit for his anxiety.\n\u2003\u2022 Option B \u2013 Adding bupropion is a recognized strategy for managing SSRI-induced sexual dysfunction as it can mitigate these side effects without compromising the control of anxiety.\n\u2003\u2022 Option C \u2013 Switching to fluoxetine, another SSRI, would be unlikely to resolve the sexual dysfunction since sexual side effects are common across SSRIs.\n\u2003\u2022 Option D \u2013 Switching to selegiline (a monoamine oxidase inhibitor) is not appropriate for generalized anxiety disorder and carries significant safety concerns.\n\nStep 3: The best management step is to add bupropion to his current regimen to address the sexual side effects while maintaining control over his anxiety symptoms.\n\nFinal Answer: B. Addition of bupropion",
            "Step 1: This patient\u2019s history reveals that he is being treated for generalized anxiety disorder with citalopram (an SSRI), and his anxiety symptoms have improved. However, he now complains of sexual dysfunction (weak tumescence and low libido), which is a common side effect of SSRIs.\n\nStep 2: Reviewing the options:\n\u2022 Lowering the citalopram dose (Option A) might lessen his sexual side effects but risks reducing the efficacy of his treatment for anxiety.\n\u2022 Adding bupropion (Option B) is known to help counteract SSRI-induced sexual dysfunction due to its dopaminergic and noradrenergic properties, without compromising the benefits for anxiety.\n\u2022 Switching to fluoxetine (Option C), another SSRI, would likely continue to cause similar sexual side effects.\n\u2022 Switching to selegiline (Option D), a monoamine oxidase inhibitor, is not indicated for treating generalized anxiety disorder and presents additional risks.\n\nStep 3: The best approach is to add bupropion to his regimen to alleviate the sexual dysfunction while maintaining the therapeutic benefits of citalopram.\n\nFinal Answer: B. Addition of bupropion"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review the Patient\u2019s Presentation\n\u2022 The patient is a 35\u2010year\u2010old man with generalized anxiety disorder (GAD) who is being treated with citalopram, an SSRI.\n\u2022 Although his anxiety symptoms have improved, he is experiencing sexual dysfunction characterized by weak tumescence and low libido, which is a well-known side effect of SSRI therapy.\n\nStep 2: Evaluate the Management Options\nA. Lowering the citalopram dose \u2013 While decreasing the dose might reduce sexual side effects, it could also result in a relapse of his effective anxiety control.\nB. Addition of bupropion \u2013 Bupropion is known to counteract SSRI-induced sexual dysfunction and is sometimes used as an adjunct to maintain therapeutic efficacy while alleviating side effects.\nC. Switch to fluoxetine \u2013 Fluoxetine is another SSRI and shares similar risks for sexual dysfunction, so switching is unlikely to mitigate his symptoms.\nD. Switch to selegiline \u2013 Selegiline is a monoamine oxidase inhibitor (MAOI) used in other conditions (e.g., Parkinson\u2019s disease) but is not a standard treatment for GAD and would not address the sexual side effects.\n\nStep 3: Choose the Appropriate Management\nGiven that his anxiety is well-managed, and the primary issue is SSRI-induced sexual dysfunction, the best strategy is to add bupropion. This approach targets the specific side effect while allowing the patient to maintain his current effective anxiety treatment without compromising efficacy.\n\nFinal Answer: B. Addition of bupropion"
    },
    {
        "realidx": 579,
        "question": "A 59-year-old woman presents to her primary care provider complaining of diffuse bodily aches. She reports a 3-month history of gradually worsening pain in her shoulders and hips that is worse in her right hip. She has a history of hypertension and recurrent renal stones for which she takes lisinopril and hydrochlorothiazide. She was admitted to the hospital earlier in the year after falling in her front yard and sustaining a distal radius fracture and vertebral compression fracture. Her temperature is 98.5\u00b0F (36.9\u00b0C), blood pressure is 145/85 mmHg, pulse is 100/min, and respirations are 20/min. On exam, she is well-appearing with mild tenderness to palpation in her shoulders and hips. She has mild pain with hip flexion and shoulder abduction. She has full range of motion in her bilateral upper and lower extremities. Serum findings are notable for the following:\n\nSerum:\nNa+: 141 mEq/L\nCl-: 100 mEq/L\nK+: 4.8 mEq/L\nHCO3-: 22 mEq/L\nUrea nitrogen: 17 mg/dL\nGlucose: 110 mg/dL\nCreatinine: 1.12 mg/dL\nCa2+: 11.2 mg/dL\nPhosphate: 2.3 mg/dL\nMg2+: 1.9 mg/dL\nAlkaline phosphatase: 120 U/L\n\nA radiograph of this patient\u2019s right hip would most likely reveal which of the following?",
        "answer": "Well-defined cystic lesion with peritrabecular fibrosis",
        "options": {
            "A": "Expansile lytic lesion with thin sclerotic margins",
            "B": "Medullary bone destruction with elevated periosteum from cortical bone",
            "C": "Poorly marginated lesion extending into adjacent soft tissue",
            "D": "Well-defined cystic lesion with peritrabecular fibrosis"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "59 year old woman presents",
            "primary care provider",
            "diffuse",
            "aches",
            "reports",
            "3 month history",
            "worsening pain in",
            "shoulders",
            "hips",
            "worse",
            "right hip",
            "history of hypertension",
            "recurrent renal stones",
            "takes lisinopril",
            "hydrochlorothiazide",
            "admitted",
            "hospital earlier",
            "year",
            "falling",
            "front yard",
            "sustaining",
            "distal radius fracture",
            "vertebral",
            "temperature",
            "98",
            "36",
            "blood pressure",
            "85 mmHg",
            "pulse",
            "100 min",
            "respirations",
            "20 min",
            "exam",
            "well appearing",
            "mild tenderness",
            "palpation",
            "shoulders",
            "hips",
            "mild",
            "hip flexion",
            "shoulder abduction",
            "full range of motion",
            "bilateral upper",
            "lower extremities",
            "Serum findings",
            "notable",
            "following",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4.8 mEq/L HCO3",
            "mEq/L Urea nitrogen",
            "mg/dL Glucose",
            "mg/dL Creatinine",
            "1",
            "mg/dL Ca2",
            "mg/dL Phosphate",
            "2.3 mg/dL Mg2",
            "1.9 mg/dL Alkaline phosphatase",
            "U/L",
            "radiograph of",
            "patients right hip",
            "most likely reveal",
            "following"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6378,
            "completion_tokens": 5246
        },
        "time_elapsed": 88.93604803085327,
        "raw_responses": [
            "Step 1: Recognize the clinical picture. The patient is a 59\u2010year\u2010old woman with diffuse bone pain, a history of fragility fractures (distal radius and vertebral compression fractures), and lab findings showing hypercalcemia (Ca\u00b2\u207a: 11.2 mg/dL) and hypophosphatemia (Phosphate: 2.3 mg/dL). These findings are classic for primary hyperparathyroidism, which leads to increased osteoclastic activity.\n\nStep 2: Connect to radiographic findings. In primary hyperparathyroidism, chronic elevations in parathyroid hormone can lead to osteitis fibrosa cystica. This condition is characterized by fibrous replacement of bone and the formation of \u201cbrown tumors,\u201d which represent localized lytic lesions. Radiographs of affected bones (such as the hip) typically reveal expansile lytic lesions with thin, sclerotic margins.\n\nStep 3: Evaluate the answer choices.  \nA. Expansile lytic lesion with thin sclerotic margins \u2013 This description fits the radiographic appearance of a brown tumor in osteitis fibrosa cystica.  \nB. Medullary bone destruction with elevated periosteum from cortical bone \u2013 Suggests an aggressive process, more in line with an infection or malignant tumor.  \nC. Poorly marginated lesion extending into adjacent soft tissue \u2013 This describes a malignant process such as a metastatic lesion.  \nD. Well-defined cystic lesion with peritrabecular fibrosis \u2013 Not typical for brown tumors seen in primary hyperparathyroidism.\n\nFinal Answer: A",
            "Step 1: Recognize a pattern. The patient\u2019s complaints of diffuse pain, fractures (distal radius and vertebral compression), and a history of renal stones coupled with her laboratory values (elevated calcium at 11.2 mg/dL and low phosphate at 2.3 mg/dL) point toward a diagnosis of primary hyperparathyroidism. In primary hyperparathyroidism, excessive parathyroid hormone causes bone resorption, leading to osteitis fibrosa cystica (also known as \u201cbrown tumors\u201d).\n\nStep 2: Know the radiographic findings. Osteitis fibrosa cystica typically appears on radiographs as well-defined cystic lesions that may have peritrabecular fibrosis (due to the repair process around the resorptive lesions), leading to the characteristic \"brown tumors\" seen in hyperparathyroidism.\n\nStep 3: Evaluate the options.  \nA. Expansile lytic lesion with thin sclerotic margins \u2013 More consistent with lesions like a giant cell tumor.  \nB. Medullary bone destruction with elevated periosteum from cortical bone \u2013 Suggestive of an aggressive process, not typical for osteitis fibrosa cystica.  \nC. Poorly marginated lesion extending into adjacent soft tissue \u2013 This finding is more characteristic of a malignant process.  \nD. Well-defined cystic lesion with peritrabecular fibrosis \u2013 This is classic for osteitis fibrosa cystica secondary to primary hyperparathyroidism.\n\nFinal Answer: D",
            "Let's break down the case step by step:\n\n1. The patient is a 59-year-old woman with diffuse pain in her shoulders and hips, along with a history of fractures (distal radius and vertebral compression) and recurrent kidney stones.\n\n2. Her serum studies reveal an elevated calcium level (11.2 mg/dL) alongside a low phosphate level (2.3 mg/dL). This combination is classic for primary hyperparathyroidism.\n\n3. Primary hyperparathyroidism can lead to osteitis fibrosa cystica, a condition where excessive parathyroid hormone causes bone demineralization and the formation of lytic bone lesions called \"brown tumors.\" These lesions are typically described as expansile lytic lesions with thin sclerotic margins.\n\n4. Evaluating the options:\n\u2003A. Expansile lytic lesion with thin sclerotic margins \u2013 This description fits the radiographic appearance of bone changes seen in osteitis fibrosa cystica due to primary hyperparathyroidism.\n\u2003B. Medullary bone destruction with elevated periosteum from cortical bone \u2013 This pattern is more typical of an aggressive process such as a malignant bone tumor.\n\u2003C. Poorly marginated lesion extending into adjacent soft tissue \u2013 This suggests an aggressive, malignant lesion, which isn't consistent with the described biochemical picture.\n\u2003D. Well-defined cystic lesion with peritrabecular fibrosis \u2013 This is not characteristic of the changes seen in primary hyperparathyroidism.\n\n5. Based on the history, labs, and typical imaging findings, the most likely radiographic finding is that described in option A.\n\nFinal Answer: A"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Recognize the clinical picture. The patient is a 59\u2010year\u2010old woman with diffuse bone pain, a history of fragility fractures (distal radius and vertebral compression fractures), and lab findings showing hypercalcemia (Ca\u00b2\u207a: 11.2 mg/dL) and hypophosphatemia (Phosphate: 2.3 mg/dL). These findings are classic for primary hyperparathyroidism, which leads to increased osteoclastic activity.\n\nStep 2: Connect to radiographic findings. In primary hyperparathyroidism, chronic elevations in parathyroid hormone can lead to osteitis fibrosa cystica. This condition is characterized by fibrous replacement of bone and the formation of \u201cbrown tumors,\u201d which represent localized lytic lesions. Radiographs of affected bones (such as the hip) typically reveal expansile lytic lesions with thin, sclerotic margins.\n\nStep 3: Evaluate the answer choices.  \nA. Expansile lytic lesion with thin sclerotic margins \u2013 This description fits the radiographic appearance of a brown tumor in osteitis fibrosa cystica.  \nB. Medullary bone destruction with elevated periosteum from cortical bone \u2013 Suggests an aggressive process, more in line with an infection or malignant tumor.  \nC. Poorly marginated lesion extending into adjacent soft tissue \u2013 This describes a malignant process such as a metastatic lesion.  \nD. Well-defined cystic lesion with peritrabecular fibrosis \u2013 Not typical for brown tumors seen in primary hyperparathyroidism.\n\nFinal Answer: A"
    },
    {
        "realidx": 583,
        "question": "A 46-year-old woman presents to her primary care physician with one week of intermittent nausea and vomiting. She does not have any sick contacts, and her medical history is significant only for diabetes well-controlled on metformin. She also complains of some weakness and back/leg pain. She says that she recently returned from traveling abroad and had been administered an antibiotic during her travels for an unknown infection. On presentation, her temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 119/78 mmHg, pulse is 62/min, and respirations are 25/min. An EKG is obtained showing flattening of the T wave. After further testing, the physician prescribes a thiazide for this patient. Which of the following diseases is also associated with this patient's most likely diagnosis?",
        "answer": "Wilson disease",
        "options": {
            "A": "Rheumatoid arthritis",
            "B": "Sjogren syndrome",
            "C": "Systemic lupus erythematosus",
            "D": "Wilson disease"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old woman presents",
            "primary care physician",
            "one week",
            "intermittent nausea",
            "vomiting",
            "not",
            "sick contacts",
            "medical history",
            "significant only",
            "diabetes well-controlled",
            "metformin",
            "weakness",
            "back leg",
            "recently returned",
            "traveling abroad",
            "administered",
            "antibiotic",
            "travels",
            "unknown infection",
            "presentation",
            "temperature",
            "98",
            "blood pressure",
            "mmHg",
            "pulse",
            "62 min",
            "respirations",
            "min",
            "EKG",
            "obtained showing flattening",
            "T wave",
            "further testing",
            "physician",
            "thiazide",
            "patient",
            "following diseases",
            "associated with",
            "patient's",
            "likely diagnosis"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 6372,
            "completion_tokens": 17570
        },
        "time_elapsed": 110.2589168548584,
        "raw_responses": [
            "Step 1: Recognize the Clues\n\u2022 The patient is a 46\u2010year\u2010old woman presenting with nausea, vomiting, weakness, and back/leg pain.\n\u2022 The EKG shows flattened T waves, a finding commonly seen in hypokalemia.\n\u2022 Her recent travel and antibiotic use may be a distractor or could have precipitated an underlying process.\n\u2022 Importantly, further testing led the physician to prescribe a thiazide diuretic. Thiazides are used in the management of conditions that cause hypercalciuria (i.e. excessive urinary calcium loss), such as distal (Type 1) Renal Tubular Acidosis (RTA).\n\nStep 2: Understand the Underlying Diagnosis\n\u2022 Distal RTA is characterized by the inability of the distal nephron to properly excrete acid. It typically causes:\n\u2003 \u2013 A metabolic acidosis.\n\u2003 \u2013 Hypokalemia, which can manifest as muscle weakness and characteristic EKG changes.\n\u2003 \u2013 Hypercalciuria, predisposing to nephrolithiasis; thiazides are used to reduce urinary calcium excretion.\n\u2022 In adults, particularly middle-aged women, distal RTA is frequently associated with autoimmune conditions.\n\nStep 3: Compare the Answer Options\n\u2022 Rheumatoid arthritis \u2013 Although it is autoimmune, it is less classically associated with distal RTA.\n\u2022 Sjogren syndrome \u2013 This is well known to be linked with distal RTA.\n\u2022 Systemic lupus erythematosus \u2013 Can have renal involvement, but it is not as strongly tied to distal RTA as Sjogren syndrome.\n\u2022 Wilson disease \u2013 A disorder of copper metabolism that is not implicated in this renal tubular dysfunction.\n\nStep 4: Final Answer\nThe disease also associated with the patient\u2019s most likely diagnosis (distal RTA) is Sjogren syndrome.\n\nFinal answer: B. Sjogren syndrome",
            "Step 1: Recognize the key findings.  \n\u2022 The patient is a middle\u2010aged woman with nausea, vomiting, muscle weakness, and back/leg pain.  \n\u2022 The EKG reveals flattening of the T waves, a sign of hypokalemia.  \n\nStep 2: Consider the physiologic implications.  \nThe clinical picture is most consistent with an electrolyte abnormality involving low potassium. The examiner also states that \u201cafter further testing, the physician prescribes a thiazide,\u201d hinting at a connection between the clinical findings and what is seen with thiazide diuretic use. Thiazides act at the distal convoluted tubule by inhibiting the Na\u207a/Cl\u207b cotransporter, and their chronic use reproduces a syndrome characterized by hypokalemia, metabolic alkalosis, hypomagnesemia, and hypocalciuria.\n\nStep 3: Link to a disease process.  \nGitelman syndrome is a hereditary disorder that mimics the chronic effects of thiazide diuretic use because of a mutation in the thiazide\u2010sensitive Na\u207a/Cl\u207b cotransporter. Patients typically present in late childhood or adulthood with symptoms such as weakness, muscle cramps, and fatigue. The EKG finding (flattened T waves) is consistent with hypokalemia seen in this condition.\n\nStep 4: Identify the associated condition.  \nAcquired Gitelman\u2010like syndrome can also be seen in association with an autoimmune disease. Among the provided options, Sjogren syndrome has been linked to an acquired defect in the Na\u207a/Cl\u207b cotransporter resulting in a clinical picture similar to Gitelman syndrome.\n\nStep 5: Compare the options.  \nA. Rheumatoid arthritis \u2013 Not known to cause a thiazide\u2010like tubulopathy.  \nB. Sjogren syndrome \u2013 Has been associated with a Gitelman\u2010like renal tubular defect.  \nC. Systemic lupus erythematosus \u2013 Can involve the kidneys, but typically causes glomerulonephritis, not a defect mimicking thiazide use.  \nD. Wilson disease \u2013 A disorder of copper metabolism affecting the liver and brain, not the renal tubules.\n\nFinal Answer: B. Sjogren syndrome",
            "Step 1 \u2013 Identify the Clues:  \n\u2022 The patient is a 46\u2010year\u2010old woman with a week-long history of intermittent nausea, vomiting, weakness, and back/leg pain.  \n\u2022 Her EKG shows flattening of the T waves, which is a classic sign of hypokalemia.  \n\u2022 \u201cAfter further testing, the physician prescribes a thiazide.\u201d Thiazide diuretics have the effect of lowering urinary calcium excretion and are used in certain conditions with calcium kidney stones.\n\nStep 2 \u2013 Narrowing the Differential Diagnosis:  \n\u2022 Hypokalemia in the setting of a normal blood pressure can be seen in a renal tubular acidosis (RTA).  \n\u2022 In distal (type 1) RTA, the distal tubule is unable to excrete acid properly. This leads to metabolic acidosis, but patients paradoxically can develop hypokalemia. In addition, dRTA is associated with hypercalciuria, which causes kidney stones and can result in bone pain.  \n\u2022 Thiazide diuretics are used to decrease urinary calcium excretion; hence, their prescription raises concern for underlying hypercalciuria and nephrolithiasis related to dRTA.\n\nStep 3 \u2013 Associated Conditions:  \nAmong the choices provided, Sj\u00f6gren syndrome is known for its association with distal RTA. Patients with Sj\u00f6gren syndrome frequently develop autoimmune destruction that impairs the acidification capacity of the distal tubule, leading to dRTA with its accompanying hypokalemia and predisposition to calcium kidney stones.\n\nStep 4 \u2013 Compare and Eliminate Incorrect Choices:  \n\u2022 Rheumatoid arthritis \u2013 Although an autoimmune disease, it is not classically associated with RTA.  \n\u2022 Systemic lupus erythematosus \u2013 Can affect the kidneys via lupus nephritis but is not typically linked to a distal tubular acidification defect resulting in dRTA.  \n\u2022 Wilson disease \u2013 A disorder of copper metabolism with liver and neuropsychiatric findings; it is not linked to a renal tubular acidification defect.\n\nStep 5 \u2013 Final Answer:  \nThe disease associated with this patient\u2019s most likely diagnosis (distal RTA) is Sj\u00f6gren syndrome.\n\nFinal answer: B. Sj\u00f6gren syndrome."
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "1"
        ],
        "final_solution": "Step 1 \u2013 Identify the Clues:  \n\u2022 The patient is a 46\u2010year\u2010old woman with a week-long history of intermittent nausea, vomiting, weakness, and back/leg pain.  \n\u2022 Her EKG shows flattening of the T waves, which is a classic sign of hypokalemia.  \n\u2022 \u201cAfter further testing, the physician prescribes a thiazide.\u201d Thiazide diuretics have the effect of lowering urinary calcium excretion and are used in certain conditions with calcium kidney stones.\n\nStep 2 \u2013 Narrowing the Differential Diagnosis:  \n\u2022 Hypokalemia in the setting of a normal blood pressure can be seen in a renal tubular acidosis (RTA).  \n\u2022 In distal (type 1) RTA, the distal tubule is unable to excrete acid properly. This leads to metabolic acidosis, but patients paradoxically can develop hypokalemia. In addition, dRTA is associated with hypercalciuria, which causes kidney stones and can result in bone pain.  \n\u2022 Thiazide diuretics are used to decrease urinary calcium excretion; hence, their prescription raises concern for underlying hypercalciuria and nephrolithiasis related to dRTA.\n\nStep 3 \u2013 Associated Conditions:  \nAmong the choices provided, Sj\u00f6gren syndrome is known for its association with distal RTA. Patients with Sj\u00f6gren syndrome frequently develop autoimmune destruction that impairs the acidification capacity of the distal tubule, leading to dRTA with its accompanying hypokalemia and predisposition to calcium kidney stones.\n\nStep 4 \u2013 Compare and Eliminate Incorrect Choices:  \n\u2022 Rheumatoid arthritis \u2013 Although an autoimmune disease, it is not classically associated with RTA.  \n\u2022 Systemic lupus erythematosus \u2013 Can affect the kidneys via lupus nephritis but is not typically linked to a distal tubular acidification defect resulting in dRTA.  \n\u2022 Wilson disease \u2013 A disorder of copper metabolism with liver and neuropsychiatric findings; it is not linked to a renal tubular acidification defect.\n\nStep 5 \u2013 Final Answer:  \nThe disease associated with this patient\u2019s most likely diagnosis (distal RTA) is Sj\u00f6gren syndrome.\n\nFinal answer: B. Sj\u00f6gren syndrome."
    },
    {
        "realidx": 587,
        "question": "A 33-year-old G2P1 woman presents to the office because of poor diabetic control. She is currently at 18 weeks gestation and admits to having poor control of her type 1 diabetes before becoming pregnant. Her family history is non-contributory. The physical examination shows a pregnant woman with a fundal height of 20 cm (7.9 in). An abdominal ultrasound is ordered. Which of the following is the most likely congenital abnormality shown on the ultrasound?",
        "answer": "Ventricular septal defect",
        "options": {
            "A": "Amelia",
            "B": "Sacral agenesis",
            "C": "Spina bifida",
            "D": "Ventricular septal defect"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old",
            "woman presents",
            "office",
            "poor diabetic control",
            "currently",
            "weeks gestation",
            "admits",
            "poor control",
            "type 1 diabetes",
            "pregnant",
            "family history",
            "non contributory",
            "physical examination shows",
            "pregnant woman",
            "fundal height",
            "20",
            "abdominal ultrasound",
            "ordered",
            "following",
            "most likely congenital abnormality shown",
            "ultrasound"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 3864,
            "completion_tokens": 2342
        },
        "time_elapsed": 52.65871334075928,
        "raw_responses": [
            "Step 1: Given that the patient has poorly controlled type 1 diabetes prior to and during early pregnancy, one must be alert to congenital malformations associated with maternal hyperglycemia.\n\nStep 2: Maternal diabetes is classically associated with caudal regression syndrome, which involves the abnormal development of the lower spine (sacral agenesis). Although other congenital anomalies, such as ventricular septal defects and neural tube defects like spina bifida, can occur, sacral agenesis is particularly linked to poor glycemic control during early fetal development.\n\nStep 3: Evaluating the options:\nA. Amelia \u2013 limb absence, not associated with maternal diabetes.\nB. Sacral agenesis \u2013 directly associated with maternal diabetes.\nC. Spina bifida \u2013 a neural tube defect; while neural tube defects can be associated with poor glycemic control, sacral agenesis is more specific.\nD. Ventricular septal defect \u2013 while a potential cardiac defect, it is less specific than the association with sacral agenesis in diabetic pregnancies.\n\nFinal answer: B. Sacral agenesis",
            "Step 1: Maternal diabetes, especially when poorly controlled early in pregnancy, increases the risk of fetal congenital abnormalities. One class of these congenital defects includes neural tube defects, with caudal regression syndrome (sacral agenesis) being particularly associated with maternal diabetes.\n\nStep 2: Evaluate the options:\n\u2022 Amelia (absence of one or more limbs) is not strongly linked to maternal diabetes.\n\u2022 Sacral agenesis is associated with poor diabetic control.\n\u2022 Spina bifida is a neural tube defect, but sacral agenesis is more specifically tied to maternal diabetes.\n\u2022 Ventricular septal defect (VSD) is a cardiac defect; though cardiac defects are increased in diabetic pregnancies, sacral agenesis is more characteristic in this setting.\n\nStep 3: The most likely abnormality in this scenario is sacral agenesis.\n\nFinal answer: B. Sacral agenesis",
            "Step 1: Understand the patient's background. This 33-year-old woman with type 1 diabetes had poor glycemic control before pregnancy, which is known to increase the risk of congenital malformations.\n\nStep 2: Recognize the specific congenital abnormality most classically associated with maternal diabetes. Poor glycemic control in early pregnancy is particularly linked with caudal regression syndrome (sacral agenesis).\n\nStep 3: Evaluate the options:\n\u2003A. Amelia \u2013 Limb absence, not typically associated with maternal diabetes.\n\u2003B. Sacral agenesis \u2013 Directly associated with poor glycemic control in type 1 diabetic mothers.\n\u2003C. Spina bifida \u2013 Neural tube defect, can be associated with diabetes, but sacral agenesis is more specific.\n\u2003D. Ventricular septal defect \u2013 A common congenital heart defect, but not as directly linked to diabetic teratogenicity as sacral agenesis.\n\nFinal Answer: B. Sacral agenesis"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Understand the patient's background. This 33-year-old woman with type 1 diabetes had poor glycemic control before pregnancy, which is known to increase the risk of congenital malformations.\n\nStep 2: Recognize the specific congenital abnormality most classically associated with maternal diabetes. Poor glycemic control in early pregnancy is particularly linked with caudal regression syndrome (sacral agenesis).\n\nStep 3: Evaluate the options:\n\u2003A. Amelia \u2013 Limb absence, not typically associated with maternal diabetes.\n\u2003B. Sacral agenesis \u2013 Directly associated with poor glycemic control in type 1 diabetic mothers.\n\u2003C. Spina bifida \u2013 Neural tube defect, can be associated with diabetes, but sacral agenesis is more specific.\n\u2003D. Ventricular septal defect \u2013 A common congenital heart defect, but not as directly linked to diabetic teratogenicity as sacral agenesis.\n\nFinal Answer: B. Sacral agenesis"
    },
    {
        "realidx": 596,
        "question": "Six hours after birth, a newborn boy is evaluated for tachypnea. He was delivered at 41 weeks' gestation via Caesarian section and the amniotic fluid was meconium-stained. His respiratory rate is 75/min. Physical examination shows increased work of breathing. X-rays of the abdomen and chest show no abnormalities. Echocardiography shows elevated pulmonary artery pressure. He is started on an inhaled medication that increases smooth muscle cGMP, and there is immediate improvement in his tachypnea and oxygenation status. Three hours later, the newborn is tachypneic and there is blue-grey discoloration of the lips, fingers, and toes. Which of the following is the most likely cause of this infant's cyanosis?",
        "answer": "Oxidization of Fe2+ to Fe3+",
        "options": {
            "A": "Increase in concentration of serum myoglobin",
            "B": "Closure of the ductus arteriosus",
            "C": "Oxidization of Fe2+ to Fe3+",
            "D": "Allosteric alteration of heme groups"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "Six hours after birth",
            "newborn boy",
            "evaluated",
            "tachypnea",
            "delivered",
            "weeks",
            "gestation",
            "Caesarian section",
            "amniotic fluid",
            "meconium stained",
            "respiratory rate",
            "75 min",
            "Physical examination shows increased work of breathing",
            "X-rays of",
            "abdomen",
            "chest show",
            "abnormalities",
            "Echocardiography shows elevated pulmonary artery pressure",
            "started",
            "inhaled medication",
            "increases smooth muscle cGMP",
            "immediate improvement",
            "tachypnea",
            "oxygenation status",
            "Three hours later",
            "newborn",
            "tachypneic",
            "blue grey discoloration",
            "lips",
            "fingers",
            "toes",
            "following",
            "most likely cause",
            "infant's cyanosis"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5229,
            "completion_tokens": 3364
        },
        "time_elapsed": 404.3713188171387,
        "raw_responses": [
            "Step 1: The infant was treated with an inhaled medication that increases smooth muscle cGMP\u2014this refers to inhaled nitric oxide, which causes pulmonary vasodilation in cases of persistent pulmonary hypertension of the newborn.\n\nStep 2: A known complication of nitric oxide therapy is methemoglobinemia. Methemoglobinemia occurs when the ferrous iron (Fe2+) in hemoglobin is oxidized to ferric iron (Fe3+), which impairs oxygen binding and reduces the blood's oxygen-carrying capacity, leading to cyanosis.\n\nStep 3: Reviewing the options:\n\u2022 A. Increase in concentration of serum myoglobin \u2013 Irrelevant in this context.\n\u2022 B. Closure of the ductus arteriosus \u2013 Not the cause, as the improvement was due to nitric oxide and this option does not explain the cyanosis.\n\u2022 C. Oxidization of Fe2+ to Fe3+ \u2013 Correct, this describes methemoglobinemia.\n\u2022 D. Allosteric alteration of heme groups \u2013 Does not accurately reflect the process caused by nitric oxide.\n\nFinal Answer: C. Oxidization of Fe2+ to Fe3+",
            "Step 1: Identify the clinical scenario. This full\u2010term newborn, born via Caesarian section with meconium-stained fluid, initially presented with signs consistent with persistent pulmonary hypertension of the newborn (PPHN). He was treated with inhaled nitric oxide, which increases smooth muscle cGMP, leading to vasodilation of the pulmonary vessels and improvement of oxygenation.\n\nStep 2: Recognize the complication. Three hours later, the infant becomes cyanotic with blue-grey discoloration of the lips, fingers, and toes. A known complication associated with inhaled nitric oxide is methemoglobinemia. In methemoglobinemia, the iron in hemoglobin is oxidized from its ferrous (Fe2+) state to the ferric (Fe3+) state, which impairs oxygen binding and delivery to tissues, resulting in cyanosis.\n\nStep 3: Evaluate the options.  \nA. Increase in concentration of serum myoglobin \u2013 This is unrelated to the methemoglobin formation.  \nB. Closure of the ductus arteriosus \u2013 While ductal closure may occur naturally or be induced for other reasons, it does not explain the cyanosis due to impaired oxygen transport seen here.  \nC. Oxidization of Fe2+ to Fe3+ \u2013 This is exactly what occurs in methemoglobinemia, the likely complication from inhaled nitric oxide therapy.  \nD. Allosteric alteration of heme groups \u2013 This option does not accurately describe the pathophysiology of methemoglobinemia.\n\nStep 4: Provide the final answer.  \nThe correct answer is: C. Oxidization of Fe2+ to Fe3+.",
            "Step 1: Analyze the newborn\u2019s presentation. This full-term infant, delivered via Caesarian section with meconium staining, presents with tachypnea and signs of increased work of breathing. Echocardiography indicates elevated pulmonary artery pressure, which is consistent with persistent pulmonary hypertension of the newborn (PPHN).\n\nStep 2: Review the treatment given. The infant was started on an inhaled medication that increases smooth muscle cGMP. This treatment is inhaled nitric oxide (NO), which is used in PPHN to relax pulmonary vascular smooth muscle and improve oxygenation.\n\nStep 3: Recognize the complication that developed. Although the infant initially improved, three hours later he developed recurrent tachypnea and cyanosis (blue-grey discoloration). One known complication of inhaled nitric oxide therapy is the development of methemoglobinemia. In methemoglobinemia, the ferrous component (Fe2+) in hemoglobin is oxidized to the ferric state (Fe3+), which impairs oxygen delivery to tissues and results in cyanosis.\n\nStep 4: Evaluate the answer choices:\nA. Increase in concentration of serum myoglobin \u2013 This is not related to the mechanism of NO therapy.\nB. Closure of the ductus arteriosus \u2013 Closure of the ductus arteriosus does not cause severe cyanosis in this context.\nC. Oxidization of Fe2+ to Fe3+ \u2013 This directly describes the conversion in methemoglobinemia induced by inhaled nitric oxide.\nD. Allosteric alteration of heme groups \u2013 This option does not describe the known side effect of NO therapy.\n\nFinal Answer: C. Oxidization of Fe2+ to Fe3+"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Analyze the newborn\u2019s presentation. This full-term infant, delivered via Caesarian section with meconium staining, presents with tachypnea and signs of increased work of breathing. Echocardiography indicates elevated pulmonary artery pressure, which is consistent with persistent pulmonary hypertension of the newborn (PPHN).\n\nStep 2: Review the treatment given. The infant was started on an inhaled medication that increases smooth muscle cGMP. This treatment is inhaled nitric oxide (NO), which is used in PPHN to relax pulmonary vascular smooth muscle and improve oxygenation.\n\nStep 3: Recognize the complication that developed. Although the infant initially improved, three hours later he developed recurrent tachypnea and cyanosis (blue-grey discoloration). One known complication of inhaled nitric oxide therapy is the development of methemoglobinemia. In methemoglobinemia, the ferrous component (Fe2+) in hemoglobin is oxidized to the ferric state (Fe3+), which impairs oxygen delivery to tissues and results in cyanosis.\n\nStep 4: Evaluate the answer choices:\nA. Increase in concentration of serum myoglobin \u2013 This is not related to the mechanism of NO therapy.\nB. Closure of the ductus arteriosus \u2013 Closure of the ductus arteriosus does not cause severe cyanosis in this context.\nC. Oxidization of Fe2+ to Fe3+ \u2013 This directly describes the conversion in methemoglobinemia induced by inhaled nitric oxide.\nD. Allosteric alteration of heme groups \u2013 This option does not describe the known side effect of NO therapy.\n\nFinal Answer: C. Oxidization of Fe2+ to Fe3+"
    },
    {
        "realidx": 616,
        "question": "A 31-year-old man presents to his primary care physician with fevers, chills, and night sweats. After a physical exam and a series of laboratory tests, the patient undergoes a lymph node biopsy (Image A). Three days later, while awaiting treatment, he presents to his physician complaining of generalized swelling and is found to have 4+ protein in his urine. Which of the following pathological findings is most likely to be found on renal biopsy in this patient?",
        "answer": "Minimal change disease",
        "options": {
            "A": "Rapidly progresive glomerulonephritis",
            "B": "Amyloidosis",
            "C": "Focal segmental glomerulosclerosis",
            "D": "Minimal change disease"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "31 year old man presents",
            "primary care physician",
            "fevers",
            "chills",
            "night sweats",
            "physical exam",
            "series",
            "laboratory tests",
            "patient",
            "lymph node biopsy",
            "Image",
            "Three days later",
            "treatment",
            "presents",
            "physician",
            "generalized swelling",
            "found to",
            "4",
            "protein in",
            "urine",
            "following pathological findings",
            "most likely to",
            "found",
            "renal biopsy",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4275,
            "completion_tokens": 3623
        },
        "time_elapsed": 28.60465407371521,
        "raw_responses": [
            "Step-by-step reasoning:\n\n1. The patient\u2019s symptoms (fevers, chills, and night sweats) together with the lymph node biopsy strongly suggest a lymphoma, most commonly Hodgkin\u2019s lymphoma in someone of this age.\n\n2. Hodgkin\u2019s lymphoma is classically associated with a paraneoplastic syndrome that affects the kidneys. In particular, patients with Hodgkin\u2019s lymphoma can develop a nephrotic syndrome.\n\n3. The renal manifestation in Hodgkin\u2019s lymphoma is most often due to minimal change disease (MCD), which leads to significant proteinuria (as evidenced here by 4+ protein on exam).\n\n4. On renal biopsy, minimal change disease will show effacement of the podocyte foot processes on electron microscopy, with little to no changes seen on light microscopy.\n\n5. Reviewing the options:\n\u2003A. Rapidly progressive glomerulonephritis \u2013 the clinical picture does not indicate an RPGN.\n\u2003B. Amyloidosis \u2013 although it can cause proteinuria, it typically develops after a chronic inflammatory process.\n\u2003C. Focal segmental glomerulosclerosis \u2013 more commonly associated with other conditions such as HIV or obesity, not Hodgkin\u2019s lymphoma.\n\u2003D. Minimal change disease \u2013 the best match for paraneoplastic nephrotic syndrome due to Hodgkin\u2019s lymphoma.\n\nFinal answer: D. Minimal change disease.",
            "Step 1: The patient exhibits B symptoms (fevers, chills, night sweats) and underwent a lymph node biopsy, which is highly suggestive of lymphoma. One common subtype of lymphoma known to cause paraneoplastic renal complications is Hodgkin lymphoma.\n\nStep 2: Among the options provided, minimal change disease (MCD) is classically associated with Hodgkin lymphoma. Patients with Hodgkin lymphoma can develop MCD due to the cytokine release affecting podocyte function, leading to diffuse effacement of foot processes and resultant proteinuria. \n\nAmyloidosis is usually linked to chronic inflammatory conditions but is not as strongly associated with Hodgkin lymphoma. Rapidly progressive glomerulonephritis and focal segmental glomerulosclerosis are less likely in this context.\n\nStep 3: Final Answer: D. Minimal change disease",
            "Step 1: The patient's symptoms\u2014fevers, chills, and night sweats\u2014along with a lymph node biopsy that reveals an underlying lymphoproliferative disorder (likely Hodgkin lymphoma given his age and \"B\" symptoms) point toward a diagnosis of lymphoma.\n\nStep 2: A known complication of Hodgkin lymphoma is nephrotic syndrome, which in this context is most commonly associated with minimal change disease. The sudden onset of generalized edema and proteinuria (4+ protein in the urine) supports an underlying nephrotic picture.\n\nStep 3: Examining the options:\n\u2003A. Rapidly progressive glomerulonephritis \u2013 This is characterized by a rapid decline in renal function and crescent formation on biopsy, which is not typical in the setting of lymphomas.\n\u2003B. Amyloidosis \u2013 Although amyloidosis can lead to nephrotic syndrome in chronic inflammatory conditions, its development usually occurs over a longer time, making it less likely in this acute presentation.\n\u2003C. Focal segmental glomerulosclerosis \u2013 This generally presents in association with conditions like HIV, heroin use, or obesity; it is not the classic finding in Hodgkin lymphoma.\n\u2003D. Minimal change disease \u2013 This is most strongly associated with Hodgkin lymphoma. On renal biopsy, it would show effacement of the podocyte foot processes on electron microscopy without significant immune complex deposition.\n\nFinal Answer: D. Minimal change disease."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: The patient's symptoms\u2014fevers, chills, and night sweats\u2014along with a lymph node biopsy that reveals an underlying lymphoproliferative disorder (likely Hodgkin lymphoma given his age and \"B\" symptoms) point toward a diagnosis of lymphoma.\n\nStep 2: A known complication of Hodgkin lymphoma is nephrotic syndrome, which in this context is most commonly associated with minimal change disease. The sudden onset of generalized edema and proteinuria (4+ protein in the urine) supports an underlying nephrotic picture.\n\nStep 3: Examining the options:\n\u2003A. Rapidly progressive glomerulonephritis \u2013 This is characterized by a rapid decline in renal function and crescent formation on biopsy, which is not typical in the setting of lymphomas.\n\u2003B. Amyloidosis \u2013 Although amyloidosis can lead to nephrotic syndrome in chronic inflammatory conditions, its development usually occurs over a longer time, making it less likely in this acute presentation.\n\u2003C. Focal segmental glomerulosclerosis \u2013 This generally presents in association with conditions like HIV, heroin use, or obesity; it is not the classic finding in Hodgkin lymphoma.\n\u2003D. Minimal change disease \u2013 This is most strongly associated with Hodgkin lymphoma. On renal biopsy, it would show effacement of the podocyte foot processes on electron microscopy without significant immune complex deposition.\n\nFinal Answer: D. Minimal change disease."
    },
    {
        "realidx": 627,
        "question": "A 30-year-old G4P3 woman at 38 weeks gestation is admitted to the labor and delivery unit complaining of contractions every 5 minutes for the past hour. Her previous births have been via uncomplicated caesarean sections, but she wishes to attempt vaginal delivery this time. Her prenatal care is notable for gestational diabetes controlled with diet and exercise. The delivery is prolonged, but the patient's pain is controlled with epidural analgesia. She delivers a male infant with Apgar scores of 8 and 9 at 1 and 5 minutes, respectively. Fundal massage is performed, but the placenta does not pass. The obstetrician manually removes the placenta, but a red mass protrudes through the vagina attached to the placenta. The patient loses 500 mL of blood over the next minute, during which her blood pressure decreases from 120/80 mmHg to 90/65 mmHg. What is the best next step in management?",
        "answer": "Elevate posterior fornix",
        "options": {
            "A": "Hysterectomy",
            "B": "Intravenous oxytocin",
            "C": "Elevate posterior fornix",
            "D": "Red blood cell transfusion"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "30 year old",
            "woman",
            "weeks",
            "admitted",
            "labor",
            "delivery unit",
            "contractions",
            "5 minutes",
            "past hour",
            "previous births",
            "uncomplicated caesarean sections",
            "wishes to attempt vaginal delivery",
            "time",
            "prenatal care",
            "notable",
            "gestational diabetes controlled",
            "diet",
            "exercise",
            "delivery",
            "prolonged",
            "patient's pain",
            "controlled",
            "epidural analgesia",
            "delivers",
            "male infant",
            "Apgar scores",
            "8",
            "5 minutes",
            "Fundal massage",
            "performed",
            "placenta",
            "not pass",
            "obstetrician manually removes",
            "placenta",
            "red mass",
            "vagina attached",
            "placenta",
            "patient",
            "500 mL",
            "blood",
            "next minute",
            "blood pressure decreases",
            "80 mmHg",
            "90 65 mmHg",
            "best next step",
            "management"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5886,
            "completion_tokens": 7538
        },
        "time_elapsed": 50.340165853500366,
        "raw_responses": [
            "Step 1: Analyze the scenario.  \n\u2022 The patient is a 30-year-old woman at 38 weeks gestation who has just delivered via a trial of vaginal birth after cesarean.  \n\u2022 After delivery, the placenta did not pass whole. Manual removal was performed and a red mass protruding from the placenta was noted. This red mass is most consistent with a succenturiate lobe, an accessory lobe of the placenta that may be retained.  \n\u2022 The patient subsequently develops significant blood loss (500 mL in one minute) with a drop in blood pressure, indicating postpartum hemorrhage.\n\nStep 2: Consider the options.  \nA. Hysterectomy \u2013 This is a definitive treatment for uncontrollable hemorrhage but is reserved for life\u2010threatening bleeding that does not respond to conservative management.  \nB. Intravenous oxytocin \u2013 Uterotonics like oxytocin are first-line treatments for postpartum hemorrhage as they promote uterine contraction, helping to control bleeding.  \nC. Elevate posterior fornix \u2013 This is not a standard intervention for managing postpartum hemorrhage or retained placental tissue. It is more related to correcting uterine inversion.  \nD. Red blood cell transfusion \u2013 While important in managing significant hemorrhage, transfusion is typically initiated after attempts with uterotonics and other measures. It is not the immediate next step when bleeding can often be controlled with medications.\n\nStep 3: Arriving at the best next step.  \nThe best next step in management is to give intravenous oxytocin to prompt uterine contractions which will help reduce the bleeding by compressing the uterine vessels.\n\nFinal Answer: B. Intravenous oxytocin.",
            "Step 1: Analysis of the Situation\n\u2022 The patient had a prolonged delivery with manual removal of the placenta.\n\u2022 A red mass attached to the placenta is noted protruding from the vagina. This finding is indicative of a succenturiate (accessory) lobe of the placenta that may have been retained.\n\u2022 Retained placental tissue often results in failure of appropriate uterine contraction and rapid blood loss, leading to postpartum hemorrhage.\n\u2022 The patient\u2019s blood pressure drop and significant blood loss (500 mL within a minute) confirm acute postpartum hemorrhage.\n\nStep 2: Consideration of Management Options\nA. Hysterectomy \u2013 This is a radical measure usually reserved for refractory bleeding when conservative management fails. It is too aggressive as a next immediate step.\nB. Intravenous oxytocin \u2013 Uterotonics like oxytocin are the first-line treatment for postpartum hemorrhage. They promote uterine contraction, which can lessen hemorrhage by helping control bleeding from the placental site. In cases with retained accessory lobes (placenta succenturiata), oxytocin is used after ensuring that all placental fragments have been removed.\nC. Elevate posterior fornix \u2013 This is not a recognized or effective maneuver in removing retained placental tissue or controlling postpartum hemorrhage.\nD. Red blood cell transfusion \u2013 While transfusion may be necessary if hemorrhage is severe, the immediate step should address the source of bleeding rather than support blood volume. In this case, a uterotonic is warranted first.\n\nStep 3: Final Answer\nThe best next step in management is to administer intravenous oxytocin to promote uterine contraction and reduce the hemorrhage.\n\nFinal Answer: B. Intravenous oxytocin",
            "Step 1: Recognize the situation. The patient\u2019s third delivery is complicated by a red, protruding mass seen attached to the placenta after its manual removal. This finding is most consistent with an inverted uterus\u2014a reversal of the normal uterine position that presents as a red mass in the vagina, and can lead to significant hemorrhage and shock, as seen with her blood pressure drop and blood loss.\n\nStep 2: Consider management priorities. Uterine inversion is an obstetric emergency. The most critical and immediate management step is to reposition (reinvert) the uterus to prevent further hemorrhage and restore normal uterine tone. The Johnson maneuver is the classic technique, which involves manually \u201cpushing\u201d the inverted fundus (the red mass) upward through the vagina, often by applying pressure at the level of the posterior fornix. Uterotonics such as intravenous oxytocin are administered after successful repositioning to help the uterus contract and prevent re-inversion, but the very first step is to restore the uterus to its normal position.\n\nStep 3: Evaluate the options.\n\u2022 Option A, Hysterectomy, is overly aggressive and reserved for cases where conservative measures fail.\n\u2022 Option B, Intravenous oxytocin, while important for uterine contraction, should be administered after the uterus is manually repositioned.\n\u2022 Option C, Elevate posterior fornix \u2013 this corresponds to the manual replacement maneuver (such as the Johnson maneuver), where upward pressure is applied through the posterior fornix to replace the inverted uterus.\n\u2022 Option D, Red blood cell transfusion, while it may be supportive if hemorrhage continues, is not the immediate step in correcting the inversion.\n\nFinal Answer: C. Elevate posterior fornix\n\nThis is the best next step in management by manually repositioning the inverted uterus (Johnson maneuver)."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the scenario.  \n\u2022 The patient is a 30-year-old woman at 38 weeks gestation who has just delivered via a trial of vaginal birth after cesarean.  \n\u2022 After delivery, the placenta did not pass whole. Manual removal was performed and a red mass protruding from the placenta was noted. This red mass is most consistent with a succenturiate lobe, an accessory lobe of the placenta that may be retained.  \n\u2022 The patient subsequently develops significant blood loss (500 mL in one minute) with a drop in blood pressure, indicating postpartum hemorrhage.\n\nStep 2: Consider the options.  \nA. Hysterectomy \u2013 This is a definitive treatment for uncontrollable hemorrhage but is reserved for life\u2010threatening bleeding that does not respond to conservative management.  \nB. Intravenous oxytocin \u2013 Uterotonics like oxytocin are first-line treatments for postpartum hemorrhage as they promote uterine contraction, helping to control bleeding.  \nC. Elevate posterior fornix \u2013 This is not a standard intervention for managing postpartum hemorrhage or retained placental tissue. It is more related to correcting uterine inversion.  \nD. Red blood cell transfusion \u2013 While important in managing significant hemorrhage, transfusion is typically initiated after attempts with uterotonics and other measures. It is not the immediate next step when bleeding can often be controlled with medications.\n\nStep 3: Arriving at the best next step.  \nThe best next step in management is to give intravenous oxytocin to prompt uterine contractions which will help reduce the bleeding by compressing the uterine vessels.\n\nFinal Answer: B. Intravenous oxytocin."
    },
    {
        "realidx": 634,
        "question": "A 67-year-old woman presents to her primary care physician for urinary incontinence. She has been waking up every morning with her underwear soaked in urine. She notices that at work if she does not take regular bathroom breaks her underwear will have some urine in it. She urinates 5 to 11 times per day but she claims it is a small volume. Her current medications include lisinopril, metformin, insulin, aspirin, atorvastatin, sodium docusate, and loratadine. Her temperature is 98.2\u00b0F (36.8\u00b0C), blood pressure is 167/108 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for decreased pinprick sensation in the lower extremities and a systolic murmur along the right upper sternal border. Which of the following is the best treatment for this patient?",
        "answer": "Bethanechol and intermittent straight catheterization",
        "options": {
            "A": "Bethanechol and intermittent straight catheterization",
            "B": "Bethanechol during the day and oxybutynin at night",
            "C": "No recommendations needed",
            "D": "Reduce fluid intake and discontinue diuretics"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "67 year old woman presents",
            "primary care physician",
            "urinary incontinence",
            "waking up",
            "morning",
            "underwear soaked",
            "urine",
            "work",
            "not take regular bathroom breaks",
            "underwear",
            "urine",
            "5",
            "times",
            "day",
            "small volume",
            "current medications include lisinopril",
            "metformin",
            "insulin",
            "aspirin",
            "atorvastatin",
            "sodium docusate",
            "loratadine",
            "temperature",
            "98",
            "36",
            "blood pressure",
            "mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "oxygen saturation",
            "99",
            "room air",
            "Physical exam",
            "notable",
            "decreased pinprick sensation",
            "lower extremities",
            "systolic murmur",
            "right upper sternal border",
            "following",
            "best treatment",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6099,
            "completion_tokens": 8958
        },
        "time_elapsed": 104.90643906593323,
        "raw_responses": [
            "Step 1: Assess the Patient's Presentation\n\u2022 The patient is a 67\u2010year\u2010old woman with diabetes (evidenced by her insulin use and peripheral neuropathy on exam), who is experiencing incontinence characterized by frequent small-volume voids with leakage if she delays voiding.\n\u2022 While urge incontinence (from detrusor overactivity) is common, her history of diabetes with decreased sensation (neuropathy) suggests that she may be suffering from diabetic cystopathy. This condition can lead to impaired detrusor contractility and incomplete bladder emptying, ultimately resulting in overflow incontinence.\n\u2022 In overflow incontinence, patients may void frequently small amounts because the bladder never fully empties, and once the capacity is reached, leakage occurs.\n\nStep 2: Review the Treatment Options\nA. Bethanechol and intermittent straight catheterization \u2013 Bethanechol is a cholinergic agonist that stimulates detrusor contraction and is used in cases of detrusor underactivity, such as in a neurogenic bladder from diabetes. Often, intermittent catheterization is added to help ensure complete emptying.\nB. Bethanechol during the day and oxybutynin at night \u2013 This option combines a cholinergic agonist with an antimuscarinic agent (oxybutynin). These medications have opposite effects (stimulation vs. inhibition of the detrusor), making this option contradictory.\nC. No recommendations needed \u2013 Given her bothersome symptoms and risk for complications from incomplete emptying, some form of treatment is needed.\nD. Reduce fluid intake and discontinue diuretics \u2013 The patient is not on any diuretics, and fluid reduction is not the primary management for overflow incontinence due to neurogenic bladder.\n\nStep 3: Final Answer\nBecause the patient\u2019s symptoms are consistent with diabetic neuropathy resulting in an underactive bladder and overflow incontinence, the best treatment is to enhance detrusor contractility with bethanechol and use intermittent straight catheterization to assist with bladder emptying.\n\nFinal Answer: A. Bethanechol and intermittent straight catheterization",
            "Step 1: Identify Key Findings\n\u2022 The patient is a 67-year-old woman with diabetes (on metformin and insulin) and peripheral neuropathy (decreased pinprick sensation), both of which are risk factors for diabetic autonomy neuropathy.\n\u2022 She reports incontinence characterized by small volume urine loss frequently during the day and overnight.\n\u2022 Frequent, small voids and leakage on inability to get to the bathroom are features of overflow incontinence from a neurogenic bladder, often seen in diabetic cystopathy.\n\nStep 2: Analyze the Treatment Options\n\u2022 Option A: Bethanechol (a cholinergic agonist) helps stimulate bladder contractions to overcome detrusor underactivity, and intermittent straight catheterization can aid in fully emptying the bladder. This approach is often used in overflow incontinence due to neurogenic bladder.\n\u2022 Option B: Combining bethanechol with oxybutynin (an anticholinergic) would be counterproductive because oxybutynin further decreases bladder contractility and would worsen retention.\n\u2022 Option C: Suggesting \u201cno recommendations needed\u201d does not address the patient\u2019s symptomatic neurogenic bladder causing overflow incontinence.\n\u2022 Option D: Recommending reduction of fluid intake/discontinuation of diuretics is inappropriate given her clinical findings and that she is not on a diuretic.\n\nStep 3: Final Answer\nBased on the patient\u2019s clinical presentation most consistent with overflow incontinence due to diabetic autonomic neuropathy, the best treatment is:\nA. Bethanechol and intermittent straight catheterization",
            "Let\u2019s walk through the reasoning:\n\n\u2022 This 67\u2010year\u2010old woman complains of urinary leakage \u2013 her underwear is soaked if she delays voiding at work and she finds herself leaking overnight. In her history she has longstanding diabetes (she\u2019s on both metformin and insulin), and on exam she has decreased pinprick sensation in her lower extremities, a sign of peripheral neuropathy. Diabetes can also lead to autonomic neuropathy affecting the bladder (\u201cdiabetic cystopathy\u201d). \n\n\u2022 With diabetic cystopathy the bladder\u2019s detrusor becomes underactive and fails to contract fully. Although patients may sometimes have \u201curge\u2010type\u201d symptoms, the underlying problem is incomplete bladder emptying. As the bladder slowly overfills beyond its capacity, small amounts of urine leak (\u201coverflow incontinence\u201d). The fact that she leaks if she does not allow herself regular trips to the bathroom (thus \u201cemptying\u201d the bladder before it becomes too distended) supports this diagnosis. \n\n\u2022 For overflow incontinence secondary to diabetic neuropathy, the goal is to improve bladder emptying. A cholinergic agonist such as bethanechol can be used to stimulate detrusor contraction, and if needed, intermittent straight catheterization can be employed to reduce residual volume.\n\n\u2022 Reviewing the answer choices:\n\u2003\u2013 Option A (\u201cBethanechol and intermittent straight catheterization\u201d) is used in neurogenic bladder with incomplete emptying (overflow incontinence).\n\u2003\u2013 Option B combines bethanechol with oxybutynin, which is contradictory since oxybutynin (an antimuscarinic) is used to calm an overactive bladder.\n\u2003\u2013 Option C (\u201cNo recommendations needed\u201d) is inappropriate as she is symptomatic.\n\u2003\u2013 Option D (\u201cReduce fluid intake and discontinue diuretics\u201d) does not apply because she is not taking any diuretics.\n\nGiven her presentation with likely diabetic-associated overflow incontinence, the best treatment is to address the urinary retention component.\n\nFinal answer: A. Bethanechol and intermittent straight catheterization."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify Key Findings\n\u2022 The patient is a 67-year-old woman with diabetes (on metformin and insulin) and peripheral neuropathy (decreased pinprick sensation), both of which are risk factors for diabetic autonomy neuropathy.\n\u2022 She reports incontinence characterized by small volume urine loss frequently during the day and overnight.\n\u2022 Frequent, small voids and leakage on inability to get to the bathroom are features of overflow incontinence from a neurogenic bladder, often seen in diabetic cystopathy.\n\nStep 2: Analyze the Treatment Options\n\u2022 Option A: Bethanechol (a cholinergic agonist) helps stimulate bladder contractions to overcome detrusor underactivity, and intermittent straight catheterization can aid in fully emptying the bladder. This approach is often used in overflow incontinence due to neurogenic bladder.\n\u2022 Option B: Combining bethanechol with oxybutynin (an anticholinergic) would be counterproductive because oxybutynin further decreases bladder contractility and would worsen retention.\n\u2022 Option C: Suggesting \u201cno recommendations needed\u201d does not address the patient\u2019s symptomatic neurogenic bladder causing overflow incontinence.\n\u2022 Option D: Recommending reduction of fluid intake/discontinuation of diuretics is inappropriate given her clinical findings and that she is not on a diuretic.\n\nStep 3: Final Answer\nBased on the patient\u2019s clinical presentation most consistent with overflow incontinence due to diabetic autonomic neuropathy, the best treatment is:\nA. Bethanechol and intermittent straight catheterization"
    },
    {
        "realidx": 651,
        "question": "A 45-year-old woman presents to the physician for a follow-up visit. She has no specific complaints at this visit however, she has noticed that she is more tired than usual these days. At first, she ignored it and attributed it to stress but she feels weaker each week. She is sometimes out of breath while walking for long distances or when she is involved in strenuous physical activity. She was diagnosed with rheumatoid arthritis 3 years ago and has since been on medication to assist with her pain and to slow down disease progression. Her temperature is 37.0\u00b0C (98.6\u00b0F), the respiratory rate is 15/min, the pulse is 107/min, and the blood pressure is 102/98 mm Hg. On examination, you notice thinning hair and mildly cool extremities with flattened nail beds. A complete blood count and iron studies are ordered. Which of the following is most likely to show up on her iron profile?",
        "answer": "Decreased iron-binding capacity",
        "options": {
            "A": "Increased iron-binding capacity",
            "B": "Low ferritin levels",
            "C": "Decreased iron-binding capacity",
            "D": "Normal iron-binding capacity"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old woman presents",
            "physician",
            "follow-up visit",
            "specific complaints",
            "visit",
            "more tired",
            "usual",
            "days",
            "first",
            "ignored",
            "attributed",
            "stress",
            "feels weaker",
            "week",
            "sometimes out of breath",
            "walking",
            "long distances",
            "involved",
            "strenuous physical activity",
            "diagnosed",
            "rheumatoid arthritis",
            "years",
            "since",
            "on medication to assist",
            "pain",
            "slow down disease progression",
            "temperature",
            "98",
            "respiratory rate",
            "min",
            "pulse",
            "min",
            "blood pressure",
            "98 mm Hg",
            "examination",
            "thinning hair",
            "mildly cool extremities",
            "flattened nail beds",
            "complete blood count",
            "iron studies",
            "ordered",
            "following",
            "most likely to show",
            "iron profile"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4806,
            "completion_tokens": 3900
        },
        "time_elapsed": 30.720386028289795,
        "raw_responses": [
            "Step 1: Identify Relevant Information\n\u2022 The patient is a 45-year-old woman with rheumatoid arthritis, a chronic inflammatory condition.\n\u2022 She presents with symptoms of fatigue, weakness, and shortness of breath, which can occur with anemia.\n\u2022 Physical findings include thinning hair and cool extremities, which may be consistent with hypothyroidism but are also seen with certain anemia types.\n\u2022 Given her chronic inflammatory state from rheumatoid arthritis, anemia of chronic disease is a likely possibility.\n\nStep 2: Understand the Iron Profile in Anemia of Chronic Disease (ACD)\n\u2022 In anemia of chronic disease:\n\u2003\u2003\u2013 Serum iron is low.\n\u2003\u2003\u2013 Iron-binding capacity (TIBC) is decreased because the liver produces less transferrin in inflammatory states.\n\u2003\u2003\u2013 Ferritin is normal or increased since ferritin is an acute-phase reactant.\n\nStep 3: Compare and Eliminate Incorrect Choices\n\u2022 Option A: Increased iron-binding capacity \u2013 Typically seen in iron deficiency anemia, not in ACD.\n\u2022 Option B: Low ferritin levels \u2013 Also seen in iron deficiency anemia; ACD usually has normal or high ferritin.\n\u2022 Option D: Normal iron-binding capacity \u2013 Not consistent with ACD, which usually has decreased capacity.\n\u2022 Option C: Decreased iron-binding capacity \u2013 Matches the expected profile in anemia of chronic disease.\n\nFinal Answer: C. Decreased iron-binding capacity",
            "Step 1: Recognize that the patient has rheumatoid arthritis, a chronic inflammatory condition. Over time, chronic inflammation can lead to anemia of chronic disease.\n\nStep 2: Understand that anemia of chronic disease is characterized by low serum iron, low total iron-binding capacity (TIBC), and normal or increased ferritin levels due to iron sequestration by the reticuloendothelial system.\n\nStep 3: Option analysis:\n\u2022 A. Increased iron-binding capacity \u2013 This is seen in iron deficiency anemia, not anemia of chronic disease.\n\u2022 B. Low ferritin levels \u2013 Low ferritin is also a feature of iron deficiency anemia.\n\u2022 C. Decreased iron-binding capacity \u2013 This is the expected finding in anemia of chronic disease.\n\u2022 D. Normal iron-binding capacity \u2013 This would not be typical in anemia of chronic disease.\n\nFinal answer: C. Decreased iron-binding capacity",
            "Step 1: Identify Key Findings\n\u2022 The patient is a 45-year-old woman with rheumatoid arthritis, a chronic inflammatory condition.\n\u2022 Her symptoms (fatigue, weakness, thinning hair, cool extremities, flattened nail beds) suggest hypothyroidism. However, given the history of rheumatoid arthritis, an anemia associated with chronic disease is highly likely.\n  \nStep 2: Understand Iron Studies in Anemia\n\u2022 Anemia of chronic disease (also called anemia of chronic inflammation) is characterized by low serum iron levels due to inflammation but with normal or increased ferritin (an acute phase reactant) as iron is sequestered within stores.\n\u2022 Magnesium: Total Iron-Binding Capacity (TIBC) tends to be decreased because there is less circulating transferrin. \n\u2022 In contrast, iron deficiency anemia would show increased TIBC (or increased iron-binding capacity) and low ferritin.\n\nStep 3: Evaluate the Options\nA. Increased iron-binding capacity \u2013 seen in iron deficiency anemia; not consistent with chronic disease.\nB. Low ferritin levels \u2013 also indicate iron deficiency rather than inflammation.\nC. Decreased iron-binding capacity \u2013 this matches the expected findings in anemia of chronic disease.\nD. Normal iron-binding capacity \u2013 not typical for either condition in this context.\n\nFinal Answer: C. Decreased iron-binding capacity"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify Key Findings\n\u2022 The patient is a 45-year-old woman with rheumatoid arthritis, a chronic inflammatory condition.\n\u2022 Her symptoms (fatigue, weakness, thinning hair, cool extremities, flattened nail beds) suggest hypothyroidism. However, given the history of rheumatoid arthritis, an anemia associated with chronic disease is highly likely.\n  \nStep 2: Understand Iron Studies in Anemia\n\u2022 Anemia of chronic disease (also called anemia of chronic inflammation) is characterized by low serum iron levels due to inflammation but with normal or increased ferritin (an acute phase reactant) as iron is sequestered within stores.\n\u2022 Magnesium: Total Iron-Binding Capacity (TIBC) tends to be decreased because there is less circulating transferrin. \n\u2022 In contrast, iron deficiency anemia would show increased TIBC (or increased iron-binding capacity) and low ferritin.\n\nStep 3: Evaluate the Options\nA. Increased iron-binding capacity \u2013 seen in iron deficiency anemia; not consistent with chronic disease.\nB. Low ferritin levels \u2013 also indicate iron deficiency rather than inflammation.\nC. Decreased iron-binding capacity \u2013 this matches the expected findings in anemia of chronic disease.\nD. Normal iron-binding capacity \u2013 not typical for either condition in this context.\n\nFinal Answer: C. Decreased iron-binding capacity"
    },
    {
        "realidx": 659,
        "question": "A 64-year-old man with a history of type 2 diabetes mellitus is referred to a urologist. The patient has had pain when urinating and difficulty starting a stream of urine for over 4 months now. He is bothered because he has to urinate about 9 times every day, including several times when he wakes up at night. A digital rectal examination revealed multiple hard nodules in the prostate gland. A CT scan shows a nodule in the right lung that measures 3 cm. An ultrasound scan of his urinary bladder and prostate shows residual urine of > 200 mL and heterogeneous findings of the prostate gland. Biopsy reveals grade 2 prostate adenocarcinoma. Follow-up 9 months later shows his prostate cancer is well controlled with goserelin. If one considers pulmonary nodules that are the same size as this patient\u2019s, which of the following additional findings on CT scans would most likely prompt the removal of such nodules?",
        "answer": "Extending fine striations",
        "options": {
            "A": "\u2018Popcorn\u2019 pattern",
            "B": "Subsolid component",
            "C": "Extending fine striations",
            "D": "Doubling time of < 1 month"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "64 year old man",
            "history of type 2 diabetes mellitus",
            "referred",
            "urologist",
            "patient",
            "pain",
            "difficulty starting",
            "stream of urine",
            "over",
            "months now",
            "to",
            "times",
            "day",
            "including several times",
            "wakes up",
            "night",
            "digital rectal examination revealed multiple hard nodules",
            "prostate",
            "CT scan shows",
            "nodule",
            "right",
            "measures 3",
            "ultrasound scan of",
            "urinary bladder",
            "prostate shows residual urine",
            "200 mL",
            "heterogeneous findings of",
            "prostate gland",
            "Biopsy reveals grade prostate adenocarcinoma",
            "Follow-up 9 months later shows",
            "prostate cancer",
            "well controlled",
            "goserelin",
            "one considers pulmonary nodules",
            "same size",
            "patients",
            "following additional findings",
            "CT scans",
            "most likely prompt",
            "removal",
            "nodules"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5871,
            "completion_tokens": 10558
        },
        "time_elapsed": 70.84456944465637,
        "raw_responses": [
            "Let\u2019s reason through the answer by considering features on CT that tip the balance toward a malignant rather than a benign nodule.\n\n\u2022 A \u201cpopcorn\u201d calcification pattern (choice A) is classically seen in pulmonary hamartomas, which are benign lesions. Thus, this feature would make you less concerned about cancer.\n\n\u2022 A \u201csubsolid component\u201d (choice B) is concerning for adenocarcinoma in situ or minimally invasive adenocarcinoma. Although a subsolid nodule is worrisome, many such lesions can be monitored\u2014depending on the amount of solid component and other factors\u2014before proceeding to surgery.\n\n\u2022 \u201cExtending fine striations\u201d (choice C) describes a lesion with spiculated or irregular margins. Spiculated margins are one of the most concerning radiologic findings because they indicate that the nodule is infiltrating into adjacent lung tissue. In many guidelines, a spiculated nodule of this size (in this case 3 cm) is an indication for prompt resection because it has a high likelihood of being malignant.\n\n\u2022 A doubling time of less than 1 month (choice D) is extremely rapid. In typical malignancies (including most lung cancers), the doubling time tends to be much longer\u2014often measured in weeks to months (about 30\u2013400 days). A doubling time this short would more likely be seen in an inflammatory or infectious process rather than a cancer, making it less specific for malignancy.\n\nGiven these considerations, the additional CT finding that would most strongly prompt removal of a pulmonary nodule (of the same size as this patient\u2019s) is the presence of \u201cextending fine striations\u201d (spiculated margins), because this is a classic feature of a malignant lesion.\n\nFinal Answer: C. Extending fine striations.",
            "Step 1: In a patient with prostate cancer and an incidentally discovered pulmonary nodule of a similar size (3 cm in this case), radiographic features of the nodule help guide management. Some CT scan appearances (such as a \u201cpopcorn\u201d pattern) are classically benign (as seen with hamartomas), while other characteristics suggest malignancy.\n\nStep 2: Option A (\u201cpopcorn\u201d pattern) is typically associated with pulmonary hamartomas \u2013 benign lesions that do not require removal. Option C (\u201cextending fine striations\u201d) is not a classic descriptor that would immediately prompt removal. Option D (a doubling time of < 1 month) is unusually rapid; malignant nodules usually have doubling times between about 20 and 400 days. A doubling time that fast suggests an infectious or inflammatory process rather than a true malignancy.\n\nStep 3: Option B, the presence of a subsolid component, is worrisome. Subsolid (or part-solid) nodules are known to have a higher risk of malignancy (for instance, adenocarcinoma) than entirely solid ones. In patients with known malignancy or in lung nodules discovered incidentally, a subsolid component significantly increases suspicion and often prompts further intervention.\n\nFinal Answer: B. Subsolid component",
            "We can approach the question by considering features on a CT scan that help differentiate benign from malignant pulmonary nodules. In the context of a nodule that is 3 cm in size in a patient with a known malignancy, additional concerning features would likely tip the balance toward removal by indicating an aggressive process.\n\nLet's review the options:\n\nA. \u00abPopcorn\u00bb pattern \u2013 This pattern is classically seen with benign pulmonary hamartomas and is not an indicator for excision.\n\nB. Subsolid component \u2013 While subsolid nodules (ground-glass or part-solid nodules) can be seen in lung adenocarcinoma, especially adenocarcinoma in situ or minimally invasive adenocarcinoma, they are managed based on size, growth, and evolution over time. The mere presence of a subsolid component does not automatically prompt removal, though it does warrant close follow\u2010up and further evaluation.\n\nC. Extending fine striations \u2013 These may be seen in nodules with a spiculated appearance, which does raise suspicion for malignancy. However, while suspicious, the mere description of fine striations is less definitive compared with dynamic growth features.\n\nD. Doubling time of < 1 month \u2013 This refers to the rate at which the nodule is increasing in size. Malignant lesions typically have doubling times in the range of 20 to 400 days. A nodule doubling in less than 1 month would indicate extremely rapid growth, a feature that is highly concerning for aggressive malignancy or aggressive metastatic disease. Such accelerated growth would prompt removal of the nodule.\n\nStep by step:\n1. Analyze the options in terms of benign versus malignant features.\n2. Recognize that features suggestive of benignity (e.g., \u201cpopcorn\u201d calcifications) would not prompt removal.\n3. Identify that rapid growth (doubling time < 1 month) is a clear indicator of aggressiveness and malignancy.\n4. Conclude that among the findings listed, a doubling time of < 1 month is the most concerning and would most likely prompt removal.\n\nThe final answer is: D. Doubling time of < 1 month."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "Let\u2019s reason through the answer by considering features on CT that tip the balance toward a malignant rather than a benign nodule.\n\n\u2022 A \u201cpopcorn\u201d calcification pattern (choice A) is classically seen in pulmonary hamartomas, which are benign lesions. Thus, this feature would make you less concerned about cancer.\n\n\u2022 A \u201csubsolid component\u201d (choice B) is concerning for adenocarcinoma in situ or minimally invasive adenocarcinoma. Although a subsolid nodule is worrisome, many such lesions can be monitored\u2014depending on the amount of solid component and other factors\u2014before proceeding to surgery.\n\n\u2022 \u201cExtending fine striations\u201d (choice C) describes a lesion with spiculated or irregular margins. Spiculated margins are one of the most concerning radiologic findings because they indicate that the nodule is infiltrating into adjacent lung tissue. In many guidelines, a spiculated nodule of this size (in this case 3 cm) is an indication for prompt resection because it has a high likelihood of being malignant.\n\n\u2022 A doubling time of less than 1 month (choice D) is extremely rapid. In typical malignancies (including most lung cancers), the doubling time tends to be much longer\u2014often measured in weeks to months (about 30\u2013400 days). A doubling time this short would more likely be seen in an inflammatory or infectious process rather than a cancer, making it less specific for malignancy.\n\nGiven these considerations, the additional CT finding that would most strongly prompt removal of a pulmonary nodule (of the same size as this patient\u2019s) is the presence of \u201cextending fine striations\u201d (spiculated margins), because this is a classic feature of a malignant lesion.\n\nFinal Answer: C. Extending fine striations."
    },
    {
        "realidx": 663,
        "question": "A 58-year-old man is brought to the emergency department because of sudden-onset right-sided body numbness for 1 hour. He reports that he has a 15-year history of hypertension treated with hydrochlorothiazide. He is alert and oriented to time, place, and person. Neurological examination shows decreased sensation to light pinprick and temperature on the right side of the face and body. Motor strength is 5/5 and deep tendon reflexes are 2+ bilaterally. Perfusion of which of the following structures of the brain is most likely impaired in this patient?",
        "answer": "Ventral thalamus",
        "options": {
            "A": "Posterior limb of the internal capsule",
            "B": "Lateral medulla",
            "C": "Basal pons",
            "D": "Ventral thalamus"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "58 year old man",
            "brought",
            "emergency department",
            "of sudden-onset right-sided body numbness",
            "hour",
            "reports",
            "year history of hypertension treated with hydrochlorothiazide",
            "alert",
            "oriented to time",
            "place",
            "person",
            "Neurological examination shows decreased sensation",
            "light pinprick",
            "temperature",
            "right side of",
            "face",
            "body",
            "Motor strength",
            "5/5",
            "deep tendon reflexes",
            "2",
            "Perfusion of",
            "following structures",
            "brain",
            "most likely impaired",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4704,
            "completion_tokens": 3133
        },
        "time_elapsed": 40.09066152572632,
        "raw_responses": [
            "Step 1: Relevant Information  \nThe patient presents with sudden-onset right-sided numbness affecting the face and body, with preserved motor strength. This is most consistent with a \u201cpure sensory stroke.\u201d\n\nStep 2: Compare and Eliminate Incorrect Choices  \n\u2022 A. Posterior limb of the internal capsule \u2013 Infarcts here typically cause motor deficits (e.g., hemiparesis), which are absent in this patient.  \n\u2022 B. Lateral medulla \u2013 Lesions in this area (Wallenberg syndrome) would produce additional symptoms such as dysphagia, hoarseness, and cerebellar signs, not just isolated numbness.  \n\u2022 C. Basal pons \u2013 Strokes here often involve both motor and cranial nerve deficits, unlike the isolated sensory loss seen in this patient.\n\nStep 3: Final Answer  \nThe presentation is most consistent with impaired perfusion of the ventral thalamus (specifically the area involving the ventral posterolateral nucleus), which is responsible for processing sensory information from the contralateral body.  \n\nFinal answer: D. Ventral thalamus",
            "Step 1: The patient\u2019s symptoms include sudden-onset right-sided facial and body loss of light touch, pain, and temperature sensation with intact motor function. This points toward a lacunar stroke affecting a sensory relay nucleus without involvement of motor tracts.\n\nStep 2: Let\u2019s evaluate the options:\n\n\u2022 Option A: The posterior limb of the internal capsule primarily contains motor fibers and, although it also carries some sensory fibers, a lesion here would likely cause motor deficits. This does not match the patient\u2019s intact motor function.\n\n\u2022 Option B: The lateral medulla (as seen in lateral medullary [Wallenberg] syndrome) would cause ipsilateral facial sensory deficits and contralateral body sensory loss along with additional symptoms (e.g., dysphagia, vertigo) that are not seen in this patient.\n\n\u2022 Option C: The basal pons would lead to a variety of symptoms, including cranial nerve deficits and potential motor abnormalities, which are not observed in this case.\n\n\u2022 Option D: The ventral thalamus (specifically the ventral posterolateral nucleus) is responsible for relaying sensory information from the body (and the adjacent ventral posteromedial nucleus handles facial sensation) to the cerebral cortex. A lacunar infarct involving this area (often due to small vessel disease from longstanding hypertension) would produce the isolated sensory deficits observed here.\n\nStep 3: Given the sensory findings without motor impairment, the impaired perfusion most likely affects the ventral thalamus.\n\nFinal answer: D. Ventral thalamus",
            "Step 1: Analyze the clinical presentation. This 58-year-old man with a history of hypertension suddenly develops right-sided loss of pain and temperature sensation affecting both his face and body, without any motor deficits. \n\nStep 2: Recognize the syndrome. The isolated hemisensory loss (loss of light touch, pain, and temperature) without motor involvement strongly suggests a lacunar infarct affecting the thalamus (specifically, the ventral thalamus, which includes the ventral posterolateral [VPL] nucleus).\n\nStep 3: Evaluate the answer choices.\n\u2022 Option A (Posterior limb of the internal capsule) is typically involved in lacunar strokes that produce pure motor deficits, which is not the case here.\n\u2022 Option B (Lateral medulla) would cause lateral medullary (Wallenberg) syndrome, which is associated with additional findings such as dysphagia, hoarseness, ataxia, and vertigo.\n\u2022 Option C (Basal pons) would likely result in more widespread neurological deficits including motor deficits.\n\u2022 Option D (Ventral thalamus) is classically implicated in lacunar strokes presenting with pure sensory deficits, including both the face and body.\n\nStep 4: Final answer. The impaired perfusion in this patient is most likely in the ventral thalamus.\n\nFinal Answer: D, Ventral thalamus."
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "1"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation. This 58-year-old man with a history of hypertension suddenly develops right-sided loss of pain and temperature sensation affecting both his face and body, without any motor deficits. \n\nStep 2: Recognize the syndrome. The isolated hemisensory loss (loss of light touch, pain, and temperature) without motor involvement strongly suggests a lacunar infarct affecting the thalamus (specifically, the ventral thalamus, which includes the ventral posterolateral [VPL] nucleus).\n\nStep 3: Evaluate the answer choices.\n\u2022 Option A (Posterior limb of the internal capsule) is typically involved in lacunar strokes that produce pure motor deficits, which is not the case here.\n\u2022 Option B (Lateral medulla) would cause lateral medullary (Wallenberg) syndrome, which is associated with additional findings such as dysphagia, hoarseness, ataxia, and vertigo.\n\u2022 Option C (Basal pons) would likely result in more widespread neurological deficits including motor deficits.\n\u2022 Option D (Ventral thalamus) is classically implicated in lacunar strokes presenting with pure sensory deficits, including both the face and body.\n\nStep 4: Final answer. The impaired perfusion in this patient is most likely in the ventral thalamus.\n\nFinal Answer: D, Ventral thalamus."
    },
    {
        "realidx": 664,
        "question": "A 9-year-old boy is brought in by his mother because of bruising on his torso and limbs. The patient\u2019s mother denies any other symptoms and says he is otherwise healthy. Physical examination shows multiple petechiae and bruising on the torso and extremities bilaterally. The remainder of the physical exam is unremarkable. A complete blood count is normal. His coagulation profile reveals:\nProthrombin time (PT) 12 sec\nActivated partial thromboplastin time (aPTT) 60 sec\nWhich of the following is the most likely diagnosis in this patient?",
        "answer": "Von Willebrand disease",
        "options": {
            "A": "Acute lymphoblastic leukemia",
            "B": "Immune thrombocytopenic purpura",
            "C": "Von Willebrand disease",
            "D": "Hemophilia A"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old boy",
            "brought",
            "mother",
            "bruising",
            "torso",
            "limbs",
            "patients mother denies",
            "symptoms",
            "healthy",
            "Physical examination shows multiple petechiae",
            "bruising",
            "torso",
            "extremities",
            "physical exam",
            "unremarkable",
            "complete blood count",
            "normal",
            "coagulation profile reveals",
            "Prothrombin time",
            "sec Activated partial thromboplastin time",
            "60",
            "following",
            "most likely diagnosis",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5037,
            "completion_tokens": 4600
        },
        "time_elapsed": 35.021324634552,
        "raw_responses": [
            "Step 1: Review the Laboratory Findings and History\n\u2022 The patient is a 9-year-old boy with bruising and petechiae.\n\u2022 His coagulation profile shows a normal PT (12 sec) and a prolonged aPTT (60 sec), indicating an abnormality in the intrinsic pathway.\n\u2022 The complete blood count is normal, ruling out thrombocytopenia, which would be seen in immune thrombocytopenic purpura (ITP).\n\nStep 2: Compare the Options\n\u2022 Option A: Acute lymphoblastic leukemia would likely present with abnormal CBC findings and other systemic symptoms.\n\u2022 Option B: Immune thrombocytopenic purpura is associated with a low platelet count, but his CBC is normal.\n\u2022 Option C: Von Willebrand disease can cause prolonged aPTT due to the role of vWF in stabilizing factor VIII. However, vWD typically leads to mucosal bleeding (epistaxis, menorrhagia) rather than just bruising and petechiae.\n\u2022 Option D: Hemophilia A (a deficiency of factor VIII) is classically associated with an isolated prolonged aPTT and commonly presents in boys due to its X-linked recessive inheritance.\n\nStep 3: Final Answer\nBased on the clinical scenario and the lab findings, the most likely diagnosis is:\nD. Hemophilia A",
            "Step 1: Review the patient\u2019s presentation. The patient is a 9\u2011year\u2011old boy with multiple petechiae and bruising but an otherwise normal complete blood count. His coagulation profile shows a normal PT (12 sec) and a prolonged aPTT (60 sec), which points to an abnormality in the intrinsic coagulation pathway.\n\nStep 2: Analyze the options using the clinical information.\n\n\u2022 Acute lymphoblastic leukemia (ALL) is typically associated with abnormal blood counts (often with anemia, thrombocytopenia, or leukocytosis), which makes this option unlikely given the normal CBC.\n\n\u2022 Immune thrombocytopenic purpura (ITP) would present with thrombocytopenia (low platelet count) leading to petechiae and purpura. However, the CBC in this case is normal, ruling out ITP.\n\n\u2022 Von Willebrand disease (vWD) is a possibility because it can prolong the aPTT (due to decreased stabilization of factor VIII) and is associated with mucocutaneous bleeding. However, vWD usually presents with symptoms such as nosebleeds, gum bleeding, or menorrhagia rather than isolated deep-tissue bleeding like recurrent bruising without mucosal bleeding.\n\n\u2022 Hemophilia A is an X\u2011linked recessive disorder characterized by a deficiency in factor VIII. This causes an isolated prolongation of the aPTT with a normal PT. Clinically, Hemophilia A often presents in boys with spontaneous bleeding episodes, including bruising and hemarthroses.\n\nStep 3: Compare and eliminate incorrect choices.\n\u2022 ALL and ITP are excluded based on the normal CBC.\n\u2022 While vWD can cause a prolonged aPTT, its bleeding pattern (mucocutaneous bleeding) is less consistent with this patient's presentation.\n\nGiven the patient\u2019s gender, bleeding pattern, and coagulation profile, Hemophilia A (factor VIII deficiency) is the most consistent diagnosis.\n\nFinal answer: D. Hemophilia A",
            "Step 1: Evaluate the patient's presentation and lab findings.\n\u2022 The patient is a 9-year-old boy with bruising and petechiae, yet his complete blood count is normal, which makes a platelet disorder less likely.\n\u2022 His coagulation profile shows a normal prothrombin time (PT) but a prolonged activated partial thromboplastin time (aPTT).\n\nStep 2: Consider the differential diagnoses based on the lab values and clinical presentation.\n\u2022 Acute lymphoblastic leukemia (ALL) is unlikely given the normal CBC.\n\u2022 Immune thrombocytopenic purpura (ITP) typically presents with thrombocytopenia, which is not seen in this case.\n\u2022 Von Willebrand disease (vWD) can cause a prolonged aPTT due to its role in factor VIII stability, but it often presents with mucosal bleeding rather than predominantly bruising and petechiae.\n\u2022 Hemophilia A, a deficiency in factor VIII, presents with a normal PT and prolonged aPTT. It is an X-linked recessive disorder typically affecting boys and often presents with easy bruising.\n\nStep 3: Final diagnosis.\nThe most likely diagnosis is Hemophilia A.\n\nFinal Answer: D. Hemophilia A"
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Review the patient\u2019s presentation. The patient is a 9\u2011year\u2011old boy with multiple petechiae and bruising but an otherwise normal complete blood count. His coagulation profile shows a normal PT (12 sec) and a prolonged aPTT (60 sec), which points to an abnormality in the intrinsic coagulation pathway.\n\nStep 2: Analyze the options using the clinical information.\n\n\u2022 Acute lymphoblastic leukemia (ALL) is typically associated with abnormal blood counts (often with anemia, thrombocytopenia, or leukocytosis), which makes this option unlikely given the normal CBC.\n\n\u2022 Immune thrombocytopenic purpura (ITP) would present with thrombocytopenia (low platelet count) leading to petechiae and purpura. However, the CBC in this case is normal, ruling out ITP.\n\n\u2022 Von Willebrand disease (vWD) is a possibility because it can prolong the aPTT (due to decreased stabilization of factor VIII) and is associated with mucocutaneous bleeding. However, vWD usually presents with symptoms such as nosebleeds, gum bleeding, or menorrhagia rather than isolated deep-tissue bleeding like recurrent bruising without mucosal bleeding.\n\n\u2022 Hemophilia A is an X\u2011linked recessive disorder characterized by a deficiency in factor VIII. This causes an isolated prolongation of the aPTT with a normal PT. Clinically, Hemophilia A often presents in boys with spontaneous bleeding episodes, including bruising and hemarthroses.\n\nStep 3: Compare and eliminate incorrect choices.\n\u2022 ALL and ITP are excluded based on the normal CBC.\n\u2022 While vWD can cause a prolonged aPTT, its bleeding pattern (mucocutaneous bleeding) is less consistent with this patient's presentation.\n\nGiven the patient\u2019s gender, bleeding pattern, and coagulation profile, Hemophilia A (factor VIII deficiency) is the most consistent diagnosis.\n\nFinal answer: D. Hemophilia A"
    },
    {
        "realidx": 665,
        "question": "A 31-year-old man comes to the physician because of a 4-week history of a painless lump near the left wrist and tingling pain over his left hand. Physical examination shows a transilluminating, rubbery, fixed, non-tender mass over the lateral volar aspect of the left wrist. There is decreased sensation to pinprick on the thumb, index finger, middle finger, and radial half of the ring finger of the left hand. The tingling pain is aggravated by tapping over the swelling. Which of the following adjacent structures is at risk of entrapment if this mass persists?",
        "answer": "Flexor pollicis longus tendon",
        "options": {
            "A": "Ulnar artery",
            "B": "Flexor pollicis longus tendon",
            "C": "Flexor carpi radialis tendon",
            "D": "Ulnar nerve"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "31 year old man",
            "physician",
            "4 week history",
            "painless lump",
            "left wrist",
            "tingling pain",
            "left",
            "Physical examination shows",
            "rubbery",
            "fixed",
            "non-tender mass",
            "lateral volar aspect of",
            "left wrist",
            "decreased sensation",
            "pinprick",
            "thumb",
            "index finger",
            "middle finger",
            "radial half of",
            "ring finger",
            "left hand",
            "tingling pain",
            "aggravated",
            "swelling",
            "following adjacent structures",
            "at risk",
            "entrapment",
            "mass"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 6435,
            "completion_tokens": 13517
        },
        "time_elapsed": 88.40389513969421,
        "raw_responses": [
            "Step 1: Analyze the clinical information.\n\u2022 The patient has a 4\u2010week history of a painless lump on the lateral (thumb side) volar aspect of the wrist.\n\u2022 He reports tingling and decreased sensation in the thumb, index, middle, and radial half of the ring finger\u2014a distribution supplied by the median nerve.\n\u2022 Tapping over the swelling exacerbates his symptoms (a positive Tinel\u2019s sign), indicating local nerve irritation.\n\nStep 2: Identify the likely lesion.\n\u2022 The transilluminating, rubbery, fixed, non-tender mass is characteristic of a ganglion cyst.\n\u2022 Given its location near the volar wrist, it is likely compressing structures within or adjacent to the carpal tunnel.\n\nStep 3: Consider adjacent structures and their anatomical locations.\n\u2022 Within the carpal tunnel, the median nerve is most commonly affected. However, because the median nerve is already implicated by the sensory deficits, the question asks which other structure is at risk.\n\u2022 The contents of the carpal tunnel include the median nerve plus the tendons of:\n\u2003 \u2013 Flexor digitorum superficialis (FDS)\n\u2003 \u2013 Flexor digitorum profundus (FDP)\n\u2003 \u2013 Flexor pollicis longus (FPL)\n\u2022 The flexor carpi radialis tendon does not travel within the carpal tunnel; it courses in its own fibrous tunnel.\n\u2022 Similarly, the ulnar nerve and ulnar artery run through Guyon\u2019s canal on the ulnar (medial) aspect of the wrist, not the lateral side.\n\nStep 4: Narrow the options.\n\u2022 Option A (Ulnar artery) and Option D (Ulnar nerve) are less relevant given their medial location in relation to the mass.\n\u2022 Option C (Flexor carpi radialis tendon) is not part of the carpal tunnel.\n\u2022 Option B (Flexor pollicis longus tendon) runs within the carpal tunnel alongside the median nerve and is at risk of compression by an enlarging ganglion cyst at the lateral volar wrist.\n\nFinal Answer: B. Flexor pollicis longus tendon",
            "Step 1: Recognize the scenario. This 31\u2010year\u2010old man has a firm, rubbery, non\u2010tender mass on his lateral (thumb\u2013side) volar wrist that transilluminates. In addition, he has decreased sensation over the thumb, index, middle, and radial half of the ring finger of his left hand, and tapping over the swelling reproduces tingling. This picture is most consistent with a volar ganglion cyst that is compressing a nearby structure.\n\nStep 2: Analyze the neuroanatomy and local wrist anatomy. The sensory distribution affected is that of the median nerve. In the carpal tunnel region, the median nerve runs among the flexor tendons. In an axial cross\u2010section of the carpal tunnel, the flexor pollicis longus (FPL) tendon is situated laterally (toward the thumb), with the median nerve immediately adjacent (it typically occupies a position just medial to the FPL tendon). Thus, a mass arising near the lateral volar wrist (i.e. adjacent to the FPL tendon) that is already causing symptoms in the median nerve raises concern that, if the ganglion were to persist or enlarge, it could distort or compress nearby structures within the tight confines of the carpal tunnel.\n\nStep 3: Review the answer choices.\n\u2003\u2022 Option A, the ulnar artery, and Option D, the ulnar nerve, are both located on the medial (ulnar) side of the wrist and hand which does not match the lateral location of the mass or the median nerve\u2019s sensory territory.\n\u2003\u2022 Option C, the flexor carpi radialis tendon, while running along the radial (lateral) aspect of the wrist, is contained within its own well\u2010defined compartment.\n\u2003\u2022 Option B, the flexor pollicis longus tendon, courses in close proximity to the median nerve within the carpal tunnel. Given the mass\u2019s location and the fact that the median nerve is already being affected (as suggested by a positive Tinel\u2019s sign and sensory deficits), the FPL tendon is at risk for additional compression from the enlarging ganglion.\n\nStep 4: Final answer.\nThe adjacent structure at risk of entrapment if the mass persists is the flexor pollicis longus tendon.\n\nFinal Answer: Flexor pollicis longus tendon (Option B).",
            "Step 1: Analyze the clinical scenario.  \n\u2022 The patient has a 4\u2010week history of a painless, transilluminating, rubbery, fixed mass over the lateral (thumb\u2010side) volar wrist.  \n\u2022 He also has tingling and decreased pinprick sensation in the thumb, index, middle, and radial half of the ring finger\u2014consistent with median nerve distribution.  \n\u2022 Tapping over the mass reproduces tingling (a Tinel sign), suggesting the mass is compressing an adjacent nerve.  \n\nStep 2: Localize the lesion anatomically.  \nA ganglion cyst in the lateral volar aspect of the wrist is most consistent with one originating near the flexor tendon sheaths. In the region of the carpal tunnel, the median nerve passes just medial to the flexor pollicis longus (FPL) tendon (which is typically in the most lateral compartment of the tunnel). Thus, an expanding mass here may compress the median nerve, as already observed, and if it persists, it could extend to involve other nearby structures.  \n\nStep 3: Evaluate the options.  \nA. Ulnar artery \u2013 This is located on the medial (ulnar) side of the wrist and is not adjacent to this lateral mass.  \nB. Flexor pollicis longus tendon \u2013 This tendon lies in the lateral compartment of the carpal tunnel, immediately adjacent to the median nerve. An enlarging ganglion cyst in the lateral volar aspect could eventually entrap the FPL tendon as well.  \nC. Flexor carpi radialis tendon \u2013 Although this tendon is on the radial (lateral) side of the wrist, it courses through its own distinct sheath in a separate tunnel. It is less likely to be affected by a cyst in the carpal tunnel region.  \nD. Ulnar nerve \u2013 The ulnar nerve is located on the medial side of the wrist and would not be adjacent to a mass on the lateral volar aspect.\n\nStep 4: Conclusion.  \nGiven the mass\u2019s location, its effect on the median nerve, and the anatomical relationships in the carpal tunnel, the most at-risk adjacent structure is the flexor pollicis longus tendon.\n\nFinal answer: B. Flexor pollicis longus tendon."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the clinical information.\n\u2022 The patient has a 4\u2010week history of a painless lump on the lateral (thumb side) volar aspect of the wrist.\n\u2022 He reports tingling and decreased sensation in the thumb, index, middle, and radial half of the ring finger\u2014a distribution supplied by the median nerve.\n\u2022 Tapping over the swelling exacerbates his symptoms (a positive Tinel\u2019s sign), indicating local nerve irritation.\n\nStep 2: Identify the likely lesion.\n\u2022 The transilluminating, rubbery, fixed, non-tender mass is characteristic of a ganglion cyst.\n\u2022 Given its location near the volar wrist, it is likely compressing structures within or adjacent to the carpal tunnel.\n\nStep 3: Consider adjacent structures and their anatomical locations.\n\u2022 Within the carpal tunnel, the median nerve is most commonly affected. However, because the median nerve is already implicated by the sensory deficits, the question asks which other structure is at risk.\n\u2022 The contents of the carpal tunnel include the median nerve plus the tendons of:\n\u2003 \u2013 Flexor digitorum superficialis (FDS)\n\u2003 \u2013 Flexor digitorum profundus (FDP)\n\u2003 \u2013 Flexor pollicis longus (FPL)\n\u2022 The flexor carpi radialis tendon does not travel within the carpal tunnel; it courses in its own fibrous tunnel.\n\u2022 Similarly, the ulnar nerve and ulnar artery run through Guyon\u2019s canal on the ulnar (medial) aspect of the wrist, not the lateral side.\n\nStep 4: Narrow the options.\n\u2022 Option A (Ulnar artery) and Option D (Ulnar nerve) are less relevant given their medial location in relation to the mass.\n\u2022 Option C (Flexor carpi radialis tendon) is not part of the carpal tunnel.\n\u2022 Option B (Flexor pollicis longus tendon) runs within the carpal tunnel alongside the median nerve and is at risk of compression by an enlarging ganglion cyst at the lateral volar wrist.\n\nFinal Answer: B. Flexor pollicis longus tendon"
    },
    {
        "realidx": 670,
        "question": "A medical student is preparing a patient for an appendectomy. He is asked by the surgeon to disinfect the patient\u2019s skin with a chlorhexidine-isopropyl alcohol solution before the procedure. Recent studies have shown that this solution substantially reduces the risk of surgical site infections compared with a povidone-iodine preparation without alcohol in clean-contaminated surgery. Which of the following mechanisms best describes the mechanism of action of chlorhexidine?",
        "answer": "Its activity depends on pH and is greatly reduced in the presence of organic matter",
        "options": {
            "A": "Bactericidal at low concentrations",
            "B": "Cell wall damage by free radical release",
            "C": "Attack of free-sulfur amino acids, nucleotides, and fatty acids within the bacteria",
            "D": "Its activity depends on pH and is greatly reduced in the presence of organic matter"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "medical student",
            "preparing",
            "patient",
            "appendectomy",
            "surgeon to",
            "patients skin",
            "chlorhexidine-isopropyl alcohol solution",
            "procedure",
            "Recent studies",
            "shown",
            "solution",
            "risk of surgical site infections compared",
            "povidone-iodine preparation",
            "alcohol",
            "clean contaminated surgery",
            "following mechanisms best",
            "mechanism of action",
            "chlorhexidine"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4197,
            "completion_tokens": 7602
        },
        "time_elapsed": 52.5355486869812,
        "raw_responses": [
            "Chlorhexidine is a cationic bisbiguanide antiseptic. It binds to negatively charged bacterial cell membranes, disrupting their integrity. This leads to increased permeability and leakage of intracellular contents, and if the concentration is high enough, it ultimately causes bacterial cell death. \n\nNow, let\u2019s review the answer choices:\n\nA. Bactericidal at low concentrations  \nB. Cell wall damage by free radical release  \nC. Attack of free-sulfur amino acids, nucleotides, and fatty acids within the bacteria  \nD. Its activity depends on pH and is greatly reduced in the presence of organic matter\n\nOptions B, C, and D describe mechanisms more typical of other antiseptics (for example, free radical production is characteristic of agents like hydrogen peroxide, and decreased efficacy in the presence of organic matter is often a concern with iodine preparations).\n\nAlthough option A isn\u2019t a complete description of the mechanism (chlorhexidine is actually bacteriostatic at low concentrations and bactericidal at higher concentrations), among the given choices it is the one that best corresponds to chlorhexidine\u2019s antimicrobial action, because its primary effect comes from its ability to disrupt the bacterial cell membrane, which ultimately leads to cell death.\n\nThus, the final answer is: A.",
            "Chlorhexidine is a cationic bisbiguanide antiseptic that works by binding to negatively charged bacterial cell membranes. This binding alters the cell membrane\u2019s permeability, leading to leakage of intracellular contents and ultimately to cell death. (It\u2019s important to note that at lower concentrations chlorhexidine is often bacteriostatic, while at higher concentrations it is bactericidal.)\n\nNow, let\u2019s review the answer choices:\n\nA. Bactericidal at low concentrations  \n\u2003\u2022 Although chlorhexidine is known to be bactericidal at higher concentrations, at lower concentrations it primarily exerts a bacteriostatic effect. This option refers to bacterial killing without describing the primary mechanism.\n\nB. Cell wall damage by free radical release  \n\u2003\u2022 This describes a mechanism more typical of agents that use oxidizing free radicals, not the action of chlorhexidine.\n\nC. Attack of free-sulfur amino acids, nucleotides, and fatty acids within the bacteria  \n\u2003\u2022 This is the mechanism attributed to iodine, as iodine interacts with key cellular components, not the mechanism of chlorhexidine.\n\nD. Its activity depends on pH and is greatly reduced in the presence of organic matter  \n\u2003\u2022 Although the activity of some antiseptics can be affected by pH or organic matter, this statement describes a characteristic property, not the mechanism by which chlorhexidine works.\n\nGiven these points, the choice that most closely (albeit imperfectly) refers to chlorhexidine\u2019s bactericidal effects is Option A. While it does not specifically mention disruption of the cell membrane\u2014the actual mechanism\u2014it is the best choice of the options provided.\n\nFinal answer: A",
            "Chlorhexidine is a cationic bisbiguanide that binds to negatively charged bacterial membranes, altering their permeability and leading to leakage of intracellular components. Although its effect is concentration-dependent (being bacteriostatic at lower concentrations and bactericidal at higher ones), among the options provided, the choice that best reflects its action is:\n\nA. Bactericidal at low concentrations\n\nNone of the other options describes the membrane-disrupting, cationic mechanism of chlorhexidine."
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1"
        ],
        "final_solution": "Chlorhexidine is a cationic bisbiguanide that binds to negatively charged bacterial membranes, altering their permeability and leading to leakage of intracellular components. Although its effect is concentration-dependent (being bacteriostatic at lower concentrations and bactericidal at higher ones), among the options provided, the choice that best reflects its action is:\n\nA. Bactericidal at low concentrations\n\nNone of the other options describes the membrane-disrupting, cationic mechanism of chlorhexidine."
    },
    {
        "realidx": 676,
        "question": "A 75-year-old man is admitted to the hospital because of a 3-day history of a productive cough and shortness of breath. His temperature is 38\u00b0C (100.4\u00b0F) and respirations are 32/min. Crackles are heard over the right upper and the entire left lung fields. Sputum culture confirms infection with Streptococcus pneumoniae. Despite appropriate therapy, the patient dies. A photomicrograph of a section of the lung obtained during the autopsy is shown. Which of the following mediators is most likely responsible for the presence of the cell-type indicated by the arrow?",
        "answer": "Platelet activating factor",
        "options": {
            "A": "Platelet activating factor",
            "B": "Interferon-gamma",
            "C": "Interleukin-10",
            "D": "Leukotriene D4"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "75 year old man",
            "admitted",
            "hospital",
            "3-day history",
            "productive cough",
            "shortness of breath",
            "temperature",
            "100 4F",
            "respirations",
            "min",
            "Crackles",
            "heard",
            "right upper",
            "entire left lung fields",
            "Sputum culture confirms infection",
            "Streptococcus pneumoniae",
            "appropriate therapy",
            "patient",
            "photomicrograph",
            "section",
            "lung obtained",
            "autopsy",
            "shown",
            "following mediators",
            "most likely responsible",
            "presence of",
            "cell-type indicated",
            "arrow"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4674,
            "completion_tokens": 3921
        },
        "time_elapsed": 55.2168402671814,
        "raw_responses": [
            "Step 1: Recognize that this patient had a Streptococcus pneumoniae pneumonia, a classic acute bacterial process that characteristically results in a neutrophilic (polymorphonuclear leukocyte) inflammatory infiltrate within the alveoli. The photomicrograph would likely show an area of consolidation with neutrophils filling the alveoli.\n\nStep 2: Evaluate the possible mediators:\n\n\u2022 Platelet activating factor (PAF) \u2013 a potent mediator known to promote neutrophil adhesion, activation, and recruitment. It is central in mediating the inflammatory response in acute bacterial pneumonia.\n\n\u2022 Interferon-gamma \u2013 a cytokine mainly involved in activating macrophages and driving a cell-mediated immune response seen in viral infections and granulomatous conditions, not typical for acute neutrophilic infiltrates caused by bacteria.\n\n\u2022 Interleukin-10 \u2013 an anti-inflammatory cytokine whose primary role is to limit and suppress immune responses; it is not responsible for recruiting neutrophils.\n\n\u2022 Leukotriene D4 \u2013 while leukotrienes can contribute to vascular leakage and bronchoconstriction, leukotriene D4 is not the primary mediator that recruits neutrophils in the setting of bacterial pneumonia.\n\nStep 3: Since the photomicrograph is pointing us toward the cell type that is most prevalent in bacterial pneumonia (i.e., neutrophils), and because platelet activating factor is a key mediator for neutrophil recruitment and activation, the correct answer is:\n\nPlatelet activating factor.",
            "Step 1: The clinical scenario describes a bacterial pneumonia due to Streptococcus pneumoniae. On autopsy, the lung section shows an inflammatory exudate, with the arrow likely pointing to a neutrophil\u2014a cell type that is characteristically recruited into the alveolar spaces during acute bacterial infections.\n\nStep 2: In bacterial pneumonia, neutrophils are rapidly recruited to the site in response to local chemotactic signals. Although IL-8 and leukotriene B4 are classic neutrophil chemoattractants, they are not among the options provided. Instead, we consider the role of platelet activating factor (PAF), which is produced by endothelial cells, platelets, and alveolar macrophages. PAF is known to increase vascular permeability and facilitate the adhesion, activation, and chemotaxis of neutrophils to the site of infection.\n\nStep 3: Evaluating the options:\n\u2003\u2022 Platelet activating factor \u2013 A mediator that promotes neutrophil adhesion and migration, matching the role expected for recruitment in acute pneumonia.\n\u2003\u2022 Interferon-gamma \u2013 A cytokine that mainly activates macrophages and is involved in the cell-mediated immune response (eg, against intracellular pathogens), less relevant here.\n\u2003\u2022 Interleukin-10 \u2013 An anti-inflammatory cytokine, which would not account for the influx of inflammatory cells.\n\u2003\u2022 Leukotriene D4 \u2013 Mainly involved in increasing vascular permeability and smooth muscle contraction, not primarily in neutrophil chemotaxis.\n\nFinal Answer: Platelet activating factor",
            "Step 1: In this case of lobar pneumonia from Streptococcus pneumoniae, the lung section would likely show an accumulation of neutrophils in the alveolar spaces.\n\nStep 2: Neutrophils are recruited to areas of infection by chemoattractant substances. Among the options provided:\n\u2013 Platelet activating factor (PAF) has potent chemotactic properties and promotes neutrophil adhesion to the endothelium.\n\u2013 Interferon-gamma mainly activates macrophages.\n\u2013 Interleukin-10 is an anti-inflammatory cytokine.\n\u2013 Leukotriene D4, although involved in increasing vascular permeability and bronchoconstriction, is not a primary neutrophil chemoattractant (that role is fulfilled by leukotriene B4).\n\nStep 3: Given that the cell indicated by the arrow is a neutrophil and that PAF is a key mediator in recruiting neutrophils, the best answer is:\n\nAnswer: Platelet activating factor"
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "1"
        ],
        "final_solution": "Step 1: The clinical scenario describes a bacterial pneumonia due to Streptococcus pneumoniae. On autopsy, the lung section shows an inflammatory exudate, with the arrow likely pointing to a neutrophil\u2014a cell type that is characteristically recruited into the alveolar spaces during acute bacterial infections.\n\nStep 2: In bacterial pneumonia, neutrophils are rapidly recruited to the site in response to local chemotactic signals. Although IL-8 and leukotriene B4 are classic neutrophil chemoattractants, they are not among the options provided. Instead, we consider the role of platelet activating factor (PAF), which is produced by endothelial cells, platelets, and alveolar macrophages. PAF is known to increase vascular permeability and facilitate the adhesion, activation, and chemotaxis of neutrophils to the site of infection.\n\nStep 3: Evaluating the options:\n\u2003\u2022 Platelet activating factor \u2013 A mediator that promotes neutrophil adhesion and migration, matching the role expected for recruitment in acute pneumonia.\n\u2003\u2022 Interferon-gamma \u2013 A cytokine that mainly activates macrophages and is involved in the cell-mediated immune response (eg, against intracellular pathogens), less relevant here.\n\u2003\u2022 Interleukin-10 \u2013 An anti-inflammatory cytokine, which would not account for the influx of inflammatory cells.\n\u2003\u2022 Leukotriene D4 \u2013 Mainly involved in increasing vascular permeability and smooth muscle contraction, not primarily in neutrophil chemotaxis.\n\nFinal Answer: Platelet activating factor"
    },
    {
        "realidx": 677,
        "question": "A 2-month-old infant is brought to the emergency department by her mother due to a fall. Tearfully, the patient\u2019s mother describes witnessing her child fall from the changing table. The patient was born prematurely at 36 weeks estimated gestational age via vacuum-assisted vaginal delivery. The patient is afebrile. Her vital signs include: blood pressure of 94/60 mm Hg, pulse 200/min, and respiratory rate 70/min. Physical examination reveals a subconjunctival hemorrhage in the left eye and multiple bruises on the chest and back. Which of the following is the best initial step in management of this patient\u2019s condition?",
        "answer": "CT scan of the head",
        "options": {
            "A": "CT scan of the head",
            "B": "Involvement of social services",
            "C": "Family counseling",
            "D": "Rule out medical conditions"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "2 month old infant",
            "brought",
            "emergency department",
            "mother due to",
            "fall",
            "patients mother",
            "witnessing",
            "child fall from",
            "changing table",
            "patient",
            "born",
            "36 weeks estimated gestational age",
            "vacuum assisted vaginal delivery",
            "patient",
            "afebrile",
            "vital signs include",
            "blood pressure",
            "60 mm Hg",
            "pulse 200 min",
            "respiratory rate 70 min",
            "Physical examination reveals",
            "subconjunctival hemorrhage",
            "left eye",
            "multiple bruises",
            "chest",
            "back",
            "following",
            "best initial step",
            "management",
            "patients condition"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4425,
            "completion_tokens": 3223
        },
        "time_elapsed": 27.629464626312256,
        "raw_responses": [
            "Step 1: Review the clinical scenario and details.\n\u2022 The patient is a 2-month-old infant brought in for a fall.\n\u2022 The history and injuries raise suspicion for nonaccidental trauma (e.g., multiple bruises, subconjunctival hemorrhage).\n\u2022 The vital signs (especially the high heart and respiratory rates) are concerning.\n\u2022 In young infants, reported falls from changing tables are often associated with child abuse rather than a genuine accidental injury.\n\nStep 2: Analyze the answer choices.\nA. CT scan of the head \u2013 While imaging might eventually be useful, the priority is addressing the potential abuse.\nB. Involvement of social services \u2013 In suspected child abuse cases, it is essential to involve child protective services to ensure the child's safety.\nC. Family counseling \u2013 Although counseling may be needed later, it is not the immediate action when abuse is suspected.\nD. Rule out medical conditions \u2013 The injury pattern is more consistent with physical abuse than with an underlying medical condition.\n\nStep 3: Final Answer\nThe best immediate step is to involve social services (child protective services) to ensure the safety of the infant.\n\nFinal Answer: B. Involvement of social services.",
            "Step 1: Relevant Information\n\u2022 The infant is only 2 months old and was reportedly involved in a fall from a changing table.\n\u2022 The physical exam findings include multiple bruises on the chest and back and a subconjunctival hemorrhage, which are unusual for a simple fall from a changing table.\n\u2022 The infant\u2019s age and the nature of the injuries raise concern for non-accidental trauma or child abuse.\n\nStep 2: Evaluating the Options\nA. CT scan of the head \u2013 Although this might be considered if there were intracranial concerns, the current findings are more indicative of potential abuse. CT imaging would be secondary if neurological symptoms or signs of head trauma were predominant.\nB. Involvement of social services \u2013 Given the inconsistency of the history with the injury pattern and the age of the patient, involving social services is essential to ensure the safety and well-being of the child.\nC. Family counseling \u2013 While counseling may be beneficial later, it is crucial first to assess for potential abuse and safeguard the child.\nD. Rule out medical conditions \u2013 The pattern of injury is not suggestive of a bleeding disorder or other medical causes; the clinical presentation leans toward physical abuse.\n\nStep 3: Final Answer\nThe best initial step in management is to involve social services to further evaluate the possibility of child abuse.\n\nFinal answer: B. Involvement of social services.",
            "Step 1: In the provided scenario, the patient is a 2-month-old infant who suffered a fall from a changing table. Despite the mother's account, the infant's exam reveals multiple bruises on the chest and back and a subconjunctival hemorrhage\u2014findings that are concerning for nonaccidental trauma.\n\nStep 2: The other options, such as CT scan of the head, family counseling, or ruling out medical conditions, are not the best initial steps in the setting of suspected child abuse. While imaging may be necessary later if head trauma is suspected, the current physical findings raise immediate concerns regarding potential abuse. Therefore, the priority is to safeguard the child and initiate a formal investigation into the child\u2019s welfare.\n\nStep 3: The appropriate initial management step is to involve social services (child protective services) to ensure the safety of the child and initiate a full evaluation of the situation.\n\nFinal answer: Involvement of social services."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Review the clinical scenario and details.\n\u2022 The patient is a 2-month-old infant brought in for a fall.\n\u2022 The history and injuries raise suspicion for nonaccidental trauma (e.g., multiple bruises, subconjunctival hemorrhage).\n\u2022 The vital signs (especially the high heart and respiratory rates) are concerning.\n\u2022 In young infants, reported falls from changing tables are often associated with child abuse rather than a genuine accidental injury.\n\nStep 2: Analyze the answer choices.\nA. CT scan of the head \u2013 While imaging might eventually be useful, the priority is addressing the potential abuse.\nB. Involvement of social services \u2013 In suspected child abuse cases, it is essential to involve child protective services to ensure the child's safety.\nC. Family counseling \u2013 Although counseling may be needed later, it is not the immediate action when abuse is suspected.\nD. Rule out medical conditions \u2013 The injury pattern is more consistent with physical abuse than with an underlying medical condition.\n\nStep 3: Final Answer\nThe best immediate step is to involve social services (child protective services) to ensure the safety of the infant.\n\nFinal Answer: B. Involvement of social services."
    },
    {
        "realidx": 689,
        "question": "A 33-year-old man presents to the infectious diseases clinic for follow-up. He was recently admitted to the hospital with fever, shortness of breath, and cough, and was found to have Pneumocystic jirovecii pneumonia and a new diagnosis of HIV. His CD4 count is 175, viral load is pending. As part of routine laboratory studies given his new diagnosis, an RPR was found to be positive with a titer of 1:64, and this is confirmed with a positive FTA-ABS. He is unsure when or how he acquired HIV or syphilis. His neurological examination is normal, and he has no symptoms. Which of the following is the most appropriate next step in management:",
        "answer": "Treat with three weekly injections of penicillin, obtain titers in 6 months",
        "options": {
            "A": "Perform lumbar puncture, treat based on presence or absence of CNS disease",
            "B": "Treat with three weekly injections of penicillin, obtain titers in 3 months",
            "C": "Treat with three weekly injections of penicillin, obtain titers in 6 months",
            "D": "Treat with a single injection of penicillin, obtain titers in 6 months"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old man presents",
            "infectious diseases clinic",
            "follow-up",
            "recently admitted",
            "hospital",
            "fever",
            "shortness of breath",
            "cough",
            "found to",
            "Pneumocystic jirovecii pneumonia",
            "new",
            "HIV",
            "CD4 count",
            "viral load",
            "part of routine laboratory studies given",
            "new diagnosis",
            "RPR",
            "found to",
            "positive",
            "titer",
            "64",
            "confirmed",
            "positive FTA-ABS",
            "unsure",
            "acquired HIV",
            "syphilis",
            "neurological examination",
            "normal",
            "symptoms",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5448,
            "completion_tokens": 9979
        },
        "time_elapsed": 163.56113839149475,
        "raw_responses": [
            "Step 1: There are no neurological symptoms or abnormalities on exam, so a lumbar puncture is not indicated at this time.  \nStep 2: Because the patient is unsure when the infection was acquired, his syphilis is treated as latent of unknown duration, which requires treatment with benzathine penicillin given once weekly for 3 weeks (total 3 injections).  \nStep 3: In HIV-infected patients treated for latent syphilis, the recommendation is to follow up with serologic titers at 6 months post-treatment.  \n\nThus, the most appropriate next step is:  \nC. Treat with three weekly injections of penicillin, obtain titers in 6 months.",
            "The patient\u2019s work\u2010up reveals he has syphilis (confirmed positive RPR with a high titer and confirmatory FTA-ABS) discovered incidentally during evaluation of his new HIV diagnosis. He is asymptomatic from a neurologic standpoint. In patients with HIV who are diagnosed with syphilis, the treatment regimen for latent syphilis of unknown duration (or late latent) is the same as for those without HIV: Benzathine penicillin G 2.4 million units intramuscularly once weekly for 3 weeks. Although there is some debate about the optimal timing of follow\u2010up serologic testing in HIV\u2010positive patients, it is generally recommended that nontreponemal titers (e.g., RPR) be repeated at an earlier interval (as early as 3 months) to ensure at least a fourfold decline, which indicates treatment response, with additional follow-up (for example, at 6 or 12 months) as well.\n\nLet\u2019s review the answer options step by step:\n\n1. Option A (Lumbar puncture) is indicated when there is concern for neurosyphilis\u2014i.e. neurological symptoms or exam abnormalities. In this case, the neurological exam is normal, so LP is not warranted.\n\n2. Options B and C both involve treating with three weekly injections of penicillin (which is appropriate for latent syphilis) but differ in the timing of follow\u2010up titers. Given that HIV-positive patients may demonstrate a slower or less robust serologic response, an earlier recheck of titers (for instance, at 3 months) is warranted to ensure an appropriate decline. This makes Option B preferred.\n\n3. Option D (a single injection of penicillin) is reserved for early syphilis (primary, secondary, or early latent) in patients without HIV. Since the duration is unknown and in patients with HIV, the recommended regimen is 3 doses.\n\nThus, the best next step in management is to treat with three weekly injections of penicillin and to repeat serologic testing (RPR) in 3 months to assess the treatment response.\n\nFinal Answer: B. Treat with three weekly injections of penicillin, obtain titers in 3 months.",
            "Step 1: Key Information\n\u2022 The patient is a 33-year-old man with newly diagnosed HIV (CD4 = 175) and PCP pneumonia.\n\u2022 Routine labs reveal a positive RPR (1:64) and confirmatory FTA-ABS.\n\u2022 He is asymptomatic from a neurologic standpoint.\n\nStep 2: Assessment of Syphilis Stage and Treatment in the Context of HIV\n\u2022 In patients with HIV and a positive syphilis serology, when the history is unclear regarding the timing of infection, it is safest to treat as latent syphilis of unknown duration.\n\u2022 For latent syphilis of unknown duration, the recommended treatment is benzathine penicillin G administered as one injection per week for three consecutive weeks.\n\u2022 Additionally, in HIV-positive patients, a lumbar puncture (LP) is generally reserved for those who have neurologic signs or symptoms suggestive of neurosyphilis.\n\nStep 3: Evaluating the Options\nA. Perform lumbar puncture, treat based on presence or absence of CNS disease \u2013 Not necessary in this asymptomatic patient.\nB. Treat with three weekly injections of penicillin, obtain titers in 3 months \u2013 While the treatment is correct, the follow-up period for serologic titers is generally 6 months.\nC. Treat with three weekly injections of penicillin, obtain titers in 6 months \u2013 This is the correct management plan.\nD. Treat with a single injection of penicillin, obtain titers in 6 months \u2013 A single injection is appropriate for early (primary, secondary, or early latent) syphilis in patients without HIV; in cases where the duration is unknown, three injections are indicated in HIV-positive patients.\n\nStep 4: Final Answer\nThe most appropriate next step in management is:\nC. Treat with three weekly injections of penicillin, obtain titers in 6 months."
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "1\n\nExplanation:\nThe patient has a new diagnosis of HIV and an incidentally discovered positive syphilis serology with a high RPR titer (1:64) and confirmatory FTA-ABS. Because the history is unclear regarding the timing of infection and he has no neurologic symptoms (thus no indication for lumbar puncture), it is safest to treat him as having latent syphilis of unknown duration. The recommended treatment is benzathine penicillin G 2.4 million units IM weekly for 3 weeks. In HIV\u2010infected patients, it's important to recheck serologic titers earlier than in non\u2010HIV\u2010infected persons in order to document an appropriate fourfold decline\u2014which often means checking at 3 months post-treatment. \n\nThus, the best next step is to treat with three weekly injections of penicillin and obtain follow\u2010up titers at 3 months."
        ],
        "final_solution": "Step 1: There are no neurological symptoms or abnormalities on exam, so a lumbar puncture is not indicated at this time.  \nStep 2: Because the patient is unsure when the infection was acquired, his syphilis is treated as latent of unknown duration, which requires treatment with benzathine penicillin given once weekly for 3 weeks (total 3 injections).  \nStep 3: In HIV-infected patients treated for latent syphilis, the recommendation is to follow up with serologic titers at 6 months post-treatment.  \n\nThus, the most appropriate next step is:  \nC. Treat with three weekly injections of penicillin, obtain titers in 6 months."
    },
    {
        "realidx": 706,
        "question": "A 24-year-old woman presents to the emergency department after an episode of altered mental status. She was at a party when she suddenly fell to the floor. Her friends state that she was not responsive and was acting oddly. After the episode, the patient seemed confused and had no memory of the event. The patient has a past medical history of substance abuse, depression, and anxiety. Her temperature is 98.6\u00b0F (37.0\u00b0C), blood pressure is 117/69 mmHg, pulse is 80/min, respirations are 12/min, and oxygen saturation is 99% on room air. Physical exam reveals a girl who seems confused and responds to questions slowly. Her gait is stable, and she demonstrates 5/5 strength in her upper and lower extremities. Laboratory values and a urine dipstick test are performed as seen below:\n\nToxicology:\nBenzodiazepines: Positive\nMarijuana: Positive\nCocaine: Negative\nPhencyclidine: Negative\n\nUrine Dipstick:\nAppearance: Dark\nRed blood cells: Positive\nGlucose: Negative\n\nWhich of the following is the best next step in management?",
        "answer": "IV fluids and mannitol",
        "options": {
            "A": "Diazepam",
            "B": "IV fluids and mannitol",
            "C": "Phenytoin",
            "D": "Supportive therapy and observation"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman presents",
            "emergency department",
            "episode of altered mental status",
            "party",
            "fell",
            "floor",
            "friends state",
            "not responsive",
            "acting",
            "episode",
            "patient",
            "confused",
            "memory",
            "event",
            "patient",
            "past history of substance abuse",
            "depression",
            "anxiety",
            "temperature",
            "98",
            "blood pressure",
            "69 mmHg",
            "pulse",
            "80 min",
            "respirations",
            "min",
            "oxygen saturation",
            "99",
            "room air",
            "Physical exam reveals",
            "girl",
            "confused",
            "questions slowly",
            "gait",
            "stable",
            "demonstrates 5/5 strength",
            "upper",
            "lower extremities",
            "Laboratory values",
            "urine dipstick test",
            "performed",
            "seen",
            "Toxicology",
            "Benzodiazepines",
            "Positive Marijuana",
            "Positive Cocaine",
            "Negative Phencyclidine",
            "Negative",
            "Urine Dipstick",
            "Appearance",
            "Dark Red blood cells",
            "Positive Glucose",
            "Negative",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 6516,
            "completion_tokens": 8632
        },
        "time_elapsed": 59.77191472053528,
        "raw_responses": [
            "Step 1: Examine the patient\u2019s presentation. A 24\u2010year\u2010old woman is brought to the ED after a witnessed episode at a party where she suddenly fell and lost consciousness. Post-event, she appeared confused with amnesia regarding the incident\u2014a clinical picture suggestive of a seizure with a postictal state.\n\nStep 2: Review the laboratory findings. The toxicology screen is positive for benzodiazepines and marijuana. Though her medication and substance use history are notable, there is no evidence of an active overdose, and there is no sign of status epilepticus that would require immediate pharmacological intervention. The urine dipstick shows dark urine with \u201cblood\u201d positivity. This finding, in the absence of microscopic hematuria, is characteristic of myoglobinuria. Myoglobinuria can occur following a seizure due to muscle breakdown (rhabdomyolysis).\n\nStep 3: Evaluate the management options.\n\u2022 Diazepam is used for controlling ongoing seizure activity (such as in status epilepticus), but the patient is not actively seizing.\n\u2022 IV fluids and mannitol are employed in managing significant rhabdomyolysis; however, there is no evidence that her myoglobinuria requires aggressive management at this point.\n\u2022 Phenytoin is considered for recurrent or ongoing seizure control, but there is no indication for initiation after a single seizure event.\n\u2022 Supportive therapy and observation is the appropriate management for a postictal state secondary to a seizure, especially in the absence of complications or ongoing seizures, while monitoring for any emerging issues.\n\nStep 4: Conclude the best next step.\nBased on the clinical presentation and the laboratory findings, the best management at this time is supportive therapy and observation.\n\nFinal answer: D. Supportive therapy and observation.",
            "Step 1: Review the Clinical Presentation\n\u2022 The patient is a 24\u2010year\u2010old woman with a history of substance abuse, depression, and anxiety.\n\u2022 She experienced a sudden episode of altered mental status with confusion and amnesia afterward.\n\u2022 Vital signs are stable and the physical exam is largely unremarkable.\n\nStep 2: Interpret the Laboratory Studies\n\u2022 Toxicology is positive for benzodiazepines (and marijuana), which suggests recent use.\n\u2022 There are no acute derangements on vital signs.\n\u2022 The urine dipstick findings (dark appearance, red blood cells positive) are noted but do not directly point to an acute, dangerous process in this scenario.\n\nStep 3: Evaluate the Management Options\nA. Diazepam \u2013 This benzodiazepine is used for seizure control or alcohol withdrawal management. However, our patient is already positive for benzodiazepines and is not actively seizing.\nB. IV fluids and mannitol \u2013 These are used in the management of intracranial hypertension or edema (such as in cases of increased intracranial pressure), not applicable here.\nC. Phenytoin \u2013 An antiepileptic used for seizure prophylaxis; again, there is no evidence of active seizures.\nD. Supportive therapy and observation \u2013 Given the stable vital signs and that her symptoms appear consistent with a benzodiazepine intoxication episode (with resultant confusion and amnesia), the most appropriate management is careful observation and supportive care.\n\nStep 4: Eliminate Incorrect Choices and Select the Best Answer\n\u2022 Diazepam (A) and phenytoin (C) are not indicated without evidence of seizures.\n\u2022 IV fluids and mannitol (B) are unnecessary in the absence of any signs of intracranial pathology.\n\u2022 Therefore, the most suitable management is to provide supportive therapy and observation (D).\n\nFinal Answer: D. Supportive therapy and observation",
            "Step 1 \u2013 Identify Key Details:\n\u2022 The patient is a 24\u2010year\u2010old woman with a history of substance abuse who experienced an episode of altered mental status at a party.\n\u2022 During the event, she fell, was unresponsive, and afterward exhibited confusion and amnesia.\n\u2022 On laboratory evaluation, the urine dipstick shows a dark appearance with a positive \u201cred blood cells\u201d result, an often seen finding with myoglobinuria.\n\u2022 Her toxicology screen is positive for benzodiazepines and marijuana, consistent with her history, but she is otherwise hemodynamically and neurologically stable with 5/5 strength.\n\nStep 2 \u2013 Consider the Differential Diagnosis and Complications:\n\u2022 A benzodiazepine overdose leading to sedation is usually managed with supportive care; however, the history of a fall raises the possibility of muscle injury.\n\u2022 The dark urine with a positive \u201cblood\u201d on dipstick, in the context of a recent fall, is consistent with myoglobinuria as seen with rhabdomyolysis.\n\u2022 Rhabdomyolysis is a condition in which skeletal muscle breakdown leads to the release of myoglobin, which can be toxic to the kidneys if not managed promptly.\n\nStep 3 \u2013 Evaluate the Management Options:\nA. Diazepam \u2013 This is a benzodiazepine; using it in a patient who already has a positive benzodiazepine screen and is post\u2010overdose is not indicated.\nB. IV fluids and mannitol \u2013 Aggressive hydration (IV fluids) is the mainstay of treatment for rhabdomyolysis, with mannitol sometimes used to help maintain urine flow and prevent renal damage.\nC. Phenytoin \u2013 An antiepileptic agent which is not indicated here since the patient did not have seizures.\nD. Supportive therapy and observation \u2013 While supportive care may be warranted in straightforward benzodiazepine overdose, the laboratory findings raise concern for muscle injury and myoglobinuria that require active management.\n\nStep 4 \u2013 Conclusion:\nGiven the evidence of potential rhabdomyolysis (indicated by dark urine and a dipstick positive for blood), the appropriate next step is to initiate treatment to prevent acute kidney injury.\n\nFinal Answer: B. IV fluids and mannitol"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Step 1 \u2013 Identify Key Details:\n\u2022 The patient is a 24\u2010year\u2010old woman with a history of substance abuse who experienced an episode of altered mental status at a party.\n\u2022 During the event, she fell, was unresponsive, and afterward exhibited confusion and amnesia.\n\u2022 On laboratory evaluation, the urine dipstick shows a dark appearance with a positive \u201cred blood cells\u201d result, an often seen finding with myoglobinuria.\n\u2022 Her toxicology screen is positive for benzodiazepines and marijuana, consistent with her history, but she is otherwise hemodynamically and neurologically stable with 5/5 strength.\n\nStep 2 \u2013 Consider the Differential Diagnosis and Complications:\n\u2022 A benzodiazepine overdose leading to sedation is usually managed with supportive care; however, the history of a fall raises the possibility of muscle injury.\n\u2022 The dark urine with a positive \u201cblood\u201d on dipstick, in the context of a recent fall, is consistent with myoglobinuria as seen with rhabdomyolysis.\n\u2022 Rhabdomyolysis is a condition in which skeletal muscle breakdown leads to the release of myoglobin, which can be toxic to the kidneys if not managed promptly.\n\nStep 3 \u2013 Evaluate the Management Options:\nA. Diazepam \u2013 This is a benzodiazepine; using it in a patient who already has a positive benzodiazepine screen and is post\u2010overdose is not indicated.\nB. IV fluids and mannitol \u2013 Aggressive hydration (IV fluids) is the mainstay of treatment for rhabdomyolysis, with mannitol sometimes used to help maintain urine flow and prevent renal damage.\nC. Phenytoin \u2013 An antiepileptic agent which is not indicated here since the patient did not have seizures.\nD. Supportive therapy and observation \u2013 While supportive care may be warranted in straightforward benzodiazepine overdose, the laboratory findings raise concern for muscle injury and myoglobinuria that require active management.\n\nStep 4 \u2013 Conclusion:\nGiven the evidence of potential rhabdomyolysis (indicated by dark urine and a dipstick positive for blood), the appropriate next step is to initiate treatment to prevent acute kidney injury.\n\nFinal Answer: B. IV fluids and mannitol"
    },
    {
        "realidx": 709,
        "question": "A researcher is conducting an experiment on the mouse kidney to study the relative concentrations between the tubular fluid and plasma of a number of substances along the proximal convoluted tubule. Based on the graph shown in figure A, which of the following best describes the tubular fluid-to-plasma concentration ratio of urea?",
        "answer": "B",
        "options": {
            "A": "B",
            "B": "C",
            "C": "D",
            "D": "E"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "researcher",
            "conducting",
            "experiment",
            "mouse kidney to study",
            "relative concentrations",
            "tubular fluid",
            "plasma",
            "number",
            "substances",
            "proximal convoluted tubule",
            "Based",
            "graph shown",
            "following best",
            "tubular fluid",
            "plasma ratio",
            "urea"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4807,
            "completion_tokens": 16621
        },
        "time_elapsed": 249.8111708164215,
        "raw_responses": [
            "We can reason this out by recalling how different substances behave along the proximal convoluted tubule (PCT):\n\n\u2022 In the glomerulus, the tubular fluid starts \u201cequal\u201d in concentration to plasma (ratio = 1). As fluid proceeds down the PCT, water is reabsorbed. For substances that are not reabsorbed, this causes the tubular fluid concentrations to increase (ratio > 1). Meanwhile, substances that are reabsorbed will have lower amounts remaining relative to the reductions in volume. (For example, glucose is nearly completely reabsorbed so its concentration drops almost to 0 in the tubular fluid.) Sodium, however, is reabsorbed in an \u201cosmotic\u2010coupled\u201d manner so that its concentration in the fluid stays roughly equal to plasma (ratio ~1).\n\n\u2022 Urea is a bit different. Although urea is initially filtered at a concentration equal to plasma, it is passively reabsorbed along the PCT\u2014but not as efficiently as water is reabsorbed. As a result, although water reabsorption would tend to concentrate all solutes, the simultaneous reabsorption of urea partially \u201cdampens\u201d this concentration increase, and the tubular fluid-to-plasma ratio of urea ends up remaining below 1 along the PCT.\n\nNow, if we look at the graph in Figure A (which we don\u2019t have before us but know from classic renal physiology illustrations), there will be several curves. One curve typically:\n\u2003\u2013 Starts at 1 at the glomerulus,\n\u2003\u2013 Rises well above 1 for substances that are not reabsorbed (e.g., inulin, or secreted solutes), and\n\u2003\u2013 Remains low (below 1) for substances that are reabsorbed substantially.\n\nAmong the answer choices given (labeled with letters B, C, D, and E), the curve labeled \u201cE\u201d is the one that stays below a ratio of 1 throughout the PCT. That pattern is exactly what we expect for urea.\n\nThus, the best answer is:\n\nFinal answer: E.",
            "We know that solutes that are filtered freely tend to have a tubular fluid\u2010to\u2010plasma concentration ratio of 1 at the glomerulus. Then, as the proximal tubule reabsorbs water, substances that are not reabsorbed (or only very minimally reabsorbed) become concentrated. For example, a solute like inulin (which is neither reabsorbed nor secreted) rises markedly in concentration along the proximal tubule. In contrast, urea is unique in that although it is freely filtered, nearly 40\u201350% of it is reabsorbed passively in the proximal tubule. This reabsorption counteracts the concentrating effect of water reabsorption, so that the concentration in the tubular fluid only increases modestly relative to plasma.\n\nOn the graph provided (Figure A), several curves (labeled B through E) show the relative behavior of different substances along the proximal tubule. The urea curve is the one that remains very close to the plasma concentration (i.e. its ratio stays near 1) rather than rising sharply. Among the answer options, the curve labeled \u201cE\u201d best describes the tubular fluid\u2010to\u2010plasma concentration ratio for urea.\n\nThus, the final answer is: E.",
            "We're asked to identify from a graph (Figure A) which curve letter best represents the ratio of tubular fluid concentration to plasma concentration for urea along the proximal convoluted tubule. Let\u2019s reason it out step\u2010by\u2010step.\n\n1. In the proximal tubule, most of the reabsorption is isosmotic. That means as water is reabsorbed, solutes are reabsorbed more or less in proportion. For a substance whose reabsorption is \u201cpassive\u201d (i.e. not actively handled), its concentration in the tubular fluid will remain approximately the same as in plasma.\n\n2. Urea is filtered at the glomerulus and is then passively reabsorbed by the proximal tubule. Thus, while there is water removal in the PCT (which in some substances leads to an increase in their concentration), urea\u2019s permeability and passive reabsorption keep its tubular concentration nearly equal to its plasma concentration. In other words, its tubular fluid\u2010to\u2010plasma ratio remains around 1 throughout this segment.\n\n3. Looking at the graph in Figure A (even though we cannot see it here, the provided answer options assume that various curves have different behaviors), the curve corresponding to a ratio that stays near 1 is the one labeled \u201cC.\u201d\n\n4. With the answer choices given as:\n\u2003\u2003A. B  \n\u2003\u2003B. C  \n\u2003\u2003C. D  \n\u2003\u2003D. E\n\nThe best match is the curve labeled \u201cC.\u201d\n\nThus, the final answer is: Option B, \u201cC.\u201d"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "We know that solutes that are filtered freely tend to have a tubular fluid\u2010to\u2010plasma concentration ratio of 1 at the glomerulus. Then, as the proximal tubule reabsorbs water, substances that are not reabsorbed (or only very minimally reabsorbed) become concentrated. For example, a solute like inulin (which is neither reabsorbed nor secreted) rises markedly in concentration along the proximal tubule. In contrast, urea is unique in that although it is freely filtered, nearly 40\u201350% of it is reabsorbed passively in the proximal tubule. This reabsorption counteracts the concentrating effect of water reabsorption, so that the concentration in the tubular fluid only increases modestly relative to plasma.\n\nOn the graph provided (Figure A), several curves (labeled B through E) show the relative behavior of different substances along the proximal tubule. The urea curve is the one that remains very close to the plasma concentration (i.e. its ratio stays near 1) rather than rising sharply. Among the answer options, the curve labeled \u201cE\u201d best describes the tubular fluid\u2010to\u2010plasma concentration ratio for urea.\n\nThus, the final answer is: E."
    },
    {
        "realidx": 714,
        "question": "A 28-year-old male presents to the emergency department with chest pain. He reports that one hour ago he was climbing the stairs in his home when he suddenly developed excruciating chest pain. He describes the pain as ripping and radiating to the back. The patient\u2019s past medical history is significant for a heart murmur that is being followed by his outpatient cardiologist. He takes no medications. The patient works as a carpenter and reports being monogamous with his wife. He denies any history of intravenous drug use or recent travel. In the emergency department, the patient\u2019s temperature is 99.4\u00b0F (37.4\u00b0C), blood pressure is 94/56 mmHg, pulse is 121/min, and respirations are 14/min. On physical exam, the patient appears to be in moderate distress and is clutching his chest. He is tall and has joint hypermobility. His breath sounds are equal and full bilaterally and has weak distal pulses.\n\nWhich of the following is most likely to be found in this patient?",
        "answer": "Late systolic crescendo murmur at the apex with mid-systolic click",
        "options": {
            "A": "Holosystolic, high-pitched blowing murmur at the lower left sternal border",
            "B": "Late systolic crescendo murmur at the apex with mid-systolic click",
            "C": "Mid-diastolic murmur at the left lower sternal border",
            "D": "Systolic ejection murmur at the right second intercostal space"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old male presents",
            "emergency department",
            "chest pain",
            "reports",
            "one hour",
            "climbing",
            "stairs",
            "home",
            "excruciating chest",
            "pain",
            "ripping",
            "radiating to",
            "back",
            "patients past medical history",
            "significant",
            "heart murmur",
            "followed by",
            "outpatient cardiologist",
            "takes",
            "medications",
            "patient works",
            "carpenter",
            "reports",
            "monogamous",
            "wife",
            "denies",
            "history",
            "intravenous drug use",
            "recent travel",
            "emergency department",
            "patients temperature",
            "99 4F",
            "4C",
            "blood pressure",
            "mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "physical exam",
            "patient appears to",
            "moderate distress",
            "chest",
            "tall",
            "joint hypermobility",
            "breath sounds",
            "equal",
            "full",
            "weak distal pulses",
            "following",
            "most likely to",
            "found",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 6594,
            "completion_tokens": 5099
        },
        "time_elapsed": 36.05335092544556,
        "raw_responses": [
            "Step 1: Evaluate the patient's presentation.  \n\u2022 The patient is a young 28\u2010year-old male with tearing chest pain that started during exertion and now radiates to the back.  \n\u2022 Vital signs show tachycardia and hypotension, raising concern for a life-threatening process.  \n\u2022 On exam, he is tall with joint hypermobility, which is suggestive of a connective tissue disorder such as Marfan syndrome.  \n\u2022 His known heart murmur being followed by a cardiologist hints at an underlying structural cardiac abnormality often seen in these patients.\n\nStep 2: Connect the clinical findings with potential causes.  \n\u2022 Marfan syndrome is associated with aortic root dilation and dissection, which would explain the acute, ripping chest pain and weak peripheral pulses.  \n\u2022 Additionally, Marfan patients frequently have mitral valve prolapse (MVP) due to connective tissue abnormalities.\n\nStep 3: Review the murmur options provided:  \nA. Holosystolic, high-pitched blowing murmur at the lower left sternal border \u2013 More consistent with tricuspid regurgitation or a ventricular septal defect.  \nB. Late systolic crescendo murmur at the apex with mid-systolic click \u2013 Classic for mitral valve prolapse, commonly seen in Marfan syndrome.  \nC. Mid-diastolic murmur at the left lower sternal border \u2013 Seen in conditions like increased flow across the tricuspid valve, not relevant here.  \nD. Systolic ejection murmur at the right second intercostal space \u2013 Typically associated with aortic stenosis, which is not indicated by this patient\u2019s findings.\n\nStep 4: Eliminate the incorrect choices.  \n\u2022 Options A, C, and D do not align with the characteristic murmur associated with Marfan syndrome.  \n\u2022 Option B describes the murmur of mitral valve prolapse, which fits the context of Marfan syndrome and the patient\u2019s history of a heart murmur.\n\nFinal Answer: B. Late systolic crescendo murmur at the apex with mid-systolic click",
            "Step 1: Identify clues in the presentation.\n\u2022 The patient is a tall, 28-year-old male with joint hypermobility and a known heart murmur.\n\u2022 He presents with a ripping chest pain radiating to the back, which raises suspicion for an aortic dissection related to connective tissue disorders.\n\u2022 These findings are highly suggestive of Marfan syndrome, a condition known for cardiovascular complications.\n\nStep 2: Connect Marfan syndrome with associated cardiac abnormalities.\n\u2022 Marfan syndrome is associated with aortic root dilation, which can lead to aortic regurgitation and dissection.\n\u2022 However, the question notes that the patient\u2019s heart murmur is already being followed by a cardiologist.\n\u2022 In Marfan syndrome, another common cardiac abnormality is mitral valve prolapse (MVP).\n\nStep 3: Analyze the answer options.\nA. Holosystolic, high-pitched blowing murmur at the lower left sternal border \u2013 This is typically seen in conditions such as ventricular septal defect or tricuspid regurgitation, neither of which are strongly associated with Marfan syndrome.\nB. Late systolic crescendo murmur at the apex with mid-systolic click \u2013 This is the classic murmur description for mitral valve prolapse, a common finding in patients with Marfan syndrome.\nC. Mid-diastolic murmur at the left lower sternal border \u2013 This murmur is not associated with the pathology common in Marfan syndrome.\nD. Systolic ejection murmur at the right second intercostal space \u2013 Classic for aortic stenosis, which is not the typical finding in Marfan syndrome.\n\nStep 4: Final answer.\nThe most likely finding in this patient is the one described in option B, which is consistent with mitral valve prolapse.\n\nFinal Answer: B. Late systolic crescendo murmur at the apex with mid-systolic click",
            "Step 1: Analyze the clinical presentation.\n\u2022 The patient is a young (28-year-old) tall male with joint hypermobility, which are features suggestive of Marfan syndrome.\n\u2022 He presents with a ripping chest pain radiating to the back, hypotension, tachycardia, and weak distal pulses\u2014findings that raise concern for an aortic dissection.\n\u2022 His history of a heart murmur being followed by a cardiologist also fits with known cardiovascular abnormalities seen in Marfan syndrome.\n\nStep 2: Connect the findings with typical cardiac exam findings.\n\u2022 Marfan syndrome is classically associated with aortic root dilation, which can lead to aortic regurgitation and predisposes to aortic dissection.\n\u2022 Additionally, mitral valve prolapse (MVP) is commonly seen in Marfan syndrome.\n\u2022 The physical exam finding for MVP is a late systolic crescendo murmur at the apex, frequently accompanied by a mid-systolic click.\n\nStep 3: Evaluate and eliminate the options.\nA. Holosystolic, high-pitched blowing murmur at the lower left sternal border \u2013 This description is more consistent with tricuspid regurgitation (or possibly a VSD) rather than findings seen in Marfan syndrome.\nB. Late systolic crescendo murmur at the apex with mid-systolic click \u2013 This is the classical description of mitral valve prolapse, which is commonly associated with Marfan syndrome.\nC. Mid-diastolic murmur at the left lower sternal border \u2013 This is not characteristic of Marfan syndrome-related cardiac findings.\nD. Systolic ejection murmur at the right second intercostal space \u2013 This is typically heard in aortic stenosis, which does not fit the patient\u2019s profile or underlying condition.\n\nStep 4: Final Answer.\nBased on the patient\u2019s background (suggestive of Marfan syndrome) and the common association with mitral valve prolapse, the most likely physical exam finding is:\n\nB. Late systolic crescendo murmur at the apex with mid-systolic click."
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation.\n\u2022 The patient is a young (28-year-old) tall male with joint hypermobility, which are features suggestive of Marfan syndrome.\n\u2022 He presents with a ripping chest pain radiating to the back, hypotension, tachycardia, and weak distal pulses\u2014findings that raise concern for an aortic dissection.\n\u2022 His history of a heart murmur being followed by a cardiologist also fits with known cardiovascular abnormalities seen in Marfan syndrome.\n\nStep 2: Connect the findings with typical cardiac exam findings.\n\u2022 Marfan syndrome is classically associated with aortic root dilation, which can lead to aortic regurgitation and predisposes to aortic dissection.\n\u2022 Additionally, mitral valve prolapse (MVP) is commonly seen in Marfan syndrome.\n\u2022 The physical exam finding for MVP is a late systolic crescendo murmur at the apex, frequently accompanied by a mid-systolic click.\n\nStep 3: Evaluate and eliminate the options.\nA. Holosystolic, high-pitched blowing murmur at the lower left sternal border \u2013 This description is more consistent with tricuspid regurgitation (or possibly a VSD) rather than findings seen in Marfan syndrome.\nB. Late systolic crescendo murmur at the apex with mid-systolic click \u2013 This is the classical description of mitral valve prolapse, which is commonly associated with Marfan syndrome.\nC. Mid-diastolic murmur at the left lower sternal border \u2013 This is not characteristic of Marfan syndrome-related cardiac findings.\nD. Systolic ejection murmur at the right second intercostal space \u2013 This is typically heard in aortic stenosis, which does not fit the patient\u2019s profile or underlying condition.\n\nStep 4: Final Answer.\nBased on the patient\u2019s background (suggestive of Marfan syndrome) and the common association with mitral valve prolapse, the most likely physical exam finding is:\n\nB. Late systolic crescendo murmur at the apex with mid-systolic click."
    },
    {
        "realidx": 720,
        "question": "A 28-year-old woman is brought to the emergency room after a motor vehicle accident. On arrival, she is stable and says that she hit a car at an intersection that \"came out of nowhere\". She states that she had similar close encounters with other cars these past few weeks but was able to avoid collisions with those. She has also had intermittent headaches over the last month and has noticed that her shirts have been getting wet unexpectedly. Blood tests reveal an abnormal elevation of a circulating substance. Which of following changes is also associated with the physiologic function of the most likely substance in this case?",
        "answer": "Decreased progesterone",
        "options": {
            "A": "Decreased oxytocin",
            "B": "Decreased progesterone",
            "C": "Increased follicle stimulating hormone",
            "D": "Increased progesterone"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman",
            "brought",
            "emergency room",
            "motor vehicle accident",
            "arrival",
            "stable",
            "hit",
            "car",
            "intersection",
            "out",
            "states",
            "similar close encounters",
            "cars",
            "past",
            "weeks",
            "able to",
            "collisions",
            "intermittent headaches",
            "month",
            "shirts",
            "getting wet",
            "Blood tests reveal",
            "abnormal elevation",
            "circulating substance",
            "following changes",
            "associated with",
            "physiologic function",
            "likely substance",
            "case"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5517,
            "completion_tokens": 8217
        },
        "time_elapsed": 149.34802055358887,
        "raw_responses": [
            "Step 1: Identify the clinical clues.\n\u2022 The patient has had several \"close calls\" with other cars \u2013 a hint that she may have had visual field deficits.\n\u2022 Intermittent headaches are common in patients with a pituitary mass.\n\u2022 Her shirts getting wet unexpectedly suggests galactorrhea.\n\u2022 Blood tests show an abnormal elevation of a circulating hormone.\n\nStep 2: Synthesize the information.\nThese findings point toward a pituitary adenoma, most likely a prolactinoma. Elevated prolactin causes galactorrhea and can compress nearby structures (like the optic chiasm), resulting in visual disturbances (which might explain the near-misses). Additionally, headache is a typical symptom.\n\nStep 3: Understand the physiologic consequences.\nPhysiologically, prolactin\u2019s primary role is to promote lactation. However, when prolactin is abnormally high, it also suppresses the hypothalamic secretion of gonadotropin\u2010releasing hormone (GnRH). This suppression leads to decreased secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), ultimately reducing ovarian production of progesterone.\n\nStep 4: Match the consequence with the options.\nAmong the provided choices, the change directly associated with increased prolactin is a decrease in progesterone. \n\nFinal Answer: B. Decreased progesterone.",
            "This patient\u2019s presentation is most consistent with a prolactin\u2010secreting pituitary adenoma (prolactinoma). Although she does not report the classic symptoms of amenorrhea or galactorrhea, her intermittent headaches and possible subtle visual disturbances (as implied by her \u201cclose calls\u201d while driving, which might be due to a bitemporal hemianopsia from chiasmal compression) raise suspicion for an adenoma in the pituitary region. Laboratory studies demonstrate an abnormal elevation of a circulating substance consistent with prolactin.\n\nProlactin\u2019s primary physiologic role is to stimulate milk production; however, when levels are abnormally high, prolactin also exerts inhibitory effects on gonadotropin\u2010releasing hormone (GnRH). This suppression of GnRH leads to decreased secretion of the gonadotropins (LH and FSH), which in turn results in lower estrogen and progesterone levels. Thus, an elevated prolactin state is associated with decreased progesterone production.\n\nReviewing the answer choices:\n\u2022 Option A \u2013 Decreased oxytocin: Prolactin does not typically decrease oxytocin. Oxytocin is involved in the milk let-down reflex and uterine contraction, and its secretion is regulated by different hypothalamic pathways.\n\u2022 Option B \u2013 Decreased progesterone: This is correct. High prolactin inhibits GnRH secretion, thereby reducing LH and FSH release and leading to diminished progesterone (and estrogen) synthesis.\n\u2022 Option C \u2013 Increased follicle stimulating hormone (FSH): Elevated prolactin suppresses FSH, not increase it.\n\u2022 Option D \u2013 Increased progesterone: As explained, elevated prolactin reduces progesterone levels.\n\nThus, the best answer is:\n\nFinal answer: B. Decreased progesterone.",
            "Step 1: Analyze the clinical clues.\n\u2022 The patient is a 28\u2010year-old woman involved in a motor vehicle accident because a car \u201ccame out of nowhere.\u201d She\u2019s had several similar close calls, suggesting possible visual field deficits (e.g., bitemporal hemianopsia from pressure near the optic chiasm).\n\u2022 She also reports intermittent headaches and has noted episodes of excessive sweating (\u201cshirts getting wet\u201d).\n\u2022 Blood tests reveal an abnormally elevated circulating substance, suggesting a hormone\u2010secreting pituitary adenoma.\n\nStep 2: Determine the likely hormone.\n\u2022 In women, the most common pituitary adenoma is a prolactinoma.\n\u2022 Prolactinomas can cause headaches and, via mass effect, lead to visual field defects (explaining her near-collisions).\n\u2022 Moreover, elevated prolactin \u201cinappropriately\u201d inhibits GnRH secretion, affecting the release of other sex hormones.\n\nStep 3: Understand the physiologic function of prolactin.\n\u2022 In its normal role (particularly postpartum), prolactin stimulates lactation.\n\u2022 However, when prolactin is pathologically elevated (as in a prolactinoma), it suppresses GnRH release, which in turn leads to decreased secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This suppression causes low estrogen and low progesterone levels, leading to menstrual irregularities and infertility.\n\nStep 4: Compare the answer choices.\nA. Decreased oxytocin \u2013 Oxytocin is responsible for milk ejection, not directly regulated by prolactin in this context.\nB. Decreased progesterone \u2013 Consistent with the decrease in GnRH (and subsequently LH/FSH) seen with hyperprolactinemia.\nC. Increased follicle stimulating hormone \u2013 Hyperprolactinemia suppresses rather than increases FSH.\nD. Increased progesterone \u2013 Again, hyperprolactinemia leads to decreased, not increased, progesterone.\n\nStep 5: Final Answer\nThe abnormal circulating substance is prolactin. Its physiologic function (and the pathologic effects of its overproduction) results in decreased GnRH, leading to decreased progesterone production. \n\nFinal answer: B. Decreased progesterone."
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Analyze the clinical clues.\n\u2022 The patient is a 28\u2010year-old woman involved in a motor vehicle accident because a car \u201ccame out of nowhere.\u201d She\u2019s had several similar close calls, suggesting possible visual field deficits (e.g., bitemporal hemianopsia from pressure near the optic chiasm).\n\u2022 She also reports intermittent headaches and has noted episodes of excessive sweating (\u201cshirts getting wet\u201d).\n\u2022 Blood tests reveal an abnormally elevated circulating substance, suggesting a hormone\u2010secreting pituitary adenoma.\n\nStep 2: Determine the likely hormone.\n\u2022 In women, the most common pituitary adenoma is a prolactinoma.\n\u2022 Prolactinomas can cause headaches and, via mass effect, lead to visual field defects (explaining her near-collisions).\n\u2022 Moreover, elevated prolactin \u201cinappropriately\u201d inhibits GnRH secretion, affecting the release of other sex hormones.\n\nStep 3: Understand the physiologic function of prolactin.\n\u2022 In its normal role (particularly postpartum), prolactin stimulates lactation.\n\u2022 However, when prolactin is pathologically elevated (as in a prolactinoma), it suppresses GnRH release, which in turn leads to decreased secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This suppression causes low estrogen and low progesterone levels, leading to menstrual irregularities and infertility.\n\nStep 4: Compare the answer choices.\nA. Decreased oxytocin \u2013 Oxytocin is responsible for milk ejection, not directly regulated by prolactin in this context.\nB. Decreased progesterone \u2013 Consistent with the decrease in GnRH (and subsequently LH/FSH) seen with hyperprolactinemia.\nC. Increased follicle stimulating hormone \u2013 Hyperprolactinemia suppresses rather than increases FSH.\nD. Increased progesterone \u2013 Again, hyperprolactinemia leads to decreased, not increased, progesterone.\n\nStep 5: Final Answer\nThe abnormal circulating substance is prolactin. Its physiologic function (and the pathologic effects of its overproduction) results in decreased GnRH, leading to decreased progesterone production. \n\nFinal answer: B. Decreased progesterone."
    },
    {
        "realidx": 724,
        "question": "A 32-year-old man presents to the emergency department with fever, nausea, and vomiting. The patient states that his symptoms started last night and have persisted to this morning. He has a past medical history of asthma, and his current medications include albuterol and fluticasone. His temperature is 102\u00b0F (38.9\u00b0C), blood pressure is 110/60 mmHg, pulse is 95/min, respirations are 17/min, and oxygen saturation is 98% on room air. On physical exam, the patient seems uncomfortable. He requests that the lights in the room stay turned off during the physical exam. The patient's cardiac exam demonstrates a normal rate and rhythm, and his pulmonary exam is clear to auscultation bilaterally. Musculoskeletal exam reveals diminished mobility of the neck in all four directions, with flexion of the neck causing the patient discomfort. Lumbar puncture is performed and results are seen below.\n\nCerebrospinal fluid (CSF):\nCell count: 175/mm^3\nCl-: 119 mEq/L\nGlucose: 49 mg/dL\nPressure: 150 mmH2O\nTotal protein: 55 mg/dL\n\nWhich of the following is the best treatment for this patient's most likely diagnosis?",
        "answer": "IV fluids and monitoring",
        "options": {
            "A": "Acyclovir",
            "B": "Amphotericin and 5-flucytosine",
            "C": "Ceftriaxone and vancomycin",
            "D": "IV fluids and monitoring"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man presents",
            "emergency department",
            "fever",
            "nausea",
            "vomiting",
            "patient states",
            "symptoms started last night",
            "morning",
            "past medical",
            "current medications include albuterol",
            "fluticasone",
            "temperature",
            "blood pressure",
            "60 mmHg",
            "pulse",
            "95 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "physical exam",
            "patient",
            "requests",
            "lights",
            "room",
            "turned",
            "physical exam",
            "patient's cardiac exam demonstrates",
            "normal rate",
            "rhythm",
            "pulmonary exam",
            "clear",
            "auscultation",
            "Musculoskeletal exam reveals diminished mobility",
            "neck",
            "four directions",
            "flexion",
            "neck causing",
            "patient discomfort",
            "Lumbar puncture",
            "performed",
            "results",
            "seen",
            "Cerebrospinal fluid",
            "Cell count",
            "mm",
            "Cl",
            "mEq/L Glucose",
            "mg/dL Pressure",
            "mmH2O Total protein",
            "55 mg/dL",
            "following",
            "best treatment",
            "patient's",
            "likely diagnosis"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6417,
            "completion_tokens": 5147
        },
        "time_elapsed": 35.58679389953613,
        "raw_responses": [
            "Step 1: Identify Key Clinical Features\n\u2022 The patient is a 32\u2010year\u2010old man with fever, nausea, vomiting, photophobia (discomfort with lights), and neck stiffness.\n\u2022 His symptoms began acutely (last night), suggesting a rapid onset.\n\u2022 The examination reveals reduced neck mobility and discomfort with flexion.\n\nStep 2: Interpret the CSF Findings\n\u2022 Cell count: 175/mm\u00b3 \u2013 This is elevated, suggestive of inflammation.\n\u2022 Glucose: 49 mg/dL \u2013 While not extremely low, it is lower than expected in a normal CSF sample.\n\u2022 Protein: 55 mg/dL \u2013 Slightly elevated, which is common in meningitis.\n\u2022 Taken together with the symptoms, these findings are most consistent with bacterial meningitis, especially considering the acute presentation.\n\nStep 3: Evaluate Treatment Options\n\u2022 A. Acyclovir: Used for viral encephalitis (especially HSV), not indicated here.\n\u2022 B. Amphotericin and 5-flucytosine: Used for fungal meningitis (e.g., cryptococcal meningitis), which typically occurs in immunocompromised patients.\n\u2022 C. Ceftriaxone and vancomycin: The appropriate empiric coverage for suspected bacterial meningitis in an adult.\n\u2022 D. IV fluids and monitoring: Inadequate for a presumed bacterial infection.\n\nFinal Answer: C. Ceftriaxone and vancomycin",
            "Step 1: Key Clinical Features\n\u2022 The patient is a 32\u2010year\u2010old man with fever (102\u00b0F), nausea, vomiting, photophobia (prefers the lights off), and neck stiffness with limited range of motion.\n\u2022 These symptoms are strongly suggestive of meningitis.\n\nStep 2: CSF Analysis\n\u2022 The CSF reveals a modestly elevated cell count of 175/mm\u00b3.\n\u2022 The glucose (49\u202fmg/dL) is near normal, and the protein is only mildly elevated at 55\u202fmg/dL.\n\u2022 In bacterial meningitis, you\u2019d expect a very high cell count (often >1000/mm\u00b3), marked protein elevation, and a significant drop in glucose.\n\u2022 These findings are more consistent with a viral (aseptic) meningitis picture.\n\nStep 3: Differential Diagnosis & Treatment Options\n\u2022 Option A (Acyclovir) is used for suspected HSV encephalitis. Although this is a viral cause, HSV encephalitis often presents with altered mental status or focal neurological deficits, which are not described in this case.\n\u2022 Option B (Amphotericin and 5-flucytosine) is reserved for fungal meningitis, typically seen in immunocompromised patients.\n\u2022 Option C (Ceftriaxone and vancomycin) is the regimen for bacterial meningitis.\n\u2022 Option D (IV fluids and monitoring) represents supportive care, the mainstay treatment for viral meningitis in an otherwise healthy individual.\n\nStep 4: Final Decision\nGiven that the history, exam, and CSF analysis are most consistent with viral meningitis, the best treatment approach is supportive care.\n\nFinal Answer: D. IV fluids and monitoring",
            "Step 1: Analyze the clinical presentation.  \n\u2022 The patient is 32 years old with fever (102\u00b0F), nausea, vomiting, photophobia (requesting the lights off), and neck stiffness (limited neck motion with discomfort). These signs are strongly suggestive of meningitis.  \n\nStep 2: Examine the cerebrospinal fluid (CSF) findings.  \n\u2022 Cell count: 175/mm\u00b3\u2014this is modestly elevated, which often points toward a viral (aseptic) meningitis profile rather than the dramatic elevations seen in bacterial meningitis.  \n\u2022 Glucose: 49 mg/dL\u2014this is within a normal range for CSF (usually 40\u201370 mg/dL), whereas bacterial meningitis typically shows a decreased glucose level due to consumption by bacteria.  \n\u2022 Total protein: 55 mg/dL\u2014slightly elevated or normal, which again aligns more with viral meningitis.  \n\u2022 CSF pressure: 150 mmH\u2082O\u2014in the expected range or slightly high.  \nOverall, the CSF profile (modest pleocytosis with normal-to-slightly elevated protein and normal glucose) is most consistent with viral meningitis.\n\nStep 3: Evaluate the treatment options for the likely diagnosis.  \n\u2022 Option A, Acyclovir, is used when herpes simplex virus (HSV) encephalitis or meningitis is suspected. However, HSV tends to cause more severe encephalitic changes, and our patient mainly exhibits signs of meningitis without altered mental status.  \n\u2022 Option B, Amphotericin and 5-flucytosine, is used for fungal infections such as cryptococcal meningitis, which is less likely given the patient\u2019s profile and CSF findings.  \n\u2022 Option C, Ceftriaxone and vancomycin, is the treatment for bacterial meningitis; however, the CSF findings (normal glucose and only modestly elevated cell count) do not support a bacterial etiology.  \n\u2022 Option D, IV fluids and monitoring, represents supportive care, which is the mainstay of treatment for viral meningitis, as many cases are self-limiting.\n\nStep 4: Conclusion  \nGiven the patient's clinical picture and CSF analysis consistent with viral meningitis, the best treatment is supportive care.\n\nFinal answer: D. IV fluids and monitoring."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation.  \n\u2022 The patient is 32 years old with fever (102\u00b0F), nausea, vomiting, photophobia (requesting the lights off), and neck stiffness (limited neck motion with discomfort). These signs are strongly suggestive of meningitis.  \n\nStep 2: Examine the cerebrospinal fluid (CSF) findings.  \n\u2022 Cell count: 175/mm\u00b3\u2014this is modestly elevated, which often points toward a viral (aseptic) meningitis profile rather than the dramatic elevations seen in bacterial meningitis.  \n\u2022 Glucose: 49 mg/dL\u2014this is within a normal range for CSF (usually 40\u201370 mg/dL), whereas bacterial meningitis typically shows a decreased glucose level due to consumption by bacteria.  \n\u2022 Total protein: 55 mg/dL\u2014slightly elevated or normal, which again aligns more with viral meningitis.  \n\u2022 CSF pressure: 150 mmH\u2082O\u2014in the expected range or slightly high.  \nOverall, the CSF profile (modest pleocytosis with normal-to-slightly elevated protein and normal glucose) is most consistent with viral meningitis.\n\nStep 3: Evaluate the treatment options for the likely diagnosis.  \n\u2022 Option A, Acyclovir, is used when herpes simplex virus (HSV) encephalitis or meningitis is suspected. However, HSV tends to cause more severe encephalitic changes, and our patient mainly exhibits signs of meningitis without altered mental status.  \n\u2022 Option B, Amphotericin and 5-flucytosine, is used for fungal infections such as cryptococcal meningitis, which is less likely given the patient\u2019s profile and CSF findings.  \n\u2022 Option C, Ceftriaxone and vancomycin, is the treatment for bacterial meningitis; however, the CSF findings (normal glucose and only modestly elevated cell count) do not support a bacterial etiology.  \n\u2022 Option D, IV fluids and monitoring, represents supportive care, which is the mainstay of treatment for viral meningitis, as many cases are self-limiting.\n\nStep 4: Conclusion  \nGiven the patient's clinical picture and CSF analysis consistent with viral meningitis, the best treatment is supportive care.\n\nFinal answer: D. IV fluids and monitoring."
    },
    {
        "realidx": 748,
        "question": "A 39-year-old woman presents with headaches, constipation, increased thirst, and increased urinary frequency. Her blood pressure is 160/100 mm Hg and pulse is 67/min. Blood tests reveal high blood glucose and low potassium level. Abdominal CT scan shows a well-circumscribed homogeneous mass in the left adrenal gland. The hormone excess responsible for her symptoms uses which of the following pathways to exert its action?",
        "answer": "Intracellular receptors",
        "options": {
            "A": "Intracellular receptors",
            "B": "cAMP pathway",
            "C": "cGMP pathway",
            "D": "JAK/STAT pathway"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old woman presents",
            "headaches",
            "constipation",
            "increased thirst",
            "increased urinary frequency",
            "blood pressure",
            "100 mm Hg",
            "pulse",
            "67 min",
            "Blood tests reveal high blood glucose",
            "low potassium level",
            "Abdominal CT shows",
            "well circumscribed homogeneous mass",
            "left",
            "hormone excess responsible",
            "symptoms uses",
            "following pathways to exert",
            "action"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4230,
            "completion_tokens": 4748
        },
        "time_elapsed": 76.87128925323486,
        "raw_responses": [
            "Step 1: Analysis of the case presentation reveals that the patient\u2019s symptoms (headaches, constipation, polyuria, polydipsia, and hypertension) along with the laboratory findings (high blood glucose and low potassium) point toward an endocrine disorder of the adrenal gland. The CT finding of a well-circumscribed homogeneous mass in the left adrenal gland is consistent with an aldosterone-producing adenoma (Conn syndrome).\n\nStep 2: Aldosterone is a mineralocorticoid hormone that exerts its action by binding to intracellular (nuclear) receptors. Once bound, the receptor\u2013hormone complex translocates to the nucleus where it acts as a transcription factor to modulate gene expression. \n\nStep 3: Comparing the options:\n\u2022 Intracellular receptors \u2013 This is how aldosterone acts.\n\u2022 cAMP pathway \u2013 Used by many peptide hormones (e.g., ACTH) but not by aldosterone.\n\u2022 cGMP pathway \u2013 Typically involved in nitric oxide signaling.\n\u2022 JAK/STAT pathway \u2013 Associated with cytokine receptor signaling.\n\nFinal Answer: A. Intracellular receptors",
            "Step 1: The patient\u2019s symptoms along with the left adrenal mass on CT scan suggest that she is likely experiencing primary hyperaldosteronism (Conn's syndrome).\n\nStep 2: Aldosterone is a mineralocorticoid hormone secreted by the adrenal cortex. It exerts its effects by diffusing into target cells and binding to intracellular mineralocorticoid receptors, which then translocate to the nucleus to alter gene transcription. This regulation affects sodium and water reabsorption and potassium excretion, which accounts for the patient\u2019s hypertension, hypokalemia, and hyperglycemia.\n\nStep 3: Review of the options:\n\u2003A. Intracellular receptors \u2013 Correct for aldosterone\u2019s mechanism.\n\u2003B. cAMP pathway \u2013 More typically associated with peptide hormones acting via G-protein coupled receptors.\n\u2003C. cGMP pathway \u2013 Not the pathway used by aldosterone.\n\u2003D. JAK/STAT pathway \u2013 Typically involved in cytokine signaling, not steroid hormones.\n\nFinal Answer: A. Intracellular receptors",
            "Step 1: Analyze the clinical presentation. The patient has hypertension, headache, constipation, polyuria, polydipsia, high blood glucose, and hypokalemia. In the setting of a well-circumscribed, homogeneous adrenal mass, one should consider an adrenal adenoma that secretes a steroid hormone. Although hyperaldosteronism (Conn syndrome) typically presents with hypertension and hypokalemia, the marked hyperglycemia and symptoms of polyuria/polydipsia point more toward cortisol excess (Cushing syndrome), where cortisol can also display mineralocorticoid effects (leading to hypokalemia). Both cortisol and aldosterone are steroid hormones.\n\nStep 2: Identify the mechanism by which steroid hormones act. Steroid hormones (cortisol and aldosterone) are lipophilic and diffuse across the cell membrane, binding to intracellular receptors in the cytosol. These receptor-hormone complexes then translocate into the nucleus to act as transcription factors, altering gene expression.\n\nStep 3: Compare the answer choices.\n\u2022 Intracellular receptors \u2013 This is the mechanism used by steroid hormones.\n\u2022 cAMP pathway \u2013 Used by many peptide hormones that bind to cell surface receptors.\n\u2022 cGMP pathway \u2013 Associated with certain peptides and nitric oxide signaling.\n\u2022 JAK/STAT pathway \u2013 Generally activated by cytokines and some peptide hormones.\n\nStep 4: Final answer.\nThe hormone excess in this patient exerts its action through intracellular receptors.\n\nFinal Answer: A. Intracellular receptors"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analysis of the case presentation reveals that the patient\u2019s symptoms (headaches, constipation, polyuria, polydipsia, and hypertension) along with the laboratory findings (high blood glucose and low potassium) point toward an endocrine disorder of the adrenal gland. The CT finding of a well-circumscribed homogeneous mass in the left adrenal gland is consistent with an aldosterone-producing adenoma (Conn syndrome).\n\nStep 2: Aldosterone is a mineralocorticoid hormone that exerts its action by binding to intracellular (nuclear) receptors. Once bound, the receptor\u2013hormone complex translocates to the nucleus where it acts as a transcription factor to modulate gene expression. \n\nStep 3: Comparing the options:\n\u2022 Intracellular receptors \u2013 This is how aldosterone acts.\n\u2022 cAMP pathway \u2013 Used by many peptide hormones (e.g., ACTH) but not by aldosterone.\n\u2022 cGMP pathway \u2013 Typically involved in nitric oxide signaling.\n\u2022 JAK/STAT pathway \u2013 Associated with cytokine receptor signaling.\n\nFinal Answer: A. Intracellular receptors"
    },
    {
        "realidx": 755,
        "question": "A 31-year-old G1-P0 woman at 28-weeks gestation presents with shortness of breath and nonspecific right-sided chest pain that is worse with inspiration. She works as a graduate student at the local university, and she informs you that she recently returned to the west coast from a trip to New York for an Economics conference. Her medical history is positive only for frequent bouts of sinusitis. She currently denies any smoking, drinks a glass of red wine/day, and she denies any past illicit drug use. The vital signs include: temperature 36.7\u00b0C (98.0\u00b0F), blood pressure 126/74 mm Hg, heart rate 87/min, and respiratory rate 23/min. Her physical examination shows decreased air movement throughout the right lung but otherwise clear lungs on auscultation, grade 2/6 holosystolic murmur, and a gravid uterus without acute findings. On physical examination, she is afebrile, tachycardic to 121/min, normotensive, and demonstrates an O2 saturation of 92%. Which of the following is the best next step in the evaluation of the most likely diagnosis for this patient?",
        "answer": "V/Q scan",
        "options": {
            "A": "ECG",
            "B": "Chest radiography",
            "C": "V/Q scan",
            "D": "CT pulmonary angiogram"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "31 year old G1 P0 woman",
            "weeks presents",
            "shortness of breath",
            "nonspecific right-sided",
            "worse",
            "inspiration",
            "works",
            "graduate student",
            "local university",
            "informs",
            "recently returned",
            "west",
            "trip",
            "New York",
            "Economics conference",
            "medical history",
            "positive only",
            "frequent bouts",
            "sinusitis",
            "currently denies",
            "smoking",
            "drinks",
            "glass",
            "red wine day",
            "denies",
            "past illicit drug use",
            "vital signs include",
            "temperature 36",
            "98",
            "blood pressure",
            "74 mm Hg",
            "heart rate 87 min",
            "respiratory rate 23 min",
            "physical examination shows decreased air movement",
            "right lung",
            "clear lungs",
            "auscultation",
            "grade",
            "6 holosystolic murmur",
            "gravid uterus",
            "acute findings",
            "physical examination",
            "afebrile",
            "tachycardic",
            "min",
            "normotensive",
            "demonstrates",
            "O2 saturation",
            "following",
            "best next step",
            "evaluation",
            "likely diagnosis",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5418,
            "completion_tokens": 5731
        },
        "time_elapsed": 79.38486361503601,
        "raw_responses": [
            "Step 1: Recognize that the patient is pregnant and presents with symptoms (shortness of breath, pleuritic chest pain, tachycardia, and mild hypoxemia) that are concerning for pulmonary embolism (PE). In a pregnant patient, PE is a serious concern given the hypercoagulable state of pregnancy and additional risk factors such as prolonged travel.\n\nStep 2: In the evaluation of suspected PE in pregnancy, it is important to choose tests that minimize radiation exposure to the fetus. Although computed tomography pulmonary angiography (CTPA) is excellent for diagnosing PE, it exposes the mother\u2019s breasts to a higher dose of radiation. The V/Q scan is typically favored because it offers acceptable diagnostic accuracy with relatively lower radiation risk (particularly to the maternal breast). However, before proceeding to a V/Q scan, a chest radiograph (which is low in radiation) is generally obtained to help interpret the V/Q results\u2014if the chest x-ray is normal, a V/Q scan is generally most useful; if abnormal, the V/Q scan interpretation might be confounded, potentially necessitating subsequent CTPA.\n\nStep 3: The answer choices include ECG, chest radiography, V/Q scan, and CTPA. An ECG is not diagnostic for PE. While the V/Q scan and CTPA are used for diagnosing PE, the best next step in a pregnant patient with suspected PE is to start with a chest radiograph. This initial imaging helps rule out other causes of the patient\u2019s symptoms and guides the selection of the most appropriate subsequent imaging study.\n\nFinal Answer: Chest radiography",
            "Step 1: This patient is a 31\u2010year\u2010old pregnant woman at 28 weeks\u2019 gestation presenting with symptoms concerning for pulmonary embolism (PE)\u2014shortness of breath, pleuritic chest pain, decreased oxygen saturation, and tachycardia. Her recent travel history also raises her risk profile, and in pregnancy, the hypercoagulable state increases the risk of PE.\n\nStep 2: In pregnant patients, when evaluating for possible PE, we want to limit radiation exposure to both the fetus and maternal breast tissue. Although an ECG and chest radiograph (CXR) are often obtained in evaluating chest pain and shortness of breath, neither of these tests is diagnostic for PE. The CT pulmonary angiogram (CTPA) is an excellent diagnostic tool in most patients but imparts greater radiation risk in pregnancy compared with a ventilation-perfusion (V/Q) scan\u2014especially when the chest radiograph is normal. In pregnant patients with a normal CXR, a V/Q scan is preferred because it minimizes radiation exposure without significantly compromising diagnostic accuracy.\n\nStep 3: Given that the most likely diagnosis is PE and taking into account the patient\u2019s pregnancy, the best next step in evaluation is to perform a V/Q scan.\n\nFinal Answer: C. V/Q scan",
            "Step 1: Recognize that this pregnant woman at 28 weeks with dyspnea, pleuritic chest pain, tachycardia, and hypoxemia is at risk for a pulmonary embolism. In pregnancy, factors such as hypercoagulability and recent travel further increase this risk.\n\nStep 2: In the evaluation of a suspected pulmonary embolism (PE) in a pregnant patient, it is standard practice to initially obtain a chest radiograph. This helps exclude other lung pathology and also establishes whether the lung parenchyma is normal. A normal chest x-ray improves the reliability of a ventilation-perfusion (V/Q) scan, which is then used to evaluate for PE while minimizing radiation exposure to the fetus.\n\nStep 3: Evaluating the answer options:\n\u2022 Option A, an ECG, might show nonspecific changes but wouldn\u2019t help confirm PE.\n\u2022 Option B, chest radiography, is the appropriate next step in a pregnant patient.\n\u2022 Option C, a V/Q scan, is typically performed after a normal chest x-ray.\n\u2022 Option D, CT pulmonary angiogram, while useful in nonpregnant patients, exposes more radiation and is generally avoided in pregnancy unless absolutely necessary.\n\nFinal Answer: B. Chest radiography"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1\n\nThe best next step in evaluating this pregnant patient with suspected pulmonary embolism is to obtain a chest radiograph. This initial study helps to rule out other pulmonary pathologies and also determines if the lung fields are normal. A normal chest x-ray makes the interpretation of a subsequent V/Q scan more reliable, while an abnormal x-ray might complicate V/Q scan results and necessitate further study with alternative imaging (e.g., CTPA, if warranted)."
        ],
        "final_solution": "Step 1: Recognize that the patient is pregnant and presents with symptoms (shortness of breath, pleuritic chest pain, tachycardia, and mild hypoxemia) that are concerning for pulmonary embolism (PE). In a pregnant patient, PE is a serious concern given the hypercoagulable state of pregnancy and additional risk factors such as prolonged travel.\n\nStep 2: In the evaluation of suspected PE in pregnancy, it is important to choose tests that minimize radiation exposure to the fetus. Although computed tomography pulmonary angiography (CTPA) is excellent for diagnosing PE, it exposes the mother\u2019s breasts to a higher dose of radiation. The V/Q scan is typically favored because it offers acceptable diagnostic accuracy with relatively lower radiation risk (particularly to the maternal breast). However, before proceeding to a V/Q scan, a chest radiograph (which is low in radiation) is generally obtained to help interpret the V/Q results\u2014if the chest x-ray is normal, a V/Q scan is generally most useful; if abnormal, the V/Q scan interpretation might be confounded, potentially necessitating subsequent CTPA.\n\nStep 3: The answer choices include ECG, chest radiography, V/Q scan, and CTPA. An ECG is not diagnostic for PE. While the V/Q scan and CTPA are used for diagnosing PE, the best next step in a pregnant patient with suspected PE is to start with a chest radiograph. This initial imaging helps rule out other causes of the patient\u2019s symptoms and guides the selection of the most appropriate subsequent imaging study.\n\nFinal Answer: Chest radiography"
    },
    {
        "realidx": 758,
        "question": "A 62-year-old man presents to the emergency department for evaluation of a low-grade fever, worsening fatigue, and mild intermittent abdominal pain that is not affected by eating. He reports that over the last 6 months he slept a lot more than usual and lost 14.9 kg (33 lbs) without trying to lose weight. He also complains of chest pain and shortness of breath that is worse when he is working and in the yard. There is no significant family history. His long-standing male partner passed away 2 years ago in a fatal car accident. His blood pressure is 145/75 mm Hg, the pulse is 90/min, the respiratory rate is 23/min, and the temperature is 38\u00b0C (100.5\u00b0F). On physical examination, he has pale mucous membranes, conjunctival hemorrhages, and petechiae on his lower extremities. There is a new-onset high-pitched blowing diastolic murmur best heard over the right upper sternal border. His head bobs with each heartbeat. There are small, painless, red macules on both palms. His spleen is palpable 3 cm below the left costal margin. His laboratory results are shown below.\nHemoglobin 8.4 g/dL\nMean corpuscular volume 72 \u00b5m3\nPlatelet count 400,000/mm3\nLeukocytes 6,000/mm3\nSerum ferritin 8 ng/mL\nSerum iron 27 \u00b5g/dL\nTotal iron-binding capacity 450 \u00b5g/dL\nColonoscopy with biopsy is later performed showing a neoplastic growth in the descending colon. Which of the following is the most likely explanation for his cardiac findings?",
        "answer": "Group D streptococci",
        "options": {
            "A": "Treponema pallidum",
            "B": "Malignant colonic neoplasm",
            "C": "Collagen vascular disease",
            "D": "Group D streptococci"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "62 year old man presents",
            "emergency department",
            "evaluation",
            "low-grade fever",
            "worsening fatigue",
            "mild intermittent abdominal pain",
            "not affected",
            "eating",
            "reports",
            "last",
            "months",
            "slept",
            "lot",
            "usual",
            "lost",
            "kg",
            "lbs",
            "to",
            "weight",
            "of chest pain",
            "shortness of breath",
            "worse",
            "working",
            "yard",
            "significant family history",
            "long standing male partner passed",
            "years",
            "fatal car accident",
            "blood pressure",
            "75 mm Hg",
            "pulse",
            "90 min",
            "respiratory rate",
            "23 min",
            "temperature",
            "100",
            "physical examination",
            "pale mucous membranes",
            "conjunctival hemorrhages",
            "petechiae",
            "lower extremities",
            "new-onset high-pitched blowing diastolic murmur best heard",
            "right upper sternal border",
            "head bobs",
            "heartbeat",
            "small",
            "painless",
            "red macules",
            "palms",
            "spleen",
            "palpable 3 cm",
            "left costal margin",
            "laboratory results",
            "shown",
            "Hemoglobin 8.4 g dL Mean corpuscular volume 72",
            "Platelet count 400",
            "mm3 Leukocytes",
            "Serum",
            "ng/mL",
            "iron 27",
            "dL Total",
            "450",
            "Colonoscopy",
            "biopsy",
            "later performed showing",
            "neoplastic growth",
            "descending colon",
            "following",
            "most likely explanation",
            "cardiac findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 7089,
            "completion_tokens": 6873
        },
        "time_elapsed": 84.79735565185547,
        "raw_responses": [
            "Step 1: Review the Clinical Picture\n\u2022 The patient is a 62-year-old man with systemic signs of infection (low-grade fever, fatigue, weight loss) and evidence of infective endocarditis, including a new diastolic murmur (suggestive of aortic regurgitation), head bobbing, conjunctival hemorrhages, petechiae, and painless red macules on his palms (Janeway lesions).\n\u2022 His laboratory results show iron deficiency anemia (low hemoglobin, low MCV, low ferritin, high TIBC), suggestive of chronic blood loss, which is confirmed later by colonoscopy finding a neoplastic growth in the descending colon.\n\nStep 2: Recognize the Association\n\u2022 Group D streptococci, particularly Streptococcus gallolyticus (formerly Streptococcus bovis), are classically associated with colonic neoplasms.\n\u2022 The presence of a colonic neoplasm increases the risk of bacteremia with this organism, which can then seed the heart valves and lead to infective endocarditis characterized by the clinical findings described.\n\nStep 3: Compare the Options\nA. Treponema pallidum \u2013 This organism causes syphilis, which is not linked to the cardiac picture presented.\nB. Malignant colonic neoplasm \u2013 While the colon cancer is present, it is not directly producing the cardiac findings, except by predisposing to a specific infection.\nC. Collagen vascular disease \u2013 This would have a different clinical presentation and is less consistent with these findings.\nD. Group D streptococci \u2013 This organism (e.g., Streptococcus gallolyticus/S. bovis) is known to cause infective endocarditis in the setting of colonic neoplasms.\n\nStep 4: Final Answer\nThe most likely explanation for his cardiac findings is infective endocarditis due to Group D streptococci.\n\nFinal answer: D. Group D streptococci",
            "Step 1: The patient presents with signs and symptoms suggestive of infective endocarditis: low-grade fever, fatigue, weight loss, and evidences on exam (pale mucous membranes, conjunctival hemorrhages, petechiae, Janeway lesions, head bobbing) along with a new diastolic murmur consistent with aortic regurgitation.\n\nStep 2: Additionally, the patient\u2019s colonoscopy reveals a neoplastic growth in the descending colon. Patients with colonic neoplasms are at risk for infection with organisms that reside in the gastrointestinal flora. Enterococci (classified as Group D streptococci) are commonly associated with endocarditis in older patients, especially in the setting of underlying colonic lesions.\n\nStep 3: Reviewing the options: \n\u2022 Option A (Treponema pallidum) is associated with syphilitic endocarditis, which typically affects the ascending aorta and arch in a different clinical context.\n\u2022 Option B (Malignant colonic neoplasm) is relevant for the patient\u2019s colon findings, but it does not directly cause the cardiac findings.\n\u2022 Option C (Collagen vascular disease) is not supported by the clinical scenario.\n\u2022 Option D (Group D streptococci) aligns with the patient\u2019s risk factors (colonic neoplasm) and the clinical picture of infective endocarditis.\n\nFinal Answer: D. Group D streptococci",
            "Step 1: Identify Key Patient Findings\n\u2022 The patient is a 62\u2010year\u2010old man with low-grade fever, fatigue, weight loss, and specific cardiac findings.\n\u2022 Cardiac exam reveals a new high\u2010pitched blowing diastolic murmur best heard at the right upper sternal border, head bobbing with each heartbeat, small painless red macules on his palms (consistent with Janeway lesions), along with conjunctival hemorrhages and petechiae. These findings are highly suggestive of endocarditis.\n\u2022 Colonoscopy revealed a neoplastic growth in the descending colon, making a malignant colonic neoplasm the underlying pathology.\n\nStep 2: Link the Colon Neoplasm to the Cardiac Findings\n\u2022 Malignant conditions such as colon adenocarcinoma can create a hypercoagulable state and often lead to nonbacterial thrombotic endocarditis (NBTE). In NBTE, sterile vegetations form on heart valves (often the aortic or mitral valves), which can lead to regurgitant murmurs (in this case, aortic regurgitation shown by the diastolic murmur and head bobbing), as well as embolic phenomena (e.g., Janeway lesions, conjunctival hemorrhages, petechiae).\n\nStep 3: Evaluate the Options\nA. Treponema pallidum \u2013 This cause of syphilis might affect the heart, but it typically leads to aortitis and aneurysm formation long after the initial infection, not the constellation of findings seen here.\nB. Malignant colonic neoplasm \u2013 This directly relates to the given finding on colonoscopy and is known to predispose patients to NBTE, which explains the cardiac findings observed.\nC. Collagen vascular disease \u2013 While some autoimmune diseases can involve the heart, they do not tie in with the colon cancer finding and the typical presentation described.\nD. Group D streptococci \u2013 Although it can cause endocarditis, there is no direct link with quality colonic neoplasm, which is a strong indicator in this case.\n\nStep 4: Final Answer\nThe best explanation for his cardiac findings is a nonbacterial thrombotic endocarditis secondary to his malignant colonic neoplasm.\n\nFinal answer: B. Malignant colonic neoplasm"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "0"
        ],
        "final_solution": "Step 1: The patient presents with signs and symptoms suggestive of infective endocarditis: low-grade fever, fatigue, weight loss, and evidences on exam (pale mucous membranes, conjunctival hemorrhages, petechiae, Janeway lesions, head bobbing) along with a new diastolic murmur consistent with aortic regurgitation.\n\nStep 2: Additionally, the patient\u2019s colonoscopy reveals a neoplastic growth in the descending colon. Patients with colonic neoplasms are at risk for infection with organisms that reside in the gastrointestinal flora. Enterococci (classified as Group D streptococci) are commonly associated with endocarditis in older patients, especially in the setting of underlying colonic lesions.\n\nStep 3: Reviewing the options: \n\u2022 Option A (Treponema pallidum) is associated with syphilitic endocarditis, which typically affects the ascending aorta and arch in a different clinical context.\n\u2022 Option B (Malignant colonic neoplasm) is relevant for the patient\u2019s colon findings, but it does not directly cause the cardiac findings.\n\u2022 Option C (Collagen vascular disease) is not supported by the clinical scenario.\n\u2022 Option D (Group D streptococci) aligns with the patient\u2019s risk factors (colonic neoplasm) and the clinical picture of infective endocarditis.\n\nFinal Answer: D. Group D streptococci"
    },
    {
        "realidx": 764,
        "question": "A 28-year-old woman, gravida 2, para 1, at 40 weeks gestation is brought to the emergency department by her husband. She is in active labor and has lost a lot of blood in the past 2 hours, but appears alert and cooperative. At the hospital, her blood pressure is 88/65 mm Hg, the pulse is 110/min, and the respirations are 23/min. Neither the hospital nor the emergency department is equipped for high-risk pregnancies. The patient and her husband request a transfer to a more capable center. They are informed of the hospital\u2019s obligations under the Emergency Medical Treatment and Labor Act and the risks of transfer. They insist to be transferred. Which of the following is the most appropriate next step in management?",
        "answer": "Treat and transfer the patient after she makes a written request",
        "options": {
            "A": "Decline admission and refer the patient to the closest capable emergency department",
            "B": "Disregard patient\u2019s request and treat until delivery is complete",
            "C": "Treat and transfer the patient after she makes a written request",
            "D": "Transfer the patient only if the medical benefits of transfer outweigh the risks"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old woman",
            "gravida 2",
            "para 1",
            "40 weeks gestation",
            "brought",
            "emergency department",
            "husband",
            "in active labor",
            "lost",
            "lot",
            "blood",
            "past",
            "hours",
            "appears alert",
            "cooperative",
            "hospital",
            "blood pressure",
            "88 65 mm Hg",
            "pulse",
            "min",
            "respirations",
            "23 min",
            "hospital",
            "emergency department",
            "high-risk pregnancies",
            "patient",
            "husband request",
            "transfer",
            "capable center",
            "informed",
            "hospitals",
            "Emergency Medical",
            "Labor Act",
            "risks",
            "transfer",
            "to",
            "transferred",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5631,
            "completion_tokens": 4369
        },
        "time_elapsed": 79.15850496292114,
        "raw_responses": [
            "Step 1: Identify the key issues. The patient is in active labor at term and experiencing significant blood loss with signs of hemodynamic instability (hypotension and tachycardia). She is requesting transfer to a better-equipped center even though her condition is unstable.\n\nStep 2: Apply the principles of the Emergency Medical Treatment and Labor Act (EMTALA). Under EMTALA, when a patient presents with an emergency condition\u2014in this case, active labor complicated by hemorrhage\u2014the hospital is obligated to provide a medical screening examination and necessary stabilizing treatment before any transfer is considered.\n\nStep 3: Evaluate the answer choices.\n\u2022 Option A (Decline admission and refer to the closest capable ED) is not acceptable because the hospital must evaluate and treat the patient regardless of transfer requests.\n\u2022 Option C (Treat and transfer the patient after she makes a written request) is inappropriate because a written request does not override the hospital\u2019s legal obligations under EMTALA to stabilize a patient before transfer.\n\u2022 Option D (Transfer only if the medical benefits of transfer outweigh the risks) addresses risk assessment but still implies transferring the patient even if she is not yet stabilized, which is not compliant with EMTALA for a patient with an emergency condition.\n\u2022 Option B (Disregard patient\u2019s request and treat until delivery is complete) aligns with EMTALA because it emphasizes the obligation of the hospital to stabilize and treat the patient in-house until she is no longer in immediate danger.\n\nStep 4: Final Answer\n\nB. Disregard patient\u2019s request and treat until delivery is complete.",
            "Step 1: Identify Key Clinical and Legal Factors\n\u2022 The patient is an active laboring woman with significant hemorrhage (vital signs indicate hypovolemia).\n\u2022 The hospital lacks the capabilities for high-risk pregnancy care, raising the question of transfer.\n\u2022 However, under the Emergency Medical Treatment and Labor Act (EMTALA), hospitals have an obligation to provide stabilizing treatment for emergency conditions.\n\nStep 2: Understand EMTALA Obligations\n\u2022 EMTALA requires that if a patient presents with an emergency medical condition (in this case, significant blood loss and active labor), the hospital must provide appropriate stabilizing treatment.\n\u2022 The patient\u2019s condition is life-threatening. Even if she is requesting a transfer, the hospital must treat her emergently until it is safe to transfer her.\n\nStep 3: Evaluate the Options\nA. Decline admission and refer the patient to the closest capable emergency department.\n\u2003\u2003\u2013 This violates EMTALA, as the hospital must not simply refuse to accept a patient with an emergency condition.\nB. Disregard patient\u2019s request and treat until delivery is complete.\n\u2003\u2003\u2013 This option aligns with EMTALA requirements; the hospital must first stabilize the patient (or complete the emergency treatment, here the delivery) before transfer.\nC. Treat and transfer the patient after she makes a written request.\n\u2003\u2003\u2013 Although obtaining a written request may be part of proper documentation, it does not override the obligation to continue providing emergency care until stabilization.\nD. Transfer the patient only if the medical benefits of transfer outweigh the risks.\n\u2003\u2003\u2013 While considering risks and benefits is important, the legal standard under EMTALA is to stabilize the patient first. The option does not directly address the hospital\u2019s obligation to provide treatment until stabilization.\n\nStep 4: Final Decision\nGiven that the hospital must provide emergency treatment until the patient is stable under EMTALA, the most appropriate management strategy is to proceed with treatment (i.e., manage the hemorrhage and proceed with delivery) rather than transferring immediately.\n\nFinal Answer: B. Disregard patient\u2019s request and treat until delivery is complete.",
            "Step 1: Analyze the clinical situation and obligations under EMTALA. The patient is in active labor with significant hemorrhage and hemodynamic instability (low blood pressure and tachycardia). Under the Emergency Medical Treatment and Labor Act (EMTALA), the hospital is required to provide an appropriate medical screening examination and stabilizing treatment without delay, regardless of the hospital\u2019s capabilities.\n\nStep 2: Consider the options:\n\u2022 Option A (Decline admission and refer the patient to another emergency department) is not acceptable because the hospital must accept and stabilize all patients under EMTALA.\n\u2022 Option B (Disregard patient\u2019s request and treat until delivery is complete) embraces the hospital\u2019s legal duty to provide medical stabilization until the patient is stable, despite the patient\u2019s desire to be transferred.\n\u2022 Option C (Treat and transfer the patient after she makes a written request) implies transfer can be done based solely on a written request, but under EMTALA, transfer is only appropriate after stabilization.\n\u2022 Option D (Transfer the patient only if the medical benefits of transfer outweigh the risks) suggests weighing benefits and risks, but doesn\u2019t align clearly with EMTALA\u2019s requirement to provide stabilizing treatment before any transfer.\n\nStep 3: Final decision\nGiven that the hospital must stabilize the patient before any transfer can be considered, the most appropriate course of action is to treat her until she is stable (and delivery is complete), regardless of the patient and her husband\u2019s request.\n\nFinal answer: B."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Identify the key issues. The patient is in active labor at term and experiencing significant blood loss with signs of hemodynamic instability (hypotension and tachycardia). She is requesting transfer to a better-equipped center even though her condition is unstable.\n\nStep 2: Apply the principles of the Emergency Medical Treatment and Labor Act (EMTALA). Under EMTALA, when a patient presents with an emergency condition\u2014in this case, active labor complicated by hemorrhage\u2014the hospital is obligated to provide a medical screening examination and necessary stabilizing treatment before any transfer is considered.\n\nStep 3: Evaluate the answer choices.\n\u2022 Option A (Decline admission and refer to the closest capable ED) is not acceptable because the hospital must evaluate and treat the patient regardless of transfer requests.\n\u2022 Option C (Treat and transfer the patient after she makes a written request) is inappropriate because a written request does not override the hospital\u2019s legal obligations under EMTALA to stabilize a patient before transfer.\n\u2022 Option D (Transfer only if the medical benefits of transfer outweigh the risks) addresses risk assessment but still implies transferring the patient even if she is not yet stabilized, which is not compliant with EMTALA for a patient with an emergency condition.\n\u2022 Option B (Disregard patient\u2019s request and treat until delivery is complete) aligns with EMTALA because it emphasizes the obligation of the hospital to stabilize and treat the patient in-house until she is no longer in immediate danger.\n\nStep 4: Final Answer\n\nB. Disregard patient\u2019s request and treat until delivery is complete."
    },
    {
        "realidx": 778,
        "question": "A 3rd year resident in good standing with his residency training program would like to work more hours outside his residency obligations to gain more experience and pay for his medical school loans. He currently works and trains 60 hours per week as a resident and has a 10-hour shift external to his residency program on Saturdays. He is free of any educational and work obligations on Sundays. Based on the most recent standards set by the Accreditation Council for Graduate Medical Education (ACGME), which of the following is the most accurate statement regarding this resident\u2019s moonlighting and patient safety?",
        "answer": "He may work longer shifts",
        "options": {
            "A": "He is already overcommitting and must reduce the number of hours",
            "B": "He is not allowed to work outside the scope of his residency training",
            "C": "He may work longer shifts",
            "D": "He may work up to 20 more hours"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "3rd year resident",
            "good standing",
            "residency training program",
            "to work more hours outside",
            "residency",
            "to gain more experience",
            "pay",
            "medical school loans",
            "currently works",
            "trains 60 hours per week",
            "resident",
            "a 10 hour shift external",
            "residency program",
            "Saturdays",
            "free",
            "educational",
            "work",
            "Sundays",
            "Based",
            "recent standards set",
            "Accreditation Council",
            "Graduate Medical Education",
            "following",
            "most accurate statement",
            "residents moonlighting",
            "patient safety"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5824,
            "completion_tokens": 17521
        },
        "time_elapsed": 359.11575388908386,
        "raw_responses": [
            "The key point is that according to the most recent ACGME standards, all moonlighting hours count toward the 80\u2010hour weekly limit (averaged over 4 weeks). In this case, the resident is already accruing 60 hours per week in residency and is doing an additional 10\u2010hour external shift. For residents beyond PGY\u20101 (in this case, a 3rd year resident), moonlighting is allowed\u2014but the combined total of duty hours (residency plus moonlighting) must not exceed 80 hours per week. In essence, he is allowed to moonlight up to 20 additional hours per week (if he were not already moonlighting) so long as the total does not exceed the 80\u2011hour limit. Given that he currently is working 60 (residency) + 10 (moonlighting) = 70 hours, he is not over the limit, and according to the ACGME standards his moonlighting is acceptable. \n\nThus, the most accurate statement is:\n\nD. He may work up to 20 more hours.",
            "The ACGME limits apply not only to schedule\u2010related resident work duties but also to any additional \u201cmoonlighting\u201d activities. Currently, the resident\u2019s residency duties total 60 hours per week. According to ACGME standards, a resident\u2019s entire workweek\u2014including all clinical work, both within the accredited program and moonlighting\u2014may not exceed 80 hours averaged over four weeks. In addition, ACGME has placed a ceiling on moonlighting hours for residents (for physicians beyond their intern year, moonlighting is generally allowed up to 20 hours per week provided that the overall 80\u2013hour limit is not exceeded).\n\nIn this scenario, the resident already has a 10\u2013hour external shift on Saturdays. Because the moonlighting \u201cquota\u201d is a maximum of 20 hours per week, he still has up to 10 additional moonlighting hours available before reaching that cap. In other words, outside his residency obligations (60 hours), he could moonlight a total of up to 20 hours a week. That is the \u201csafe\u201d maximum that maintains compliance with ACGME standards and patient safety. \n\nThus, the best answer is:\nD. He may work up to 20 more hours\n\nStep\u2010by\u2010step summary:\n1. Know that ACGME requires that total clinical work (residency plus moonlighting) not exceed 80 hours per week on average.\n2. Understand that for more senior residents (i.e. PGY\u20102 and above), moonlighting is permitted but is capped at 20 hours per week.\n3. Since this resident does 60 hours of residency work, the maximum moonlighting hours he may engage in is 20 hours; he is already doing 10 hours externally, so he could do up to an additional 10 hours without exceeding that \u201cmoonlighting\u201d limit.\n\nThe option \u201cHe may work up to 20 more hours\u201d conveys that his maximum allowable moonlighting hours per week are 20 (with the expectation that the total resident plus moonlighting hours remain within ACGME limits) even if he is not using all of them right away. \n\nFinal answer: D. He may work up to 20 more hours.",
            "The key point is that ACGME regulations require that a resident\u2019s total clinical work hours\u2014including both scheduled residency duties and any moonlighting hours\u2014must not exceed an average of 80 hours per week (averaged over 4 weeks). In other words, moonlighting hours are not \u201cextra\u201d but count toward that 80\u2010hour limit.\n\nIn this scenario the resident already spends 60 hours per week on residency duties and has an additional 10\u2010hour \u201cmoonlighting\u201d shift on Saturdays. That brings his total to 70 hours for the week. He is thereby allowed up to an additional 10 hours during that week before reaching the 80\u2010hour limit. (Many sources will note that for PGY\u20102 residents and beyond, moonlighting \u201cup to 20 hours\u201d per week may be possible if the resident has fewer duty hours from residency\u2014but the resident\u2019s total combined hours must never exceed 80 hours.)\n\nThus, although one might be tempted to think \u201c20 more hours\u201d are available (since 80 \u2013 60 = 20), one must remember that his already\u2010scheduled 10\u2010hour external shift is included in that ceiling. In effect, he is allowed a maximum of 80 hours total\u2014so he may add at most 10 more hours that week on top of his current 70 hours.\n\nAmong the answer choices provided, the only option that correctly mentions the quantitative limit related to moonlighting is:\n\nD. He may work up to 20 more hours\n\nUnder the ACGME restrictions for a resident with a 60\u2010hour residency commitment, \u201cworking up to 20 additional hours\u201d is sometimes stated as the moonlighting allowance. However, in this case his existing 10\u2010hour shift already uses 10 of those additional hours, so he would only be able to do another 10 hours if he wished to stay within an 80\u2010hour total weekly limit.\n\nThus, based on the most recent ACGME standards regarding moonlighting and patient safety, the best answer among the given choices is:\n\nFinal answer: D\n\n(Keep in mind that while \u201cD\u201d is technically correct in that the ACGME rules allow up to 80 total duty hours a week\u2014which for a resident doing 60 regular hours would seem to leave room for 20 hours\u2014the resident\u2019s current moonlighting already occupies 10 of those hours. The important teaching point is that all moonlighting and residency clinical work must be counted, so if the resident desires additional moonlighting beyond his current 10-hour shift, he must stay below that 80-hour cap to safeguard patient safety.)"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "1"
        ],
        "final_solution": "The key point is that ACGME regulations require that a resident\u2019s total clinical work hours\u2014including both scheduled residency duties and any moonlighting hours\u2014must not exceed an average of 80 hours per week (averaged over 4 weeks). In other words, moonlighting hours are not \u201cextra\u201d but count toward that 80\u2010hour limit.\n\nIn this scenario the resident already spends 60 hours per week on residency duties and has an additional 10\u2010hour \u201cmoonlighting\u201d shift on Saturdays. That brings his total to 70 hours for the week. He is thereby allowed up to an additional 10 hours during that week before reaching the 80\u2010hour limit. (Many sources will note that for PGY\u20102 residents and beyond, moonlighting \u201cup to 20 hours\u201d per week may be possible if the resident has fewer duty hours from residency\u2014but the resident\u2019s total combined hours must never exceed 80 hours.)\n\nThus, although one might be tempted to think \u201c20 more hours\u201d are available (since 80 \u2013 60 = 20), one must remember that his already\u2010scheduled 10\u2010hour external shift is included in that ceiling. In effect, he is allowed a maximum of 80 hours total\u2014so he may add at most 10 more hours that week on top of his current 70 hours.\n\nAmong the answer choices provided, the only option that correctly mentions the quantitative limit related to moonlighting is:\n\nD. He may work up to 20 more hours\n\nUnder the ACGME restrictions for a resident with a 60\u2010hour residency commitment, \u201cworking up to 20 additional hours\u201d is sometimes stated as the moonlighting allowance. However, in this case his existing 10\u2010hour shift already uses 10 of those additional hours, so he would only be able to do another 10 hours if he wished to stay within an 80\u2010hour total weekly limit.\n\nThus, based on the most recent ACGME standards regarding moonlighting and patient safety, the best answer among the given choices is:\n\nFinal answer: D\n\n(Keep in mind that while \u201cD\u201d is technically correct in that the ACGME rules allow up to 80 total duty hours a week\u2014which for a resident doing 60 regular hours would seem to leave room for 20 hours\u2014the resident\u2019s current moonlighting already occupies 10 of those hours. The important teaching point is that all moonlighting and residency clinical work must be counted, so if the resident desires additional moonlighting beyond his current 10-hour shift, he must stay below that 80-hour cap to safeguard patient safety.)"
    },
    {
        "realidx": 784,
        "question": "A 42-year-old woman presents to her obstetrician for a prenatal care appointment at 10 weeks gestation. The patient recently found out she was pregnant after having unprotected intercourse with her husband for the past year. She states that she is feeling well and has experienced some nausea and vomiting. She is currently taking prenatal vitamins and folate supplements. Her temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 127/68 mmHg, pulse is 90/min, respirations are 19/min, and oxygen saturation is 98% on room air. On physical exam, you notice a gravid uterus 10 cm above the pubic symphysis. The patient's external genitalia appear within normal limits. Which of the following is the next best step in management?",
        "answer": "Cell-free DNA testing",
        "options": {
            "A": "Amniocentesis",
            "B": "Cell-free DNA testing",
            "C": "Chorionic villus sampling",
            "D": "Regular follow up appointments"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman presents",
            "obstetrician",
            "prenatal care appointment",
            "10 weeks gestation",
            "patient recently found out",
            "pregnant",
            "unprotected intercourse",
            "husband",
            "past year",
            "states",
            "feeling well",
            "experienced",
            "nausea",
            "vomiting",
            "currently taking prenatal vitamins",
            "folate supplements",
            "temperature",
            "99",
            "blood pressure",
            "68 mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "physical exam",
            "gravid uterus 10",
            "pubic symphysis",
            "patient's external genitalia appear",
            "normal limits",
            "following",
            "next best step",
            "management"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4446,
            "completion_tokens": 4516
        },
        "time_elapsed": 33.116671085357666,
        "raw_responses": [
            "Step 1: Recognize that the patient is a 42-year-old pregnant woman at 10 weeks gestation. Advanced maternal age is associated with an increased risk of chromosomal abnormalities.\n\nStep 2: Evaluate the options:\n\u2022 Amniocentesis is typically performed during the second trimester (around 15\u201320 weeks) and is invasive.\n\u2022 Chorionic villus sampling (CVS) is invasive and performed between 10 and 13 weeks but carries a risk of miscarriage.\n\u2022 Cell-free DNA testing is noninvasive, can be performed as early as 10 weeks, and screens for common chromosomal abnormalities.\n\u2022 Regular follow-up appointments do not address the increased risk for chromosomal abnormalities associated with advanced maternal age.\n\nStep 3: The next best step in management is to offer cell-free DNA testing.\n\nFinal Answer: B. Cell-free DNA testing",
            "Step 1: Relevant information is that the patient is a 42-year-old woman at 10 weeks gestation. Advanced maternal age (over 35 years) places her at a higher risk for fetal chromosomal abnormalities.\n\nStep 2: Amniocentesis (Option A) is typically performed during the second trimester (15\u201320 weeks) and is invasive. Chorionic villus sampling (Option C) is also invasive and, although it can be done during the first trimester (10\u201313 weeks), it is usually reserved for high-risk patients who have abnormal screening results or significant risk factors. Regular follow-up appointments (Option D) would be part of routine management, but given her risk factors, additional screening for aneuploidy is indicated now. Cell-free DNA testing (Option B) is a noninvasive screening method available from 10 weeks onward and is recommended for women with advanced maternal age.\n\nStep 3: Final answer: B. Cell-free DNA testing.",
            "Step 1: Note that the patient is 42 years old\u2014an advanced maternal age\u2014which increases the risk of fetal chromosomal abnormalities. Her presentation is otherwise unremarkable and she is already taking appropriate prenatal supplements.\n\nStep 2: In pregnant women of advanced maternal age, noninvasive screening for aneuploidy is recommended. Cell\u2010free DNA (also known as noninvasive prenatal testing or NIPT) is a screening test that can be performed as early as 10 weeks gestation. It is preferred over invasive diagnostic procedures such as chorionic villus sampling (CVS) or amniocentesis, which carry a risk of complications and are generally reserved for use after abnormal screening results are obtained.\n\nStep 3: Option analysis:\n\u2022 Option A \u2013 Amniocentesis is typically done in the second trimester and is invasive.\n\u2022 Option B \u2013 Cell\u2010free DNA testing is noninvasive, can be performed at 10 weeks, and is appropriate in a patient with advanced maternal age.\n\u2022 Option C \u2013 Chorionic villus sampling, though available in the first trimester, is an invasive diagnostic test reserved for when screening tests are abnormal or in women who desire definitive diagnosis.\n\u2022 Option D \u2013 Regular follow up appointments are important but do not address the need for appropriate aneuploidy screening in an advanced maternal age patient.\n\nFinal Answer: B. Cell-free DNA testing."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Note that the patient is 42 years old\u2014an advanced maternal age\u2014which increases the risk of fetal chromosomal abnormalities. Her presentation is otherwise unremarkable and she is already taking appropriate prenatal supplements.\n\nStep 2: In pregnant women of advanced maternal age, noninvasive screening for aneuploidy is recommended. Cell\u2010free DNA (also known as noninvasive prenatal testing or NIPT) is a screening test that can be performed as early as 10 weeks gestation. It is preferred over invasive diagnostic procedures such as chorionic villus sampling (CVS) or amniocentesis, which carry a risk of complications and are generally reserved for use after abnormal screening results are obtained.\n\nStep 3: Option analysis:\n\u2022 Option A \u2013 Amniocentesis is typically done in the second trimester and is invasive.\n\u2022 Option B \u2013 Cell\u2010free DNA testing is noninvasive, can be performed at 10 weeks, and is appropriate in a patient with advanced maternal age.\n\u2022 Option C \u2013 Chorionic villus sampling, though available in the first trimester, is an invasive diagnostic test reserved for when screening tests are abnormal or in women who desire definitive diagnosis.\n\u2022 Option D \u2013 Regular follow up appointments are important but do not address the need for appropriate aneuploidy screening in an advanced maternal age patient.\n\nFinal Answer: B. Cell-free DNA testing."
    },
    {
        "realidx": 785,
        "question": "A 6-year-old boy is brought to the physician because of abdominal distention, fatigue, and night sweats over the past 4 months. He also has a 2-month history of post-prandial fullness and recurrent nonbilious vomiting. He appears pale. Abdominal examination shows hepatosplenomegaly and shifting dullness; there is mild tenderness to palpation. Examination of the skin shows multiple nonblanching maculae. A CT scan of the abdomen shows mesenteric and retroperitoneal lymph node enlargement and nodular thickening of the omentum. A photomicrograph of a biopsy specimen from an enlarged mesenteric lymph node is shown. Immunohistochemical staining of the Ki-67 nuclear antigen shows that the proliferation index of the specimen is > 99%. The structure indicated by the arrows is most likely which of the following?",
        "answer": "Macrophage",
        "options": {
            "A": "Neutrophil",
            "B": "Human immunodeficiency virus",
            "C": "B lymphocytes",
            "D": "Macrophage"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old boy",
            "brought",
            "physician",
            "abdominal distention",
            "fatigue",
            "night sweats",
            "past",
            "months",
            "2 month history",
            "post-prandial fullness",
            "recurrent",
            "vomiting",
            "appears pale",
            "Abdominal examination shows hepatosplenomegaly",
            "shifting dullness",
            "mild tenderness",
            "palpation",
            "Examination of",
            "skin shows multiple",
            "maculae",
            "CT scan",
            "abdomen shows mesenteric",
            "retroperitoneal lymph node enlargement",
            "nodular thickening",
            "omentum",
            "photomicrograph",
            "biopsy specimen",
            "enlarged mesenteric lymph node",
            "shown",
            "staining",
            "Ki-67 nuclear antigen shows",
            "proliferation index",
            "specimen",
            "99",
            "structure indicated",
            "arrows",
            "most likely",
            "following"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5148,
            "completion_tokens": 4088
        },
        "time_elapsed": 32.25365400314331,
        "raw_responses": [
            "Step 1: Recognize that the patient\u2019s clinical presentation (abdominal distention, hepatosplenomegaly, \"B\" symptoms like night sweats, and an abdominal mass with lymphadenopathy) along with a CT scan showing nodular omental thickening suggests an aggressive abdominal lymphoma in a child.\n\nStep 2: Note that the biopsy shows a Ki-67 proliferation index of >99%, which is classic for Burkitt lymphoma. This lymphoma is known for its \u201cstarry sky\u201d appearance on histology.\n\nStep 3: In the \u201cstarry sky\u201d pattern, the \u201csky\u201d is composed of densely arranged rapidly proliferating tumor cells (which are B lymphocytes), and the \u201cstars\u201d are benign macrophages that have engulfed apoptotic tumor cells.\n\nStep 4: The photomicrograph\u2019s arrows most likely indicate these lighter \u201cstars.\u201d Although the tumor itself is made up of B lymphocytes, the arrows in the provided image are pointing to the macrophages present within the tumor.\n\nFinal Answer: D. Macrophage",
            "Step 1: The patient is a 6-year-old boy with abdominal distention, hepatosplenomegaly, and B-symptoms (night sweats, fatigue), along with CT findings of mesenteric and retroperitoneal lymph node enlargement and omental involvement. These findings raise concern for a lymphoproliferative disorder.\n\nStep 2: The biopsy shows a proliferation index (Ki-67) of greater than 99%, which is characteristic of Burkitt lymphoma. Burkitt lymphoma, a high-grade B-cell non-Hodgkin lymphoma, often exhibits a \u201cstarry sky\u201d appearance on microscopy. \n\nStep 3: The \u201cstarry sky\u201d appearance is due to the presence of interspersed macrophages (tingible body macrophages) that have engulfed apoptotic tumor cells. These macrophages appear as lighter \u201cstars\u201d against a dark background of rapidly proliferating malignant B lymphocytes.\n\nStep 4: Among the provided options:\n\u2003A. Neutrophil \u2013 Not typically seen causing this \u201cstarry sky\u201d pattern.\n\u2003B. Human immunodeficiency virus \u2013 Not a cellular structure; it\u2019s a virus.\n\u2003C. B lymphocytes \u2013 Although Burkitt lymphoma is composed of malignant B lymphocytes, the arrows in the photomicrograph are most likely not indicating these densely packed malignant cells.\n\u2003D. Macrophage \u2013 These are the cells responsible for the \u201cstar\u201d appearance in the \u201cstarry sky\u201d pattern of Burkitt lymphoma.\n\nFinal Answer: D. Macrophage",
            "Step 1: Identify Key Findings\n\u2022 The patient is a 6-year-old boy with abdominal distention, hepatosplenomegaly, a history of night sweats, and gastrointestinal symptoms.\n\u2022 CT findings include mesenteric and retroperitoneal lymphadenopathy with omental thickening.\n\u2022 The biopsy shows a very high proliferation index (Ki-67 > 99%), which is characteristic of an aggressive lymphoma, such as Burkitt lymphoma.\n\u2022 Burkitt lymphoma histology is noted for the \"starry sky\" appearance, in which interspersed macrophages (tingible body macrophages) engulf apoptotic tumor cells.\n\nStep 2: Analyze the Options\nA. Neutrophil \u2013 These are not typically highlighted in Burkitt lymphoma\u2019s histology.\nB. Human immunodeficiency virus \u2013 HIV is a virus, not a cell structure.\nC. B lymphocytes \u2013 While Burkitt lymphoma is derived from B lymphocytes, the arrows in the photomicrograph (described as a \"starry sky\" pattern) are not pointing to the malignant B cells.\nD. Macrophage \u2013 In the \"starry sky\" appearance of Burkitt lymphoma, the clear spaces (the \"stars\") are the tingible body macrophages actively phagocytosing apoptotic tumor cells.\n\nStep 3: Conclusion\nThe arrows in the photomicrograph most likely indicate the macrophages responsible for the \"starry sky\" appearance seen in high-proliferation lymphomas such as Burkitt lymphoma.\n\nFinal Answer: D. Macrophage"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify Key Findings\n\u2022 The patient is a 6-year-old boy with abdominal distention, hepatosplenomegaly, a history of night sweats, and gastrointestinal symptoms.\n\u2022 CT findings include mesenteric and retroperitoneal lymphadenopathy with omental thickening.\n\u2022 The biopsy shows a very high proliferation index (Ki-67 > 99%), which is characteristic of an aggressive lymphoma, such as Burkitt lymphoma.\n\u2022 Burkitt lymphoma histology is noted for the \"starry sky\" appearance, in which interspersed macrophages (tingible body macrophages) engulf apoptotic tumor cells.\n\nStep 2: Analyze the Options\nA. Neutrophil \u2013 These are not typically highlighted in Burkitt lymphoma\u2019s histology.\nB. Human immunodeficiency virus \u2013 HIV is a virus, not a cell structure.\nC. B lymphocytes \u2013 While Burkitt lymphoma is derived from B lymphocytes, the arrows in the photomicrograph (described as a \"starry sky\" pattern) are not pointing to the malignant B cells.\nD. Macrophage \u2013 In the \"starry sky\" appearance of Burkitt lymphoma, the clear spaces (the \"stars\") are the tingible body macrophages actively phagocytosing apoptotic tumor cells.\n\nStep 3: Conclusion\nThe arrows in the photomicrograph most likely indicate the macrophages responsible for the \"starry sky\" appearance seen in high-proliferation lymphomas such as Burkitt lymphoma.\n\nFinal Answer: D. Macrophage"
    },
    {
        "realidx": 791,
        "question": "A 5-year-old boy is brought to his pediatrician\u2019s office by his parents after they noticed blood in his urine. The child has been complaining of difficulty in passing urine and has lower abdominal pain. He seems more bloated than usual. On some occasions, he starts crying while passing urine, primarily because of a burning sensation. A urinalysis is performed, and the results are as follows:\nUrine pH 6.2\nUrine specific gravity 1.010\nGlucose Negative\nKetones Negative\nRBCs 1-2/hpf\nWBCs 0-1/hpf\nCasts 2-3/hpf\nThe pediatrician believes the boy has a bladder infection with a double-stranded DNA virus. Which of the following conditions is also commonly associated with this viral infection?",
        "answer": "Gastroenteritis",
        "options": {
            "A": "Gastroenteritis",
            "B": "Painful dermatomal vesicles",
            "C": "Lymphadenopathy",
            "D": "Vesicular rash"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "5 year old boy",
            "brought",
            "pediatricians office",
            "parents",
            "blood in",
            "urine",
            "child",
            "difficulty",
            "passing urine",
            "lower abdominal pain",
            "more bloated",
            "usual",
            "occasions",
            "starts crying",
            "passing urine",
            "burning sensation",
            "urinalysis",
            "performed",
            "results",
            "follows",
            "Urine pH 6",
            "specific gravity",
            "Glucose Negative Ketones",
            "RBCs",
            "hpf",
            "0",
            "Casts 2-3 hpf",
            "pediatrician",
            "boy",
            "bladder infection",
            "double-stranded DNA virus",
            "following conditions",
            "associated",
            "viral infection"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4467,
            "completion_tokens": 5346
        },
        "time_elapsed": 39.71648550033569,
        "raw_responses": [
            "Step 1: Identify the virus. Double-stranded DNA viruses include adenovirus, herpes simplex virus, varicella zoster virus, CMV, among others. In children, hemorrhagic cystitis (bladder infection with blood in urine, pain during urination) is most commonly associated with adenovirus.\n\nStep 2: Consider adenovirus\u2019s clinical associations. Adenovirus is known to cause respiratory infections and gastroenteritis, particularly in young children.\n\nStep 3: Evaluate the options.\n\u2022 Option A (Gastroenteritis) is associated with adenovirus.\n\u2022 Option B (Painful dermatomal vesicles) is typical of varicella zoster virus reactivation (shingles), not adenovirus.\n\u2022 Option C (Lymphadenopathy) is non-specific and not commonly linked to adenovirus bladder infection.\n\u2022 Option D (Vesicular rash) is more consistent with primary varicella (chickenpox) or herpesvirus infections, not adenovirus.\n\nFinal Answer: A. Gastroenteritis",
            "Step 1: Recognize the virus. The physician believes the boy\u2019s bladder infection is caused by a double-stranded DNA virus. In children, adenovirus\u2014a non-enveloped, double-stranded DNA virus\u2014is well known for causing hemorrhagic cystitis.\n\nStep 2: Know adenovirus's associated conditions. In addition to hemorrhagic cystitis, adenovirus is frequently implicated in pediatric cases of gastroenteritis (especially with serotypes 40 and 41), as well as respiratory and ocular infections.\n\nStep 3: Evaluate the options.\n\u2022 Option A, Gastroenteritis \u2013 Correct, as adenovirus is also a common cause of gastroenteritis in children.\n\u2022 Option B, Painful dermatomal vesicles \u2013 Suggestive of herpes zoster, which is also a double-stranded DNA virus but not linked with adenoviral hemorrhagic cystitis.\n\u2022 Option C, Lymphadenopathy \u2013 Not specifically associated with adenovirus.\n\u2022 Option D, Vesicular rash \u2013 Typically seen with varicella-zoster virus, not adenovirus.\n\nFinal Answer: A. Gastroenteritis",
            "Step 1: Identify the pathogen. The pediatrician suspects a bladder infection caused by a double\u2010stranded DNA virus. Among the dsDNA viruses, adenovirus is known to cause hemorrhagic cystitis in children. \n\nStep 2: Consider common associations. Adenovirus infections are also classically associated with respiratory illness (pharyngoconjunctival fever) and gastroenteritis in children.\n\nStep 3: Evaluate the answer options.\n\u2022 Option A \u2013 Gastroenteritis: Commonly associated with adenovirus.\n\u2022 Option B \u2013 Painful dermatomal vesicles: Typical of herpes zoster (varicella zoster virus), not adenovirus.\n\u2022 Option C \u2013 Lymphadenopathy: Can be seen with other viral infections (like EBV) but not a classic finding in adenovirus infection.\n\u2022 Option D \u2013 Vesicular rash: More characteristic of herpes simplex virus infections rather than adenovirus.\n\nStep 4: Conclusion. Given that adenovirus is the likely culprit and it is associated with gastroenteritis, the correct answer is:\n\nFinal Answer: A. Gastroenteritis"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Recognize the virus. The physician believes the boy\u2019s bladder infection is caused by a double-stranded DNA virus. In children, adenovirus\u2014a non-enveloped, double-stranded DNA virus\u2014is well known for causing hemorrhagic cystitis.\n\nStep 2: Know adenovirus's associated conditions. In addition to hemorrhagic cystitis, adenovirus is frequently implicated in pediatric cases of gastroenteritis (especially with serotypes 40 and 41), as well as respiratory and ocular infections.\n\nStep 3: Evaluate the options.\n\u2022 Option A, Gastroenteritis \u2013 Correct, as adenovirus is also a common cause of gastroenteritis in children.\n\u2022 Option B, Painful dermatomal vesicles \u2013 Suggestive of herpes zoster, which is also a double-stranded DNA virus but not linked with adenoviral hemorrhagic cystitis.\n\u2022 Option C, Lymphadenopathy \u2013 Not specifically associated with adenovirus.\n\u2022 Option D, Vesicular rash \u2013 Typically seen with varicella-zoster virus, not adenovirus.\n\nFinal Answer: A. Gastroenteritis"
    },
    {
        "realidx": 803,
        "question": "A 75-year-old woman presents to the emergency department with 30 minutes of slurred speech and arm weakness. On the drive over to the hospital, her symptoms have resolved completely. The patient has a past medical history of hypertension, atrial fibrillation, diabetes, morbid obesity, gout, and vascular claudication. Her temperature is 99.0\u00b0F (37.2\u00b0C), blood pressure is 184/111 mmHg, pulse is 88/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals cranial nerves II-XII as grossly intact with normal strength and sensation in the patient's upper and lower extremities. The patient's memory is intact and her speech seems normal and fluent. Her gait is stable with no ataxia. An initial head CT demonstrates diffuse atrophy which is consistent with previous head CT scans. Which of the following is the best next step in management?",
        "answer": "CT angiogram",
        "options": {
            "A": "CT angiogram",
            "B": "Echocardiogram",
            "C": "Heparin",
            "D": "MRI"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "75 year old woman presents",
            "emergency department",
            "30 minutes",
            "slurred speech",
            "arm weakness",
            "drive",
            "hospital",
            "symptoms",
            "resolved completely",
            "patient",
            "past medical",
            "atrial fibrillation",
            "diabetes",
            "morbid obesity",
            "gout",
            "vascular claudication",
            "temperature",
            "99",
            "blood pressure",
            "mmHg",
            "pulse",
            "88 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "Physical exam reveals cranial nerves II XII",
            "intact",
            "normal strength",
            "sensation",
            "patient's upper",
            "lower extremities",
            "patient's memory",
            "intact",
            "speech",
            "normal",
            "fluent",
            "gait",
            "stable",
            "ataxia",
            "initial head CT demonstrates diffuse atrophy",
            "consistent with previous head CT scans",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5259,
            "completion_tokens": 3767
        },
        "time_elapsed": 58.12589645385742,
        "raw_responses": [
            "Step 1: Identify the clinical scenario.  \n\u2022 The patient experienced transient neurological deficits (slurred speech and arm weakness) that completely resolved within 30 minutes, which is consistent with a transient ischemic attack (TIA).\n\nStep 2: Review the current workup findings.  \n\u2022 The head CT only shows diffuse atrophy, which is unchanged from previous studies, and is not definitive for acute ischemia. CT is less sensitive in detecting acute or small ischemic lesions.\n\nStep 3: Evaluate the options provided.  \nA. CT angiogram \u2013 This would evaluate the cerebral vasculature for stenoses or occlusions; while useful, the immediate concern for a TIA is to identify any acute ischemic changes not seen on CT.  \nB. Echocardiogram \u2013 Often used to assess for cardioembolic sources (e.g., atrial thrombus) especially in patients with atrial fibrillation; however, it isn\u2019t the next immediate step given that we need to evaluate the brain tissue.  \nC. Heparin \u2013 Anticoagulation is not immediately indicated in this TIA scenario without evidence of ongoing stroke or high-risk thrombus.  \nD. MRI \u2013 Magnetic resonance imaging, especially diffusion-weighted imaging (DWI), is much more sensitive than CT in detecting small or early ischemic changes, which is critical after a TIA.\n\nStep 4: Conclusion.  \nThe best next step in management is to obtain an MRI of the brain to look for subtle ischemic changes that might have been missed on the CT scan.\n\nFinal answer: D. MRI.",
            "Step 1: Recognize that this patient\u2019s symptoms (slurred speech and arm weakness that fully resolved within 30 minutes) are highly suggestive of a transient ischemic attack (TIA).\n\nStep 2: Note that her initial head CT is unremarkable, which is common in TIA and minor strokes. However, CT scans can miss small acute infarcts.\n\nStep 3: Compare the options:  \n\u2003\u2022 CT angiogram is used to evaluate the vasculature for occlusions or stenoses, but there is no clinical indication of ongoing vascular occlusion given that her neurological exam is normal.  \n\u2003\u2022 Echocardiogram is valuable for assessing cardiac sources of emboli, especially in a patient with atrial fibrillation, but this is typically part of a broader work-up rather than the immediate next step.  \n\u2003\u2022 Heparin is an anticoagulant used in acute stroke management, but given that her symptoms have resolved and there is no acute infarction on CT, initiating heparin is not indicated immediately.  \n\u2003\u2022 MRI, particularly with diffusion-weighted imaging (DWI), is more sensitive than CT in detecting acute small ischemic changes and can help confirm the diagnosis of TIA or minor stroke.\n\nStep 4: Conclude that the best next step in management is to order an MRI to further evaluate for any subtle ischemic changes that might have been missed on the CT scan.\n\nFinal Answer: MRI",
            "Step 1: Identify that the patient had a transient episode of neurological symptoms (slurred speech and arm weakness that completely resolved in 30 minutes), which is consistent with a transient ischemic attack (TIA).\n\nStep 2: Consider the workup for TIA. While a head CT has been performed and shows only diffuse atrophy (without evidence of acute stroke), the next step typically involves further imaging to detect any recent ischemia that might not be visible on CT. Magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) is highly sensitive for acute infarcts or small ischemic changes.\n\nStep 3: Review the answer choices:\n\u2003A. CT angiogram \u2013 This would assess for vascular occlusions or stenosis but is not the most sensitive for identifying an acute infarct.\n\u2003B. Echocardiogram \u2013 Useful in detecting a cardioembolic source, but given the recent TIA episode, further brain imaging is prioritized.\n\u2003C. Heparin \u2013 Anticoagulation may be considered in select cases, but it is premature without further imaging, and the patient's symptoms have resolved.\n\u2003D. MRI \u2013 Offers high sensitivity for detecting acute or recent ischemia, and thus is the next best step in evaluating a suspected TIA.\n\nFinal Answer: D. MRI"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Identify that the patient had a transient episode of neurological symptoms (slurred speech and arm weakness that completely resolved in 30 minutes), which is consistent with a transient ischemic attack (TIA).\n\nStep 2: Consider the workup for TIA. While a head CT has been performed and shows only diffuse atrophy (without evidence of acute stroke), the next step typically involves further imaging to detect any recent ischemia that might not be visible on CT. Magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) is highly sensitive for acute infarcts or small ischemic changes.\n\nStep 3: Review the answer choices:\n\u2003A. CT angiogram \u2013 This would assess for vascular occlusions or stenosis but is not the most sensitive for identifying an acute infarct.\n\u2003B. Echocardiogram \u2013 Useful in detecting a cardioembolic source, but given the recent TIA episode, further brain imaging is prioritized.\n\u2003C. Heparin \u2013 Anticoagulation may be considered in select cases, but it is premature without further imaging, and the patient's symptoms have resolved.\n\u2003D. MRI \u2013 Offers high sensitivity for detecting acute or recent ischemia, and thus is the next best step in evaluating a suspected TIA.\n\nFinal Answer: D. MRI"
    },
    {
        "realidx": 822,
        "question": "A 27-year-old man presents to the emergency department due to a change in his skin color. The patient went on a long hike this morning, and his girlfriend noticed that his skin had changed color when they were driving home. The patient has a past medical history of marijuana use, IV drug use, alcohol use, and asthma. His current medications include albuterol, fluticasone, and ibuprofen. His temperature is 97.5\u00b0F (36.4\u00b0C), blood pressure is 120/75 mmHg, pulse is 60/min, respirations are 10/min, and oxygen saturation is 98% on room air. Laboratory studies are ordered and are seen below.\n\nHemoglobin: 10 g/dL\nHematocrit: 32%\nLeukocyte count: 5,500 cells/mm^3 with normal differential\nPlatelet count: 207,000/mm^3\n\nSerum:\nNa+: 139 mEq/L\nCl-: 99 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 24 mEq/L\nBUN: 17 mg/dL\nGlucose: 89 mg/dL\nCreatinine: 1.0 mg/dL\nCa2+: 10.1 mg/dL\nBilirubin, total: 11.3 mg/dL\nBilirubin, direct: 7.8 mg/dL\n\nPhysical exam is notable for a patient with skin that appears yellow/orange. Cardiac, pulmonary, abdominal, and neurological exams are within normal limits. Which of the following is associated with this patient's underlying pathology?",
        "answer": "Hyperpigmentation of the liver",
        "options": {
            "A": "A pathology responsive to sofosbuvir",
            "B": "Decreased UDP-glucuronyl transferase activity",
            "C": "Hyperpigmentation of the liver",
            "D": "Increased consumption of beta-carotene"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "27 year old man presents",
            "emergency department due",
            "change in",
            "skin color",
            "patient",
            "long",
            "morning",
            "girlfriend",
            "skin",
            "changed color",
            "driving home",
            "patient",
            "past medical history of marijuana use",
            "IV drug use",
            "alcohol use",
            "asthma",
            "current medications include albuterol",
            "fluticasone",
            "ibuprofen",
            "temperature",
            "97",
            "36 4C",
            "blood pressure",
            "75 mmHg",
            "pulse",
            "60 min",
            "respirations",
            "10/min",
            "oxygen saturation",
            "98",
            "room air",
            "Laboratory studies",
            "ordered",
            "seen",
            "Hemoglobin",
            "10 g/dL Hematocrit",
            "Leukocyte count",
            "5 500 cells mm",
            "normal differential Platelet count",
            "mm",
            "Serum",
            "Na",
            "mEq/L Cl",
            "99 mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L",
            "mg/dL Glucose",
            "mg/dL Creatinine",
            "1 0 mg/dL Ca2",
            "10",
            "mg/dL Bilirubin",
            "total",
            "mg/dL Bilirubin",
            "direct",
            "mg/dL",
            "Physical exam",
            "notable",
            "patient",
            "skin",
            "appears yellow orange",
            "Cardiac",
            "pulmonary",
            "abdominal",
            "neurological exams",
            "normal limits",
            "following",
            "associated with",
            "patient's",
            "pathology"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 6858,
            "completion_tokens": 5789
        },
        "time_elapsed": 41.89879512786865,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s lab findings and clinical presentation.  \n\u2022 The patient has a low hemoglobin level (10 g/dL) and signs of hyperbilirubinemia with a total bilirubin of 11.3 mg/dL, of which the direct (conjugated) portion is 7.8 mg/dL.  \n\u2022 His skin appears yellow/orange, and there are no other abnormal exam findings.  \n\nStep 2: Determine the likely pathology based on the labs.  \n\u2022 The predominant elevation of direct bilirubin suggests a conjugated hyperbilirubinemia, which is seen in conditions that impair the excretion of bilirubin into bile.  \n\u2022 One benign condition that causes conjugated hyperbilirubinemia is Dubin-Johnson syndrome, which is characterized by episodes of jaundice without significant liver dysfunction.  \n\nStep 3: Evaluate the provided options.  \nA. A pathology responsive to sofosbuvir \u2013 Sofosbuvir is a treatment for hepatitis C. Although hepatitis C can affect the liver, it does not typically present as isolated conjugated hyperbilirubinemia with the benign course noted here.  \nB. Decreased UDP-glucuronyl transferase activity \u2013 This defect is seen in conditions such as Gilbert syndrome, which causes unconjugated hyperbilirubinemia, not the conjugated type seen in this patient.  \nC. Hyperpigmentation of the liver \u2013 Dubin-Johnson syndrome is known for causing a grossly pigmented (often dark or black) liver due to the accumulation of pigment in hepatocytes.  \nD. Increased consumption of beta-carotene \u2013 Elevated beta-carotene leads to carotenemia, which can cause yellowing of the skin but does not alter bilirubin levels.  \n\nStep 4: Provide the final answer.  \nBased on the analysis, the condition most consistent with this patient's presentation is Dubin-Johnson syndrome, which is associated with hyperpigmentation of the liver.\n\nFinal answer: C. Hyperpigmentation of the liver",
            "Step 1: Examine the laboratory values and clinical presentation. The patient has a markedly elevated total bilirubin (11.3 mg/dL) with a predominance of direct (conjugated) bilirubin (7.8 mg/dL), indicating conjugated hyperbilirubinemia. He has no signs of hepatocellular injury on exam, and his vital signs are stable.\n\nStep 2: Consider the differential diagnosis for conjugated hyperbilirubinemia in a young patient. While bile duct obstruction or cholestasis is in the differential, a benign congenital condition such as Dubin-Johnson syndrome is most fitting. Dubin-Johnson syndrome is a hereditary condition characterized by impaired excretion of conjugated bilirubin resulting in elevated direct bilirubin.\n\nStep 3: Look at the answer choices:\n\u2022 Option A: A pathology responsive to sofosbuvir refers to hepatitis C treatment and is not consistent with an isolated conjugated hyperbilirubinemia in this context.\n\u2022 Option B: Decreased UDP-glucuronyl transferase activity is seen in conditions that cause unconjugated hyperbilirubinemia (e.g., Gilbert syndrome), not conjunctured hyperbilirubinemia.\n\u2022 Option C: Hyperpigmentation of the liver\u2014Dubin-Johnson syndrome is classically associated with a grossly black (darkly pigmented) liver on gross pathology, due to the accumulation of pigment within hepatocytes.\n\u2022 Option D: Increased consumption of beta-carotene would result in carotenemia, which causes an orange discoloration of the skin that is not true jaundice and would not explain the lab findings of hyperbilirubinemia.\n\nStep 4: By process of elimination and correlation with the patient\u2019s presentation and lab results, the underlying pathology is most consistent with Dubin-Johnson syndrome.\n\nFinal Answer: C. Hyperpigmentation of the liver.",
            "Step 1: Note the lab values. The patient\u2019s total bilirubin is 11.3 mg/dL with a direct (conjugated) bilirubin of 7.8 mg/dL. This indicates a predominantly conjugated hyperbilirubinemia.\n\nStep 2: Recognize that decreased UDP\u2010glucuronyl transferase activity (option B) is seen in conditions like Gilbert syndrome and Crigler\u2010Najjar syndrome, but those cause unconjugated hyperbilirubinemia. In contrast, this patient\u2019s labs show conjugated hyperbilirubinemia.\n\nStep 3: Option A refers to a pathology responsive to sofosbuvir (used to treat hepatitis C). Although hepatitis C is common in IV drug users, it typically presents with transaminase elevation rather than an isolated conjugated hyperbilirubinemia.\n\nStep 4: Option D (increased consumption of beta-carotene) would cause carotenemia, leading to orange discoloration of the skin; however, carotenemia does not cause elevated bilirubin levels.\n\nStep 5: Option C (hyperpigmentation of the liver) is classically associated with Dubin-Johnson syndrome, a condition seen in young patients that results in chronic conjugated hyperbilirubinemia due to an inability to properly excrete conjugated bilirubin from hepatocytes. The liver in Dubin-Johnson syndrome has a characteristic dark (pigmented) appearance on gross inspection.\n\nFinal Answer: C."
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Examine the laboratory values and clinical presentation. The patient has a markedly elevated total bilirubin (11.3 mg/dL) with a predominance of direct (conjugated) bilirubin (7.8 mg/dL), indicating conjugated hyperbilirubinemia. He has no signs of hepatocellular injury on exam, and his vital signs are stable.\n\nStep 2: Consider the differential diagnosis for conjugated hyperbilirubinemia in a young patient. While bile duct obstruction or cholestasis is in the differential, a benign congenital condition such as Dubin-Johnson syndrome is most fitting. Dubin-Johnson syndrome is a hereditary condition characterized by impaired excretion of conjugated bilirubin resulting in elevated direct bilirubin.\n\nStep 3: Look at the answer choices:\n\u2022 Option A: A pathology responsive to sofosbuvir refers to hepatitis C treatment and is not consistent with an isolated conjugated hyperbilirubinemia in this context.\n\u2022 Option B: Decreased UDP-glucuronyl transferase activity is seen in conditions that cause unconjugated hyperbilirubinemia (e.g., Gilbert syndrome), not conjunctured hyperbilirubinemia.\n\u2022 Option C: Hyperpigmentation of the liver\u2014Dubin-Johnson syndrome is classically associated with a grossly black (darkly pigmented) liver on gross pathology, due to the accumulation of pigment within hepatocytes.\n\u2022 Option D: Increased consumption of beta-carotene would result in carotenemia, which causes an orange discoloration of the skin that is not true jaundice and would not explain the lab findings of hyperbilirubinemia.\n\nStep 4: By process of elimination and correlation with the patient\u2019s presentation and lab results, the underlying pathology is most consistent with Dubin-Johnson syndrome.\n\nFinal Answer: C. Hyperpigmentation of the liver."
    },
    {
        "realidx": 829,
        "question": "A 66-year-old man presents to the emergency department for a cough and fatigue. The patient was brought in from a nursing home with documentation stating that he has seemed confused for the past day according to the staff. The patient has a past medical history of diabetes and hypertension. He is currently taking insulin, metformin, lisinopril, and atorvastatin. His temperature is 102\u00b0F (38.9\u00b0C), blood pressure is 107/58 mmHg, pulse is 120/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals crackles on pulmonary exam and S4 on cardiac auscultation. Which of the following is the next best step in management?",
        "answer": "Moxifloxacin and admission to the medical floor",
        "options": {
            "A": "Azithromycin and admission to the medical floor",
            "B": "Azithromycin and discharge",
            "C": "Azithromycin, moxifloxacin, and admission to the intensive care unit",
            "D": "Moxifloxacin and admission to the medical floor"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "66 year old man presents",
            "emergency department",
            "cough",
            "fatigue",
            "patient",
            "brought",
            "nursing",
            "documentation stating",
            "confused",
            "past day",
            "staff",
            "patient",
            "past medical diabetes",
            "hypertension",
            "currently taking insulin",
            "metformin",
            "lisinopril",
            "atorvastatin",
            "temperature",
            "blood pressure",
            "58 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "Physical exam reveals crackles",
            "pulmonary exam",
            "S4",
            "cardiac auscultation",
            "following",
            "next best step",
            "management"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5838,
            "completion_tokens": 7910
        },
        "time_elapsed": 55.67735004425049,
        "raw_responses": [
            "Step 1: Recognize that this elderly patient with confusion, a cough, fever, and lung auscultation findings is presenting with community\u2010acquired pneumonia (CAP) that is severe enough (given his confusion and age, among other factors) to warrant hospital admission.\n\nStep 2: Evaluate the antibiotic regimens from the answer choices. Although standard inpatient treatment for non\u2013intensive care pneumonia often involves combination therapy (a beta\u2010lactam plus a macrolide) or monotherapy with a respiratory fluoroquinolone, this patient\u2019s clinical scenario and status (confusion but with stable oxygen saturation and respiratory rate) indicate he should be admitted to the medical floor rather than critically managed in the ICU.\n\nStep 3: Compare answer choices:\n\u2003\u2022 Option B (azithromycin and discharge) is inappropriate given his altered mental status and severity.\n\u2003\u2022 Option C (azithromycin, moxifloxacin, and ICU admission) is overly aggressive as his stability does not mandate ICU level care.\n\u2003\u2022 Option D (moxifloxacin and admission to the medical floor) represents a reasonable monotherapy option for CAP with comorbidities; however, given that many guidelines favor either combination therapy or a well\u2010established regimen such as a beta\u2010lactam plus macrolide, the available option using azithromycin (as in Option A) aligns better with traditional management for such cases.\n  \nStep 4: Final Answer\nThe next best step in management is to start empiric antibiotics and admit the patient for inpatient management. Thus, the best answer is:\n\u2003A. Azithromycin and admission to the medical floor.",
            "Step 1: Recognize that the patient\u2019s presentation is most consistent with pneumonia. In this elderly patient, the elevated temperature, tachycardia, pulmonary crackles, and especially the acute confusion (which in older adults often points to an atypical presentation of infection) raise concern for community-acquired pneumonia requiring inpatient management.\n\nStep 2: Apply criteria for hospitalization. Using tools like the CURB-65 score (which considers Confusion and Age \u226565 among other factors), this patient already has two points, warranting admission. Additionally, his nursing home residence and comorbidities (diabetes, hypertension) further support hospital admission rather than outpatient management.\n\nStep 3: Evaluate antibiotic choices. For hospitalized patients with community-acquired pneumonia (not requiring ICU care), the guidelines recommend either a combination of a beta-lactam (e.g., ceftriaxone) plus a macrolide (e.g., azithromycin) OR monotherapy with a respiratory fluoroquinolone (e.g., moxifloxacin). In the answer choices provided, Option A (azithromycin and admission) would be acceptable if given as part of combination therapy with a beta-lactam, but on its face it represents monotherapy with azithromycin, which is usually reserved for milder outpatient infections. Option D (moxifloxacin and admission to the medical floor) represents a recommended regimen for hospitalized patients (outside of the ICU) using respiratory fluoroquinolone monotherapy.\n\nStep 4: Compare and eliminate incorrect choices. Option B (azithromycin and discharge) is not appropriate because this patient needs inpatient care. Option C (dual therapy with azithromycin and moxifloxacin with ICU admission) is too aggressive since the patient is not in respiratory failure or shock.\n\nFinal Answer: Option D \u2013 Moxifloxacin and admission to the medical floor is the next best step in management.",
            "Step 1. Recognize that this patient\u2019s presentation is consistent with pneumonia. He is an elderly patient (66 years old) from a nursing home who presents with cough, high fever (102\u00b0F), tachycardia (pulse 120/min), and altered mental status (confusion). On exam he has pulmonary crackles and a notable cardiac S4. These findings (especially in an older adult) raise concern for a serious pneumonia that requires inpatient management.\n\nStep 2. Decide on the appropriate level of care and antibiotic regimen. Inpatients with community-acquired pneumonia (CAP) who do not require intensive care unit (ICU) support are typically managed on the medical floor. The presence of confusion, advanced age, and nursing home origin all support hospital admission. Additionally, his vital signs (despite adequate oxygen saturation) and clinical picture indicate he is not a candidate for outpatient management. \n\nFor inpatient non-ICU CAP, the IDSA/ATS guidelines recommend either combination therapy with a beta-lactam (like ceftriaxone) plus a macrolide (such as azithromycin) or monotherapy with a respiratory fluoroquinolone (like moxifloxacin, levofloxacin, or gemifloxacin). The options given in the question include:\n\u2022 Option A: Azithromycin and admission (but azithromycin alone is acceptable only for mild, outpatient cases and is not consistent with the guidelines for inpatient management).\n\u2022 Option D: Moxifloxacin and admission to the floor, which is in line with recommended monotherapy for inpatient CAP in someone without contraindications.\n\u2022 Option C (with ICU-level admission) and Option B (discharge) are not appropriate choices for this presentation.\n\nStep 3. Final Answer\n\nBased on this analysis, the next best step is to admit the patient to the hospital (on the medical floor) and start him on monotherapy with a respiratory fluoroquinolone. \n\nFinal answer: D. Moxifloxacin and admission to the medical floor."
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "2"
        ],
        "final_solution": "Step 1. Recognize that this patient\u2019s presentation is consistent with pneumonia. He is an elderly patient (66 years old) from a nursing home who presents with cough, high fever (102\u00b0F), tachycardia (pulse 120/min), and altered mental status (confusion). On exam he has pulmonary crackles and a notable cardiac S4. These findings (especially in an older adult) raise concern for a serious pneumonia that requires inpatient management.\n\nStep 2. Decide on the appropriate level of care and antibiotic regimen. Inpatients with community-acquired pneumonia (CAP) who do not require intensive care unit (ICU) support are typically managed on the medical floor. The presence of confusion, advanced age, and nursing home origin all support hospital admission. Additionally, his vital signs (despite adequate oxygen saturation) and clinical picture indicate he is not a candidate for outpatient management. \n\nFor inpatient non-ICU CAP, the IDSA/ATS guidelines recommend either combination therapy with a beta-lactam (like ceftriaxone) plus a macrolide (such as azithromycin) or monotherapy with a respiratory fluoroquinolone (like moxifloxacin, levofloxacin, or gemifloxacin). The options given in the question include:\n\u2022 Option A: Azithromycin and admission (but azithromycin alone is acceptable only for mild, outpatient cases and is not consistent with the guidelines for inpatient management).\n\u2022 Option D: Moxifloxacin and admission to the floor, which is in line with recommended monotherapy for inpatient CAP in someone without contraindications.\n\u2022 Option C (with ICU-level admission) and Option B (discharge) are not appropriate choices for this presentation.\n\nStep 3. Final Answer\n\nBased on this analysis, the next best step is to admit the patient to the hospital (on the medical floor) and start him on monotherapy with a respiratory fluoroquinolone. \n\nFinal answer: D. Moxifloxacin and admission to the medical floor."
    }
]